<SUBMISSION>
<ACCESSION-NUMBER>0000898430-03-003115
<TYPE>DEF 14A
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20030618
<FILING-DATE>20030519
<EFFECTIVENESS-DATE>20030519
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>STAAR SURGICAL COMPANY
<CIK>0000718937
<ASSIGNED-SIC>3851
<IRS-NUMBER>953797439
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>0101
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>DEF 14A
<ACT>34
<FILE-NUMBER>000-11634
<FILM-NUMBER>03711152
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1911 WALKER AVE
<CITY>MONROVIA
<STATE>CA
<ZIP>91016
<PHONE>8183037902
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1911 WALKER AVE
<CITY>MONROVIA
<STATE>CA
<ZIP>91016
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SCHEDULE 14A INFORMATION </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Proxy Statement Pursuant to Section 14(a) of the Securities </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Exchange Act of 1934 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Filed by the
Registrant&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#120;</FONT> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Filed by a Party other than the Registrant&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Check the appropriate box:
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;Preliminary Proxy Statement </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;Confidential, for Use of the Commission Only </FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(as&nbsp;permitted by Rule 14a-6(a)(2)) </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><FONT FACE="WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Definitive Proxy Statement </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;Definitive Additional Materials </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;Soliciting Material Under &#167; 240.14a-12. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="5" COLOR="#000000"><B>STAAR Surgical Company </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(Name of Registrant as Specified in its
Charter) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(Name of Person(s) Filing Proxy
Statement, if other than the Registrant) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Payment of Filing Fee (Check the appropriate box): </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><FONT FACE="WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No fee required. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Total fee paid: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Fee paid previously with preliminary materials. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Amount Previously Paid: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Filing Party: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Date Filed: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>

<IMG SRC="g52875g74h80.jpg" ALT="LOGO"> </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>1911 Walker Avenue </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Monrovia, California 91016
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">May 19, 2003 </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To Our Stockholders: </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">You are cordially invited to attend the annual meeting of the
stockholders (the &#147;Annual Meeting&#148;) of STAAR Surgical Company (the &#147;Company&#148;). The Annual Meeting will be held on Wednesday, June 18, 2003 at 10:00 a.m. (California time) at the Holiday Inn, located at 924 West Huntington Drive,
Monrovia, California 91016. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The actions we
expect to take at the Annual Meeting are described in detail in the attached Proxy Statement and Notice of Annual Meeting of Stockholders. Also included with this letter is the Company&#146;s Annual Report. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Please use this opportunity to take part in the affairs of the
Company by voting on the business to come before the Annual Meeting. If you are a record holder of the Company&#146;s Common Stock on May 19, 2003, you are eligible to vote with respect to these matters, either personally at the Annual Meeting or by
proxy. It is important that your shares be voted, whether or not you plan to attend the Annual Meeting, to ensure the presence of a quorum. <B>Therefore, please complete, sign, date and return the accompanying proxy in the enclosed postage-paid
envelope.</B> Returning the proxy does NOT deprive you of your right to attend the Annual Meeting and vote your shares in person for the matters acted on at the Annual Meeting. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">We look forward to seeing you at the Annual Meeting. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Sincerely, </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g52875g67_08.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David Bailey </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">President and Chairman of the Board </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>

<IMG SRC="g52875g74h80.jpg" ALT="LOGO"> </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>1911 Walker Avenue </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Monrovia, California 91016
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Notice of Annual Meeting of Stockholders </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR
WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To Our Stockholders:
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The annual meeting of the stockholders of STAAR
Surgical Company (the &#147;Annual Meeting&#148;) will be held on Wednesday, June 18, 2003, at 10:00 a.m. (California time), at the Holiday Inn, located at 924 West Huntington Drive, Monrovia, California 91016 for the following purposes:
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To elect two Class II directors to three-year terms. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To approve the adoption of the STAAR Surgical Company 2003 Omnibus Equity Incentive Plan. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To transact such other business as may properly come before the Annual Meeting or any continuation, adjournment or postponement of the Annual Meeting.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Stockholders of record at the
close of business on May 19, 2003 (&#147;Stockholders&#148;) will be entitled to notice of and to vote at the Annual Meeting and at any continuation, adjournment or postponement thereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All Stockholders are cordially invited to attend the Annual Meeting in person. Your vote is important.
<B>Please fill in, date, sign and return the enclosed proxy in the return envelope as promptly as possible, whether or not you plan to attend the Annual Meeting.</B> Your promptness in returning the proxy will assist in the expeditious and orderly
processing of the proxies and will assist in ensuring that a quorum is present or represented. If you return your proxy, you may nevertheless attend the Annual Meeting and vote your shares in person if you wish. If you want to revoke your proxy at a
later time for any reason, you may do so in the manner described in the attached Proxy Statement. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By Order of the Board of Directors, </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g52875g38x13.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Bily </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Secretary </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Monrovia, California </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">May 19, 2003 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR
SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>1911 Walker Avenue </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Monrovia, California 91016 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>PROXY STATEMENT </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>To Be Held June 18, 2003 </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>VOTING AND PROXY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors of STAAR Surgical Company, a Delaware corporation (referred to as the &#147;Company,&#148;
&#147;we,&#148; &#147;our&#148; or &#147;us&#148;) for use at our annual meeting of stockholders (the &#147;Annual Meeting&#148;) to be held at the Holiday Inn, located at 924 West Huntington Drive, Monrovia, California 91016 on Wednesday, June 18,
2003, at 10:00 a.m. (California time), and at any continuation, adjournment or postponement of the Annual Meeting. The Notice of Annual Meeting, this Proxy Statement and the accompanying proxy card (the &#147;Proxy&#148;) are being mailed to
Stockholders on or about May 19, 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Revocability of Proxy
and Voting of Shares </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Any stockholder giving
a proxy has the power to revoke it at any time before it is exercised. The proxy may be revoked by filing an instrument of revocation or a duly executed proxy bearing a later date with the Company&#146;s Secretary at our principal executive offices
located at 1911 Walker Avenue, Monrovia, California 91016. The proxy may also be revoked by attending the Annual Meeting and voting in person. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If a proxy is properly signed, dated and returned and is not revoked, the proxy will be voted at the Annual Meeting in accordance with the
Stockholder&#146;s instructions indicated on the proxy card. <B>If no instructions are indicated on the Proxy, the Proxy will be voted &#147;FOR&#148; the election of the Board of Directors&#146; nominees and &#147;FOR&#148; the approval of the
STAAR Surgical Company 2003 Omnibus Equity Incentive Plan, and in accordance with the recommendations of the Board of Directors as to any other matter that may properly be brought before the Annual Meeting or any continuations, adjournments or
postponements of the Annual Meeting. </B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David
Bailey and John Bily, the designated proxyholders (the &#147;Proxyholders&#148;), are members of the Company&#146;s management. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Record Date, Voting Rights and Outstanding Shares </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors has fixed May 19, 2003 as the record date (the &#147;Record Date&#148;) for determining holders of our common
stock, $.01 par value per share (&#147;Common Stock&#148;), who are entitled to vote at the Annual Meeting and any continuation, adjournment or postponement of the Annual Meeting. As of the Record Date, we had 17,101,487 shares of Common Stock
outstanding and entitled to vote. Each share of Common Stock entitles the record holder at the close of business on the Record Date (the &#147;Stockholder&#148;) to one vote on each matter to be voted on at the Annual Meeting. A majority of the
shares of Common Stock issued and outstanding and entitled to vote at the Annual Meeting, either present in person or represented by proxy, will constitute a quorum at the Annual Meeting. Votes withheld, abstentions and broker non-votes shall be
counted for purposes of determining the presence or absence of a quorum for the transaction of business at the Annual Meeting. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Directors are
elected by a plurality of the votes cast in the election. <B>Our Certificate of Incorporation and our Bylaws divide our Board of Directors into three classes, namely, Class I, Class II and Class III, with each class to be elected for a three-year
term on a staggered basis. Proxies cannot be voted for a greater number of persons than the number of nominees named.</B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">For the purpose of determining whether the Stockholders have approved matters other than the election of directors, abstentions are
treated as shares present or represented and voting, so abstaining has the same effect as a negative vote. Shares held by brokers who do not have discretionary authority to vote on a particular matter and who have not received voting instructions
from their customers (&#147;broker non-votes&#148;) are not counted or deemed to be present or represented for the purpose of determining whether Stockholders have approved that matter, but they are counted as present for the purpose of determining
the existence of a quorum at the Annual Meeting. Accordingly, broker non-votes have the effect of reducing the number of affirmative votes required to achieve the majority vote. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under our Bylaws, nominations for the Board of Directors made by Stockholders must be made by written notice
delivered or mailed by first class United States mail, postage prepaid, to the Secretary of the Company not less than 14 days nor more than 50 days prior to the Annual Meeting, provided that if less than 20 days&#146; notice of the meeting is given
to Stockholders, the written notice shall be delivered or mailed, as prescribed, to the secretary of the Company not later than the close of the seventh day following the day on which notice of the Annual Meeting was mailed to Stockholders. Each
such written notice must set forth (i) the name, age, business address and, if known, residence address of each nominee proposed in such notice, (ii) the principal occupation or employment or each such nominee, and (iii) the number of shares of
stock of the Company that are beneficially owned by each such nominee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Solicitation </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The cost of
solicitation of proxies, including expenses in connection with preparing and mailing this Proxy Statement, will be borne by the Company. Copies of solicitation materials will be furnished to brokerage houses, nominees, fiduciaries and custodians to
forward to beneficial owners of Common Stock held in their names. We will reimburse brokerage firms and other persons representing beneficial owners of stock for their reasonable expenses in forwarding solicitation materials to the owners. The cost
of soliciting proxies for the Annual Meeting is estimated at $38,000. In addition to this original solicitation of proxies by mail, our directors, officers and other employees may, without additional compensation, solicit proxies by telephone,
facsimile and personal interviews. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Transaction of Other
Business </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Recently, the SEC amended its rule
governing a company&#146;s ability to use discretionary proxy authority with respect to voting on stockholder proposals that have not been submitted by the stockholder in time to be included in the Proxy Statement. As a result of that rule change,
if a stockholder proposal is not submitted to the Company on or before March 26, 2003, the Proxies solicited by the Board of Directors for the Annual Meeting will confer on the holders of the Proxy the authority to vote the shares in accordance with
their best judgment and discretion if the proposal is presented at the Annual Meeting without any discussion of the proposal in the Proxy Statement for such meeting. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As of the day this Proxy Statement goes to press, management knows of no business that will be presented for
consideration at the Annual Meeting other than as stated in the Notice of Meeting. If, however, other matters are properly brought before the Annual Meeting, including, among other things, consideration of a motion to adjourn the Annual Meeting to
another time or place in order to solicit additional proxies in favor of the recommendations of the Board of Directors, the Proxyholders intend to vote the shares represented by the Proxies on such matters in accordance with the recommendation of
the Board of Directors, and the authority to do so is included in the Proxy. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>PROPOSAL NO.
1 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ELECTION OF DIRECTORS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Two Class II directors are to be elected to our Board of
Directors at the Annual Meeting. These directors will hold office for a three-year term. The Board of Directors has nominated Mr. Donald Duffy and Dr.&nbsp;Volker&nbsp;D. Anhaeusser. We expect that these nominees will be available for election, but
if either of them is not a candidate at the time the election occurs, it is intended that your Proxy will be voted for the election of another nominee to be designated by the Board of Directors to fill any such vacancy. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No Proxies are sought with respect to the election of the
presently serving Class III directors (Mr.&nbsp;John&nbsp;Gilbert and Mr. David Morrison) or the Class I director (Mr. David Bailey), as the terms of these directors do not expire until the annual meetings of stockholders to be held in 2004 and
2005, respectively. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT
YOU VOTE &#147;FOR&#148; THE ELECTION OF MR.&nbsp;DONALD DUFFY AND DR. VOLKER D. ANHAEUSSER AS THE CLASS II DIRECTORS. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>OWNERS AND MANAGEMENT </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following table sets forth each beneficial owner (other than directors and named executive officers) of
more than 5% of our Common Stock<B>. </B>This information is based on publicly available information filed with the Securities and Exchange Commission as of the Record Date. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="59%" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name and Address of Beneficial Owners</B></FONT></P><HR WIDTH="230" SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number&nbsp;of&nbsp;Shares and Nature of Beneficial&nbsp;Ownership</B></FONT></P><HR SIZE="1"
NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Percent of Outstanding Common&nbsp;Stock</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="59%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wellington Management Company, LLP</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75 State Street</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Boston, Massachusetts 02109</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,450,000</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.42</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="59%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Dimensional Fund Advisors Inc.</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1299 Ocean Avenue, 11th Floor</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Santa Monica, CA 90401</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,021,950</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.93</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="59%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Federated Investors, Inc.</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Federated Investors Tower</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">5800 Corporate Drive</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Pittsburgh, PA 15222</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,007,400</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.9</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD></TR>
</TABLE><HR WIDTH="28%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Shares are as of December 31, 2002 and include 1,090,000 shares with respect to which there is shared power to vote and 1,450,000 shares with respect to which there
is shared power of disposition. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Shares are as of December 31, 2002 and consist of 1,021,950 shares with respect to which the holder has sole voting and dispositive power . </FONT></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Shares are as of December 31, 2002 and consist of 1,007,400 shares with respect to which the holder has sole voting and dispositive power.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following table sets forth, as
of the Record Date, information with respect to the shares of Common Stock beneficially owned by (i) each director and director nominee; (ii) each person who is an executive officer named in the Summary Compensation Table below; and (iii) all
executive officers and directors as a group. The term &#147;executive officer&#148; is defined as the President, Chief Financial Officer, any vice-president in charge of a principal business function (such as administration or finance), or any other
person who performs similar policy making functions for the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Shares Beneficially Owned</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" WIDTH="42%" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Beneficial Owner(1)</B></FONT></P><HR WIDTH="111" SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Shares of Common&nbsp;Stock Owned(2)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Shares&nbsp;Subject to Options Exercisable On or Before
July&nbsp;18,&nbsp;2003(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Total</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Percent&nbsp;of Class(4)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David Bailey</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">50,754</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">840,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">890,754</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Bily</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33,333</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33,333</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Santos</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">103,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">108,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Helene Lamielle</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Nicholas Curtis</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">28,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Guenther Roepstorff</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Volker Anhaeusser</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14,425</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">90,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">104,425</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John R. Gilbert</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">60,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">60,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David Morrison</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">80,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">80,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Donald Duffy</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="42%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All current directors and executive officers<BR>as a group</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,179</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,256,333</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="13%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,329,512</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.8</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="3" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="3" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="3" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE><HR WIDTH="28%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Less than 1%. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The business address of each person named is c/o STAAR Surgical Company, 1911 Walker Avenue, Monrovia, California 91016. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Pursuant to Rule 13d-3(a), includes all shares of common stock over which the listed person has, directly or indirectly, through any contract, arrangement,
understanding, relationship, or otherwise, voting power, which includes the power to vote, or to direct the voting of, the shares, or investment power, which includes the power to dispose, or to direct the disposition of, the shares. The Company
believes that each individual or entity named has sole investment and voting power with respect to shares of Common Stock indicated as beneficially owned by them, subject to community property laws, where applicable, except where otherwise noted.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Calculated pursuant to Rule 13d-3(d)(1) of the Securities Exchange Act of 1934. Under Rule 13d-3(d)(1), shares not outstanding that are subject to options, warrants,
rights or conversion privileges exercisable on or before July 18, 2003 (60 days after the record date) are deemed outstanding for the purpose of calculating the number and percentage owned by any person, but not deemed outstanding for the purpose of
calculating the percentage owned by each other person listed. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Based on 17,101,487 shares of Common Stock outstanding on the transfer records as of the Record Date. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>IDENTIFICATION OF THE BOARD OF DIRECTORS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Our Certificate of Incorporation and our Bylaws divide our
Board of Directors into three classes, designated Class I, Class II and Class III, with the number of directors in each class to be as nearly equal as possible, and with each class to be elected for a three-year term on a staggered basis. Our Bylaws
permit the Board of Directors to fix the number of its members so long as there are no less than three directors and no more than seven directors. At present, the Board of Directors consists of five members. One member serves as a Class I director,
two members serve as Class II directors, and two members serve as Class III directors. Mr. David Bailey presently serves as our Class I director, and is subject to re-election at the Annual Meeting to be held in the year 2005. Mr. Donald Duffy and
Dr. Volker D. Anhaeusser presently serve as our Class II directors, and are subject to re-election at this Annual Meeting. Messrs. John R. Gilbert and David Morrison serve as our Class III directors, and are subject to re-election at the Annual
Meeting to be held in the year 2004. Information regarding the business experience of each nominee and director is provided below. There are no family relationships among our executive officers and directors. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>David Bailey, Class I Director </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Director since December 2000 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Chairman of the Board of Directors since January 11, 2001 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">President and Chief Executive Officer
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 46 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Bailey has served as our President, Chief Executive Officer and Chairman since 2001, and as a director since 2000. Prior to joining,
Mr. Bailey served as Global President of CIBA Vision Corporation&#146;s surgical business unit based in Atlanta, Georgia. As a member of that company&#146;s senior executive committee, Mr. Bailey was involved in the management of a business with
revenue in excess of $1 billion and employing over six&nbsp;thousand people. From April 1995 through May 1999, Mr. Bailey served on the global management boards of both Bausch &amp; Lomb and ChironVision. In 1993, Mr. Bailey was the European
Managing Director of Johnson &amp; Johnson&#146;s European professional sector, with operating responsibility for Iolab Corporation, an ophthalmic products company that was a subsidiary of Johnson &amp; Johnson at that time. Mr. Bailey completed his
formal education in the United Kingdom, obtaining a Master&#146;s degree from Durham University, and a Bachelor of Arts degree with honors from York University. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Mr. Donald Duffy, Class II Director Nominee </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Director since February 2003 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Chairman of Audit Committee </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 66 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Duffy&#146;s relevant previous experiences include the position of Chief Financial Officer of the Iolab
Corporation subsidiary of Johnson &amp; Johnson from 1987 to 1992, J &amp; J Ultrasound division of Johnson &amp; Johnson from 1986 to 1987 and Alpha Wire Corporation from 1984 to 1985. Prior to his position as Chief Financial Officer, he was the
Chief Information Services Officer for J &amp; J Products Division of Johnson &amp; Johnson from 1976 to 1984 and held various financial positions for Johnson &amp; Johnson from 1962 to 1976. Mr.&nbsp;Duffy earned an MBA in management from Pace
University in 1972 and a BS in Accounting from the University of South Dakota in 1958. Mr. Duffy was appointed on January 29, 2003 to fill the vacancy created by the resignation of Dr. Peter Utrata. Mr. Duffy serves as chairman of the Company&#146;s
audit committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Dr. Volker D. Anhaeusser, Class II Director
Nominee </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Director since April 2000 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 47 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Dr. Anhaeusser is a resident of Karlsruhe, Germany. He is a principal member and shareholder of the German law firm of Anhaeusser, Unger, &amp; Bergien, whose specialty is corporate and business law. </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Dr.&nbsp;Anhaeusser received his Masters in Law degree in 1979 from Mainz University. Dr. Anhaeusser serves on the Board of Directors of
several German based corporations, as well as serving on the Board of Directors of our subsidiary, Canon-STAAR Company, Inc. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>John R. Gilbert, Class III Director </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Director since February 2001 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 66 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Gilbert&#146;s senior executive experience includes a 12-year career with Iolab Corporation, an
ophthalmic products company that was then a subsidiary of Johnson &amp; Johnson, and 18 years with Ethicon, Inc., a surgical device and surgical products subsidiary of Johnson &amp; Johnson. At Iolab, Mr. Gilbert was promoted from Vice President,
Marketing to President and, in 1987, to Vice Chairman. While at Iolab Mr. Gilbert was responsible for that company&#146;s franchise worldwide, while also serving as Vice President of Johnson &amp; Johnson International. At Ethicon, Mr. Gilbert began
as a sales representative and held a series of increasingly responsible positions, becoming Vice President, Sales and a member of the Management Board in 1976. He has had significant sales and general management experience in the areas of
intraocular lenses, viscoelastic materials and other ophthalmic products. Mr. Gilbert is presently a Director of Rita Medical, a developer and marketer of a proprietary radio-frequency system for the treatment of cancerous and benign tumors. Mr.
Gilbert is a veteran of the U.S. Army and a graduate of Texas A&amp;M University with a Bachelor of Science degree in Industrial Technology. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>David Morrison, Class III Director </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Director since May 2001 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 58 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Morrison has 35 years experience in various executive positions, both within the United States and
internationally. Since 1998, Mr. Morrison has been providing consulting services relating to marketing, with an emphasis in the field of surgical ophthalmology. Following the acquisition by Chiron Vision of Iolab in March 1995, Mr. Morrison was
appointed President and Chief Operating Officer of the combined businesses, which were based in Claremont, California. Mr. Morrison began his career with Chiron Vision as President of International Operations in October 1994. Prior to joining Chiron
Vision, Mr. Morrison was employed by the Gillette Company as Area Vice President for Europe. In 1981, Mr. Morrison joined Cooper Vision as its Area Vice President for Europe, Africa and the Middle East. When Mr. Morrison decided to end his career
with Cooper Vision in 1989, he was President of International Operations and Co-Chief Operating Officer. Mr.&nbsp;Morrison began his career at Warner Lambert/Parke Davis in 1970, eventually attaining a senior marketing position. Mr. Morrison holds
an Honors Degree in Economics and is a post-graduate in Business Administration. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>COMPENSATION OF DIRECTORS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">No cash fees were paid to directors for their service on the Board of Directors during the year 2002. Directors standing for election are granted options to purchase 60,000 shares of our Common Stock
on their election or re-election. Directors are elected for three-year terms. The option exercise price is the closing price of the Common Stock on the date of grant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On his re-election to the Board of Directors on May 30, 2002, Mr. Bailey received options to purchase 60,000
shares of our Common Stock at an exercise price of $5.19. These options vest in three equal amounts of 20,000 shares during each year of service with the first vesting on the date of grant. On January 2, 2002, Dr.&nbsp;Anhaeusser received options to
purchase 45,000 shares of our Common Stock at a price of $3.81 for service as a director of Canon-STAAR Company Inc., a 50% joint venture of the Company with Canon Inc. and Canon Sales Co. Inc. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors can change the compensation of
directors at any time. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">During fiscal year 2002, Dr. Volker Anhaeusser, Mr. John Gilbert and Mr. David Morrison served on our Compensation Committee. None of these individuals is employed by the Company. Except for Mr. Morrison, none of these individuals
was a party to any transactions with the Company during fiscal year 2002. Mr.&nbsp;Morrison is the sole owner of DRM Strategic Services Ltd., which received consulting fees of $73,000&nbsp;during fiscal year 2002 under a Consulting Agreement with
the Company. See &#147;Certain Relationships and Related Transactions&#151;Consulting Agreement.&#148; </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Compensation issues were also brought before the full Board of Directors, which included Mr. David Bailey and Dr. Peter Utrata.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>IDENTIFICATION OF EXECUTIVE OFFICERS
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>David Bailey, President and Chief Executive Officer
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">See discussion of business experience above. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>John Bily, Chief Financial Officer </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 55 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Mr. Bily joined the Company in January 2002. Before joining the Company, Mr. Bily spent 11 years with Allergan, Inc., an international pharmaceutical company, most recently as Vice President Controller Worldwide Operations, where he
was responsible for the financial management of Allergan, Inc.&#146;s global manufacturing and operations organization. Mr. Bily joined Allergan, Inc. in 1989 as Vice President Controller of Allergan Optical, the global contact lens and contact lens
care division. Mr. Bily earned his Masters in Business Administration in Finance/Accounting from Arizona State University and his Bachelor of Arts degree in History from the University of Dallas. Mr. Bily also served in the United States Air Force.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>John Santos, Senior Vice President, Planning and Corporate
Development </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 47 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Santos has served as our Senior Vice President, Planning and Corporate Development since January 2001. Mr. Santos served as our Chief
Financial Officer from May 2000 until December 2001, as Vice President-Controller from April 1999 and as Controller from October 1992. Prior to 1992, Mr. Santos was Corporate Controller of Calmar, Inc. (now Calmar-St. Gobain), a manufacturer of
trigger and fine mist sprayers, spray dispensers and pharmaceutical spray devices. He held various management positions at Calmar, Inc. from 1984 to 1992. Mr. Santos received a Masters of Business Administration from Pepperdine University and a
Bachelor of Arts degree in Business Administration with an emphasis in Accounting from California State University, Fullerton. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Helene Lamielle, Vice President, Scientific Affairs </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 45 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Dr. Lamielle, who joined us in January 2002, is an experienced medical and surgical ophthalmologist with 11 years of ophthalmic industry experience in pharmaceuticals and medical devices and across major subspecialties such as
retina, cataract and refractive surgery. Before joining us, Dr. Lamielle was Vice President of Scientific Affairs, Implantable Products at Bausch &amp; Lomb Surgical, the ophthalmic surgery product unit of the global eye care firm. Her
responsibilities included management of research and development for surgical products for cataract and refractive indications and management of Clinical and Regulatory Affairs for all surgical products. Dr. Lamielle earned her medical degree from
the University of Lyon, France. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Nicholas Curtis, Senior
Vice President, Sales &amp; Marketing </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 47 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Curtis, who joined us in August 2002, is an experienced sales and marketing professional with over
20&nbsp;years experience in selling and marketing cataract and refractive surgical products. Prior to joining the Company, Mr. Curtis served as Vice President for TLC Vision Inc. from 1998 to 2002, where he was responsible for managing the
company&#146;s business development in the Great Lakes Region. Prior to 1998, Mr. Curtis held various sales management positions with Chiron Vision, Allergan Medical Optics, and American Medical Optics, a division of American Hospital Supply Corp.
Mr. Curtis received a Bachelor of Science degree in Speech-Communication Studies from Northwestern University. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Guenther Roepstorff, President, Domilens GmbH </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Age 58 </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Roepstorff is the President and founder of Domilens, GmbH,
our German subsidiary, a position he has held since 1987. From 1983 to 1987, Mr. Roepstorff was managing director of Intermedics, where he was responsible for ophthalmic and cardiovascular products for the domestic German and the European markets.
From 1979 to 1983, he established the Iolab Corporation intraocular lens business in Germany, Austria and Switzerland as an independent company within the Johnson &amp; Johnson group of companies. For more than 10&nbsp;years he held various
management positions at Johnson &amp; Johnson within the general surgery and dental product divisions. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SUMMARY COMPENSATION </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following table shows the compensation paid over the past three fiscal years with respect to: (i) the
Company&#146;s Chief Executive Officer during the 2002 fiscal year and (ii) the four other most highly compensated executive officers (in terms of salary and bonus) serving at the end of the 2002 fiscal year whose annual salary and bonus exceeded
$100,000 (the &#147;named executive officers&#148;): </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Year</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="8" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Long-Term Compensation</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="8" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Annual Compensation</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Awards</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Payouts</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="bottom" WIDTH="19%" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name and</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Principal Position</B></FONT></P><HR WIDTH="86" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Salary ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Bonus ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Other Annual Compensation ($)(1)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Restricted Stock Awards ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Securities Underlying Options/SARs (2)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>LTIP Payouts ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>All Other Compensation ($)(3)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="19%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David Bailey Chairman, CEO and President</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">359,450</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">300,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">110,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">8,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">210,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">150,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">500,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="7%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">29,039</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">164,446</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="19%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Bily</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">192,308</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">100,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="7%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16,534</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="19%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Santos</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Senior Vice President, Planning and Corporate Development</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">159,471</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">155,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">142,308</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10,984</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">60,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="7%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7,572</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">10,937</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10,691</FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="19%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Helene Lamielle</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Vice President, Scientific Affairs</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">180,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="7%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6,325</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="19%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Nicholas Curtis Senior Vice President, Sales and Marketing</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">61,538</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="7%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,390</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="19%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Guenther Roepstorff President, Domilens GmbH</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">216,898</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">256,910</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">249,669</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">87,000</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">43,389</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25,471</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14,362</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">859,534</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">22,131</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">50,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="7%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">33,564</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">32,618</FONT></P></TD></TR>
</TABLE><HR WIDTH="28%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Included in this column are the costs of an automobile allowance for Mr. Bailey and Mr. Roepstorff, and for Mr. Santos taxes paid by the Company related to a bonus
received in 2000. Also included for Mr. Roepstorff in 2001 are $180,000 in consulting fees and $658,000 for the early termination of the consulting arrangement, paid at a discount. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No stock appreciation rights were granted in 2002, 2001 or 2000. The options issued to Mr. Roepstorff in 2000 were cancelled in 2002 in connection with a purchase
agreement between Mr. Roepstorff and the Company to acquire his remaining interest in our German subsidiary, Domilens, GmbH. This transaction is further described in &#147;Certain Relationships and Related Transactions&#151;Purchase Agreement.&#148;
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The amounts reported in this column, for all officers other than Mr. Bailey and Mr. Roepstorff, consist solely of the cost of life insurance premiums. Mr.
Bailey&#146;s &#147;All Other Compensation&#148; includes the cost of life and disability insurance premiums, in addition to relocation related expenses of $135,771 paid in 2001. Mr. Roepstorff&#146;s &#147;All Other Compensation&#148; also includes
the cost of pension plan contributions. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>OPTION/SAR
GRANTS IN LAST FISCAL YEAR </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following
table provides certain information with respect to individual grants of stock options and/or stock appreciation rights in the 2002 fiscal year to each of the named executive officers: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number of Securities Underlying Options/SARs Granted (2)(5) (#)</B></FONT></P><HR
SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>% of Total Options/SARs Granted to Employees in Fiscal Year (3)(4)</B></FONT></P><HR
SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Exercise or Base Price ($/Sh)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Expiration Date</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Potential Realizable Value at Assumed Annual Rates of Stock Price Appreciation for
Option Term (1)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="bottom" WIDTH="35%" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name</B></FONT></P><HR WIDTH="30" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>5% ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>10% ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="35%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David Bailey</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">150,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">21</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.81</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/2/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">359,413</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">910,824</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">60,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.19</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5/29/2007</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">86,034</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">190,113</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="35%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Bily</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">100,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.29</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12/11/2006</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">90,897</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">200,858</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="35%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Santos</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="35%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Helene Lamielle</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.62</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/14/2007</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">95,732</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">211,542</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="35%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Nicholas Curtis</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.45</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7/14/2007</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">71,488</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">157,969</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="35%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Guenther Roepstorff</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="9%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;&nbsp;&nbsp;</FONT></P></TD></TR>
</TABLE><HR WIDTH="28%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The potential realizable dollar value of any given option is the difference between (i) the fair market value of the stock underlying such option as of the date of
grant, adjusted to reflect hypothetical 5% and 10% annual growth rates simple interest from the date of grant of such option until the expiration date of such option, and (ii) the exercise price for such option. The 5% and 10% are hypothetical
growth rates prescribed by the SEC for illustration purposes only and are not a forecast or prediction as to future stock prices. The actual amount that a named executive officer may realize will depend on various factors on the date the option is
exercised, so there is no assurance that the value realized by a named executive officer will be at or near the value set forth above in the chart. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All options were granted at fair market value on the date of grant, and vest in three equal amounts at the end of each year of service following the date of grant,
except for David Bailey&#146;s options, which vest in three equal amounts with the first vesting on the date of grant </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No SARs were granted to the named executive officers in the 2002 fiscal year. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The numerator in calculating this percentage includes options granted to each named executive officer in his or her capacity both as an officer (employee) and, if
applicable, as a director. The denominator in calculating this percentage is 724,155, which represents options granted to all of the employees of the Company, including the named executive officers, which includes, if applicable, grants of options
attributable to them in their capacities as directors. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(5)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Options to purchase the following numbers of shares have been granted to the named executive officers during fiscal year 2003, as of the Record Date: David Bailey,
140,000, John Bily, 50,000, Helene Lamielle, 50,000, and Nicholas Curtis, 60,000. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>AGGREGATED
OPTIONS/SAR EXERCISES IN LAST FISCAL YEAR AND </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>FISCAL YEAR-END OPTION/SAR VALUES </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following table provides certain information with respect
to the named executive officers concerning: (i) options exercised in fiscal year 2002; and (ii) the number and value of unexercised options as of the 2002 fiscal year end: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="41%" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name</B></FONT></P><HR WIDTH="30" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Shares Acquired On&nbsp;Exercise (1) (#)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>

<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Value Realized (2) ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number&nbsp;of&nbsp;Securities Underlying&nbsp;Unexercised Options/SARs At FY-End (#)
Exercisable/ Unexercisable</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Value&nbsp;of&nbsp;Unexercised</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>In-The-Money Options/SARs at FY-End (3) ($) Exercisable/ Unexercisable</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">David Bailey</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="20%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">820,000/40,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="18%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">186,000/0</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Bily</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="20%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33,333/66,667</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="18%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">21,666/43,334</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Santos</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="20%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">82,999/20,001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="18%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0/0</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Helene Lamielle</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="20%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25,000/50,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="18%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16,250/32,500</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Nicholas Curtis</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="20%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0/75,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="18%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0/48,750</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Guenther Roepstorff</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#151;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="20%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0/0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="18%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0/0</FONT></P></TD></TR>
</TABLE><HR WIDTH="28%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No SARs were granted or exercised by any named executive officer in 2002, nor did any named executive officer hold any unexercised SARs at the end of the 2002 fiscal
year. No options were exercised by any named executive officer in 2002. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The dollar values are calculated by determining the difference between the fair market value of the securities underlying the options and the price of the options at
exercise. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The dollar value provided represents the cumulative difference in the fair market value of the Common Stock underlying all in-the-money options as of the last day of
the 2002 fiscal year and the exercise prices for such options. Options are &#147;in-the-money&#148; if the fair market value of the underlying Common Stock as of the last day of the 2002 fiscal year exceeds the exercise price of such options. The
fair market value of the Common Stock for purposes of this calculation is $4.20, based on the closing price for the Company&#146;s stock as quoted on the Nasdaq National Market on January 3, 2003, the last day of the Company&#146;s 2002 fiscal year.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>EQUITY
COMPENSATION PLAN INFORMATION </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(c)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" WIDTH="41%" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Plan Category</B></FONT></P><HR WIDTH="80" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number&nbsp;of&nbsp;Securities to</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>be&nbsp;Issued&nbsp;Upon&nbsp;Exercise</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>of
Outstanding Options,</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Warrants and Rights</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Weighted&nbsp;Average</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Exercise Price</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number&nbsp;of&nbsp;Securities Remaining&nbsp;Available&nbsp;for</B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Future Issuance under</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><B>Equity Compensation</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Plans (excluding</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>securities reflected in</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>column
(a))</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Plans Approved by Stockholders</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,423,165</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.52</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">407,739</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Plans Not Approved by Stockholders</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">715,150</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.64</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">434,329</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD><HR WIDTH="0" SIZE="1" NOSHADE ALIGN="left" COLOR="#ffffff"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD><HR WIDTH="0" SIZE="1" NOSHADE ALIGN="left" COLOR="#ffffff"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="41%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Total Securities</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3,138,315</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.86</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">842,068</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="3" NOSHADE COLOR="#000000"></TD>
<TD><HR WIDTH="0" SIZE="3" NOSHADE ALIGN="left" COLOR="#ffffff"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="3" NOSHADE COLOR="#000000"></TD>
<TD><HR WIDTH="0" SIZE="3" NOSHADE ALIGN="left" COLOR="#ffffff"></TD></TR>
</TABLE><HR WIDTH="28%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Represents awards granted under the 1991 Stock Option Plan of STAAR Surgical Company, the 1998 STAAR Surgical Company Stock Plan (the &#147;1998 Plan&#148;) and the
STAAR Surgical Company Stock Option Plan and Agreement for Chief Executive Officer. Securities remaining available for issuance are pursuant to the 1998 Plan only. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the terms of the 1995 STAAR Surgical Company Consultant Plan and the 1996 STAAR Surgical Company Non-Qualified Stock Plan, the maximum number of shares that
may be issued or granted under the plan shall be increased by (i) the number of shares or stock rights tendered by a recipient as payment of option shares or awarded shares; (ii) the number of shares subject to an option that is terminated
unexercised or expires; and (iii) the number of restricted shares granted that are subsequently forfeited by the holders thereof. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>EMPLOYMENT
AGREEMENTS WITH NAMED EXECUTIVE OFFICERS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>David Bailey,
President, Chief Executive Officer and Chairman of the Board of Directors </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">On December 19, 2000, we entered into an employment agreement with Mr. David Bailey to act as our Chief Executive Officer and President. The agreement is for a term of three years and will be
automatically renewed for successive three-year periods unless terminated pursuant to provisions stated in the agreement. In order to encourage Mr. Bailey to join the Company, he was granted an option to purchase 500,000 shares of our Common Stock
at an exercise price of $11.25 per share, the fair market value on the date of the agreement. The right to exercise the options vested in three installments over a period of two years beginning with the effective date of the agreement. In addition,
we paid a bonus of $110,000 in fiscal year 2001 representing the bonus forfeited by Mr. Bailey due to the termination of his prior employment and relocation costs. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The agreement provides for a base salary of $300,000 in the first year, increasing to $350,000 during the
remaining of the term of the agreement. The agreement also provides for adjustments to Mr. Bailey&#146;s annual salary based on increases in the cost of living during the previous twelve months. Additionally, Mr. Bailey is entitled to an automobile
allowance. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Each year during the term of the
employment agreement, Mr. Bailey and the Compensation Committee will establish performance goals, including earnings, cash flow and other objectives, and so long as he meets those goals, Mr. Bailey is to receive an annual bonus of up to 60% of his
base annual salary. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the terms of the
agreement, Mr. Bailey&#146;s employment may be terminated for cause (as defined in the agreement), on Mr. Bailey&#146;s death or disability, or on 12 months written notice by Mr. Bailey. If Mr. Bailey&#146;s employment is terminated by election of
the Company or due to a change of control (as defined in the agreement), Mr. Bailey will be entitled to receive severance equal to three years annual base salary, plus accrued bonus and vacation, and immediate vesting of any unvested options.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>John Bily, Chief Financial Officer </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On January 3, 2002, we entered into an employment agreement
with Mr. John Bily to act as our Chief Financial Officer. The agreement does not have a stated term. In order to encourage Mr. Bily to join the Company, he was granted an option to purchase 100,000 shares of our Common Stock at an exercise price of
$3.29 per share, the fair market value on the date of the agreement. The right to exercise these options vests over a period of three years, and 33,333 shares are currently vested. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The agreement provides for a base salary, currently $200,000, which may be adjusted periodically by the
Company. Mr. Bily may also earn an annual bonus of up to 40% of his annual salary if he achieves established performance goals. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the terms of the agreement, Mr. Bily&#146;s employment may be terminated for cause (as defined in the agreement) or poor
performance, on Mr. Bily&#146;s death, or on 90 days&#146; written notice by Mr. Bily. If Mr. Bily&#146;s employment is terminated by the Company without cause, on 90 days&#146; written notice, he will be entitled to severance equal to six months
salary. Should Mr. Bily&#146;s employment be terminated due to a change of control (as defined in the agreement), Mr. Bily will receive severance equal to one year&#146;s salary and the immediate vesting of any unvested stock options. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>John Santos, Senior Vice President, Planning and Corporate Development
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On April 28, 1999, we entered into an
employment agreement with Mr. John Santos. The agreement is for a term of three years, and is automatically renewed on the expiration of each term unless otherwise re-negotiated or terminated pursuant to its terms. Mr. Santos has worked in various
capacities for us and in August 2001, was </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">appointed as Senior Vice President, Planning and Corporate Development, with no other changes in his employment arrangement. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Pursuant to his employment agreement, Mr. Santos receives an
annual salary of $159,650 per year. This compensation may be increased at the discretion of the Board of Directors. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In conjunction with his agreement to continue providing services to us, Mr. Santos received an option to purchase 25,000 shares of our
Common Stock at an exercise price of $10.63 per share. The option vested in equal increments over a period of three years and became fully vested on June 16, 2002. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If Mr. Santos&#146; employment is terminated as a result of a change of control (as defined in the
agreement), he will receive, in addition to any compensation earned through the effective date of his termination, one year&#146;s annual salary, the immediate vesting of any unvested option, and the principal amount and all accrued interest of any
loan made to him by the Company will be forgiven. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Helene
Lamielle, Vice President, Scientific Affairs </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">On January 22, 2002, we entered into an employment agreement with Dr. Helene Lamielle to act as our Vice President, Scientific Affairs. The agreement does not have a stated term. In order to encourage Dr. Lamielle to join the
Company, she was granted an education reimbursement allowance of up to $27,000 for an advanced degree. She was also granted an option to purchase 75,000 shares of our Common Stock at an exercise price of $4.62 per share, the fair market value on the
date of the agreement. The right to exercise these options vests over a period of three years, and 25,000 shares are currently vested. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The agreement provides for a base salary, currently $200,000, which may be adjusted periodically by the Company. Dr. Lamielle may also
earn an annual bonus of no more than 25% of her annual salary if she achieves established performance goals. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the terms of the agreement, Dr. Lamielle&#146;s employment may be terminated for cause (as defined in the agreement) or poor
performance (as defined in the agreement), on Dr. Lamielle&#146;s death, or on 90 days&#146; written notice by Dr. Lamielle. If Dr. Lamielle&#146;s employment is terminated by the Company without cause, she will be entitled to severance equal to six
months salary. Should Dr. Lamielle&#146;s employment be terminated due to a change of control (as defined in the agreement), she will receive severance equal to one year&#146;s salary and the immediate vesting of any unvested stock options.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Nicholas Curtis, Senior Vice President, Sales and Marketing
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On July 12, 2002, we entered into an
employment agreement with Mr. Nicholas Curtis to act as our Senior Vice President, Sales and Marketing for the U.S. and Canada. The agreement does not have a stated term. In order to encourage Mr. Curtis to join the Company, he was granted an option
to purchase 75,000 shares of our Common Stock at an exercise price of $3.45 per share, the fair market value on the date of the agreement. The right to exercise these options vests over a period of three years, none of which are currently vested. In
addition, we have agreed to pay certain relocation costs associated with Mr. Curtis&#146; upcoming relocation from his home in Illinois. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The agreement provides for a base salary, currently $200,000, which may be adjusted periodically. Mr.&nbsp;Curtis may also earn an annual
bonus of up to 50% of his annual salary if he achieves established performance goals. Should certain performance targets be exceeded, this amount could be increased. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In February 2003, Mr. Curtis&#146; employment agreement was amended to include a provision for termination
due to a change of control (as defined in the agreement). Should Mr. Curtis&#146; employment be terminated due to a change of control, he will receive severance equal to one year&#146;s salary plus any accrued bonuses as calculated based on length
of employment and immediate vesting of any unvested stock options. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Guenther Roepstorff,
President, Domilens GmbH </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On January 3,
2003, our employment agreement with Mr. Guenther Roepstorff to act as President of our subsidiary, Domilens GmbH, was modified in connection with the purchase of his minority interest in Domilens. The agreement, which expires December 31, 2007,
provides for an annual salary of DM 450,000 (U.S. $230,085 at January 3, 2003). In addition to his salary, Mr. Roepstorff is entitled to a 5% bonus on net income. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>REPORT OF THE COMPENSATION COMMITTEE </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>The Report of the Compensation Committee of the Board of
Directors shall not be deemed incorporated by reference by any general statement incorporating by reference this Proxy Statement into any filing under the Securities Act of 1933 (the &#147;Securities Act&#148;) or under the Securities Exchange Act
of 1934 (the &#147;Exchange Act&#148;), except to the extent that the Company specifically incorporates this information by reference, and shall not otherwise be deemed filed under such Acts. </I></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>General.</I>&nbsp;&nbsp;&nbsp;&nbsp;During the year 2002,
the Compensation Committee was comprised of Mr. David Morrison, Mr.&nbsp;John Gilbert and Dr. Volker Anhaeusser. The Compensation Committee establishes specific awards under our equity plans, such as stock options, and determines the compensation
for the Company&#146;s executive officers. Executive compensation can include salary, bonus, and option grants as well as other perquisites that vary with the level of responsibility. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In determining the compensation for a particular executive officer, the Compensation Committee was guided in
the year 2002 by the following objectives: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#149;</FONT></TD>
<TD WIDTH="006" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">attracting and retaining officers by maintaining competitive compensation packages; and </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#149;</FONT></TD>
<TD WIDTH="006" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">motivating officers to achieve and maintain superior performance levels. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee believes that total compensation for executive officers should be sufficiently
competitive with compensation paid by companies of similar size and market place position. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Base Compensation.</I>&nbsp;&nbsp;&nbsp;&nbsp;Base pay is baseline cash compensation and is determined by market forces. The Compensation Committee sets base pay based on what it believes is
comparable to compensation paid by companies of similar size and market place position. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Annual Cash Bonuses.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee, in its sole discretion, approves the payment of bonuses from time to time to the Company&#146;s employees, including its
executive officers, as an incentive to influence employees to be productive over the course of each fiscal year. The determination of which executive officers should receive a bonus and what the amount of the bonus should be is based on a subjective
analysis of the executive&#146;s level of responsibility, performance of duties and attainment of performance goals, and also takes into consideration other types and amounts of compensation paid to the executive, such as commissions. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Long-term Stock Ownership
Plans.</I>&nbsp;&nbsp;&nbsp;&nbsp;During the 2002 fiscal year the Company had several active stock plans in place for employees, officers and directors including the 1998 STAAR Surgical Company Stock Plan, the 1996 STAAR Surgical Company
Non-Qualified Stock Plan, the 1991 Stock Option Plan of STAAR Surgical Company and the STAAR Surgical Company Stock Option Plan and Agreement for Chief Executive Officer. From time to time the Company has also issued non-qualified options that were
not part of a formal plan. With the exception of the 1996 STAAR Surgical Company Non-Qualified Stock Plan and non-qualified options that were not part of a formal plan, the stockholders of the Company have approved these plans. The plans afford the
Company the ability to make stock grants and to grant incentive stock options, non-qualified stock options, and stock appreciation rights to, among others, the Company&#146;s directors, officers and employees. The 1995 STAAR Surgical Company
Consultant Stock Plan, which also was not approved by the stockholders, has not been used to make grants to officers, directors or employees of the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee&#146;s objective is to grant stock or options to purchase stock under its stock plans subject to vesting
conditions based on continued employment. These vesting requirements are intended to create a more productive workforce by acting as an inducement for long-term employment with the Company, thereby lending stability to our employee base and
encouraging more long-term productivity by our employees as they see their efforts translate into greater share value. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><I>Compensation for Chief Executive Officer.</I>&nbsp;&nbsp;&nbsp;&nbsp;Mr. Bailey&#146;s compensation is described in the section of this Annual Report entitled &#147;Employment Agreements with Named Executive Officers.&#148; Mr.
Bailey&#146;s base compensation of $350,000 was based on competitive market forces, his extensive experience in the ophthalmic products industry and his successful management of the surgical division of CIBA Vision Corporation, a private company
with over $1 billion in revenues. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">During the
2002 fiscal year, the Compensation Committee recommended, and the Board of Directors approved, the grant of an option to Mr. Bailey allowing him to purchase 150,000 shares of the Company&#146;s Common Stock at $3.81 per share (exercise price is the
fair market value of the Common Stock on the date of grant). These options became fully vested when Mr. Bailey achieved certain goals established by the Compensation Committee. These goals included: the attainment of positive cash flow, the hiring
of key executives, the launch of a product line in Germany and other key international markets, and the approval of the U.S. FDA of an investigational device exemption for the Toric ICL. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In addition to his compensation as Chief Executive Officer, Mr. Bailey is entitled to stock options on
reelection to the Board of Directors. Accordingly, on May 30, 2002, Mr. Bailey received options to purchase 60,000 shares of our Common Stock at an exercise price of $5.19. These options vest in three equal amounts of 20,000 shares during each year
of service with the first vesting on the date of grant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><I>Policy under &#167;162(m) of the Internal Revenue Code.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has not formulated a policy in qualifying compensation paid to executive officers for deductibility under Section 162(m)
of the Internal Revenue Code, and does not foresee the necessity of doing so in the near future. Should limitations on the deductibility of compensation become a material issue, the Compensation Committee will, at such time, determine whether such a
policy should be implemented, either in general or with respect to specific transactions. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Members of the Compensation Committee </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John Gilbert </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Dr. Volker D. Anhaeusser </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">David Morrison </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>EMPLOYEE BENEFIT PLANS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>1998 STAAR Surgical Company Stock Plan. </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1998 STAAR Surgical Company Stock Plan (the &#147;1998 Plan&#148;) was adopted by the Board of Directors on
April 17, 1998 and approved by the stockholders on May 29, 1998. The 1998 Plan was amended by the Board of Directors on November 1, 2000 to add additional shares, and the amendment was approved by the stockholders on May 25, 2001. Under the 1998
Plan, as amended, a total of 2,500,000 shares of common stock were authorized for grants to employees, officers and directors of incentive awards, including stock options, stock awards and stock appreciation rights. Stock options under the 1998 Plan
may either be issued in a form intended to qualify as incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), or &#147;non-qualified options,&#148; which are not intended to
satisfy Section 422 of the Code. Stock awards may be outright grants or restricted awards, which until fully vested are forfeited to the Company if the holder fails to remain employed by the Company or fails to satisfy specified performance goals.
Options granted under the 1998 Plan are not transferable, except by will or the laws of descent. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">An option granted under the 1998 Plan may not be priced at less than 100% of fair market value on the date of grant and expires ten years from the date of grant. No incentive stock option may be
granted under the 1998 Plan to any person who, at the time of the grant, owns (or is deemed to own) stock possessing more than 10% of the total combined voting power of the Company or any affiliate of the Company, unless the option exercise price is
at least 110% of the fair market value of the stock subject to the option on the date of the grant and the term of the option does not exceed five years from the date of the grant. As of the Record Date, 350,000 shares have been issued on the
exercise of options granted, 1,947,000 shares were subject to outstanding options with exercise prices ranging from $2.05 to $13.65 per share, and 142,000 shares were available for issuance upon the grant of awards under the 1998 Plan. The 1998 Plan
expires on April 17, 2008, after which time no additional options can be granted under it, but previously granted options will remain exercisable in accordance with the applicable option agreements. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>STAAR Surgical Company Stock Option Plan and Agreement for
Chief Executive Officer </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On December 20,
2000, the Board of Directors granted options to purchase up to 500,000 shares of common stock to David Bailey in consideration of his agreeing to serve as the Company&#146;s Chief Executive officer. The terms of the grant were memorialized in the
Stock Option Plan and Agreement for the Company&#146;s Chief Executive Officer (the &#147;CEO Plan&#148;), which was approved by the stockholders on May 25, 2001. The options granted pursuant to the CEO Plan have a term of ten years, vest over a
period of two years, and have an exercise price of $11.125 per share, which was the market price of the common stock on the date of grant. As of the Record Date, options to purchase 500,000 shares of common stock remain outstanding under the CEO
Plan. The CEO Plan does not provide for additional grants. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><I>1996 STAAR Surgical Company Non-Qualified Stock Plan </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">The 1996 Non-Qualified Stock Plan (the &#147;1996 Plan&#148;) was approved by the Board of Directors on May 6, 1996. The 1996 Plan was not approved by the stockholders. Under the 1996 Plan, 500,000
shares of common stock were authorized for grants to employees of incentive awards in the form of stock options and stock awards. Generally, stock options under the plan are granted at fair market value at the date of the grant, become exercisable
over a three-year period, or as determined by the Board of Directors, and expire over periods not exceeding ten years from date of grant. Options granted under the 1996 Plan are not transferable. On the Record Date, options to purchase 145,000
shares of common stock were outstanding under the 1996 Plan, all with an exercise price of $6.25 per share, and 333,000 shares were available for additional grants. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">19 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>The 1995
STAAR Surgical Company Consultant Stock Plan </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The 1995 STAAR Surgical Company Consultant Stock Plan (the &#147;1995 Consultant Plan&#148;) was approved by the Board of Directors on May 31, 1995. The 1995 Consultant Plan was not approved by the stockholders. Under the 1995
Consultant Plan, as amended, a total of 1,150,000 shares of common stock were authorized for grants to consultants of the Company and its affiliates. Awards under the 1995 Consultant Plan may be options and stock awards. Stock awards may be in the
form of restricted shares, which until fully vested may be forfeited to the Company if the holder fails to satisfy performance goals or fails to continue to provide services for the Company. Options granted under the 1995 Consultant Plan expire ten
years after the date of grant unless an earlier date is specified in an option certificate or agreement. The 1995 Consultant Plan is administered by a committee consisting of at least two members of the Board of Directors, or by the full Board of
Directors, which determines purchase price, any vesting provisions and certain other terms of the awards. The 1995 Consultant Plan has not been used to make grants to officers, directors or employees of the Company. The 1995 Consultant Plan expires
on May 31, 2005, after which time no additional options can be granted under it, but previously granted options will remain exercisable in accordance with the applicable option agreements. At the Record Date, options to purchase 458,000 shares of
common stock are outstanding under the 1995 Consultant Plan, and 102,000 shares are available for future awards. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>1991 Stock Option Plan of STAAR Surgical Company </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company&#146;s 1991 Stock Option Plan (the &#147;1991 Plan&#148;) was adopted on August 1, 1991 and
approved by the stockholders on May 28, 1992. Under the 1991 Plan, as amended, 2.0 million shares were reserved for issuance. Generally, options under this plan were granted at fair market value on the date of the grant, become exercisable over a
three-year period, or as determined by the Board of Directors, and expire over periods not exceeding ten years from the date of grant. Options granted under the 1991 Plan are not transferable. At the Record Date, options to purchase 286,000 shares
of common stock were outstanding under the 1991 Plan, with exercise prices ranging between $4.75 to $11.25 per share. The 1991 Plan, which had a term of ten years, has terminated for purposes of making additional grants, but previously granted
options will remain exercisable until the termination date provided in the applicable option agreements. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>401(k) Plan </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company maintains a 401(k) profit sharing plan (&#147;401(k) Plan&#148;) for the benefit of qualified employees in North America.
Employees who participate may elect to make salary deferral contributions to the 401(k) Plan up to $12,000 of the employees&#146; eligible payroll, subject to annual Internal Revenue Code maximum limitations. The Company makes a contribution of 25%
for every $1.00 contributed by the participant, up to 6% of the participant&#146;s eligible payroll. In addition, the Company may make a discretionary contribution to the qualified employees, in accordance with the 401(k) Plan. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STOCK PERFORMANCE GRAPH </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Set forth below is a line graph, assuming an initial investment of $100 on December 31, 1997, comparing the
yearly percentage change in the cumulative total stockholder return for the last five fiscal years of the Common Stock relative to the cumulative total stockholder return for the same time period of: (i) United States and foreign companies listed on
the Nasdaq Stock Market (the &#147;Nasdaq Index&#148;); and (ii) United States and foreign companies listed on the Nasdaq Stock Market that operate in the surgical, medical and dental instrument and supply industries (the &#147;Peer Index&#148;),
based on Standard Industrial Classification (&#147;SIC&#148;) codes in the range of 3840 through 3849 (the Company&#146;s SIC code is 3845). The Nasdaq Index and the Peer Index were prepared by the Center for Research in Security Prices of the
University of Chicago&#146;s Graduate School of Business. The graph is not necessarily indicative of future price performance. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>The graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Proxy Statement into
any filing under the Securities Act or under the Exchange Act, except to the extent that the Company specifically incorporates this information by reference, and shall not otherwise be deemed filed under such Acts. </I></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g52875g91d05.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">21 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Indebtedness of Management </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Two members of the Company&#146;s management during fiscal
2002 have indebtedness to the Company in significant amounts. They incurred this indebtedness prior to July 30, 2002, the date when Section 402 of the Sarbanes-Oxley Act of 2002, which generally prohibits loans to officers and directors, became
effective. Since that date, the terms of the indebtedness have not been materially modified nor has the Company extended any additional credit or renewed any credit of the borrowers. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Peter J. Utrata </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As of January 3, 2003, Dr. Peter J. Utrata, one of our directors until January 28, 2003, was indebted to us
in the amount of $1,530,500. Excluding interest, this is the largest aggregate amount of indebtedness owed by Dr.&nbsp;Utrata during fiscal 2002. The following table sets forth the date on which each loan was made and the principal amount of the
loan: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="48%" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Date of Loan</B></FONT><HR WIDTH="73" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Amount of Loan</B></FONT><HR WIDTH="93" SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:22%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">June 16, 1999</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$1,258,000</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:22%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">June 2, 2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$ &nbsp;&nbsp;272,500</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">We
received full recourse promissory notes from Dr. Utrata memorializing these loans. The loans were used by Dr. Utrata to exercise options to purchase our Common Stock. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The promissory note in the amount of $1,258,000 is due to be paid in full on June 15, 2004 and bears interest
at the lower of the lowest rate allowable by the Internal Revenue Service without the imputation of interest or 7%. Payment of the promissory note is partly secured with 120,000 shares of our Common Stock, pursuant to the terms of a Stock Pledge
Agreement executed by Dr. Utrata. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The promissory
note in the amount of $272,500 is due to be paid in full on June 1, 2005 and bears interest at the lower of the lowest rate allowable by the Internal Revenue Service without the imputation of interest or 7%. Payment of the promissory note is partly
secured with 20,000 shares of our Common Stock, pursuant to the terms of a Stock Pledge Agreement executed by Dr. Utrata, as additional security for repayment of this loan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A promissory note in the amount of $100,000, plus accrued interest, was paid in full on November 10, 2002.
Dr. Utrata resigned as director on January 28, 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B><I>John Santos </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As of
January 3, 2003, Mr. John Santos, one of our executive officers, was indebted to us in the amount of $74,500. Excluding interest, this is the largest aggregate amount of indebtedness owed by Mr. Santos during fiscal 2002. The following table sets
forth the date on which each loan was made and the principal amount of the loan: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="48%" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Date of Loan</B></FONT><HR WIDTH="73" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Amount of Loan</B></FONT><HR WIDTH="93" SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:22%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">July 19, 1996</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$25,000</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:22%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">August 28, 1998</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$30,000</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:22%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">September 8, 1998</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$14,500</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:22%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">April 11, 2001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="48%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$&nbsp;&nbsp;5,000</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">We
received full recourse demand notes from Mr. Santos memorializing these loans, which were taken by Mr.&nbsp;Santos as personal loans. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">22 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">These notes
have no set term; however they are due at the Company&#146;s option on 60 days&#146; written notice. The notes bear interest at rates ranging from 5%-7%, or the lower of the lowest rate allowable by the Internal Revenue Service without the
imputation of interest. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Consulting Agreement
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>David Morrison </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On March 1, 2001, we entered into a Consulting Agreement with
DRM Strategic Services Ltd., a private limited company wholly owned by our director, Mr. David Morrison. Pursuant to this Consulting Agreement, we pay DRM Strategic Services Ltd. the sum of $1,000 for each day Mr. Morrison performs duties as a
consultant, but in no month is DRM Strategic Services Ltd. paid for less than six days of work. In conjunction with this Consulting Agreement, we issued to Mr. Morrison an option to purchase 20,000 shares of our Common Stock. The option exercise
price is $3.99, the closing price on the date of grant. The duties that Mr. Morrison performs on behalf of DRM Strategic Services Ltd. include performing market research on behalf of the Company, assisting the Company in identifying licensing and
co-marketing opportunities throughout the world and assisting the Company with identifying and building strategic relationships within the worldwide ophthalmic industry. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Purchase Agreement </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Guenther Roepstorff </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">During the 2002 fiscal year, we entered into a purchase agreement with Mr. Guenther Roepstorff to acquire the remaining 20% interest in
our 80% owned German subsidiary, Domilens GmbH. Pursuant to this agreement, the Company acquired the remaining shares in a non-cash transaction at its book value of $426,000 in exchange for cancellation of amounts due from Mr. Roepstorff of $955,000
less bonuses due to Mr. Roepstorff of $87,000, resulting in goodwill of $442,000. The terms of the agreement also provided for the cancellation of 75,000 unexercised stock options previously issued to Mr. Roepstorff, the subsidiary&#146;s president,
and also included an agreement not to compete with the Company for a period of ten years. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>MEETINGS OF
THE BOARD OF DIRECTORS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of
Directors held two meetings during the 2002 fiscal year and took action by consent four times during the 2002 fiscal year. All directors attended all of the meetings of the Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>REPORT ON COMMITTEES </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors has three standing committees. Information regarding the functions of the Board&#146;s
committees, their present membership and the number of meetings held by each committee during the 2002 fiscal year is described below. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Audit Committee.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee annually recommends the selection of the independent auditors to be
engaged by the Company for the next fiscal year, reviews with the independent auditors the plan and results of the audit engagement, reviews the scope and results of the Company&#146;s procedures for internal auditing and inquires as to the adequacy
of the Company&#146;s internal accounting controls. Beginning in fiscal year 2003, the Audit Committee will select the Company&#146;s independent auditors. The Report of the Audit Committee appears below. The current members of the Audit Committee
are Mr. Donald Duffy, who serves as chairman of the committee, Mr. John R. Gilbert and Dr. Volker Anhaeusser. The Audit Committee met two times in the year 2002. Effective May 2, 2003, the Audit Committee recommended, and the Board of Directors
adopted, a revised charter for the Audit Committee. A copy of the Audit Committee&#146;s charter, as amended, is attached to this Proxy Statement as Appendix A. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Compensation Committee.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee is authorized to fix the
compensation of senior officers of the Company and to administer the Company&#146;s various equity plans. During 2002, the members of the Compensation Committee included Mr. John Gilbert, Mr. David Morrison and Dr. Volker Anhaeusser. The
Compensation Committee did not meet during the 2002 fiscal year and took action by consent four times. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Litigation Committee.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Litigation Committee was formed primarily for the purpose of managing the legal
actions filed against the Company by Mr. John Wolf. When asked by the Board of Directors, the Litigation Committee also undertakes a review of potential disputes with third parties and determines a course of action for the resolution of them. The
current members of the Litigation Committee are Mr. David Bailey, Mr. John R. Gilbert and Dr. Volker Anhaeusser. The Litigation Committee did not meet during the 2002 fiscal year. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors does not have a Nominating Committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">24 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>REPORT OF THE AUDIT COMMITTEE </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>The Report of the Audit Committee of the Board of Directors
shall not be deemed incorporated by reference by any general statement incorporating by reference this Proxy Statement into any filing under the Securities Act or under the Exchange Act, except to the extent that the Company specifically
incorporates this information by reference, and shall not otherwise be deemed filed under such Acts. </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee of the Board of Directors is currently composed of three directors who are independent directors as defined under Rule
4200(a)(14) of the National Association of Securities Dealers&#146; Marketplace Rules. The Audit Committee operates under a written charter adopted by the Board of Directors. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee oversees the Company&#146;s financial reporting process on behalf of the Board of
Directors. Management is responsible for the Company&#146;s financial statements and the financial reporting process, including the system of internal controls. The independent auditors are responsible for expressing an opinion on the conformity of
those audited financial statements with generally accepted accounting principles. In fulfilling its oversight responsibilities, the Audit Committee has reviewed and discussed with management and the independent auditors the audited financial
statements that have been included in our Annual Report on Form&nbsp;10-K for the year ended January 3, 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee has discussed with the independent auditors the matters required to be discussed by Statement on Auditing Standards
No. 61, <I>Communication with Audit Committees</I>, as amended. In addition, the Audit Committee has discussed with the independent auditors the auditors&#146; independence from the Company and its management including the matters in the written
disclosures provided to the Audit Committee as required by Independence Standards Board Standard No. 1, <I>Independence Discussions with Audit Committees</I>. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee recommended to the Board of Directors, and the Board of Directors has approved, the inclusion of the audited financial
statements in the Annual Report on Form 10-K for the 2002 fiscal year for filing with the Securities and Exchange Commission. The Audit Committee has not yet recommended the selection of our independent auditors for the fiscal year ending January 2,
2004. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee considered whether the
fees paid the auditors for non-audit services were compatible with maintaining the auditors&#146; independence, and concluded that they were. These fees are listed below under the caption &#147;Independent Public Accountants.&#148; </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Effective May 2, 2003, the Board of Directors approved a
revised charter for the Audit Committee based on recommendations by the Committee. A copy of the charter, as revised, is attached to this Proxy Statement as Appendix A. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Members of the Audit Committee </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Donald Duffy </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">John R. Gilbert </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Dr. Volker Anhaeusser </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Dated: May 2, 2003 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Section 16(a) of the Securities Exchange Act, as amended (the
&#147;Exchange Act&#148;) requires our directors, executive officers and persons who own more than 10% of our Common Stock to file reports of ownership and changes in ownership of our Common Stock with the Securities and Exchange Commission (the
&#147;Commission&#148;). Directors, executive officers and persons who own more than 10% of our Common Stock are also required by Commission regulations to furnish to us copies of all Section 16(a) forms they file. The Commission has established
specific due dates for these reports and requires the Company to report in this Proxy Statement any failure by these persons to file or failure to file on a timely basis. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To our knowledge, based solely on a review of the copies of such reports received or written representations
from the reporting persons, we believe that during our 2002 fiscal year our directors, executive officers and persons who own more than 10% of our Common Stock complied with all Section 16(a) filing requirements, with the exception of David Bailey,
John Gilbert, David Morrison, John Bily, Helene Lamielle and Nicholas&nbsp;Curtis. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>INDEPENDENT PUBLIC ACCOUNTANTS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee has not yet presented to the Board of Directors its selection of an auditor for the 2003 fiscal year, therefore the Company is not requesting approval of its choice of an auditor
for the 2003 fiscal year. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Representatives of BDO
Seidman, LLP, independent public auditors for the Company for the 2002 fiscal year, will be present at the Annual Meeting, will have an opportunity to make a statement, and will be available to respond to appropriate questions. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Audit Fees:</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The aggregate
fees billed for professional services rendered for the audit of our annual financial statements for the most recent fiscal year and the reviews of the financial statements included in our Forms 10-Q for the most recent fiscal year totaled $360,000.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>All Other
Fees:</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Fees for services rendered totaled $101,000, which consisted of the following: $2,000 for preparation of and attendance at the annual stockholder meeting and $99,000 for tax work. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Financial Information Systems Design and
Implementation.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Company paid no fees to BDO Seidman, LLP for professional services rendered in the design and implementation of financial information systems. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee, in reliance on statements by management
and the independent auditors, has determined that the provision of the non-audit services described above is compatible with maintaining the independence of BDO Seidman, LLP. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">26 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>PROPOSAL NO.
2 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>TO APPROVE THE STAAR SURGICAL COMPANY
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>2003 OMNIBUS EQUITY INCENTIVE PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On May 14, 2003, the Board of Directors adopted the STAAR Surgical Company 2003 Omnibus Equity Incentive Plan
(the &#147;2003 Incentive Plan&#148;) subject to the approval of the Stockholders at the Annual Meeting. Under the 2003 Incentive Plan, employees, non-employee directors and consultants of the Company and its subsidiaries are eligible to receive
shares of Common Stock of the Company or other securities or benefits with a value derived from the value of the Common Stock of the Company. A copy of the 2003 Incentive Plan is attached to this Proxy Statement as Appendix B. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The 2003 Incentive Plan is a new plan that also consolidates
the Company&#146;s existing incentive plans. The 4,913,629 shares of Common Stock available for awards on adoption of the 2003 Incentive Plan consist of 1,000,000 shares that would become newly available for incentive awards if Stockholders approve
the 2003 Incentive Plan, and 3,913,629 shares already available or subject to outstanding awards under the 1991 Stock Option Plan of STAAR Surgical Company, the 1995 STAAR Surgical Company Consultant Stock Plan, the 1996 STAAR Surgical Company
Non-Qualified Stock Plan, the 1998 STAAR Surgical Company Stock Plan and the STAAR Surgical Company Stock Option Plan and Agreement for Chief Executive Officer (the &#147;Existing Plans&#148;). If Stockholders approve the 2003 Incentive Plan, no
further awards will be made under the Existing Plans. The 2003 Incentive Plan also provides that on each January 1 during the life of the plan the number of shares of Common Stock available for awards will automatically increase by a number of
shares equal to 2% of the Company&#146;s outstanding stock, up to a maximum of 1,586,371 additional shares, and a maximum total of 6,500,000 shares issuable pursuant to incentive stock options. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE PROPOSED 2003
OMNIBUS EQUITY INCENTIVE PLAN. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following
is a brief summary of the 2003 Incentive Plan, which is qualified in its entirety by reference to Appendix B. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Purpose </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The purpose of the 2003 Incentive Plan is to enable the Company to attract, retain and motivate officers, directors, employees and independent contractors by providing for performance-based benefits, and to strengthen the mutuality
of interests between these persons and the Company&#146;s stockholders. The 2003 Incentive Plan is designed to meet this intent by offering performance-based stock and cash incentives and other equity-based incentive awards, thereby providing a
proprietary interest in pursuing the long-term growth, profitability and financial success of the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To simplify the administration and regulatory compliance for the Company&#146;s various incentive plans, the Board of Directors has
provided that the 2003 Incentive Plan amends and restates the Existing Plans, and combines the Existing Plans with the 2003 Incentive Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Shares Subject to Plan </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The maximum number of shares of Common Stock that may be issued as awards granted under the 2003 Incentive Plan may not exceed the sum of
(1) 4,913,629 shares and (2) the cumulative number of shares added on each January 1, which is equal to 2% of the total number of shares of Common Stock outstanding on the immediately preceding December 31, up to an additional 1,586,371 shares. The
maximum number of shares of Common Stock that may be issued pursuant to incentive stock options under this Plan may not exceed </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">27 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6,500,000. Of the 4,913,629 shares of Common Stock available for awards on adoption of the 2003 Incentive Plan, 1,000,000 are shares that
would become newly available for incentive awards and 3,913,629 are shares already available or subject to outstanding awards under the Existing Plans. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Administration </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The 2003 Incentive Plan is administered by a committee (the &#147;Committee&#148;) of two or more directors appointed by the Board of
Directors, each of whom is an &#147;outside director&#148; within the meaning of Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), and who otherwise complies with the requirements of Rule 16b-3 promulgated
under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). The Committee has full and final authority to select the recipients of awards and to grant such awards. Subject to the provisions of the 2003 Incentive Plan, the
Committee has a wide degree of flexibility in determining the terms and conditions of awards and the number of shares to be issued pursuant thereto, including conditioning the receipt or vesting of awards on the achievement by the participant of
specified performance criteria. The expenses of administering the 2003 Incentive Plan are borne by the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Terms of Awards </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000"><B><I>General </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The 2003 Incentive Plan authorizes the Committee to enter into any type of arrangement with an eligible recipient that, by its terms, involves or might involve the issuance of Common Stock or any other security or benefit with a
value derived from the value of Common Stock. Awards are not restricted to any specified form or structure and may include, without limitation, sales or bonuses of stock, restricted stock, stock options, stock appreciation rights, phantom stock,
dividend equivalents, performance units or performance shares. An award may consist of one such security or benefit or two or more of them in tandem or in the alternative. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">An award granted under the 2003 Incentive Plan may include a provision accelerating the receipt of benefits
on the occurrence of specified events, such as a change of control of the Company or a dissolution, liquidation, merger, reclassification, sale of substantially all of the property and assets of the Company or other significant corporate
transactions. The Committee may grant options that either are intended to be &#147;incentive stock options&#148; as defined under Section 422 of the Code, or are not intended to be incentive options (&#147;non-qualified stock options&#148;).
Incentive stock options may be granted only to employees. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">No incentive stock option may be granted under the 2003 Incentive Plan to any person who, at the time of the grant, owns (or is deemed to own) stock possessing more than 10% of the total combined voting power of the Company or any
affiliate of the Company, unless the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of the grant and the term of the option does not exceed five years from the date of the grant. In
addition, the aggregate fair market value, determined at the time of the grant, of the shares of Common Stock with respect to which incentive stock options are exercisable for the first time by an optionee during any calendar year (under all such
plans of the Company and its subsidiaries) may not exceed $100,000. As a result of enactment of Section 162(m) of the Code, and to provide the Committee flexibility in structuring awards, the 2003 Incentive Plan states that in the case of stock
options and stock appreciation rights, no person may receive in any year a stock option to purchase more than 200,000 shares or a stock appreciation right measured by more than 200,000 shares. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If awards granted under the 2003 Incentive Plan expire, are
canceled or otherwise terminate without being exercised, the Common Stock not purchased pursuant to the award will again become available for issuance under the 2003 Incentive Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Payment of Exercise Price </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">An award may permit the recipient to pay all or part of the purchase price of the shares or other property
issuable pursuant thereto, or to pay all or part of such recipient&#146;s tax withholding obligation with respect to such </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">28 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">issuance, by delivering previously owned shares of capital stock of the Company or other property, or subject to the prohibitions on loans to
officers and directors under Item 402 of the Sarbanes-Oxley Act of 2002, by reducing the amount of shares or other property otherwise issuable pursuant to the award or by delivering a promissory note, the terms and conditions of which will be
determined by the Committee. The exercise price and any withholding taxes are payable in cash by consultants and non-employee directors, although the Committee at its discretion may permit such payment by delivery of shares of Common Stock, or by
delivery of broker instructions authorizing a loan secured by the shares acquired on exercise or payment of proceeds from the sale of such shares. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Amendment </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Subject to limitations imposed by law, the Board of Directors may amend or terminate the 2003 Incentive Plan at any time and in any
manner. However, no such amendment or termination may deprive the recipient of any award previously granted under the 2003 Incentive Plan or any rights thereunder without the recipient&#146;s consent. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Section 16(b) </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Pursuant to Section 16(b) of the Exchange Act, directors,
certain officers and ten percent stockholders of the Company are generally liable to the Company for repayment of any &#147;short-swing&#148; profits realized from any non-exempt purchase and sale of Common Stock occurring within a six-month period.
Rule 16b-3, promulgated under the Exchange Act, provides an exemption from Section 16(b) liability for certain transactions by an officer or director pursuant to an employee benefit plan that complies with such Rule. Specifically, the grant of an
option under an employee benefit plan that complies with Rule 16b-3 will not be deemed a purchase of a security for purposes of Section 16(b). The 2003 Incentive Plan is designed to comply with Rule 16b-3. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Term </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Awards may not be granted under the 2003 Incentive Plan on or
after the tenth anniversary of the adoption of the 2003 Incentive Plan. However, any award that was duly granted on or prior to that date will remain outstanding and subject to exercise or settlement in accordance with its terms. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Performance Goals </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee will determine the business criteria for
performance goals under the 2003 Incentive Plan on a case-by-case basis, except that stock options and stock appreciation rights by their nature increase compensation based purely on increases in the fair market value of the Common Stock after the
date an award is granted. Similarly, the Committee will determine the maximum amount of compensation that could be paid to any participant, or the formula used to calculate the amount of compensation to be paid to the participant if a performance
goal is obtained, on a case-by-case basis, except that stock options by their nature result in maximum possible compensation equal to the difference between the exercise price of the option and the fair market value of the Common Stock on the date
of option exercise, times the maximum number of shares for which grants may be made to any participant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Adjustments </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If there is any change in the stock subject to the 2003 Incentive Plan or subject to any award made under the 2003 Incentive Plan (through
merger, consolidation, reorganization, recapitalization, stock dividend, dividend in kind, stock split, liquidating dividend, combination or exchange of shares, change in corporate structure or otherwise), the 2003 Incentive Plan and shares
outstanding thereunder will be appropriately adjusted as to the class and the maximum number of shares subject to the 2003 Incentive Plan and the class, number of shares and price per share of stock subject to such outstanding options as determined
by the Committee to be fair and </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">29 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">equitable to the holders, the Company and the stockholders. In addition, the Committee may also make adjustments in the number of shares
covered by, and the price or other value of any outstanding awards under the 2003 Incentive Plan in the event of a spin-off or other distribution (other than normal cash dividends) of Company assets to stockholders. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Securities Act Registration </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company intends to register under the Securities Act of
1933, as amended, the shares of Common Stock issuable pursuant to the 2003 Incentive Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Federal Income Tax Treatment </I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">The following is a brief description of the federal income tax treatment that generally will apply to awards made under the 2003 Incentive Plan, based on federal income tax laws in effect on the date
hereof. The exact federal income tax treatment of any award will depend on the specific nature of such award. Such an award may, depending on the conditions applicable to the award, be taxable as an option, an award of restricted or unrestricted
stock, an award that is payable in cash or otherwise. The following discussion is based on present federal tax laws and regulations and does not purport to be complete. Participants may also be subject to foreign, state and local taxes, which are
not described below. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Incentive Stock
Options.</I><B></B><I></I>&nbsp;&nbsp;&nbsp;&nbsp;Under the 2003 Incentive Plan, the Company may grant participants stock options that are intended to qualify as &#147;incentive stock options&#148; within the meaning of Section 422 of the Code.
Generally, the optionee is not taxed, and the Company is not entitled to a deduction, on the grant or exercise of an incentive stock option. However, if the optionee sells the shares acquired on the exercise of an incentive stock option at any time
within (i) one year after the date of exercise of the option or (ii) two years after the date of grant of the option (a &#147;disqualifying disposition&#148;), then the optionee will recognize ordinary income in an amount equal to the excess, if
any, of the lesser of the sale price or the fair market value on the date of exercise over the exercise price of the option. The Company generally will be entitled to a deduction in an amount equal to the amount of ordinary income recognized by the
optionee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Special rules will apply, however, if
the optionee is subject to Section 16(b) of the Exchange act at the time of a disqualifying distribution. In that case, unless the optionee elects to be taxed immediately, the acquisition date of the shares and the time of recognition of income will
be postponed during the period of time (the &#147;Section&nbsp;16(b) Period&#148;) that a sale of the stock acquired on exercise of the option could subject the optionee to suit under Section 16(b). In addition, the amount of income recognized will
be the lesser of (i) the difference between the option price and the fair market value of the acquired shares at the end of the Section 16(b) period (rather than the date of exercise) and (ii) the total amount of gain realized on the sale.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In addition to the regular income tax, an
optionee may be subject to the federal alternative minimum tax if his or her alternative minimum taxable income (&#147;AMTI&#148;) exceeds certain amounts. The excess of the fair market value of the stock received on exercise of an incentive stock
option over the exercise price generally is includable in the participant&#146;s AMTI. In the case of a participant who exercises an incentive stock option within six months after its date of grant and whose sale of stock could subject him or her to
suit under Section 16(b) of the Exchange Act, generally the excess of the fair market value over the exercise price on the date six months following the date of grant is includable in AMTI. However, if a disqualifying disposition occurs at a loss in
the same taxable year that the excess was includable in AMTI, the includable amount is limited to the excess of the amount realized on the disqualifying disposition over the exercise price. For the purpose of the alternative minimum tax, the gain or
loss on sale of stock is calculated by including a basis adjustment for the amount included in AMTI on exercise. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If the holder of an incentive stock option pays the exercise price with previously acquired shares of stock, the exchange should not
affect the incentive stock option tax treatment of the option exercised. However, if stock previously acquired through the exercise of an incentive stock option is used to pay the exercise price, then the </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">30 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">exchange of the previously acquired shares of stock will be considered a disposition of such shares for the purpose of determining whether a
disqualifying disposition has occurred. Otherwise, generally no gain or loss is recognized on the exchange, and the shares of stock received by the participant that are equal in number to the previously acquired shares exchanged therefore will have
the same basis and holding period for long-term capital gain purposes as the previously acquired shares. However, the optionee will not be able to utilize the old holding period for the purpose of satisfying the incentive stock option one-year and
two-year holding period requirements. Shares of stock received by the optionee in excess of the number of previously acquired shares generally will have a basis of zero and a holding period that commences as of the date the shares of stock are
issued to the optionee on exercise of the incentive stock option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000"><I>Non-Qualified Stock Options.</I>&nbsp;&nbsp;&nbsp;&nbsp;The grant of an option or other similar right to acquire stock that does not qualify for treatment as an incentive stock option generally is not a taxable event for
the optionee. On exercise of such an option, the optionee generally will recognize ordinary income in an amount equal to the excess of the fair market value of the stock acquired on exercise (determined as of the date of exercise) over the exercise
price of such option, and the Company will be entitled to a deduction equal to such amount. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Special rules will apply, however, if the optionee is subject to Section 16 of the Exchange Act. In that case the optionee will not recognize ordinary income, and the Company will not be entitled to a
deduction, until the expiration of the Section 16(b) Period. When the Section 16(b) Period expires, the optionee will recognize ordinary income, and the Company will be entitled to a deduction, equal to the excess of the fair market value of the
stock (determined as of the expiration of the Section 16(b) Period) over the option exercise price. Such an optionee may elect under Section 83(b) of the Code to recognize ordinary income on the date of exercise, in which case the Company would be
entitled to a deduction at that time equal to the amount of the ordinary income recognized. Such an election must be filed within 30 days after the stock is considered to be received for income tax purposes. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If a holder of a non-qualified stock option pays the exercise
price in cash, his or her basis in the shares acquired is equal to the fair market value of the stock on the date ordinary income is recognized and, on a subsequent disposition, any further gain or loss is taxable either as a short-term or long-term
capital gain or loss, depending on how long the shares of stock are held. The holding period for such shares commences as of the date ordinary income is recognized. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If a holder of a non-qualified stock option pays the exercise price with previously acquired shares of stock,
he or she will recognize ordinary income in an amount equal to the excess of the fair market value of the stock received over the exercise price. No additional gain or loss is recognized as a result of the disposition of previously acquired shares
of stock. The shares of stock received by the participant, equal in number to the previously acquired shares exchanged therefor, will have the same basis and holding period as such previously acquired shares. The shares of stock received by the
participant in excess of the number of previously acquired shares will have a basis equal to the fair market value of such additional shares as of the date ordinary income is recognized. The holding period for such additional shares will commence as
of the date ordinary income is recognized. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Generally, gain or loss from a disposition of shares is characterized as &#147;short-term&#148; for shares held for 12&nbsp;months or less, and &#147;long term&#148; if held more than 12 months. Short-term capital gains are taxed at
ordinary income rates, while long-term capital gains are normally taxed at a rate of twenty percent (20%). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Other Types of Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;Awards under the 2003 Incentive Plan may also include stock sales, stock bonuses or
other grants of stock. Stock issued pursuant to these awards may be subject to certain restrictions. Pursuant to Section 83 of the Code, stock sold or granted under the 2003 Incentive Plan will give rise to taxable income at the earliest time at
which the stock is not subject to a substantial risk of forfeiture or is freely transferable for purposes of Section 83. At that time, the holder will recognize ordinary income equal to the excess of the fair market value of the shares (determined
as of such time) over the purchase price, and the Company will be </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">31 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">entitled to a deduction equal to such amount. If the holder of the stock is a person subject to Section 16(b) of the Exchange Act and if the
sale of the stock at a profit could subject such person to suit under Section 16(b), income will be recognized in accordance with the rules described above regarding stock issued to such persons on the exercise of such an option. Alternatively, if
the holder of stock makes a timely election under Section 83(b) of the Code, the holder will recognize ordinary income on the date of issuance of the stock equal to the excess of the fair market value of the shares (determined on the date of
issuance) over the purchase price, and that amount will then be deductible by the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Awards may also be granted under the 2003 Incentive Plan that do not fall clearly into the categories described above. The federal income tax treatment of these awards will depend on the specific terms
of such awards. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Change in Control
</I></B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee may specify in any award
agreement the treatment of the award if the Company undergoes a Change in Control. In general, a &#147;Change in Control&#148; will be considered to take place whenever (1) any person or entity becomes a 25% beneficial owner of the Company&#146;s
voting stock, (2) a merger, tender offer, sale of assets or other business combination results in the persons serving as directors prior to the transaction no longer comprising a majority of the Board of Directors, (3) a transaction approved by the
stockholders results in the Company ceasing to be an independent public company or results in the sale of all or substantially all of the assets of the Company, or (4) a transaction or series of transactions (including a tender offer or exchange
offer) that results in a person or group of persons (other than the Company or by a Company-sponsored employee benefit plan), acquiring beneficial ownership more than 50% of the Company&#146;s voting securities. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If no other treatment is specified in an Award Agreement, the
following will take place on a Change in Control: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#149;</FONT></TD>
<TD WIDTH="006" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">stock options will vest in full immediately before the completion of the Change in Control, unless the successor company assumes the options or the Company affirms
the options; </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#149;</FONT></TD>
<TD WIDTH="006" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">stock options held by non-employee directors will vest in full immediately before the completion of the Change in Control, whether or not the options are assumed by
a successor company or affirmed by the Company; </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#149;</FONT></TD>
<TD WIDTH="006" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Restrictions on grants of restricted stock will be deemed satisfied on the date of the Change in Control and any performance-related grants will be deemed to have
been earned on the date of the Change in Control. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Any accelerated vesting is subject to the Committee&#146;s determination that the acceleration will not result in an &#147;excess parachute payment&#148; under Code Section 280G. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Withholding </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company generally will be required to withhold applicable
taxes with respect to any ordinary income recognized by a participant on exercise of a non-qualified stock option or recognition of income in connection with awards made under the 2003 Incentive Plan. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B><I>Limitations on Deductibility </I></B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The terms of the agreements pursuant to which specific awards
are made under the 2003 Incentive Plan may provide for accelerated vesting or payment of an award in connection with a change in ownership or control of the Company. In that event and depending on the individual circumstances of the recipient,
certain amounts with respect to such awards may constitute &#147;excess parachute payments&#148; under the golden parachute provisions of the Code. Pursuant to such provisions, an employee will be subject to a 20% excise tax on any &#147;excess
parachute payment,&#148; and the Company will be denied any deduction with respect to such excess parachute payment. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">32 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In addition,
Section 162(m) of the Code renders nondeductible to the Company certain compensation paid to the Chief Executive Officer and four other most highly compensated executives in excess of $1,000,000 in any year unless such excess compensation is
&#147;performance-based&#148; (as defined in the Code) or is otherwise exempt from these limitations on deductibility. Options granted under the 2003 Incentive Plan at an exercise price equal to their fair market value at the date of grant are
intended to qualify for the exemption for performance-based compensation under Section 162(m). However, in light of the ambiguities in Section 162(m) and uncertainties regarding the ultimate interpretation and application in these circumstances, no
assurances can be given that the compensation paid under the 2003 Incentive Plan to any such executive officer will in fact be deductible, if it should, together with other non-exempt compensation paid to such executive officer, exceed the
$1,000,000 limit. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STOCKHOLDER PROPOSALS FOR
2004 ANNUAL MEETING </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under certain
circumstances, stockholders are entitled to present proposals at stockholder meetings. Any such proposal to be included in the Proxy Statement for the Company&#146;s 2004 annual meeting of stockholders must be submitted by a stockholder prior to
January 20, 2004, in a form that complies with applicable regulations. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Appendix A </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR Surgical Company </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Charter of the Audit Committee of the Board of Directors </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR
SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>CHARTER OF THE AUDIT
COMMITTEE </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>OF THE BOARD OF DIRECTORS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>I.</B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>MEMBERSHIP </B></FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee (the &#147;Committee&#148;) of the Board of Directors (the &#147;Board&#148;) shall meet the requirements of the Sarbanes-Oxley Act (the
&#147;Act&#148;) and applicable rules of the National Association of Securities Dealers (the &#147;NASDAQ&#148;) and the Securities and Exchange Commission (the &#147;SEC&#148;). </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No member of the Committee shall receive compensation other than director&#146;s fees and benefits for service as a director of the Company, including reasonable
compensation for Chairing and/or serving on the Committee. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">C.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Any member of the audit committee may be removed or replaced at any time by the Board of Directors and shall cease to be a member of the Audit Committee on ceasing
to be a Director. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>II.</B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>PURPOSE </B></FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee serves as the representative of the Board for the general oversight of Company affairs relating to: </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The quality and integrity of the Company&#146;s financial statements. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The independent auditor&#146;s qualifications and independence. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The performance of the Company&#146;s independent auditors. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Through its activities, the Committee facilitates open communication among directors, independent auditors, and management by meeting in private session regularly
with these parties. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>III.</B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>MEETINGS AND PROCEDURES </B></FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee shall meet in person or by telephone at least quarterly. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">It shall endeavor to determine that auditing procedures and controls are adequate to safeguard Company assets and to assess compliance with Company policies and
legal requirements. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">C.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee shall be given full access to the Chairman of the Board, Company executives and independent auditors. When any audit has been prepared by a registered
public accounting firm for the Company, the Committee shall timely receive a report from such firm on (1) all critical accounting policies and practices; (2) all alternative treatments of financial information within generally accepted accounting
principles that have been discussed with management offices of the issuer, ramifications of the use of such alternative disclosures and treatments, and the treatment preferred by the registered public accounting firm; and (3) other material written
communications between the registered public accounting firm and company management, such as any management letter or schedule of unadjusted differences. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">D.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A majority of the members shall constitute a quorum. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>IV.</B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>RESPONSIBILITIES </B></FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee shall: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Have the sole authority to appoint, compensate, oversee, evaluate and, where appropriate, replace the independent auditor. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Annually review and approve the proposed scope of each fiscal year&#146;s outside audit. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Inform each registered public accounting firm performing work for the Company that such firm shall report directly to the Committee. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Oversee the work of any registered public accounting firm employed by the Company, including the resolution of any disagreement between management and the auditor
regarding financial reporting, for the purpose of preparing or issuing an audit opinion or related work. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Review and approve in advance any audit and non-audit services and fees to be provided by the Company&#146;s independent auditor, other than &#147;prohibited
non-auditing services&#148; and minor audit services, each as specified in the Act. The Committee has the sole authority to make these approvals, although such approval may be delegated to any committee member so long as the approval is presented to
the full Committee at a later time. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">At, or shortly after the end of each fiscal year, review with the independent auditor and Company management, the audited financial statements and related opinion
and costs of the audit of that year. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Provide any recommendations, certifications and reports that may be required by the NASDAQ or the SEC including the report of the Committee that must be included in
the Company&#146;s annual proxy statement. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Review and discuss the annual audited financial statements and quarterly financial statements with management and the independent auditor. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Establish and oversee procedures for (a) the receipt, retention, and treatment of complaints received by the Company regarding accounting, internal accounting
controls, or auditing matters; and (b) the confidential anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Have the authority to engage independent counsel and other advisors as it determines necessary to carry out its duties. The Company shall provide for appropriate
funding as determined by the Committee, in its capacity as a committee of the Board of Directors, for payment of compensation to any advisors employed by the Committee and to the independent auditor employed by the Company for the purpose of
rendering or issuing an audit report. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Ensure the rotation of the lead audit partner at least every five years. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Confirm with any independent auditor retained to provide audit services for any fiscal year that the lead (or coordinating) audit partner (having primary
responsibility for the audit), or the audit partner responsible for reviewing the audit, has not performed audit services for the Company in each of the five previous fiscal years of the Company and that the firm meets all legal and professional
requirements for independence. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Discuss with management and the independent auditor the Company&#146;s policies with respect to risk assessment and risk management. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Meet separately, periodically, with management and with the independent auditor. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In consultation with the independent auditor and management, review the integrity of the Company&#146;s financial reporting process. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Review with the Chief Executive Officer and the Chief Financial Officer on an annual basis the Company&#146;s disclosure controls and procedures, including any
significant deficiencies in, or material non-compliance with, such controls and procedures. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Review with the independent auditor (a) any audit problems or other difficulties encountered by the auditor in the course of the audit process, including any
restrictions on the scope of the independent auditor&#146;s activities or on access to requested information, and any significant disagreements with management and (b) management&#146;s responses to such matters, and all other items required by law.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Set clear hiring policies for employees or former employees of the independent auditor. At a minimum, these policies should provide that any registered public
accounting firm may not provide audit services to the Company if the CEO, Controller, CFO, Chief Accounting Officer or any person serving in an equivalent capacity for the Company was employed by the registered public accounting firm and
participated in the audit of the Company within one year of the initiation of the current audit. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">19.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Report regularly to the Board of Directors. Such report to the Board of Directors may take the form of an oral report by the Chairman or any other member of the
Committee designated by the Committee to make such report. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Perform a review and evaluation, at least annually, of the performance of the Committee. The Audit Committee shall solicit feedback from the Board, CEO, CFO, and the
external auditor on specific opportunities to improve Audit Committee effectiveness. In addition, the Committee shall review and reassess, at least annually, the adequacy of this Charter and recommend to the Board Directors any improvements to the
Charter that the Committee considers necessary or valuable. The Committee shall conduct such evaluations and reviews in such a manner as it deems appropriate. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">21.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Review periodically the effect of accounting initiatives on the financial statements of the Company. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">22.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">At least annually, receive a report by the external auditors describing any material issues raised by the most recent internal quality control review by the local
practice office or by any inquiry or investigation by governmental or professional authorities of the local practice office, within the preceding two years, and steps taken to address any such issues. The report shall also include any similar
matters pertaining to offices other than the local practice office, to the extent the audit partner is aware of such matters. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Discuss with management an outline of press releases or announcements regarding results of operations as well as general policies on earnings guidance to be provided
to analysts, rating agencies, and the general public. Review any relevant items with management and the Company&#146;s independent auditors prior to release of any such press releases or earnings guidance. The review shall be with the Chairman of
the Audit Committee or the full Committee, as may be appropriate. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Management is responsible for preparing the financial statements for the Company completely, accurately and in accordance with generally accepted accounting
principles. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">C.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The independent auditors are responsible for performing an audit of the Company&#146;s financial statements in accordance with auditing standards generally accepted
in the United States and expressing an opinion on whether the Company&#146;s financial statements present fairly, in all material aspects, the Company&#146;s financial condition and results of operations for the periods presented and conform with
accounting principles generally accepted in the United States. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Appendix B
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR Surgical Company 2003 Omnibus
Equity Incentive Plan </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>2003 OMNIBUS EQUITY INCENTIVE PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">STAAR Surgical Company, a Delaware corporation (the &#147;Company&#148;), by action of its Board of
Directors, hereby adopts the STAAR Surgical Company 2003 Omnibus Equity Incentive Plan (the &#147;Plan&#148;) with the following provisions: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.&nbsp;&nbsp;&nbsp;&nbsp;<I>Purpose and Scope</I>. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;<I>Purpose.</I>&nbsp;&nbsp;&nbsp;&nbsp;The purpose of the Plan is to promote
and advance the interests of the Company and its stockholders by enabling the Company and its Affiliates to attract, retain and motivate officers, directors, employees and independent contractors by providing for performance-based benefits, and to
strengthen the mutuality of interests between such persons and the Company&#146;s stockholders. The Plan is designed to meet this intent by offering performance-based stock and cash incentives and other equity-based incentive awards, thereby
providing a proprietary interest in pursuing the long-term growth, profitability and financial success of the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Scope.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Plan amends, restates and replaces in their entirety the following
outstanding plans of the Company (the &#147;Restated Plans&#148;): 1991 Stock Option Plan of STAAR Surgical Company, the 1995 STAAR Surgical Company Consultant Stock Plan, the 1996 STAAR Surgical Company Non-Qualified Stock Plan, the 1998 STAAR
Surgical Company Stock Plan and the STARR Surgical Company Stock Option Plan and Agreement for Chief Executive Officer. Each award or grant outstanding under a Restated Plan shall continue to be governed by the terms of that Restated Plan. Any
shares of Common Stock available for Awards under the Restated Plans, included shares that become available pursuant to Section&nbsp;4(b)(iii) of the Plan, shall be treated as part of the pool of shares of Common Stock available for Awards under the
Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">2.&nbsp;&nbsp;&nbsp;&nbsp;<I>Definitions.&nbsp;&nbsp;&nbsp;&nbsp;</I>For purposes of this Plan, the following terms shall have the meanings set forth below: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Affiliate&#148; means any parent or subsidiary (as defined in Sections 424(e) and (f) of the Code) of
the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;APB 25&#148; means Opinion 25
of the Accounting Principles Board, as amended, and any successor thereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Award&#148; means an award or grant made to a Participant under Sections 6 through 10, inclusive, of the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Board&#148; means the Board of Directors of the Company. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Change in Control&#148; means the occurrence of any one
(or more) of the following events: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(i)&nbsp;&nbsp;Any person, including a group as defined in Section 13(d)(3) of the Exchange Act, becomes the beneficial owner of stock of the Company with respect to which twenty-five percent (25%) or more of the total number of
votes for the election of the Board may be cast; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">(ii)&nbsp;&nbsp;As a result of, or in connection with, any cash tender offer, exchange offer, merger or other business combination, sale of assets or contested election, or combination of the foregoing, persons who were
directors of the Company just prior to such event shall cease to constitute a majority of the Board; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii)&nbsp;&nbsp;The stockholders of the Company shall approve an agreement providing either for a transaction in which
the Company will cease to be an independent publicly owned corporation or for a sale or other disposition of all or substantially all the assets of the Company; or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iv)&nbsp;&nbsp;acquisition in a single or series of related transactions, including without
limitation a tender offer or exchange offer, by any person or related group of persons (other than the Company or by a Company-sponsored employee benefit plan), of beneficial ownership (within the meaning of Rule 13d-3 of the </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#146;s outstanding
securities. </FONT></P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Notwithstanding
the foregoing, the formation of a holding company for the Company in which the stockholdings of the holding company after its formation are substantially the same as for the Company prior to the holding company formation does not constitute a Change
in Control for purposes of this Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;Code&#148; means the Internal Revenue Code of 1986, as amended and in effect from time to time, or any successor thereto, together with rules, regulations and authoritative interpretations promulgated thereunder. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Committee&#148; means the committee of the Board that is
provided for in Section 3 of the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;Common Stock&#148; means the common stock of the Company or any security of the Company issued in substitution, exchange or lieu thereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Company&#148; means STAAR Surgical Company, a Delaware corporation. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Consultant&#148; means any natural person who performs bona fide services for the Company or an
Affiliate as a consultant or advisor, excluding Employees and Non-Employee Directors. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Date of Grant&#148; means the effective date as of which the Committee (or the Board, as the case may be) grants an Award to a Participant. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Disability&#148; means total and permanent disability as
defined in Section 22(e)(3) of the Code. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;Employee&#148; means any individual who is a common-law employee of the Company or an Affiliate. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Exchange Act&#148; means the Securities Exchange Act of 1934, as amended and in effect from time to time, or any successor thereto,
together with rules, regulations and authoritative interpretations promulgated thereunder. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Fair Market Value&#148; means on any given date, the closing price for the Common Stock on such date, or, if the Common Stock was not traded on such date, on the next preceding day on which the
Common Stock was traded, determined in accordance with the following rules: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(i)&nbsp;&nbsp;If the Common Stock is admitted to trading or listing on a national securities exchange registered under the Exchange Act, the closing price for any day shall be the last reported sale
price, or in the case no such reported sale takes place on such date, the average of the last reported bid and ask prices, in either case on the principal national securities exchange on which the Common Stock is admitted to trading or listed;
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(ii)&nbsp;&nbsp;If not listed
or admitted to trading on any national securities exchange, the last sale price of the Common Stock on the National Association of Securities Dealers Automated Quotation National Market System (&#147;NMS&#148;) or, in the case no such reported sale
takes place, the average of the closing bid and ask prices on such date; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii)&nbsp;&nbsp;If not quoted on the NMS, the average of the closing bid and ask prices of the Common Stock on the National Association of Securities Dealers Automated Quotation System
(&#147;NASDAQ&#148;) or any comparable system; or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">(iv)&nbsp;&nbsp;If the Common Stock is not listed on NASDAQ or any comparable system, the closing bid and ask prices as furnished by any member of the National Association of Securities Dealers, Inc., selected from time to
time by the Committee for that purpose. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;FASB&#148; means the Financial Accounting Standards Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;Incentive Stock Option&#148; means any Stock Option granted pursuant to the provisions of Section 6 of the Plan that is intended to be and is specifically designated as an &#147;incentive stock option&#148; within the meaning
of Section 422 of the Code. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Mature
Shares&#148; shall mean Shares that had been held by the Optionee for a meaningful period of time such as six months or such other period of time that is consistent with FASB&#146;s interpretation of APB 25. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Non-Employee Director&#148; means a non-Employee member
of the Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Non-Qualified Stock
Option&#148; means any Stock Option granted pursuant to the provisions of Section 6 of the Plan that is not an Incentive Stock Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Optioned Stock&#148; means the shares of Common Stock that are subject to a Stock Option. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Participant&#148; means an Employee, Non-Employee
Director, or Consultant of the Company or an Affiliate who is granted an Award under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Performance Award&#148; means an Award granted pursuant to the provisions of Section 9 of the Plan, the vesting of which is contingent on the attainment of specified performance criteria.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Performance Share Grant&#148; means an
Award of units representing shares of Common Stock granted pursuant to the provisions of Section 9 of the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Performance Unit Grant&#148; means an Award of monetary units granted pursuant to the provisions of Section&nbsp;9 of the Plan.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Plan&#148; means this STAAR Surgical
Company 2003 Omnibus Equity Incentive Plan, as set forth herein and as it may be hereafter amended and from time to time in effect. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Qualified Note&#148; means a recourse note, with a market rate of interest, that may, at the discretion of the Committee, be secured
by the Optioned Stock or otherwise. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;Restricted Award&#148; means an Award granted pursuant to the provisions of Section 8 of the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Restricted Stock Grant&#148; means an Award of shares of Common Stock granted pursuant to the provisions of Section 8 of the Plan.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Restricted Unit Grant&#148; means an Award
of units representing shares of Common Stock granted pursuant to the provisions of Section 8 of the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Service&#148; means the performance of services for the Company (or any Affiliate) by an Employee, Non-Employee Director, or
Consultant, as determined by the Committee in its sole discretion. Service shall not be considered interrupted in the case of (i) any leave of absence approved by the Company or (ii) transfers between locations of the Company or between the Company
and any Affiliate, or any successor. A leave of absence approved by the Company shall include sick leave, military leave, or any other personal leave approved by an authorized representative of the Company. For purposes of Incentive Stock Options,
no such leave may exceed ninety (90) days, unless reemployment upon expiration of such leave is guaranteed by statute or contract, including Company policies. If reemployment upon expiration of a leave of absence approved by the Company is not so
guaranteed, on the ninety-first (91st) day of such leave any Incentive Stock Option held by the Optionee shall cease to be treated as an Incentive Stock Option and shall be treated for tax purposes as a Non-Qualified Stock Option. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Stock
Appreciation Right&#148; means an Award to benefit from the appreciation of Common Stock granted pursuant to the provisions of Section 7 of the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Stock Option&#148; means an Award to purchase shares of Common Stock granted pursuant to the provisions of Section 6 of the Plan.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Subsidiary&#148; means any corporation or
entity which is a subsidiary of the Company within the meaning of Section 424(f) of the Code. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Ten Percent Stockholder&#148; means a person who owns stock (after taking into account the constructive ownership rules of Section 424(d) of the Code) possessing more than ten percent (10%) of
the total combined voting power of all classes of stock of the Company (or any Affiliate). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;Termination Date&#148; means the date on which a Participant&#146;s Service terminates, as determined by the Committee in its sole discretion. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.&nbsp;&nbsp;&nbsp;&nbsp;<I>Administration</I>. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;The Plan shall be administered
by a committee appointed by the Board. The Committee shall be comprised solely of not less than two persons who are &#147;outside directors&#148; within the meaning of Section&nbsp;162(m)(4)(C) of the Code and &#147;non-employee directors&#148;
within the meaning of Rule 16b-3 of the Exchange Act. Members of the Committee shall serve at the pleasure of the Board and the Board may from time to time remove members from, or add members to, the Committee. No person who is not an &#147;outside
director&#148; within the meaning of Section 162(m)(4)(C) of the Code and a &#147;non-employee director&#148; within the meaning of Rule 16b-3 of the Exchange Act may serve on the Committee. Appointment to the Committee of any person who is not an
&#147;outside director&#148; and a &#147;non-employee director&#148; shall automatically be null and void, and any person on the Committee who ceases to be an &#147;outside director&#148; and a &#147;non-employee director&#148; shall automatically
and without further action cease to be a member of the Committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;A majority of the members of the Committee shall constitute a quorum for the transaction of business. Action approved in writing by a majority of the members of the Committee then
serving shall be as effective as if the action had been taken by unanimous vote at a meeting duly called and held. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;The Committee is authorized to construe and interpret the Plan, to promulgate, amend, and rescind rules and
procedures relating to the implementation of the Plan, and to make all other determinations necessary or advisable for the administration of the Plan. Any determination, decision, or action of the Committee in connection with the construction,
interpretation, administration, or application of the Plan shall be binding upon all Participants and any person claiming under or through any Participant. Although the Committee is anticipated to make certain Awards that constitute &#147;qualified
performance-based compensation&#148; within the meaning of Section 162(m)(4)(C) of the Code and Treasury Regulation Section&nbsp;1.162-27(e), the Committee is also expressly authorized to make Awards that do not constitute &#147;qualified
performance-based compensation&#148; within the meaning of those provisions. By way of example, and not by way of limitation, the Committee, in its sole and absolute discretion, may issue an Award that is not based on a performance goal, as set
forth in (i) below, but is based solely on continued service to the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;The Committee may employ or retain persons other than members of the Committee to assist the Committee to carry out its responsibilities under such conditions and limitations as it may
prescribe, except that the Committee may not delegate its authority with regard to selection for participation in and the granting of Awards to persons subject to Section 16 of the Exchange Act or with regard to any of its duties under Section
162(m) of the Code necessary for awards under this Plan to constitute &#147;qualified performance-based compensation&#148; within the meaning of Section 162(m)(4)(C) of the Code and Treasury Regulation Section 1.162-27(e). </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(e)&nbsp;&nbsp;The Committee is expressly authorized to make such modifications to the Plan as are necessary to effectuate the intent of the Plan as a result of any changes in the income tax, accounting, or securities law treatment
of Participants and the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(f)&nbsp;&nbsp;The Company shall effect the granting of Awards under the Plan in accordance with the determinations made by the Committee, by execution of instruments in writing in such form as approved by the Committee.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(g)&nbsp;&nbsp;The Committee may
not increase an Award once granted, although it may grant additional Awards to the same Participant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(h)&nbsp;&nbsp;The Committee shall keep the Board informed as to its actions and make available to the Board its books and
records. Although the Committee has the authority to establish and administer the Plan, the Board reserves the right at any time to abolish the Committee and administer the Plan itself. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(i)&nbsp;&nbsp;In the case of an Award that is intended to constitute &#147;qualified
performance-based compensation&#148; within the meaning of Section 162(m)(4)(C) of the Code and Treasury Regulation Section 1.162-27(e), the Committee shall establish in writing at the time of making the Award the business criterion or criteria that
must be satisfied for payment pursuant to the Award and the amount payable upon satisfaction of those standards. Those standards are also referred to herein as performance goals. Such criterion or criteria shall be established prior to the
Participant rendering the services to which they relate and while the outcome is substantially uncertain or at such other time permitted under Treasury Regulations Section 1.162-27(e)(2). In carrying out these duties, the Committee shall use
objective written standards for establishing both the performance goal and the amount of compensation such that a third party with knowledge of the relevant facts would be able to determine whether and to what extent the goal has been satisfied and
the amount of compensation payable. The Committee shall provide a copy the document setting forth such standards to the affected Participant and shall retain such written material in its permanent books and records. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(j)&nbsp;&nbsp;In the case of remuneration
that is intended to constitute &#147;qualified performance-based compensation&#148; within the meaning of Section 162(m)(4)(C) of the Code and Treasury Regulation Section&nbsp;1.162-27(e), the Committee and the Board shall disclose to the
stockholders of the Company the material terms under which such remuneration is to be paid under the Plan, and shall seek approval of the stockholders by a majority vote in a separate stockholder vote before payment of such remuneration. For these
purposes, the material terms include the individuals (or class of individuals) eligible to receive such compensation, a description of the business criterion or criteria on which the performance goal is based, either the maximum amount of the
compensation to be paid thereunder or the formula used to calculate the amount of compensation if the performance goal is attained, and such other terms as required under Code Section 162(m)(4)(C) and the Treasury Regulations promulgated thereunder,
determined from time to time. The foregoing actions shall be undertaken in conformity with the rules of Code Section 162(m)(4)(C)(ii) and Treasury Regulations promulgated thereunder. Such remuneration shall not be payable under this Plan in the
absence of such an approving stockholder vote. In the case of remuneration that is not intended to constitute &#147;qualified performance-based compensation&#148; within the meaning of Section 162(m)(4)(C) of the Code and Treasury Regulation Section
1.162-27(e), the Committee and the Board shall make such disclosures to and seek such approval from the stockholders of the Company as they reasonably determine are required by law. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(k)&nbsp;&nbsp;To the extent required under Code Section 162(m)(4)(C) and the regulations
promulgated thereunder, before any payment of remuneration under this Plan, the Committee must certify in writing that the performance goals and any other material terms of the Award were in fact satisfied. Such certification shall be kept with the
permanent books and records of the Committee, and the Committee shall provide the affected Participant with a copy of such certification. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(l)&nbsp;&nbsp;The Committee shall use its good faith best efforts to comply with the requirements of
Section&nbsp;162(m)(4)(C) of the Code and the regulations promulgated thereunder for Awards that are intended </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">to constitute &#147;qualified performance-based compensation,&#148; but shall have no liability to the Company or any recipient in the event
one or more Awards do not so qualify. </FONT></P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">4.&nbsp;&nbsp;&nbsp;&nbsp;<I>Duration of and Common Stock Subject to the Plan</I>. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;<I>Term</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall become effective as of May 14, 2003, the date of its
adoption by the Board, subject to ratification by the stockholders of the Company within twelve (12) months after the effective date. In the event that the stockholders of the Company do not ratify the Plan within twelve (12) months after the
effective date, any Awards granted pursuant to the Plan shall be rescinded automatically. Unless sooner terminated by the Board, the Plan shall continue until May 13, 2013, one day prior to the tenth (10th) anniversary of the Plan&#146;s effective
date, when it shall terminate and no Awards may be granted under the Plan thereafter. The termination of the Plan shall not affect the Awards that are outstanding on the termination date. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Shares of Common Stock Subject to the Plan</I>.&nbsp;&nbsp;&nbsp;&nbsp;The
maximum total number of shares of Common Stock with respect to which aggregate stock Awards may be granted under the Plan (including shares of Common Stock subject to outstanding Awards under the Restated Plans) shall be four million, nine hundred
thirteen thousand, six hundred twenty-nine (4,913,629), plus the additional number of shares of Common Stock provided for in the following sentence. During the term of the Plan, on each January 1, the maximum total number of shares of Common Stock
with respect to which aggregate stock Awards may be granted under the Plan shall automatically increase by the number of shares equal to two percent (2%) of the total number of shares of Common Stock outstanding on the immediately preceding December
31. For illustrative purposes only, if the number of shares of Common Stock outstanding as of December 31, 2003 is one million (1,000,000), then the number of shares available for purposes of the Plan will be increased as of January 1, 2004 by an
additional twenty thousand (20,000) shares of Common Stock. Notwithstanding the foregoing, the annual automatic increases described above shall add a maximum of 1,586,371 shares of Common Stock to the shares available for purposes of the Plan. The
maximum number of shares of Common Stock which may be issued pursuant to Incentive Stock Options under this Plan may not exceed six million, five hundred thousand (6,500,000). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(i)&nbsp;&nbsp;All of the amounts stated in this Paragraph (b) are subject to adjustment as
provided in Section&nbsp;15 below. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(ii)&nbsp;&nbsp;For the purpose of computing the total number of shares of Common Stock available for Awards under the Plan, there shall be counted against the foregoing limitations the number of shares of Common Stock subject to
issuance upon exercise or used for payment or settlement of Awards. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii)&nbsp;&nbsp;If any Awards are forfeited, terminated, expire unexercised, settled or paid in cash in lieu of stock or exchanged for other Awards, the shares of Common Stock which were theretofore
subject to such Awards shall again be available for Awards under the Plan to the extent of such forfeiture or expiration of such Awards. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;<I>Source of Common Stock</I>.&nbsp;&nbsp;&nbsp;&nbsp;Common Stock which may be issued under the Plan may
be either authorized and unissued stock or issued stock that has been reacquired by the Company. No fractional shares of Common Stock shall be issued under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.&nbsp;&nbsp;&nbsp;&nbsp;<I>Eligibility.</I>&nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock Options may only be
granted to Employees of the Company or a Subsidiary. Employees, Non-Employee Directors, and Consultants of the Company or a Subsidiary are eligible to receive Non-Qualified Stock Options, Stock Appreciation Rights, Restricted Awards, Performance
Awards and other Awards under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">6.&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock Options.</I>&nbsp;&nbsp;&nbsp;&nbsp;Stock options granted under the Plan may be in the form of Incentive Stock Options or Non-Qualified Stock Options (collectively referred to as &#147;Stock
Options&#148;). Stock Options shall be subject to the </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">terms and conditions set forth below. Each written Stock Option agreement shall contain such additional terms and conditions, not
inconsistent with the express provisions of the Plan, as the Committee shall deem desirable. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;<I>Grant.</I>&nbsp;&nbsp;&nbsp;&nbsp;Stock Options shall be granted under the Plan on such terms and
conditions not inconsistent with the provisions of the Plan and pursuant to written agreements with the Participant in such form as the Committee may from time to time approve in its sole and absolute discretion. The terms of individual Stock Option
agreements need not be identical. Each Stock Option agreement shall state specifically whether it is intended to be an Incentive Stock Option agreement or a Non-Qualified Stock Option agreement. Stock Options may be granted alone or in addition to
other Awards under the Plan. No person may be granted (in any calendar year) options to purchase more than two hundred thousand (200,000) shares of Common Stock (subject to adjustment pursuant to Section 15 below). The foregoing sentence is an
annual limitation on grants and not a cumulative limitation. Any Stock Option repriced during a year shall count against this annual limitation. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Exercise Price.</I>&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided for in Paragraph (f) below, the
exercise price per share of Common Stock purchasable under a Stock Option shall be determined by the Committee at the time of grant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;<I>Option Term.</I>&nbsp;&nbsp;&nbsp;&nbsp;The term of each Stock Option shall be fixed by the Committee.
However, the term of any Stock Option shall not exceed ten (10) years after the Date of Grant of such Stock Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;<I>Exercisability.</I>&nbsp;&nbsp;&nbsp;&nbsp;A Stock Option shall be exercisable at such time or times and
subject to such terms and conditions as shall be determined by the Committee at the Date of Grant and set forth in the written Stock Option agreement. A written Stock Option agreement may, if permitted pursuant to its terms, become exercisable in
full upon the occurrence of events selected by the Committee that are beyond the control of the Participant (including, but not limited to, a Change in Control). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)&nbsp;&nbsp;<I>Method of Exercise.</I>&nbsp;&nbsp;&nbsp;&nbsp;A Stock Option may be
exercised, in whole or in part, by giving written notice of exercise to the Committee specifying the number of shares of Common Stock to be purchased. Such notice shall be accompanied by payment in full of the exercise price (i) in cash or (ii) if
acceptable to the Committee, in shares of Common Stock already owned by the Participant or a Qualified Note. The Committee may also permit Participants, either on a selective or aggregate basis, to simultaneously exercise Stock Options and sell the
shares of Common Stock thereby acquired, pursuant to a brokerage or similar arrangement, approved in advance by the Committee, and use the proceeds from such sale as payment of part or all of the exercise price of such shares; provided, that such
payment would not cause the Company to recognize compensation expense for financial reporting purposes or to violate Section 402 of the Sarbanes-Oxley Act of 2002, as determined by the Committee in its sole discretion. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(f)&nbsp;&nbsp;<I>Special Rules for Incentive
Stock Options.</I>&nbsp;&nbsp;&nbsp;&nbsp;The terms specified below shall be applicable to all Incentive Stock Options. Stock Options which are specifically designated as Non-Qualified Stock Options when issued under the Plan shall not be subject to
the terms of this Paragraph. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(i)&nbsp;&nbsp;<I>Exercise Price</I>.&nbsp;&nbsp;&nbsp;&nbsp;In the case of an Incentive Stock Option, the exercise price of such Stock Option may not be less than one hundred percent (100%) of the Fair Market Value of the Common
Stock on the Date of the Grant of such Stock Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">(ii)&nbsp;&nbsp;<I>Ten Percent Stockholder.</I>&nbsp;&nbsp;&nbsp;&nbsp;If any Employee to whom an Incentive Stock Option is granted is a Ten Percent Stockholder, then the exercise price of the Incentive Stock Option shall
not be less than one hundred and ten percent (110%) of the Fair Market Value of the Common Stock on the Date of Grant of such Incentive Stock Option, and the term of the Incentive Stock Option shall not exceed five (5) years measured from the Date
of Grant of such option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(iii)&nbsp;&nbsp;<I>Dollar Limitation.</I>&nbsp;&nbsp;&nbsp;&nbsp;In the case of an Incentive Stock Option, the aggregate Fair Market Value of the Optioned Stock (determined as of the Date of Grant of each Stock Option) with respect
to Stock Options granted to any Employee under the Plan (or any other option plan of the Company or any Affiliate) that may for the first time become exercisable as Incentive Stock Options during any one calendar year shall not exceed the sum of one
hundred thousand dollars ($100,000). To the extent the Employee holds two or more such Stock Options which become exercisable for the first time in the same calendar year, the foregoing limitation on the exercisability of such Stock Options as
Incentive Stock Options shall be applied on the basis of the order in which such Stock Options are granted. Any Stock Options in excess of such limitation shall automatically be treated as Non-Qualified Stock Options. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock Appreciation
Rights.</I>&nbsp;&nbsp;&nbsp;&nbsp;The grant of Stock Appreciation Rights under the Plan shall be subject to the following terms and conditions. Furthermore, the Stock Appreciation Rights shall contain such additional terms and conditions, not
inconsistent with the express terms of the Plan, as the Committee shall deem desirable. The terms of each Stock Appreciation Right granted shall be set forth in a written agreement between the Company and the Participant receiving such grant. The
terms of such agreements need not be identical. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(a)&nbsp;&nbsp;<I>Stock Appreciation Rights</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Stock Appreciation Right is an Award determined by the Committee entitling a Participant to receive an amount equal to the excess of the Fair Market Value of a
share of Common Stock on a fixed date, which shall be the date concluding a measuring period set by the Committee upon granting the Stock Appreciation Right, over the Fair Market Value of a share of Common Stock on the Date of Grant of the Stock
Appreciation Right, multiplied by the number of shares of Common Stock subject to the Stock Appreciation Right. No Stock Appreciation Rights granted in any calendar year to any person may be measured by an amount of shares of Common Stock in excess
of two hundred thousand (200,000) shares, subject to adjustment under Section 15 below. The foregoing sentence is an annual limitation on grants and not a cumulative limitation. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Grant</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Stock Appreciation Right may be granted
in addition to or completely independently of any other Award under the Plan. Upon grant of a Stock Appreciation Right, the Committee shall select and inform the Participant regarding the number of shares of Common Stock subject to the Stock
Appreciation Right and the date that constitutes the close of the measuring period. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;<I>Measuring Period</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Stock Appreciation Right shall accrue in value from the
Date of Grant over a time period established by the Committee. In the written Stock Appreciation Right agreement, the Committee may also provide (but is not required to provide) that a Stock Appreciation Right shall be automatically payable on one
or more specified dates prior to the normal end of the measuring period upon the occurrence of events selected by the Committee (including, but not limited to, a Change in Control) that are beyond the control of the Participant. The Committee may
provide (but is not required to provide) in the Stock Appreciation Right agreement that in the case of a cash payment such acceleration in payment shall also be subject to discounting of the payment to reasonably reflect the time value of money
using any reasonable discount rate selected by the Committee in accordance with Treasury Regulations under Code Section 162(m). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;<I>Form of Payment</I>.&nbsp;&nbsp;&nbsp;&nbsp;Payment pursuant to a Stock Appreciation Right may be made
(i) in cash, (ii)&nbsp;in shares of Common Stock or (iii) in any combination of the above, as the Committee shall determine in its sole and absolute discretion. The Committee may elect to make this determination either at the time the Stock
Appreciation Right is granted, at the time of payment or at any time in between such dates. However, any Stock Appreciation Right paid upon or subsequent to the occurrence of a Change in Control shall be paid in cash. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.&nbsp;&nbsp;&nbsp;&nbsp;<I>Restricted
Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;Restricted Awards granted under the Plan may be in the form of either Restricted Stock Grants or Restricted Unit Grants. Restricted Awards shall be subject to the following terms and conditions. Furthermore, the
Restricted Awards shall be pursuant to a written agreement executed both by the Company and </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">the Participant, which agreement shall contain such additional terms and conditions, not inconsistent with the express provisions of the
Plan, as the Committee shall deem desirable in its sole and absolute discretion. The terms of such written agreements need not be identical. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;<I>Restricted Stock Grants.</I>&nbsp;&nbsp;&nbsp;&nbsp;A Restricted Stock Grant is an Award of shares of
Common Stock transferred to a Participant subject to such terms and conditions as the Committee deems appropriate, as set forth in Paragraph (d) below. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Restricted Unit Grants.</I>&nbsp;&nbsp;&nbsp;&nbsp;A Restricted Unit Grant is an Award of units (with
each unit having a value equivalent to one share of Common Stock) granted to a Participant subject to such terms and conditions as the Committee deems appropriate, including, without limitation, the requirement that the Participant forfeit all or a
portion of such units upon termination of Service for specified reasons within a specified period of time, and restrictions on the sale, assignment, transfer or other disposition of such units. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;<I>Grants of
Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;Restricted Awards may be granted under the Plan in such form and on such terms and conditions as the Committee may from time to time approve. Restricted Awards may be granted alone or in addition to other Awards
under the Plan. Subject to the terms of the Plan, the Committee shall determine the number of Restricted Awards to be granted to a Participant and the Committee may impose different terms and conditions (including performance goals) on any
particular Restricted Award made to any Participant. Each Participant receiving a Restricted Stock Grant shall be issued a stock certificate in respect of such shares of Common Stock. Such certificate shall be registered in the name of such
Participant, shall be accompanied by a stock power duly executed by such Participant, and shall bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Award. The certificate evidencing the shares shall be
held in custody by the Company until the restrictions imposed thereon shall have lapsed or been removed. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;<I>Restriction Period.</I>&nbsp;&nbsp;&nbsp;&nbsp;Restricted Awards shall provide that in order for a
Participant to vest in such Awards, the Participant must continuously provide Services, subject to relief for specified reasons, for such period as the Committee may designate at the time of the Award (&#147;Restriction Period&#148;). If the
Committee so provides in the written agreement with the Participant, a Restricted Award may also be subject to satisfaction of such performance goals as are set forth in such agreement. During the Restriction Period, a Participant may not sell,
assign, transfer, pledge, encumber, or otherwise dispose of shares of Common Stock received under a Restricted Stock Grant. The Committee, in its sole discretion, may provide for the lapse of restrictions during the Restriction Period upon the
occurrence of events selected by the Committee that are beyond the control of the Participant (including, but not limited to, a Change in Control). The Committee may provide (but is not required to provide) in the written agreement with the
Participant that in the case of a cash payment such acceleration in payment shall also be subject to discounting of the payment to reasonably reflect the time value of money using any reasonable discount rate selected by the Committee in accordance
with Treasury Regulations under Code Section 162(m). Upon expiration of the applicable Restriction Period (or lapse of restrictions during the Restriction Period where the restrictions lapse in installments or by action of the Committee), the
Participant shall be entitled to receive his or her Restricted Award or portion thereof, as the case may be. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)&nbsp;&nbsp;<I>Payment of Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Participant who receives a Restricted Stock Grant shall
be paid solely by release of the restricted stock at the termination of the Restriction Period (whether in one payment, in installments or otherwise). A Participant shall be entitled to receive payment for a Restricted Unit Grant (or portion
thereof) in an amount equal to the aggregate Fair Market Value of the shares of Common Stock covered by such Award upon the expiration of the applicable Restriction Period. Payment in settlement of a Restricted Unit Grant shall be made as soon as
practicable following the conclusion of the specified Restriction Period (i) in cash, (ii) in shares of Common Stock equal to the number of units granted under the Restricted Unit Grant with respect to which such payment is made, or (iii) in any
combination of the above, as the Committee shall determine in its sole and absolute discretion. The Committee may elect to make this </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">determination either at the time the Award is granted, at the time of payment or at any time in between such&nbsp;dates.
</FONT></P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(f)&nbsp;&nbsp;<I>Rights as a Stockholder</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Participant shall have, with respect to the shares of Common Stock received under a Restricted Stock Grant, all of the rights of a stockholder of the Company,
including the right to vote the stock, and the right to receive any cash dividends. Such cash dividends shall be withheld, however, until their release upon lapse of the restrictions under the Restricted Award. Stock dividends issued with respect to
the shares covered by a Restricted Stock Grant shall be treated as additional shares under the Restricted Stock Grant and shall be subject to the same restrictions and other terms and conditions that apply to shares under the Restricted Stock Grant
with respect to which the dividends are issued. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">9.&nbsp;&nbsp;&nbsp;&nbsp;<I>Performance Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;Performance Awards granted under the Plan may be in the form of either Performance Share Grants or Performance Unit Grants. Performance Awards shall be
subject to the terms and conditions set forth below. Furthermore, the Performance Awards shall be subject to written agreements which shall contain such additional terms and conditions, not inconsistent with the express provisions of the Plan, as
the Committee shall deem desirable in its sole and absolute discretion. Such agreements need not be identical. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;<I>Performance Share Grants</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Performance Share Grant is an Award of units
(with each unit equivalent in value to one share of Common Stock) granted to a Participant subject to such terms and conditions as the Committee deems appropriate, including, without limitation, the requirement that the Participant forfeit such
units (or a portion of such units) in the event certain performance criteria are not met within a designated period of time. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Performance Unit Grants</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Performance Unit Grant is an Award of units (with
each unit representing such monetary amount as designated by the Committee) granted to a Participant subject to such terms and conditions as the Committee deems appropriate, including, without limitation, the requirement that the Participant forfeit
such units (or a portion of such units) in the event certain performance criteria are not met within a designated period of time. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;<I>Grants of Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;Performance Awards shall be granted under the Plan pursuant
to written agreements with the Participant in such form as the Committee may from time to time approve. Performance Awards may be granted alone or in addition to other Awards under the Plan. Subject to the terms of the Plan, the Committee shall
determine the number of Performance Awards to be granted to a Participant and the Committee may impose different terms and conditions on any particular Performance Award made to any Participant. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;<I>Performance Goals and
Performance Periods</I>.&nbsp;&nbsp;&nbsp;&nbsp;Performance Awards shall provide that, in order for a Participant to vest in such Awards, the Company must achieve certain performance goals (&#147;Performance Goals&#148;) over a designated
performance period selected by the Committee (&#147;Performance Period&#148;). The Performance Goals and Performance Period shall be established by the Committee, in its sole and absolute discretion. The Committee shall establish Performance Goals
for each Performance Period before the commencement of the Performance Period and while the outcome is substantially uncertain or at such other time permitted under Treasury Regulations Section 1.162-27(e)(2). The Committee shall also establish a
schedule or schedules for such Performance Period setting forth the portion of the Performance Award which will be earned or forfeited based on the degree of achievement of the Performance Goals actually achieved or exceeded. In setting Performance
Goals, the Committee may use such measures as return on equity, earnings growth, revenue growth, comparisons to peer companies, or such other measure or measures of performance in such manner as it deems appropriate. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)&nbsp;&nbsp;<I>Payment of
Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;In the case of a Performance Share Grant, the Participant shall be entitled to receive payment for each unit earned in an amount equal to the aggregate Fair Market Value of the shares of Common Stock covered by
such Award as of the end of the Performance Period. In the case of a </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Performance Unit Grant, the Participant shall be entitled to receive payment for each unit earned in an amount equal to the dollar value of
each unit times the number of units earned. The Committee, pursuant to the written agreement with the Participant, may make such Performance Awards payable in whole or in part upon the occurrence of events selected by the Committee that are beyond
the control of the Participant (including, but not limited to, a Change in Control). The Committee may provide (but is not required to provide) in the written agreement with the Participant that, in the case of a cash payment, acceleration in
payment of a Performance Award shall also be subject to discounting to reasonably reflect the time value of money using any reasonable discount rate selected by the Committee in accordance with Treasury Regulations under Code Section 162(m). Payment
in settlement of a Performance Award shall be made as soon as practicable following the conclusion of the Performance Period (i) in cash, (ii) in shares of Common Stock, or (iii) in any combination of the above, as the Committee may determine in its
sole and absolute discretion. The Committee may elect to make this determination either at the time the Award is granted, at the time of payment, or at any time in between such dates. </FONT></P></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10.&nbsp;&nbsp;&nbsp;&nbsp;<I>Other Stock-Based and
Combination Awards.</I> </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(a)&nbsp;&nbsp;The Committee may grant other Awards under the Plan pursuant to which Common Stock is or may in the future be acquired, or Awards denominated in stock units, including ones valued using measures other than market
value. Such other stock-based grants may be granted either alone or in addition to any other type of Award granted under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;The Committee may also grant Awards under the Plan in combination with other Awards or in exchange of
Awards, or in combination with or as alternatives to grants or rights under any other employee plan of the Company, including the plan of any acquired entity. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;Subject to the provisions of the Plan, the Committee shall have authority to determine the individuals to
whom and the time or times at which the Awards shall be made, the number of shares of Common Stock to be granted or covered pursuant to such Awards, and any and all other conditions and/or terms of the Awards. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.&nbsp;&nbsp;&nbsp;&nbsp;<I>Deferral
Elections</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Committee may permit a Participant to elect to defer his or her receipt of the payment of cash or the delivery of shares of Common Stock that would otherwise be due to such Participant by virtue of the
exercise, earn out or vesting of an Award made under the Plan. If any such election is permitted, the Committee shall establish rules and procedures for such payment deferrals, including the possible (a) payment or crediting of reasonable interest
on such deferred amounts credited in cash, and (b) the payment or crediting of dividend equivalents in respect of deferrals credited in units of Common Stock. The Company and the Committee shall not be responsible to any person in the event that the
payment deferral does not result in deferral of income for tax purposes. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">12.&nbsp;&nbsp;&nbsp;&nbsp;<I>Dividend Equivalents</I>.&nbsp;&nbsp;&nbsp;&nbsp;Awards of Stock Options, Stock Appreciation Rights, Restricted Unit Grants, Performance Share Grants, and other stock-based Awards may, in the
sole and absolute discretion of the Committee, earn dividend equivalents. In respect of any such Award which is outstanding on a dividend record date for Common Stock, the Participant may be credited with an amount equal to the amount of cash or
stock dividends that would have been paid on the shares of Common Stock covered by such Award had such shares been issued and outstanding on such dividend record date. The Committee shall establish such rules and procedures governing the crediting
of dividend equivalents, including the timing, form of payment, and payment contingencies of such dividend equivalents, as it deems appropriate or necessary. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13.&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination of Service</I>.&nbsp;&nbsp;&nbsp;&nbsp;The terms and conditions under which an Award may be
exercised after a Participant&#146;s termination of Service shall be determined by the Committee and reflected in the written agreement with the Participant concerning the Award. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">14.&nbsp;&nbsp;&nbsp;&nbsp;<I>Non-Transferability of Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;No Award under the Plan, and no rights or interest therein, shall be assignable or transferable by a Participant except by will or the laws of
descent and distribution. Subject to the foregoing, during the lifetime of a Participant, Awards are exercisable only by, and payments in settlement of Awards will be payable only to, the Participant or his or her legal representative if the
Participant is Disabled. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">15.&nbsp;&nbsp;&nbsp;&nbsp;<I>Adjustments Upon Changes in Capitalization, Etc.</I> </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;The existence of the Plan and the Awards granted hereunder shall not affect or restrict in any way the
right or power of the Board or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#146;s capital structure or its business, any merger or consolidation of the Company,
any issue of bonds, debentures, preferred or prior preference stocks ahead of or affecting the Common Stock or the rights thereof, the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business,
or any other corporate act or proceeding. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(b)&nbsp;&nbsp;In the event of any change in capitalization affecting the Common Stock after the effective date of this Plan, such as a stock dividend, stock split, recapitalization, merger, consolidation, split-up, combination,
exchange of stock, other form of reorganization, or any other change affecting the Common Stock, such proportionate adjustments, if any, as the Committee in its discretion may deem appropriate to reflect such change shall be made with respect to (i)
the aggregate number of shares of Common Stock for which Awards in respect thereof may be granted under the Plan, (ii) the maximum number of shares of Common Stock which may be sold or awarded to any Participant, (iii) the number of shares of Common
Stock covered by each outstanding Award, and (iv) the price per share in respect of outstanding Awards. Such adjustments shall be made by the Committee so that the adjustments shall not result in an accounting consequence under APB 25 and FASB
Interpretation No. 44, as amended, and any successor thereof. The Committee&#146;s determination with respect to the adjustments shall be final, binding, and conclusive. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;The Committee may also make such adjustments in the number of shares covered
by, and the price or other value of any outstanding Awards in the event of a spin-off or other distribution (other than normal cash dividends) of Company assets to stockholders. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16.&nbsp;&nbsp;&nbsp;&nbsp;<I>Change in Control</I>.&nbsp;&nbsp;&nbsp;&nbsp;To the extent that the Committee,
in its sole discretion, determines that the payments provided in Subsection (a) through (d) below do not constitute an &#147;excess parachute payment&#148; under Code Section 280G, and except as the Committee may in its discretion otherwise provide
in any Award agreement, in the event of a Change in Control: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;All outstanding Stock Options shall vest in their entirety and become exercisable immediately prior to the specified effective date of the Change in Control (and remain exercisable until
the time of termination specified in the relevant Award Agreement), unless such Stock Options are either (i) assumed by the successor corporation or its parent company pursuant to options providing substantially equal value and having substantially
equivalent provisions as the Stock Options granted under this Plan or (ii) the Stock Options are affirmed by the Company; </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;Notwithstanding paragraph (a) above, all Stock Options issued to non-employee directors shall vest in their
entirety and become exercisable immediately prior to the specified effective date of the Change in Control (and remain exercisable until the time of termination specified in the relevant Award Agreement) irrespective of whether such Stock Options
are assumed by the successor corporation or its parent company or are affirmed by the Company; </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)&nbsp;&nbsp;All restrictions and conditions of the Restricted Stock Grants and Restricted Unit Grants then outstanding
shall be deemed satisfied as of the date of the Change in Control; and </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(f)&nbsp;&nbsp;The Performance Share Grants and Performance Unit Grants shall be deemed to have been fully earned as of the date of the Change in Control. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">17.&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendment and Termination</I>.&nbsp;&nbsp;&nbsp;&nbsp;Without further approval of the stockholders, the Board may at any time terminate the Plan, or may amend it from time to time in such respects as the
Board may deem advisable. However, the Board may not, without approval of the stockholders, make any amendment which would (a)&nbsp;increase the aggregate number of shares of Common Stock which may be issued under the Plan (except for adjustments
pursuant to Section 15 above), (b) materially modify the requirements as to eligibility for participation in the Plan, or (c) materially increase the benefits accruing to Participants under the Plan. Notwithstanding the above, the Board may amend
the Plan to take into account changes in applicable securities laws, federal income tax laws and other applicable laws. Further, should the provisions of Rule 16b-3, or any successor rule, under the Exchange Act be amended, the Board may amend the
Plan in accordance with any modifications to that rule without the need for stockholder approval. Notwithstanding the foregoing, the Plan may not be amended more than once every six months other than to comply with the changes in the Code.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18.&nbsp;&nbsp;&nbsp;&nbsp;<I>Miscellaneous
Matters</I>. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(a)&nbsp;&nbsp;<I>Tax Withholding</I>. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">(i)&nbsp;&nbsp;The Company&#146;s obligation to deliver Common Stock and/or pay any amount under the Plan shall be subject to the satisfaction of all applicable federal, state, local, and foreign tax withholding
requirements. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(ii)&nbsp;&nbsp;The Committee may, in its discretion, provide the Participants or their successors with the right to use previously vested Common Stock in satisfaction of all or part of the taxes incurred by such Participants in
connection with the Plan; provided, however, that this form of payment shall be limited to the withholding amount calculated using the minimum applicable statutory rates. Such right may be provided to any such holder in either or both of the
following formats. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">1.&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock Withholding</I>:&nbsp;&nbsp;&nbsp;&nbsp;The election to have the Company withhold, from the Common Stock otherwise issuable under the Plan, a portion of the Common Stock with an aggregate Fair
Market Value equal to the taxes calculated using the minimum applicable statutory rates. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2.&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock Delivery</I>:&nbsp;&nbsp;&nbsp;&nbsp;The election to deliver to the Company, at the time the taxes are required to be withheld, one or more shares of Common Stock
previously acquired by the Participant or his or her successor with an aggregate Fair Market Value equal to the taxes calculated using the minimum statutory rates. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;<I>Not an Employment or Service Contract</I>.&nbsp;&nbsp;&nbsp;&nbsp;Neither
the adoption of the Plan nor the granting of any Award shall confer upon any Participant any right to continue in the Service of the Company or an Affiliate, as the case may be, nor shall it interfere in any way with the right of the Company or an
Affiliate to terminate the Services of any of its Employees, Non-Employee Directors, or Consultants at any time, with or without cause. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;<I>Unfunded Plan</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall be unfunded and the Company shall not be
required to segregate any assets that may at any time be represented by Awards under the Plan. Any liability of the Company to any person with respect to any Award under the Plan shall be based solely upon any written contractual obligations that
may be effected pursuant to the Plan. No such obligation of the Company shall be deemed to be secured by any pledge of, or other encumbrance on, any property of the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)&nbsp;&nbsp;<I>Annulment of Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;The grant of any Award
under the Plan payable in cash is provisional until cash is paid in settlement thereof. The grant of any Award payable in Common Stock is provisional until the Participant becomes entitled to the certificate in settlement thereof. Payment under any
Awards granted pursuant to the Plan is wholly contingent upon stockholder approval of the Plan. Where approval for an Award sought pursuant to Section 162(m)(4)(C)(ii) of the Code is not granted by the Company&#146;s stockholders, the Award shall be
annulled automatically. In the event the Service of a Participant is terminated for cause (as defined below), any Award which is provisional shall be annulled as of the date of </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-13 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">such termination for cause. For purposes of the Plan, the term &#147;terminated for cause&#148; means any discharge because of personal
dishonesty, willful misconduct, breach of fiduciary duty involving personal profit, continuing intentional or habitual failure to perform stated duties, violation of any law (other than minor traffic violations or similar misdemeanor offenses not
involving moral turpitude), or material breach of any provision of an employment or independent contractor agreement with the Company. </FONT></P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)&nbsp;&nbsp;<I>Other Company Benefit and Compensation Programs</I>.&nbsp;&nbsp;&nbsp;&nbsp;Payments and other benefits
received by a Participant under an Award made pursuant to the Plan shall not be deemed a part of a Participant&#146;s regular, recurring compensation for purposes of the termination indemnity or severance pay law of any state. Furthermore, such
benefits shall not be included in, nor have any effect on, the determination of benefits under any other employee benefit plan or similar arrangement provided by the Company or a Subsidiary unless expressly so provided by such other plan or
arrangement, or except where the Committee expressly determines that inclusion of an Award or portion of an Award should be included. Awards under the Plan may be made in combination with or in addition to, or as alternatives to, grants, awards or
payments under any other Company or Subsidiary plans. The Company or any Subsidiary may adopt such other compensation programs and additional compensation arrangements (in addition to this Plan) as it deems necessary to attract, retain, and motivate
officers, directors, employees or independent contractors for their service with the Company and its Subsidiaries. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(f)&nbsp;&nbsp;<I>Securities Law Restrictions</I>.&nbsp;&nbsp;&nbsp;&nbsp;No shares of Common Stock shall be issued under
the Plan unless counsel for the Company shall be satisfied that such issuance will be in compliance with applicable federal and state securities laws. Certificates for shares of Common Stock delivered under the Plan may be subject to such
stock-transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations, and other requirements of the Securities and Exchange Commission, any stock exchange upon which the Common Stock is then listed, and any
applicable federal or state securities law. The Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(g)&nbsp;&nbsp;<I>Award Agreement</I>.&nbsp;&nbsp;&nbsp;&nbsp;Each Participant receiving an
Award under the Plan shall enter into a written agreement with the Company in a form specified by the Committee agreeing to the terms and conditions of the Award and such related matters as the Committee shall, in its sole and absolute discretion,
determine. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(h)&nbsp;&nbsp;<I>Costs of Plan</I>.&nbsp;&nbsp;&nbsp;&nbsp;The costs and expenses of administering the Plan shall be borne by the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(i)&nbsp;&nbsp;<I>Governing Law</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Plan and all actions taken thereunder shall be governed by
and construed in accordance with the laws of the State of Delaware. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><DIV STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD VALIGN="top" COLSPAN="3" WIDTH="43%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">STAAR S<SMALL>URGICAL</SMALL> C<SMALL>OMPANY</SMALL>,</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">a Delaware corporation</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="43%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">/s/&nbsp;&nbsp;&nbsp;&nbsp;J<SMALL>OHN</SMALL>
B<SMALL>ILY&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SMALL></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="43%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>John Bily</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Secretary</B></FONT></P></TD></TR>
</TABLE></DIV><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Date: May 14, 2003
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-14 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Form of Notice of Option Grant and Stock Option Agreement </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Stock Option No.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>2003 OMNIBUS EQUITY INCENTIVE PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>NOTICE OF STOCK OPTION GRANT </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">You have been granted the following option to purchase Common Stock of STAAR Surgical Company, a Delaware corporation (the &#147;Company&#148;): </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Name of Optionee:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"><HR WIDTH="92%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Total Number of Shares Granted:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"><HR WIDTH="92%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(&#147;Optioned Stock&#148;)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Type of Option:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock Option</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" WIDTH="29%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;Non-Qualified Stock Option</FONT></P></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Exercise Price Per Share:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">$<U></U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Date of Grant:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"><HR WIDTH="92%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Date Exercisable:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" WIDTH="29%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">This option may be exercised with respect to the first &nbsp;&nbsp;&nbsp;&nbsp;% of the Optioned Stock
when the Optionee completes &nbsp;&nbsp;&nbsp;&nbsp; months of continuous Service after the Vesting Commencement Date. This option may be exercised with respect to an additional &nbsp;&nbsp;&nbsp;&nbsp;% of the Optioned Stock when the Optionee
completes each year of continuous Service thereafter.</FONT></P></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Vesting Commencement Date:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"><HR WIDTH="92%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="13"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="31%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Expiration Date:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="31%"><HR WIDTH="92%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-15 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By your signature and the
signature of the Company&#146;s representative below, you and the Company agree that this option is granted under and governed by the terms and conditions of the STAAR Surgical Company 2003 Omnibus Equity Incentive Plan and the Stock Option
Agreement, both of which are attached to and made a part of this document. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD VALIGN="bottom" WIDTH="44%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>OPTIONEE:</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" WIDTH="44%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR SURGICAL COMPANY</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center" WIDTH="44%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="44%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center" WIDTH="44%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Title:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="44%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="44%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Print Name</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center" WIDTH="44%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="44%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Social Security Number &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-16 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>2003 OMNIBUS EQUITY INCENTIVE PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STOCK OPTION AGREEMENT </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.&nbsp;&nbsp;&nbsp;&nbsp;<I>Definitions</I>.&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise defined herein, the
terms defined in the STAAR Surgical Company 2003 Omnibus Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined meanings in this Stock Option Agreement (&#147;Agreement&#148;). </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.&nbsp;&nbsp;&nbsp;&nbsp;<I>Grant of
Option</I>.&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the date of grant set forth on the Notice of Stock Option Grant attached hereto (the &#147;Date of Grant&#148;), STAAR Surgical Company (the &#147;Company&#148;) grants to the optionee named in the
Notice of Stock Option Grant (&#147;Optionee&#148;) the right and option (the &#147;Option&#148;) to purchase, all or any part of such number of shares of Common Stock at such exercise price per share as are set forth on the Notice of Stock Option
Grant. The Option shall be exercisable from time to time in accordance with the provisions of this Agreement during a period expiring on the expiration date set forth on the Notice of Stock Option Grant (the &#147;Expiration Date&#148;) or earlier
in accordance with Section 5 below. This Option is intended to be an Incentive Stock Option or a Non-Qualified Stock Option, as provided in the Notice of Stock Option Grant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.&nbsp;&nbsp;&nbsp;&nbsp;<I>Vesting</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Option shall become exercisable to
purchase, and shall vest with respect to, such percentage of the shares covered hereby (rounded to the nearest whole share) as may be set forth on the Notice of Stock Option Grant hereof. In each case the number of shares which may be purchased
shall be calculated to the nearest full share. The Optionee shall cease vesting in the Option on the Optionee&#146;s Termination Date. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.&nbsp;&nbsp;&nbsp;&nbsp;<I>Manner of Exercise</I>.&nbsp;&nbsp;&nbsp;&nbsp;Each exercise of the Option shall be by means of a written
notice of exercise delivered to the Committee, specifying the number of shares to be purchased and accompanied by payment to the Committee of the full purchase price of the shares to be purchased solely (i) in cash or by check payable to the order
of the Company, (ii) by delivery of Mature Shares already owned by, and in the possession of, the Optionee, valued at their Fair Market Value, or (iii) (x) by a Qualified Note made by Optionee in favor of the Company, upon the terms and conditions
determined by the Committee including, to the extent the Committee determines appropriate, a security interest in the shares issuable upon exercise or other property, or (y) through a &#147;cashless exercise,&#148; in either case complying with
applicable law (including, without limitation, state and federal margin requirements), or any combination thereof; provided, however, that such payment of the exercise price would not cause the Company to recognize compensation expense for financial
reporting purposes or to violate Section 402 of the Sarbanes-Oxley Act of 2002, as determined by the Committee in its sole discretion. Shares of Common Stock (including Mature Shares) used to satisfy the exercise price of this Option shall be valued
at their Fair Market Value determined on the date of exercise (or if such date is not a business day, as of the close of the business day immediately preceding such date). This Option may not be exercised for a fraction of a share and no partial
exercise of this Option may be for less than (a) one hundred (100) shares or (b) the total number of shares then eligible for exercise, if less than one hundred (100) shares. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Option may be exercised (i) during the lifetime of the Optionee only by the Optionee or his or her legal
representative if the Optionee is Disabled; and (ii) after the Optionee&#146;s death by his or her transferees by will or the laws of descent or distribution. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination of Service; Death or Disability</I>.&nbsp;&nbsp;&nbsp;&nbsp;Upon termination of the
Optionee&#146;s Service, other than due to death or Disability, the Option shall be exercisable until the earlier of (i) the Expiration Date or (ii) a date three (3) months after the Optionee&#146;s Termination Date, to the extent exercisable on the
Termination Date, and shall thereafter expire and be void and of no further force or effect. If the Optionee dies or becomes Disabled while the Optionee is in Service with the Company or an Affiliate, the Option shall expire on the earlier of (i)
the Expiration Date or (ii) a date one (1) year after the date of such death or Disability, to the extent exercisable on the date of death or Disability, and shall thereafter expire and be void and of no further force or effect. During such period
after death, the Option may, to the extent that it remained unexercised (but exercisable by the </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-17 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Optionee according to the Option&#146;s terms) on the date of such death, be exercised by the person or persons to whom the Optionee&#146;s
rights under the Option shall pass by the Optionee&#146;s will or by the laws of descent and distribution. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.&nbsp;&nbsp;&nbsp;&nbsp;<I>Shares to be Issued in Compliance with Federal Securities Laws and Exchange
Rules</I>.&nbsp;&nbsp;&nbsp;&nbsp;By accepting the Option, the Optionee represents and agrees, for the Optionee and his or her legal successors (by will or the laws of descent and distribution), that none of the shares purchased upon exercise of the
Option will be acquired with a view to any sale, transfer or distribution of said shares in violation of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and the rules and regulations promulgated thereunder, or any applicable
state &#147;blue sky&#148; laws. If required by the Committee at the time the Option is exercised, the Optionee or any other person entitled to exercise the Option shall furnish evidence satisfactory to the Company (including a written and signed
representation) to such effect in form and substance satisfactory to the Company, including an indemnification of the Company in the event of any violation of the Securities Act or state blue sky laws by such person. The Company shall use its
reasonable efforts to take all necessary and appropriate action to assure that the shares issuable upon the exercise of this Option shall be issued in full compliance with the Securities Act, state blue sky laws and all applicable listing
requirements of any principal securities exchange on which shares of the same class are listed. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">7.&nbsp;&nbsp;&nbsp;&nbsp;<I>Withholding of Taxes</I>.&nbsp;&nbsp;&nbsp;&nbsp;As a condition to the exercise of this Option, the Optionee shall make such arrangements as the Committee may require for
the satisfaction of any federal, state, local, or foreign withholding tax obligations that may arise in connection with such exercise. The Optionee shall also make such arrangements as the Committee may require for the satisfaction of any federal,
state, local, or foreign withholding tax obligations that may arise in connection with the disposition of shares of Common Stock acquired by exercising this Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.&nbsp;&nbsp;&nbsp;&nbsp;<I>Payment of Withholding</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Optionee will pay to the
Company an amount equal to the withholding amount (or the Company may withhold such amount from the Optionee&#146;s salary) in cash. At the Committee&#146;s election, the Optionee may pay the withholding amount with shares of Common Stock; provided,
however, that payment in stock shall be limited to the withholding amount calculated using the minimum statutory rates. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.&nbsp;&nbsp;&nbsp;&nbsp;<I>No Assignment</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Option and all other rights and privileges granted hereby shall
not be transferred, either voluntarily or by operation of law otherwise than by will or the laws of descent and distribution. Upon any attempt to so transfer or otherwise dispose of this Option or any other right or privileges granted hereby
contrary to the provisions hereof, this Option and all rights and privileges contained herein shall immediately become null and void and of no further force or effect. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10.&nbsp;&nbsp;&nbsp;&nbsp;<I>Adjustment for Reorganizations, Stock Splits,
etc</I>.&nbsp;&nbsp;&nbsp;&nbsp;If the outstanding shares of Common Stock (or any other class of shares or securities which shall have become issuable upon the exercise of this Option pursuant to this sentence) are increased, decreased, changed into
or exchanged for a different number or kind of shares or securities of the Company through reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar transaction, an appropriate and
proportionate adjustment shall be made in the maximum number and kind of shares receivable upon the exercise of this Option, without change in the total price applicable to the unexercised portion of this Option, but with a corresponding adjustment
in the price for each share or other unit of any security covered by this Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Upon the dissolution or liquidation of the Company, or upon a reorganization, merger or consolidation of the Company with one or more corporations as a result of which the Company is not the surviving
corporation, or upon a sale of substantially all the property or more than eighty percent (80%) of the then outstanding stock of the Company to another corporation, this Option shall terminate; <I>provided</I>, however, that notwithstanding the
foregoing, the Committee shall provide in writing in connection with such transaction for the appropriate satisfaction of this Option by one or more of the following alternatives (separately or in combination): (i) for this Option to become
immediately exercisable notwithstanding the provisions of Sections 3 and 4; (ii) for the </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-18 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">assumption by the successor corporation of this Option or the substitution by such corporation therefor of a new option covering the stock of
the successor corporation or its affiliates with appropriate adjustments as to the number and kind of shares and prices; (iii) for the continuance of the Plan by such successor corporation in which event the Plan and this Option shall continue in
the manner and under the terms so provided; or (iv) for the payment in cash or stock in lieu of and in complete satisfaction of this Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Adjustments under this Section shall be made by the Committee, whose determination as to what adjustments shall be made, and the extent
thereof, shall be final, binding and conclusive. No fractional shares of stock shall be issued under this Option on any such adjustment. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.&nbsp;&nbsp;&nbsp;&nbsp;<I>Participation by the Optionee in Other Company Plans</I>.&nbsp;&nbsp;&nbsp;&nbsp;Nothing herein contained
shall affect the right of the Optionee to participate in and receive benefits under and in accordance with the then current provisions of any pension, insurance, profit sharing or other employee welfare plan or program of the Company or of any
Affiliate. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12.&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Rights as a Stockholder Until Issuance of Stock Certificate</I>.&nbsp;&nbsp;&nbsp;&nbsp;Neither the Optionee nor any other person legally entitled to exercise this Option shall be entitled to any of the rights or privileges of a stockholder of the
Company in respect of any shares issuable upon any exercise of the Option unless and until a certificate or certificates representing such shares shall have been actually issued and delivered to the Optionee. No shares shall be issued and delivered
upon the exercise of this Option unless and until there shall have been full compliance with all applicable requirements of the Securities Act (whether by registration or satisfaction of an exemption therefrom), all applicable listing requirements
of a national securities exchange on which shares of the same class are listed and any other requirements of law or of any regulatory bodies having jurisdiction over such issuance and delivery. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13.&nbsp;&nbsp;&nbsp;&nbsp;<I>Not an Employment or Service
Contract</I>.&nbsp;&nbsp;&nbsp;&nbsp;Nothing herein contained shall be construed as an agreement by the Company or any of its Affiliates, express or implied, to employ the Optionee or contract for the Optionee&#146;s services, to restrict the
Company&#146;s or such Affiliate&#146;s right to discharge the Optionee or cease contracting for the Optionee&#146;s services or to modify, extend or otherwise affect in any manner whatsoever, the terms of any employment agreement or contract for
services which may exist between the Optionee and the Company or any of its Affiliates. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">14.&nbsp;&nbsp;&nbsp;&nbsp;<I>Agreement Subject to the Plan</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Option hereby granted is subject to, and the Company and the Optionee agree to be bound by, all of the terms
and conditions of the Plan, as the same shall be amended from time to time in accordance with the terms thereof, but no such amendment shall adversely affect the Optionee&#146;s rights under this Option without the prior written consent of the
Optionee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>The next page is the signature page.
</I></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-19 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">15.<I>&nbsp;&nbsp;&nbsp;&nbsp;Execution</I>.&nbsp;&nbsp;&nbsp;&nbsp;The interpretation, performance and enforcement of this Agreement shall be governed by the internal substantive laws of the State of California. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">COMPANY:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">STAAR SURGICAL COMPANY</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Its:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">OPTIONEE:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="3"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">Name</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="9" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By his or her signature below, the spouse of the Optionee agrees to be bound by all of the
terms and conditions of the foregoing Agreement.</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">OPTIONEE&#146;S SPOUSE:</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="3"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">Name</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">B-20 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B>ANNUAL MEETING OF STOCKHOLDERS OF </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="6" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B>June 18, 2003 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="5" COLOR="#000000">Please date, sign and mail </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="5" COLOR="#000000">your
proxy card in the </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="5" COLOR="#000000">envelope provided as soon </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL"
SIZE="5" COLOR="#000000">as possible. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">Please detach and
mail in the envelope provided. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B>PLEASE SIGN, DATE AND
RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B>BLUE OR BLACK INK AS SHOWN
HERE&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><FONT FACE="WINGDINGS">&#120;</FONT></FONT><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B> </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD VALIGN="top" COLSPAN="7" WIDTH="21%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>Proposal No. 1</B>&nbsp;&nbsp;&nbsp;&nbsp;Election Of Directors<B></B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="24%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>Proposal&nbsp;No.&nbsp;2</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="4%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>FOR</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>AGAINST</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>ABSTAIN</B></FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" WIDTH="21%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">NOMINEES</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP WIDTH="24%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">Approval of the 2003 Omnibus Equity Incentive Plan</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="4%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="1%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP WIDTH="24%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>FOR ALL NOMINEES</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="21%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">DONALD&nbsp;DUFFY</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="21%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">DR.&nbsp;VOLKER&nbsp;ANHAEUSSER</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ROWSPAN="2" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &#147;FOR&#148; THE ELECTION OF EACH OF THE NOMINEES
IN PROPOSAL NO. 1 AND &#147;FOR&#148; THE APPROVAL OF THE 2003 OMNIBUS EQUITY INCENTIVE PLAN.</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="1%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="24%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>WITHHOLD&nbsp;AUTHORITY</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1"
COLOR="#000000"><B>FOR&nbsp;ALL&nbsp;NOMINEES</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="1%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%; text-indent:-1%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" WIDTH="24%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>FOR&nbsp;ALL EXCEPT</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1"
COLOR="#000000">(See&nbsp;instructions&nbsp;below)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>This proxy when properly signed will be voted in the manner directed herein. If no direction is made, this proxy
will be voted &#147;FOR&#148; all of the Board of Directors&#146; nominees and &#147;FOR&#148; approval of the 2003 Omnibus Equity Incentive Plan.</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="9" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><U>INSTRUCTION:</U> To withhold authority to vote for any individual nominee(s), mark <B>&#147;FOR ALL EXCEPT&#148;
</B>and fill in the circle next to each nominee you wish to withhold, as shown here:&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="1" COLOR="#000000">&#108;</FONT><FONT
FACE="Times New Roman" SIZE="1" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="7" WIDTH="21%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">To change the address on your account, please check the box at right and indicate your new address in the address space
above. Please note that changes to the registered name(s) on the account may not be submitted via this method.</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" WIDTH="3%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2"
COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></FONT><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="17" NOWRAP WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">Signature of
Stockholder&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
Date:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;Signature of
Stockholder&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;Date:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</U></FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="17" WIDTH="8%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000"><B>Note:</B> This proxy must be signed exactly as the name appears hereon. When shares are held jointly, each holder
should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is
a partnership, please sign in partnership name by authorized person.</FONT></P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="3" COLOR="#000000"><B>STAAR SURGICAL COMPANY </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B>PROXY FOR ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000">The undersigned, a stockholder of STAAR SURGICAL COMPANY, a Delaware corporation (the &#147;Company&#148;), hereby
appoints David Bailey and John Bily, and each of them, the proxies of the undersigned, each with full power of substitution, to attend, vote and act for the undersigned at the annual meeting of the stockholders of the Company, to be held on June 18,
2003, at 10:00 a.m., and any postponements or adjournments thereof, and in connection herewith, to vote and represent all of the shares of the Company which the undersigned would be entitled to vote, as follows on the reverse side. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="ARIAL" SIZE="2" COLOR="#000000"><B>(Continued and to be signed on the reverse side) </B></FONT></P>
</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g52875g38x13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52875g38x13.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0M&4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````8@```0`````&`&<`,P`X
M`'@`,0`S`````0`````````````````````````!``````````````$`````
M8@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"*H````!````<````"L`
M``%0```X<```"(X`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``K`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U59/UFNM9@4546OHLR<S#I%E9VN#79%/K^[^7CMM8B9/7L&G*MPJ6
MVYF;0UK[<;&K=8YN_6IMUOMQ<>RUOOK9DWT[V?I%C?63J76K>F/R*>C74C`=
M7G/?DW8[06XKVYEE3&8=V>][KZJ;*/H_3L24]2][*V.LL<&,8"YSG&``-7.<
MXK)9US,SH=T?I[\G'<);F9+_`++0\$;FNIW5WYEM?_#-PO0L_P`#;:N8^L?6
MOKEU+ZNN^R]$;]BZCB!YMQ[_`+6_;<S>VGT6?8;?H._2OJ9EU?\`'+I<?K^?
MFXU.3@]&R75Y#&656W6XK*RQXWM?NIRLJ[Z+O^XZ2F5O5NK8`%_5,*EF"(];
M)Q;W7&D'_#9%-V-B_JM?^&OK?9Z+/TUM/H>K;7L+$R,'ZP]5INQ,ZS&Z=A9#
M'56LQ2_(O<UX+7^GF9#,6C'Y_P"X&3_QBV*::Z*64U#;74T,8WF&M&UHU24C
MS,W%P:#D95@KK!`&A)<YQVLJJK9NLNNL=[*J:F^K:_V5K-_YST;X'3^I&O\`
MTOV.X"/WO3<P9/\`X!O6EFX=&=C/Q<@$UV1JTEKFN:197;58SWUW4V-9;3:S
MWU6_I%DY%WUB.<[IO3<C&+L6BFVV_.K<]]GK/R:P=F%9AU5[/LG[GZ3_`())
M3>Q.N=+R[FX]=WIY+IVXU['X]Y#1N<YN+ELHR'-V_G^DKZYG,Z;]:\BW&MS#
M@9]6)8W(9C4^KAN]:O\`FG_:+/VFYVS_`$3/LGK?X>_[-ZU%VEA]29U;?32^
MW`S,&ZO[=B/;6;&R/5;1:?UFAU.53[_6QK?YO_"U7)*39O6>G8-S,?(L<;WM
MWMHJKLNLVSM]0TXS+K6U[A_..9L1L+J&'GUNLQ;18&':]NK7-=&[;;4\-LJ=
MM._](Q9U`;C?6S+%KR7=2Q*7XP=_W5?=7E55_NMK^VXUVS_NQ<E676?6ZY^/
MK55@MISG@RWU?4]?`H_XZJB[,NL9_HLK&]3^=I24[*2222G_T.[_`&+U'`NR
M+NB9553,JU^1=B95.]CK;#OML9DX[\;)9ZG[V1]N]+^;JK]&JJE+-L^L61AY
M&([IF(]U['5M+LISJ"'@L=Z_ZK3D;=GYE5?\CU/\*MI))3A]-_:_2^E8W2F=
M/.3;A5,QJL@6ULHL;4&TU76.<Y^51ZE;?4MK;AY'HO\`T?Z?^<5+IO3?K5T6
MO['B-Q<NO*]3)LLL<ZFC%OLL==D8^+CUUVWWXC_7_5:M]?\`,Y'K9%?KTU+J
M4DE.,/\`GC2\$GIN<P@[FQ?AD'M#YZOO_P"VZU,9/UJ_\KL`?^AUW_R*6LDD
MIJ8%W4[18.HXM6*YK@*_1N-[7@B=VZRC$>S:[V_S:KYW2K[.IXW5<'(&-DU`
M4Y3'MWUWXQ.\TV-#JW,NH>YUV'D-=^B?ZM;V657V+3224\_D]`^L3[QZ'UCO
M9B?GT68]#GG^KE8[,2UG_5J-/U=ZS10_&Q>IU855EKKWVXV,XY#[7'=OR,KJ
M&9U'U_=Z?J^I3^DIK^S_`**E=$DDIYO,^K76\YU61E=8;]KQ"78CJ,44L&]K
MJ<AE_P"FNS7,OH>ZO]5SL/T_Y_\`GZ:7UQP>D?66C%^P4/P>C8XEQR,0695[
MWDAQ>?M[*ZVV6?X>_(^WVV_U_P!*MKJO5L+I.+]IS'D!SA736P%]EMK]*L?&
MI9^DNOL_,K9_U"H68W7^K._3VGHV`?\``4%K\U_TP[U\L>KC8;/H?H\/[1=_
MW?K_`)M)35Z3G].Z%1U1G5,QM1JZA8+,K)>T67/LJHS6..QM3+;?L]]===./
M3[*:JZ:ZOT:MT_6*[,M8.G]*S;\<O8U^5:QN+6&.U-U;,]^/E7[/^#QU5KZ1
MA=&^M-&;76TLZK3]C-UNZW(&12'Y-/ZYD66WN9DX3,BN_?\`]P<)=(DI_]'U
M5))))2DDDDE*22224I))))2DDDDE.*Y]-'UI<_.<UAOQ:JNF.?H-P?<[/II>
M[V?:;?U-[ZVN]3(IJK]GZK:MI97UGV_L3(W?8]LUS^T9^SQZE?\`.;/?ZO\`
MW%V?]J_05/'];[.[]G?M?T).SU?2WSWV_M_]?_\`8C^PDIL?7`8__-O/MN>*
MG8]9OQK28+,FH^K@OK_X7[6VGTZ_\-_,_P"$6K0^Q]%;[6>G8YK2]DSM<1[F
M3_)<N6RMO[4P/M'J?;/M54?MG=Z&W:__`)+^P?Y(_;'_`'&W?K/\^NM24__9
M.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#8`
M+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N``Y!9&]B90!D0`````'_
MVP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`__`
M`!$(`&(!``,!$0`"$0$#$0'_W0`$`"#_Q`!W``$``@(#`0$!````````````
M"0H'"`0%!@,!`@$!`````````````````````!````8"`@$#`P(""`<`````
M`@,$!08'`0@`"1(1$Q0A%0HB-18V,5)C)#1E9C=!5"87&#@Z$0$`````````
M````````````_]H`#`,!``(1`Q$`/P"_QP'`<#B+UZ-K0K7-Q4E(V]N2*5ZY
M6>+P(2HTA(U"E2<//T"4006(0L_\,8X$-O1#NW?'87HVX[1WT),8MFNQ5\MU
M8&(HXV1Q("G(Y+`M4+;B2FM$@*=LQ\XE8V&+C2_DJ3D0_>$(P(LY"9W@.`X#
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X'_]"_QP'`<#33L5MY306@
MVZ-T(<J@N=9ZO7E+F8:-(E7J"GUIKB1'L1P4:X8$:@LEXP0(P)N?;]O`O+&<
M>N,AK#T0UJVU3T]=>,8:AD&)W;6J$64<-.C+0@^Y7(%7;KN`9)0A!,/)=)N<
M68=G/DH&')HL8R/.,!+3P,8W-<]5:\5?,[IN^>QNL:JKUG,?IE.):X`;6-B;
M0&E)BS%!XL",/5+%B@I.E3$@,4JU1Q9!!9AQ@`""'>+=B^\N_#02[=8^GJ6$
MT3(`ITK#N]OXID%60=^0N"<Y:">TIK7&4BVW+BAX&PL.4#@X+(LA7+U))?KD
M@M4:4&64&@>^MBF95;*=OVP1B5;E0-9!=0:/U^U;BC:0X%#-4M#1+'>)71<1
MI3>MP2!*N-D0%F$Q&<>@##SAY#J<=(6M2ID-0R#93LMEDB4DN.5D_?\`L:VK
M_BM8YN0SC#'T]*T6&T0O#H288$0`EM`$HLE`]PD>/+`@\5,M7^S;1UM'9.E6
MV=C;]P2-A*7S#3+?9]C<DL2:1]O;BLNH:+VUCT7C<R8+.5!08+;D,N)=V!4<
MI&,\THP.,FA)3IQM[2^]6O$!V7H5V<G"!3Q*L`-JD3>%EF4*E#(M.:99`)XP
M84K/L,TA[XE.1KTV#CB<F%X-3G'IC"3S`V?X#@.!&SO#VN:B:%/D:KFS'J=V
MCL1/$!KE6^J&N,%<KGV4L%$46L.^6QURPFIRVEN/);50B%KVM:4*KXAX23C!
M$F!"&M6.S?L&GA67.A>BO<:0L&,DC]_82^]2M5I'\92`9Z8?\(S.SI.Y?)^.
M(KWB?/U3FB&6/.!%_J#[).PSM3:CL.,^Z&+Q:8BC`8<\KX!O5I)9\O(("`6"
MLLD#0SMA6R-2-3D`1$E*BAA+R(>/+Q\<APG;O1JRI2'1SW!T8[+]+H=&U3>C
ME5O7'J@XS*BV(U=@8Q*C+2H"47"W'-*,'A[BD2<H(A#\"L&"`;@`2.ZO[NZB
M[IQ]PDVJ>Q53WLVLQ+8?("*_EK:[/T7"\I0K&P$MBHC")1$U"PD6<!*<D:4W
M!I9A>0X,*,`$-I>`X#@=')I-'87&W^8R]\:8Q$XHRNDCDTD?EZ5J8X_'V1$>
MY/#T\.:TPE&W-;6WIC#U!YHPEE%`$(6<8QG/`AK;OR#NL:7RU^AU/6/=>Q3A
M&1J"WIQUSU-V=NB.)AI#BDZD2:1P>J71H=D1)J@K'S$9JA$/W0>!PO+'`S11
M?=!UM[!63&J6B6Q::'W/+W-<P1ZJ+PKRT]?IN[2AN<B&A1#FMONB%0=&[S,3
M@J*+*:4:A0X'B,Q@LH>?7&`E(X#@.`X#@.!__]&_QP'`<#4'L&A(+*T,W5K\
M3$IDXIGJ?L-&T\>1`$8N>EKO4LM1H&U``'ZQ+U:TTL!'I]?=R'TX&O?2?+&6
M9]1W7,\,"@Q2A1ZATI$SS#2#$X@O4"AC;!I(GP6:$(A%I)%'510!X_2:`&!A
MSD(L9X$H7`KA]F55L.^_;?UY]>%Y8=W'4Z%TG<.]]FUD7D])%;WGT!E+-7%:
M0^8J0F9"[,$-5.2I8L;PA`$]&YG$FY%A06(D+&B1(E0)4R%"F3HD*).2D1HT
MA):9*D2IBPDITR9.2$!)"<@D&```#&`A#C&,8QC'`Y'`<#KW9V:F!J<WU]<V
M]E9&5O6.SP\.RQ,W-32U-R8Q8X.;FX+#"4B!O0)"1FG'&C`646#(A9P'&<\"
M`7I$EL+L>^.X:U-;SLN.D-H;T,\TH23-:!<C@\VM553D2;-K9I`SG(@DYU8G
MZTVHD>%B?R;5&08$D]"_7'`L%<!P'`KK;ST?:VBW9+&NYNCJ2?\`9FNIS3S/
MK%O+4L&C()1=M=5NB?&96R;)T8WI\*7^3J8PB9D2*0QQ`5YJFU%[V?$!IZUN
M";C7?92C=L:P:[CUZL9CLVO'5<Y-&'EH"O1+6>0,I^$KY%97&WM&UR>&3!A4
MYP6O:'9&B<D8Q8P<0#R#ZAG'@.!5I[Q-<.M'66(N.VT.EJ_2WLORW>&K$@TT
M7)HOL9?MF'&MK3$*_74+&521KO*%260-C<W/)K@UCPG1A]K*TO`\$'A/[I?)
MK[FFH^M,OVFCZ.*;'2:CZT?;MCJ%'EM+:+)=(FUK)4C/:/83@8W(#J<9E6WE
MAR4WJLF)RQF`*",0;,\#6.B-S=7]G+`OZK*%N2+6;/\`5R:D5W?L:CX7;"RM
M9FJ<)0TD,CN<X-J)$L-,=(4[IL&HC52?Y#<>7DSS+%C`0O\`?J0GOZUNHOKD
MD9#OFJ]SMYBI+>A:-TD;&S3.F=;8P1*)G3\@=8XH2*RB+$Q.4YR4`3BC<*V@
M!Y8R\D",`%@^!P*$5;#(S7-:Q"-0&`0MF0QV(PN',K='(O&6%M)"G;V=B8FE
M.D;6MN1DAP$LHDL``X_HQP,([;:=Z[;Q4V_T7LM6[+8D&>RQ'(1K`#1R6'/Q
M8?5MF$"E*$1#[#9<SGA"8G7H#R3L>F2QY&2,PL8:?=.5N6O-]3W^E=@I`[2[
M872"][8TKN&8O:<LA?.7"FW%O6UO/AFE8R!R_CBCI;%G,U9YFC4JE)PC3!G^
M[G@2N<!P'`<!P/_2O\<#0+:;M/Z[-*ERMEV<W`I.KY4A3FJUL!42D$ILQ*F*
M3B4X./K"#D2:P2RU!8,X(SEM_O)GZ"O,?Z>!HM%?R#-<;0PL<*'TL[6-BX@F
M/3E)["I+06T)="7(A=[AC:O2.2I6SK2$3FB`%21E6F3#&0/`LAQG`L!#T4@[
M&.RFQ1JD^N?1A?,HAZIQ4,:I_P!M-HM:=4S`MBINP(MV55X>YV_+'1N-,-R`
M].61G/MY\<C]S)A185E.N7=ONXT3OU\Z):`TIUIG]B4O*K`M-`W3B7SMWB%,
MTO:;HT6R4L76>R3-A;E-7L:^T21)G%4G,=5*YY)0>T-<(M,(,Y;[;Y_EMT0_
M'*)/K3!*VJML/7#=+/T8UY;-IV4,<+3)R5DD-;)O-[1D[00T`),5%?>TT:"(
MP8\G9P1@&"PB>UB[?K2A._\`JQV0W%>&_6^M*TH18&K]Z/DGTMJ*B'.OC+TB
M+^=7U;Q/%4;"V3!;`=Y5,VK+R2A>W%A<1YCH_CD'BP7XA=Z=^Y5R;0(LHNH_
MNDD!BHG)JDAHTRB9`VO/H7X$K37^\V-*<<8(0\8PD,4X#DO.1Y#@1>1AW)F_
MW8O/G(@NANEZ[RX^H/CX\2/;G:G6S6+XS6])/=5+EL:@CILW+"E;.HQG!Z,M
M$<H"3CU'@L_(4V0ZQY0=^-R*3VQ&\=:FC\1<%AOC)6(R]=S[D8F_+A[904;1
M)8UKM4RM80V^IGNGX/`J,P$.24GEG(0\D'I#C5ZKFIZ[+]SMJNQS+:XY?`U'
M/Y$S45JB"1X*(^._IM=:(115`>M;5!9GQ"G-Y=$A)!F2LDC\CA'!-!!H)"*Q
MB$>KZMH=%J^@<1;$[+%85"6!JBL3C3.DQD*5J8(ZQI$+0T-R?&<^!*<DLL/K
M],<#U?`<!P'`A\[<[P9>LC07>G?#7NJ(,P;$OD6KQK<YVP0>,D.TEGC],6BH
MJVGUFGA;P!G.*P.L@Q61AUPK]PDG"07J2/QP&F+IU$=EMTQ6KYD[=_VZ<0D2
MROXLXRI!%*MKZ),2B5N3<2YO1[4TUM(*R3IF/"M7D"9*XE.2HHH&`C5&8]`A
M#E*NCO>QU@[C#'G\@;L7.^:J2J`.K.6T1]>4'[*4T.9`WM!+LS?*=7GW#22B
M7I.00,03!%G*0Y4"#6K7G\=_;#K^O>4;1:E;B:W[.W`_FH<H%_8OJ[)I].(R
M6A1J#5A\7V$AUO.<YC#O)UYQJ1:K;69(:%N5B\_DF$A":$@L@[+=[M*VK[GV
M8=>SFY5HB-&%ZVKZX9,];+5)'4N,"4JGNPZ8F+-!K\K2(,J+T^0[B2O2<P>!
M>@"\^`!A++KILM0FV]41N\-;;6AMQ59*TX#FF6PMV*<4I2GV"#U+*]HLX*=8
MS*&K"@(%[2Y$)'-O.]2E)!1F,AP']5#K30-!/MNRBEZC@U;22^[#=+7N9^BC
M&E;7BR;#>3E*EQE,K<0!$K<UYZM<H.P$0_9+.5'F``$9YPAA$=WVQ27PJF=4
M=_H$Q.LD<^L[<:J]J+,8F`P_,B?]8RBW2&;%L<?3@]4N5YD2?4ZY0H/QDI(V
M-ZLP7Z?+&0FFJZRX/=%:P"WJRD**65U:,,C5@063MV1Y0O\`$9>SHW^/.Z;!
M@0&@*7M2\HS`1A",'EXBQ@6,XP'N^!!'TLKT]EVEV^[)QE>F=JPN?LRL1AK)
M]2)S$Z&6LU*5I7%;O,O9!X]U&Y1QQDB-4C3+BC1?,.;SQY`7CQQD)W.`X#@.
M`X'_TYS=V[(WA[`M\ICU<::V@YZKZX4!"JSEW8EMI#E)+?>:<5QM2B4P&@-?
MW<P+B**R65P4`')0\%)2CR09'Y*R"4^4#V$AND'4SH3U[M^3=<J'84=A+QD+
MI3>=@*%5E7I,G_[<)O=)"\67+QN+RU*I`(]0H6(67[2S?)5GB)1$X-$'@2/<
M!P*;&P%HS2@?S#M7A$LZU-%MG]-F^G7)48:-L22"-K6:U7DM4F4Y!E,ZX9K%
MJ]LR80+U%D:4.,>(_:SP+D_`@F[8>@/2WM`C4NEZR+I*4VN4L2H$5V"@1.6D
MYXD"0A2-A*N2+(?;9K-8@K30EGJ5).'U.E]0)%Q(<>V(,D]*>[4TVEUKDU*;
M"B^W;MZ'S8_5+;QA5N9;FYNDYK\"AAC]NX5%A+PO9[@;&$]<!8`(2%#JE<0D
M>I)0!""9#@.`X#@.`X#@.!HYV7ZUJ-P=`-O=;&Y(<ND%K4//F2&I"!D`-46"
M@9SI!79>!JC2$P0YG+.W^7N#`#Q]?40<?7`8@Z9-I6K;KK3U1LD"MP'-XI5\
M>I.Z&A]P>3)HW=U)-J2M[,:I(B6JUKFA<%L@8!N9`5@_EG-[@F/,"$1WI@)0
MN`X&@>[/9]HKU]P]^DFT.PU?0YZ:4&5*&I6Y]:I)=LO/.3)U")LB=2M:PZ8.
MIK@%<GQ\DQ,0VI0*2C5:E.0+W<!&;T#T1<;.\]@VZ\WH9WTZJ+?>_P",65KQ
MIZ\,:&'N=;0*#LD@8#;,D<#;V]M30N7W2-V3JEZ7!!(C\MH%/H:G.2GF!8*8
MIE$)0ODS7&95&Y$YPIZQ&YBW,3XV.Z^)2(3<A=\,,F2-ZI0H87K+2YIE6$JH
M)1_QU!1GCX&!%D.#8M?0RVJ_G-5V-'F^6U[94/DL!G45=BQ'-<EA\P9EL>DK
M`XE!$`9B%W9G`Y.;C`@YR`S/IG&?KP*YO1ULA$]/=:MWM(-MKEA5?D=3FTT[
MJ-+-[+D[9%FM+J]/SUD[UYE+W(9&J;"SLR?&'\EL+R66,3>D2$%!$/'A@/RU
M-ZMGNY$Q=J[U0,-J4GJM)S#FB^^V&?PN306+)(46K=&^0Q#3:./9<;?[2GD@
M^#\0;V4I0A90F9P86FPH3.)83Q:IZQ5)IIKQ4^LE&Q\F-UE4,311A@2``5A8
MXG@$8M?).^'$EE`72:7/ZM4Z.:GQ#E0O5FF>F/+TP&,>PO=>NNO/3R[]M+*$
MC6-]6Q%8KBT44.A+0JL.Q7+'VVOZ\:U1A:@XM9+)0I3IS#2B%`T:/)ZL10BD
MYGH&5-5+?E.P6L]`WO-:]#4TIN>GZ]M)XK3$A-E8X,HGL7;)07&5$A.88N<Y
MK&I.Z`*/&)O2B"<$0,@_3ZY#/O`<!P/_U+9FS'5[3M]76;M57=H7WJ1MR9%6
M>'JMA-:+%/BKI+V","5&Q5CMFM9&BE-06XQ,9BL982GMB/5&)/!/\D)1*;!(
M:_YBW?!KPKP:P6EI!V/PH+ADU0V6=#)5H_>6&P.51H$37):XS;M-+UA@!EDC
M/4LJ$/F`)H2\8$,L(>JSVJ6+4K8UXW-ZS=]M?'88'53)))45<LV\-)QEI:TI
MBX3\NLS5EYFDG0LYB4O]0G2*M)Y)GK@96`!R9P/"MOY&W32I1.QS[N8RP!XC
MYB\B00VR*LN^#SME5MKB>V*6]=#WZM4KYEU"<1D>$A1)JGVA8'D&,>OH$".\
MVQNSNV^Y^KO=+KQHO<BW0/J[>D9KA-YO$U\%O7:"MI\ZY(N&RJ=J:0M[=)'2
MMZPCN#C4*E8844`9IZLW)0?GD(0M14CVO=;FPE:L]K5MNQK:=%W9J+=E"25V
M["(%+8T6(Y&E.1S2%35Z8I5#W%(M<""3"7!(GSYG%9#Y`-*$,-2=A.]C5J.R
M)ZHW1QGF'9?MQE"8!AIC3YK469#6-R4#*1M[M;=Z,A:JJZ^A*)Q.\'1;AQ6J
M&[!0\'IRO3RP$)G_`(!=D/5F-U[W9?/4ET[:OL_LBUNT35BOE!'_`&W?-0I>
M9'75SAE2.SFH5_\`5.MS;&3'4I2(P].$CQ)3GF)&HW+T$H,9_(++VSR[).J'
MKUVI[#!1IP1-DJGJU1%M5:'8W%R1)525E-MJW,+S120D:K'RD1C,0(@@.5&!
MF$9`,09G3W5^0F[&JE9&C?7%$T)PRE*!HDVW=LO#NA2K2@JRVQP<XS49S8X.
M;,$W"56>440G/4E#&0')(@"R'CUO:%V@46:8W;4](-\2A*W,#BYG3_1&Z8#M
M*U2(]L7#3F9;*W/;H/-&'*](2-0F0'*5SD8`1(0E#,,,`0!Y_(.IZ*N$48IK
MUR=QL*E$U&0FC$6D_7],FE]?G(XU(E$UL"!7*2CW]:4O7%)_%'@_R-,`$/KD
M8?4/H=W_`,#&0I6,G5AW<RAL;LE_>79@Z\)&:W,1>09/4'NZAQGS;E(4A18P
MH-_2+/L9P(.!9]<8#G"[XT.!)<%]//?*>!0,\(SBNMY_]M*`H]244>?[ECEC
M&4L*(`:7[(318+/!@>`#P8`L,\Z+=TFH6_=N2S7NN(ULC4^P$':?OLKIK86@
MYA7$QCS4$G)IRM^5(<2B(Q[VL^)82W!T2FJ#3`!(";D6/4);N`X%?&QM+^P/
M1C;B_-B^J6+4+:E/[L&!D=YZL7W/GJMHC4^T:L"AO#M+`'-B95@E<->??+7S
M>.)C279Z,`=A&9[@T66X,U[F=.J7;R>E;#1C=?=#3+:-QBD*89/-]3[WFD1K
M1U.B[3]J5%CK!6Y``)N.2JE)1.4[@@/S@S`U`CQ9.":$%UZ?CB=QLKF#<H:^
MZ>>;,5X@=%SD7#-HK7V]A3=GY100!)4-U7VK*S,^)@`&>3>O:O$10?3'AY`R
M&W>N_2;L7J.H6SG7_3CIHQ?QZ\3\BO&_9?NWLI)6Z5*75$[KY(CS9+0:_M;F
M:J3#&4H;'=N6E&F9&)09Y&X-#>URC'Y([XA4-&;;Z8X2%>$*<<LB50[FO$E8
M2Q&`R8X,S7,++<HPO7%`QG`2EI!A`O7TSZ?06`TXK_HZ[(J&OVS=V:$[;&..
M;8[(O`77:!A>M1XZ/66QP#5MHV\EHK-)89XV5RA2%(82B=C`G.ZW!IV?DH,K
M%GNALBBU(_(1L!(XQRR^V#5:EV9<:J*S+*"TH03>>EMY"P'PP-H;+D,=865:
M]-XAX4'>VK&W&8#[&3_J9@(SMH_Q<)PBM.N=S]<MAFO=#;]@E"J27?&.UD@F
MU**V)R-C&TM^%B&OXBVR&,A8"`@3(6M0H7)0)RDGL+$`T.!J`DD;.R3M%I9N
M9('8G0-;126,LK:PIEVK&S%&677!IB!O1EI00^/IF>,KXS%<I@BP4E4XP)NR
M`*7R/SCW<AYFQI1WE=E<2>:EKZBXKTYT/-&\QEFM]VM9K9=VWKG$7@"QO>4U
M1UK6.6-FJV3'MJK&,J71W1N*/./=0N*=3XB*"+GL5_'I?H1H+MQL7M?OYM]V
M1VIK+K=;,KUO8K@ECO'X+4C4P(021YE:IF<IO/GV5RV.Q!A&<H5_=T*1RPD%
M\E`?_=RR`M==>L]!:>A6E-D`"VEBG&J&O<H/(:%9"UM2+'FIXFM6H4BE,(9(
MRT"PT9.0XSZ@$#(<^F<9QP-P>`SG&,9SG/IC'USG/TQC&/Z<YSP-&8+V5Z-6
M+LO)M.([L9`RMGXLZFM!]+R`YQBLOD!Q<:_C0M5``2-`V-MEMJF'>KJ!1'U#
MD7A`$9H\AP69@`?_U;_'`<!P.K<&-D=E#<K=6=J<U3.JPM:%+@WI%JAK68$6
M+"MN.4DF&(56!%!S@PK(1^H<?7Z8X':<"/VVNJ/K2O:;*[)MS135N<SUR6F.
M3S+G>FH4%^D+@:%8$Y=*'!$U)#Y0K.RO,$,QPRI&(>`"SG(BBL@#9^D=>*%U
MIAY=?:\TQ5U(0@LT*@46JJ"QJ!LJE8$H)/W!<AC3:W$N+F86'T,5'X,4&9^H
MQBSG.>!D&7Q*,S^)RB"35C;9/#9K'7N)2V-/*8M:T2&,R1M4LS\QNJ,W&2E;
M:[-2PU.>4+'B848(.?IG@>(HZB:=UIJ^*4K0E<12IZKA"(:",0B&-9+4R-A1
MQQBI6=[1?D<L<7%8<,]6K4#-5*U!@S3C##!B%D,L\!P'`<!P.&6W-Y*U4YDH
M493BM)3)UK@6F)`M5IT63LHR%2L(,'J"4F5)F2@C%D)?N"\<8\L^H<S@.`X#
M@.`X#@.`X#@.`X&'-B(?!K$H.ZZYLUXC\?KRQJJG]>39YE9C<5&V^,3N+.D3
M>5#WEW4HVL;;A"[CP:!0:648'/@(6,"X%//J'[]ZHI3K9UTT_CVOVTFX6]=#
M-,PIETH'6>G7:4H@)XQ/94BK)Z>[)1IQQ!IA;E"0HBE#HFPYJR3D2HXU((L(
M330E`=)?^25M[Z`@-6Z9]3U=K<GC^[VK+R]N]E2$2@Q24WK6QIB34Z4B0H`A
M,+/-0N:4@\M0$(1FX]#2>!]"/QYHG>#N&0]E/8!O#V%GEC<@DUY*+.74/09"
M9U!@I:%)5-2."5P:E2@CU*,$@?4:<TD60"(SC`?$)'-6NIKK?TJE+;.]8]/J
M=JZP&8MY)9[%3,RV46,T)Y"W8:'M,US^;N,EF+>E<FKS3&E$K0%Y(..!Z>)Q
MV!A__]:_QP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P,+W_L51FJ]
M7R*Z-B;3AM/U?%4XSWF839W):V\)F"33B6UM(S[C@^OR\)`@I&Y`2I7K#,>V
M028/.`Y"%C/9SO=OZ40EZ@-1$B2E7@A807V!;YHI54-(+BCBTV$+[2%)I2"+
MGN-N.3*#3$SJ-&B:REJ?!"DD6//&`XJ3H.:MFI$V65V[[AWUV,3)(;E8DJ(#
MLHUPU$B2K!80H/X6I*G7!D<AKV;Q"#YYKR7]TP#S6I31&&X$&(M"81$>KCNI
MVUT#CE;MU;ZV]@M<PO;C3`$5CXVV%,TPJ"**8KL!4")8$GXWW=/DE0_`;RC1
MEM322D$(!/W$G!@6=N`X#@?_U[_'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P'`<!P(2MN^WA0P7@\Z*=<]-*]X=]$A`2)6RM"XM!KAJZ,]S+:#)!M5:R5>
MG#&\,HQ&GF1YN$-W4Y2B2C,1*3DV#0QS272Z^W5:,>VR[D;B0;Z;%L2EX6P2
MAB$!B;0C78IU5A,*:ZII)\:4G\;N:-&260<]2<DTYP`40-4E.5I2EN0GQ0H4
M38B1MK:C2M[<WI4Z%`@0IRDB)"B2%`(2HT:4@!9"9*F(+"`LL`0@``.,8QC&
M.!RN!!CWT4;9KUK75F[VNT=)?MF.LFYX_M_`T!1[BD=Y=5L4!C&PM5HU+>,0
MQ-<[KQ+[[@F]A28X)VCXI18C3@XR$JFKFQ-?[;ZZ4MLS5J@\^`WA7,8L6.EK
M,`PXMJ>0MI*M4PNX"\Y+*>XXXY.0+@!SD):M,8'&<XQC.0SUP'`__]"_QP'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`B$[G-JKNU^UOKZG]43$27;S>F
M\89IOKN_KC5A*6MY':2)Y')[F5&HBC3DI%60]K5KRE/B:6B7B2J#"5!11A!@
M;$]=77Q2?6[KLST;41"U[?7-:9,KGMV3&9<+#O"VG@H`Y58TZ>SLF+%RUR6>
M04B<1@RT",("09$+`S#`WRX#@.!\CR"%1!R5424I3*2C"%"<\L!Q!Y!P,EG$
MG$F8$6:4:6+(1!%C.!8SZ9^G`KI=2A#SU[;H[:=+TJ=5SO6,?:E>]>@;NN"2
M'XNL=MS(;-8U3X`4IR2C+JFYU"LE&4$K!JS*A<L%[91A!(`L9<!P/__1O\<!
MP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P(4NZZ"3YDKW4S>*MXQ*9^Y=<
MFVD#V;L*N(4VE/,OFNOQK2]U[?*6(-0P@RNE+#!)48[$`R:47\5"I]?4?MY"
M$J=$7G5FS%.5Q?M(RYOG=46Q%6R90>5-N#RB'1E<R\B!@](K*(7-CH@4`,3+
M42DLI6A6$FISRRSBQ@"&6N`X#@.!7]V,/9W+\C7K?11-8QCFD<T4W$<K>3$I
M,*7\FL71TCB&N"G%4F-P:@1FS\Q:8CRI#DG'HI"#'F?@6`L!<!P/_]*_QP'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"$5?UX[(Z2W%+;NZH)?5[15U
MIR1SFM[]=E].TGB^N<IF;J>H7/-BZZV#$(]-G?6BP'C`L$'MB9A7Q1Q'[&3B
M$A24K&`R`@[EM?J[=@0_>>K;_P"NJ:EF?",7[0UVJ+H=Z="SC$YY4)VHK<Z;
MT#(F\9I>/C&JGMK4J`C!C"8)@O;P&YK%OAH[*%!:2-;EZI2)6:GRK*2L6Q%0
MNR@Q+C`!94EDH)@H,&GP$P.<CQC(?06/K]>!XY[[,>N:/,CI(W??33E.S,N#
M<NBTK92G5P48B#@ISBC"4$P4J1'E'BP`180"'@7T].!I-(>Z>$7*)_A767KG
M?O8=90,+V9FG$`@KA6^HT?DV"U*=O5S_`&<MD4(AAL3+<",Y-41K#^8H**,P
MG\A9#G(=[U>]:%BZTSRZ-WMU+/;KY[(-L$J5#<\_C.5R.KZPKQO4-BB-413+
M,I3MXBX7'"F)N"<M4)BSU8T"<(0A"2(U2$S7`<#_T[_'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<"J7O9_)K=_\I?\_F?^]G\F_P"`>?V[_7_]
M;^P^1P,'Z)_[M./_`,;7\O%_^B?^[7[^S?N/^GOZO^8?'X%Q!C_96?\`:_VM
8O_8_V7_"$_L_^5_\O_9>/`[3@.`X'__9
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g52875g67_08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52875g67_08.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0LR4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````5````/\````&`&<`-@`W
M`%\`,``X`````0`````````````````````````!``````````````#_````
M5``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````")8````!````<````"4`
M``%0```PD```"'H`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``E`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#M:?K+=B_6"SHG6ZZ\3[0=_2<MKCZ>0PNV?9W;_P";S:G/JKV;_P!.
M]_Z/_`^MT"S^N="Z;UW!=A=0KW-/NJM;[;:GCZ%^/;_@[6?^K-]:S^F]<=@]
M0;]7.M7!V>UE9Q<S;M9DUO#VU;]7MISM^-D-LH_P_I>MC_Z&E*>@20:LS$NR
M+L:JYEF1C;?M%+7`OKWC?5ZM8]U?JL]U>_Z:3,O%>YK675N<]SV-`<"2ZHEE
M[&Z_3I>W;;_HTE,<D/R<7(IQ+Q5>6/K9:V'&NPMAC]NONK<=^URY[%P^E65M
MISK^H=*Z@7-J-5_4LJ3:Z-OV.VS).+GL>[^;].O_`(.['INWXZI8>/TD6'#<
MZOI>?ZI_9/7,1S&MS&&TV5TOR&;:\S)]7]#U+I>5_2;?UJC_`$F/TW3LBCK?
M1J;\FACJ\NH?:,9X%C`[Z%]#][=MK:[6OK^A[TE(6=*ZOC%AQ>K6W,;,U9M5
M=S2(]H%N.W"R=W\NRZ]-5UN[&N&-UO'^PO<=M66UV_$M/MAK<D^F_&M<Y^ST
M,RJCU+/T>+9E)_\`F[51M_9F7D].#!#:JK/4IC_1_9,P9./57_X690EEL^L+
M`6L9A]2QGL<VW'L#\9Y!_P"$_7Z+][?9Z5E.,S_ADE(CU_.8;,A_3_7Z=7?9
MCF[#L.1>PUVG&=9D8#:*G^FUS'^I]DNS<BO_`$'^CV*;J;ZF7T/;;3:T/KL8
M0YKFN&YKV/;[7-<N*^K^1FX;<M_3*WY;L>^.H=+<QK'MK_FZG8N:R_-P\[J&
M+37]FM_7?UFG%HKR/LF?5=9E;GU?LP1E9E?3;O4PKG?:&4&0:;W.>WJ&/Z5F
MVS%_2MJOLQ+*V6T95^3_`*3TZTIW$E#UJ?6]#U&^MMW^E(W;9V^IL^ELW?G*
M:2E))))*?__0]56)]8.C=`NW]4ZI1O%=)Q\FP;@#CN<USOM'I^[TL6S;F,N_
M[265?:66U;%MI)*>#S/J]TW)SJZ^H76FCJ#*ZL'K=5C7?::R-U>!U)VWTG9>
MW_D_J+6;\JO[-^L?;,>O[3M-^HW2FV&QN3F-+\A^8^+R)O>TUUWR&[J[L=CM
MK;J?2MR?^]"S,1.H_5+$RL*["PK[.GX]X/J8U08^B20[U*\:]CVXMK+/T]=F
M"[$_6OUG]):MNFLU5,K+W6EC0TV/C<X@1O?L#&;W?G;6)*<'_F-T-^-9CWBR
MYF38;\K<X-%MI]KLCTJFLHQ<A]?Z*R_I]6'9;7_.(W[#ZC@5ULZ'U!U--`(;
MA9C3DTEH&UE;;GN9U"C;[=GZU;77_P!QUMI)*<7]I_66BQK<KHHR&$>ZW!RJ
M[-?^*Z@WI?\`Y\>BV=3KR<2ZK+Z?FU![75OH-9+W-(VNV6X5EU;=W[WVA:J2
M2GD>D_6&WI^'=CNHR.I]/Z<\8M.5C4GUF>F&M=B=1QW^DW[1B?1NS,/U,7_3
M?8[?T=AND].ZEU/=UK)R</'S+JVLQLKI)-C'-&_U/M3[]U.<W=Z;:ZK&/^R^
ME^K7_IGJ]F=`R&7OS.AYAZ;DVV>KD5%OK8MSO;O];$>YGI66[?TF1A68US_\
M+ZRR1@]9KRWW7=%]#.M8#=U/HF4Q@?9)=OOPNH?8:\AS7?1^VLS?II*5UCHO
M6>J=1Z8_*PPW*P[7@]7PKA4T8UK+:K'"NU_VO'RV6>AD4T>GU''_`,#9D^C?
MDJSD=$^L^7FEEW4C111B7TXV=0XMM?;<ZKTKLO`:QF(Y^-57;6[8_P#2;_7Q
MOL5O\QM])MZE;A-=U.EM&4'/:X-B'-:YS:KMC+<GTO5JV6>CZ]WI?0]1'R;+
M:L:VVBHY%S&.=70"&E[@)94'O]C/4=[-STE.)]2LS(LZ.,#J-SK.K].<ZGJ%
M=KBZUA+WNQG6.?[[:KL;TWX^3_VIK_MKH%R.#@=3Z[?3U]G4L?$RZJW8_IXV
M,2^MX+G686?;E6-OOKKL=^L8=V/C?I/TM'V3(_3+;Z7U9^18[`SZ_LO5:&;[
M:)EEC)V?:\&S_#XCG_\`7\?]'7EU4V/K24__T?54E\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^A>N?\`-_[5?Z/VC]MPSU?V1N^V
M3#?0^V>A^@V>GL]+]K_JFQ9?5*.K_P"2'=0S6GJ!S&_L^LXC/VD&[V_:6MMP
M.H?8'4?9?^4G>C]D^R?SWZ3T5X<DDI__V3A"24T$(0``````50````$!````
M#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E
M`"``4`!H`&\`=`!O`',`:`!O`'``(``V`"X`,`````$`.$))300&```````'
M``@``0`!`0#_[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#
M`P,#`0$!`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P/_P``1"`!4`/\#`1$``A$!`Q$!_]T`
M!``@_\0`<``!``,``P$!`0````````````@)"@4&!P0#"P$!````````````
M`````````!````8"`@$$``4#!`,``````@,$!08'`0@`"101$A,5(2(6%PHQ
M(Q@D)AD:03,E$0$`````````````````````_]H`#`,!``(1`Q$`/P#;<P;>
M:K2N]I)J_&MCJ1?MCH@E,62>BFFSH<NM=D3D(R7%8-?`T[N9)"1-S>I*/5`\
M?(TI)Q8SL`"8#(@D5P'`<!P'`<!P'`<!P,Z^M%A]M_9M!);=T(W+UUT*J1#<
MNQM31&"5;J6=>UZ-N:=MN7U*D#;$IOZ>GUV"38'&!N6?I&(*,99J<)A81C4)
MR0]H'H#W#9`+!??S/@CR$6`"'UK:-#`$?IGVB$`,?+R,.,_UQ@0<YQ_YQ_7@
M?4ABO\A>K1-*%OMCJLVVCS>G*.>72RZ_V1U=M%].P4;Y2)"MK1SN.M49GJF*
MP08)E(`8:J,R9\)9(`F!W4O>OL5JUC3.VQ_41:3RA2A2X?7_`$JV-I/989(,
MY*PL7):VFJNAK05B`7\I@4;:@>#,>T)>#C!"QG(>@:\=QF@&PTA%7.+E%0%[
MH@C"_P"MNVT;>M8[YCRT`@9RW'P:VDT=#(57PFA,][$J=D_M]^/E]Y)X"@M!
MX#@.`X#@.`X#@.`X#@.`X#@.`X'_T+`_Y$?483,+*K;MDURL&P-=;CIEP:$F
MSEF4JQN#E-VZL&A@=FJ/;$H6>,NC-)I%(*B/^O;I&2A$<N7001PPX'AG+2J@
MF?TG=W$$WBA45UVV1L*%M&[C&UO&&%T1,$N@4`W*K6*N1D>:]BJ$S.HQ#BW?
M]7F-RDQTCY"9&Z(5J)>8%L1IB#DR$-$W`<!P'`<!P'`<!P*.[ATTVRTVV6GF
MZ7644PV-#;RDPIIN1UW361,\'BUT38]/A"KNS7>S'Q.:T4]=JP`_(>$:\14?
MDQH,FJ1E*?:+(3/UY[)]4=@WDBNL3L5);%)A!12?5/8Q)FE=CHR^$IT1KFW$
MUO-C&U=/6EN.7EE!?XJ8^QI8(8<I7`\(L9R$]>`X$:MG-.-6=SH677VT]#5K
M>443'"5-J&>1Q(YKF)8,DY.)PC3^7A/(8NY9(4&`\EN5)C\!'G&!_CP*E%G7
MKV/:'G%NO5EN"3;5&M"HY45H%V!NK]8D):(^7C`BHC1.SB0E?<==I6M'\J=E
M:W@]P:P'")$M5#`6/(@E_J3VDU3?<^#K1?,)E6E>\[6EP-_U+OI0A0/LER6D
M,6*'[7^QD^"8%L;"AIDYIX%L:4GKDZ8H1JU"D![<B".W8HEGM^=@NC6BX=PM
MC]1*FN.A]L[?<E>J4X:JJMFU[3I=ZHH,0AXK+.BTH?62-L,,EDB=U")+XJ9Q
MPF$!3\WM("4'!S/2[M@U!1JK!T0[`YQN@WLORN3KJ-V1IX1,S+$1EY&H5-4#
MVB@T=K:;028&)L"3M`77Y6'*HT!CB9\1><Y"7^BG9O3^ZCM+:@=XA.-9MQJH
M1GJ[KTTO-$!AN.!(4JQ`WYF#)C`"FRR:K<U#JC$@DK/DU&<4M39/`F,/+*R%
MD_`<!P'`<!P'`<!P'`<#_]'?L,`#`"+,"$8!A$`8!AP(`P"QD(@B"+&<""+&
M?3.,_AG'`PH]QO1)>&LTSD>]_6XHEBRJH-9"_9\_6BID+6DM_6F]2$:EP/N[
M594N87\2^MSI,E1N,KKQ)A&F7H$V"DY)@4;4<QA<Q_'^[O(UVS48NAUFB98Q
MNI2C*F47/$F1L4M$<FT7/<QM+%;L%3'*%A(&US&).G>T)9V<M;N;CVEEI%:+
M&0T,<!P'`<!P'`S4TBU;B]@F]/9^@<.QC9C5:.::;)QND:-IS7J/THEB3?&%
M56)I`FF]DMMPTQ-W&Q3)D[+"%A91X24@`IE8$JA0G4ICTH>T6C??9_U91=RL
M?89&9VPZC,ZC+K/;>J"M(K2&Y>O$0)49&\2F84Q"2SZKV$@;$W&@,/6,!$3<
M&E*F5+G'`T@1G$!=%35QUCL)5<#NRF)HQV'5EF1MOED)F4=5A6-3VRN1?O*-
M+%C`3DJQ*<$:=6E/"6J1*RC$YY99Q1@`AYYLKI_JYN-#RH'M%0M7WE&DGDC9
MR+!BC8\ND84K`DA5.,,D@R2Y+"7@X!``Y6M*M$K]H<8^3T_#@5J,O7/O'J`Y
MIC>NS?Y\<Z81NB=23IMO^TO>Q%9-+.)<C"9&*OV,0.*78RJ8VSLA1I+<A5&R
MM.`T81F!%[<^X/47C>;>ZD$^1[&]5EPSQL1"<0N$[T%M^J-G6,X!1Q0VQ0AK
MBRW37"\30GH!&B4ED1Y884:3@!/D".`$(=THSN)ZY+YDIM=-NS,-J6ZD+\VQ
M%XU[V:)=-8K[:IJY^@2(9BJKT10642"1%J,_",MF*<B?FS@(3!9$'U"RU(K2
MKTJ9<A4IUJ%:G)5HUB0XM2E5I5)83DZE,H)$,D].>2/`P#!G(1!SC.,YQG@1
MDVMTTUZW1@K=![Z@Y;Z.,/B"75Q/6)>LBEK5!/6<\"MBL*HK*8C$<LKZ:,BP
MH!A*QO4E>_V_&<$TD0RA!FUW4+W:D^SVNFL=SK(FU;J:QV0_;7]3^Z+*>7%8
MMO'%H4XN;7>>E]S),PIOA]=;!SO7M0B4/A3(E#'79:CP,DA&A%@E0&DC3G<*
MEMXZ-C][4B[KCF=<J6QR9PN2H1,5CU#93`(M--:CM>(J!9<(=8T'=!93+T)^
M/06/8H3C.2'ISS0BAV0Z%N=]FUMMOK*@CL3[#-2'I!/]?9\I,PQ`M)D8"WTV
M1:K6I(DJEO5'4[<C:_+F\_!IX2VM>J+5^OP>60I"2NBNXL,WKUNB&P,2C,@K
MUQ<'25PFRJDF@TP9_3%N5W(G"(6-5D\0D8+.;9)%I$UF!]AY*4\]$:G4Y(*"
M>$&`E_P'`<!P'`<!P'`<!P/_TM_'`<#,/V2]*SA6-C//:GU!HR:$["ZF"[3Y
MSJB*-*8VG]IVCP3<3^".E=)RR$#;.IXR8-P'*#*=,^N/Y%`"EZH+LF"6G3?W
MEZ[=LT)61M.D2TIMU`VE0X6SK4]O!ZYS2-R%TRSGS6O7=Q:V,V9PT:D:?"T)
M:?"V/JE925<#T,2JE@7B<!P'`<!P,^.^,4M?KMWQ:NW6D:NL2Z:$M&HTM%]F
M=15E[W&2L,"K;'W]7[B1Z(^>6*92"FV%&L9W1,`H9A$>&/!/P84K%9(74:_[
M#TCM34\2O/7>S(K;=3SA#A?&YI$%_F-ZK`?0*I`N3'%IW-B?FL_.25S:O(3.
M#>I"(E224:`0,!6'KR@+T6[,IYI='E+>U:N;KU9/-PM9:\1I!(&FE;TK:4Q-
MAVMJZ"M:!NPW-%?V458+1/4B,!I"1`]&O>"BB_++P8%T7`<!P/%;FUNUZV,9
M<QV_Z,J&[&3Q5*(MLM:N8C/DJ9,L+-*4@1`E#0YY0",`<+\Y.2QXR+UQG&?Q
MX%9JKHPU#@P52[3FP-K>O60GY<E>56GFR=CPR&+G5Q6>>)9(:;F[G8%-OZ7!
M_P"028QB+!E/@``9+&0E,3A\Y=?=YNMJ=L'#[]TV[*(HC.$<^,%[UG(]);V-
M:$9QX$+1%K&IY;;E.2"1.20XORU[K%V1,$TC)A9./DR7P,[NPNO74Y);.A<I
M[$]!=_>C6^&6?-*IKVLJ&5*YYK4*99>DQ<9:F;92.1ZXZ7:0_;H<'DGF1./E
M),*!J3E)99@C>!H.V'TGF(YP?V6=/MD55$=DIPPFR.RH&8Y8D&HG8G%#&X)[
M(CLS]'R-O8FJS4PRLF1BPVP["@HU4H(7&&)5IZ@@),Z%]EM0[NDRNNW%A>->
MMP:?,RU;%Z:6FN3DV[4#^0>-,<I1F>,VH[)KQQ]I:ALDS.4-`K1*DPS@I3CL
M)PAX/KZS%ZP=P>X%%LII;;5F\=#P;?.(1<H(@H&V_8#)LT)M`Y,R5,7\:,R:
M,ZB`O3L:HS_JG)5D90LBR<'`7+\!P'`<!P'`<!P'`<#_T]_'`<#C7D+P)G=0
MQXUM(?Q-JX+&<\D*E3.2\92FX;375,A4(UJAM+6^S)Y9)I1HRL"P`819P+`?
MS.JAUINR<=P^SVHTE;))U7;Z2R\+FW:ZZK(8'R0R:!(IHM<WV23NG"'%O9XV
MQV#JQ?47BKBX)7!(TA+;S(R-O$B5@-7LJH-D_7%VT+MB+9FVB6ZM6AU-[(:1
M:6\4YJAV<D94$O-"6F4>=:6M#FM<E"Z70EP)19<L(PC6')&Y0`TM2L)+//*"
MDRNNP_LBZK=_]J-;]R)K,MKJFDMC6':&N-<V06A:+'L2CW9%+9+`'W5K8"22
M9/`GZ7($T:.9WFJY`>D6C5(L?IPP]6)6F,"S6#_R&-5HSM/1>M%S'3R)U[M)
M7;Y;-/[5VBSHZZBK)+Y+?-M0W.L=L0U0U(15G(**4Q<B$N3RK<%6,2!",ET+
M29SE<>$>-2^^1WKOLAW1T=W]=W1HJ[&Z\^K#3_9EWA;;$J[C*"0JELKKJB;3
ME3:B:F%*C>H<O0'0F0J1*#WA#DTQ>>$GX%.0]5U"[F72I-C]@]3>Q&2.37$F
MC?&[]8M7-QY6RPV&P&3!BT;KFQ(=55U*&<UC2PZ7/,.LY`LBDB/:TC+*VL0P
M@5&J$"I4H"'UF=X.['6_V(=B,-VJIBR]O-!JYORNT;5:-31-KC\FTXB-GU8S
M63#6MV9RHDW)IO"WYF?B6Y.L>W=M`H=&)P/2N!XSL)C0\;V:A"?5*VX_VC_Q
M[=EZ$9-4GB/W?.NQ*(!M598NBT-?6&*P64P`Z;4/5P9-/8%/+2RN5H!IF=N2
M.C"J(2B+"U(CE^3`[357>?K!N_V<==DJV`<:STDD&G;7NTU6*NM*RH9.Z3G=
MA6Q74"K*-(->=K86YJJMDT?/"6Y*UJEV"PIADDI2TBM<:H"5P-I3,\L\B:6U
M^C[JVOK$\H4KFSO3,N2N;2ZMJXD"A$X-KBB-/1KD*Q.8$PHTH8RS`"P(.<XS
MC/`Y+@.`X#@?F<:$@HTX>#!`)+&:/!))J@W(2PY&+!1!`##SS,XQ^4``B&+/
MX8QG.?3@4&T?-=J>YRE678.N-P6/3C2^T6\]H;:BU]@\"M3:A=]::[1Z?16]
M;BN*/RBN:ODF%ON*51IDAKD:D*P3[G@\L1F%(6-Z!Z`4!UN41C7O70$X,AI\
ML>IV\NMARPV6R=^E\B(;R'MZ6*"T;2QM?G_6EC$C:V]O;P&Y&,M.`1@\B#SO
M>OK3J+=%UKJXFMZ=*"W)H1P2O^NFWE;-S=^Y==.S8I4+T<<DZ16$MNM.HW)6
MK/`Z15YR8@5)EBH!(DPU)QHPHWMC;_:/5#M"Z]9[VIP1IJF*U96.QM&3+=*B
MT,BEFD]EQK89+5(8'*IJL>BVB2ZLRY':E9I4K^E?0.35DLPE4G4%-Q8U1(:T
MV1\99,SM<BCCNUR"/OC>D=F1]9'!(ZL[PU.!`%2!S:W-`:>B<&]:F-"82<2,
M99A8L"#G.,XSP(3=F%F[9TII!?=QZ11:$SG8JJ8RAL2+0>>QM_EK+,8[$'YJ
M?;%CB1@B[_&WUSD3E7J)S"VD)5(5"E;\9).,'&%C"%6'6/\`R*Z#V]J6HW;;
MR*G:167;!R]DK^56$:<WZNWM(V-[7QQ];:8N]V.S'T4J:WA#@I;%I"I0O"4Q
M40!,-Q"/YN!HZ`,!@`F%B",`PA&`8!8$`8!8P((@B#G.!!%C/KC./PSC@5Y:
M>=J&D>]MK7O26N-N%R>T==GQ<TSZ&/K([0Z1*6]K=`1YUET78Y*G;GI]A[1*
MA?5+5@4Y>42\1(#P%@6(C%(<U0':)U[[36Z_T+K[MK3UHW%&U3XD7U['I`8&
M0K!1E*0MD"F-IW)(@*F+:SIE'N4*V@:Y*7DLT.3/<0=@`3UX#@.`X'__U-_'
M`<!P(G;'T+J(_N\,VUV-JJO7J5:<)9+<,&N5^CXE,OJ=NB\>>761.C4]-9>'
MQ4RHFOR%HVL?DHAK2"504^5:=.:6$<^P/K3UR[3*B@"V=8F53W%!`M]C:V;*
MPA"IA%_4',U"0AZ8'!`I7)VV2)FU,\!1JG:.*C$>3%*,L6!HUZ=.K3A514<\
MCVYCTHZ5_P"0)KE`9%M;'FF0/5`7<K0!;JZW-A4=-<&T5V:Y3MF(87RKKJ21
MM,`UZ;6I4W.!R?R#,IT@!+&I*$F->OX\VK5%2@N/R*T;2V+U.8JQNZN*_P!1
M]A62KYG#(07L+.X-8MF.)4\:(3&IS(R5LI@B1:B)<CE"A"N)3*P*LJDA1O`]
M$U(_C^]>NHD(W"J)CBLRN2B]S'*#*)M2U^.T=G\0@;772&:HHFSUL]DQ1DL1
MM.92YXK"C='![<GE`%(A,2JR%9)ZM4'8=:.AWKYUIH'8S5PB(3R\:&V:E$>E
M,VKO8F8)[':XRHB$=+B\/2UPK3,4==HB9$VE.2%N<PJ#GY*),GR!?C"9/@H/
M6-`.L"*]?<XV!E$5V<VGO]EO5GIMA)C&S-AMUF"KYII>/R*,1U!''\N/LB]6
MGS'WPEN#Y`<F@;6U(08,_)(#,!R5D]-G55;DX:['GV@&K3M,6M<J<A.:"IHS
M&4[\O6EG%*5<V98JD9&*P3AA/%G&7U,X^P>`B#Z"`#(0ES,=7]:[#J,B@9YK
M[2<RHM)\&45-R:K80]U<@&D4*%:,YN@3@QJ(NWJ$2Q6:<082E+,).,$8#(1Y
MSG@4NR+HKD.N;TX3OJ&WAO?KU=5*A<YGZ_.+BHV"TU?'-:K:U:@1M)V>L>"X
MNH7F)UF3EJ4]6>1E:(*0"8L/QB#E([N-W8ZE-1S%N;URQO>!A8U"(L&Q/7-8
M[&3(WQH%]4F,RZZMVP<QS!QE!0,+52A4TK43<<=DA.4A3EY,4@#G%7\C7KS@
MK6D6;*QO<_39TRH3(W^+[0:4;"PQ[ABU:84!$CE*B)0V=QQ.H5EG@,+PE<%?
MN`+&<9]<XQP)[TQVA]<^PC:R.50;N:R2X4C492,S)^\,+8)@L68P7G*/]#2=
MU99FG68P:'^T:@`9ZY]/3U]>!,F*36&SML^Z@\MC,R9OF,3_`&T4?FJ1-GD%
M9R$TCSVA4L2_,4+'H(/O]P<_UQP.S<#/W<FH.W/6W;=G;<=6#$TVW1=S6%FV
M]Q^M^0X&6=(I&M/QF=W-I4]%K&U'"KA?FS.3%\86&8:'PQ.#X<#-*0(2PL5T
M>[)-3.P:+N[KK]/E`)S#E"MLM2A;&:C:_P!@Z;D#8H3H'I@LVJ7DW[UE4,SJ
MI"B-6IO,9S5@1E$+#A`%Z!7EO=W`3.L;_P!8JMZWF2GNR&92.73")['ZM4Q(
MWB46M'V1T1L(H)8J>Z805):6HEIA3NVN)+\&=FD%JT[FG,*P24F4JR`Y[1FE
M]KMM]G-L]S^RS5F)T4P2*LVW2_774">&U->!C'129:JE5WRF<31J97AIEC?=
MDR<4R7*=*H3MR]O:A%*TBQ.2UJN!SSOULW[H^LDMF=0]O$PYC6JCGEYZZ]C7
MR2S'3"3#4KO->":.<BG#$YU0ESB)2H.),:CW*+F'X(3&-*=*#WEAWNN>Y*D(
M^_QRI.P"O9]UH["O`2$@8GLT%&71LL<\AR%0?4>VC!Y-$SMA$IQDH@:QR9'4
MPW&0";P"]/<%.?6KI9KCM/\`\U'4%>;'#[JTXHS<^`;%ZXRJN)ZK>DD-9]N(
M7++%B396L\9DZ=&T/E6,;&0$\*8U8`EQ>G-&I\I.,0U02GJ.(=@?0]$"ZL;H
M-,.R_JVBCPXAKQSKE!DW>W46(R*0/4B6I9=7S8S&HMDZS8'-Z]ABIE&F=FY+
MDY4!&C;4I+<`(@=+/5Y66WO6_(+DM"!SS5[;&3;E[5W91>TE;#FU9;#U0[RN
M0Q]D2R:-OCNDBSL\1-<EB@V=4T+D136Y,_E%93IE2I0=@*ANJ73O8C4/^2!4
M.N$\I:&AMZDIUN+<5N;",ZM7%(S=6O%WTPZ,];3>'UT)R)BT>961[<%);<CC
MA)F4RU_/;EQ`/ICSBP_I1<!P'`<#_]7?QP'`<#IMBP*,6K7T[J^;(1.D,LB&
MR>!2YL`>:E&XQB8,BZ//R$*D@0#TXE;4XFEX,!G`P9%ZXSC..!1>1NS<O4!^
MU=`]BS"X6%ID1X=74EV7U^WKG-+%&-E3)6JO(7O-73<TX/KZ=X9DQ:(4S8Q*
MV*1*`%GY1(C1+\)`F7OYHMK_`-LFKL52-E@EL\K93&ZZM/-N:9D1!\HJ*R@H
M"W"#V?6\[BR\M0XQ=Q4%I#5Z9"O)+<DY))I)Q"Q,A6)0\)ZL]Z+DE,EL#KJ[
M"U4=C?9!J^E`8ZK&XM0V1O;6A?["2$[45/YJ%K3O2%]_,DD29$7C+>ZD",-3
MHLGB0(@NMX#@.`X#@.`X'XJ$Z=8G/2*R"52542:G4IE!0#TZA.>`11Q!Y)H1
M%G$G%BR$018R$0<YQG'IP(-6-U>];5NNKQ(;+T%TXF<FD"@E6]RUZUMJ$^8N
MJDCX\%G+Y>"(ER529@!(09R)5GW%X]@O4/X<")2W^/CU)DRY58D`U=5458QX
M30))UKK=M_T.^LA:E:4M6E1XBL+0C;$R$KL%Y(,`G1`#XP\E!P$/M]H?-(NC
M6A)>TJ&"6;C]JLH8E;:)F5,LB['=CWII4M`QD&#:E#:Y292C.;1F)2A9($#)
M6<EAS[?4./0*(>V_2Z0=<[CH[1NC&QN]M1F[O7Z;4,MV<M/L0VEC^O\`KHH:
MBH(RQP^8-42F<)8E\NF+#)5XV/#@\$"&DBZM*F1K1&XRD"[?:CH,U.WBJB,(
M]JI'*I[MM&V5S;#-YHC'H+6=QR7RWET=6YFFT3CK`;6=@P%B;EQ+(F:)$V/"
MC#&EP4)=E6<I6G!U&O9?V-]54,9X%:^L%;[T:@1!.H3)K@Z^*OCE*[&UY'VI
M,>`AZL/29(-K@%@>2WI4WSFUXZ$J4^"S?1K.]"L#"=^G?:WH%O>O41O6[8V'
MR>QF]/\`,]4])R7>N;C9#"20FN*=96<^;X[*E?TXQ?$L/1)U:0@T.0Y.]>!8
M?P.HSR`0.TXB^5_9T)B-C0.3I0(9)"9Y&V:7Q&0HBU!*LM&^1N0(G!F=DH%:
M8LW!:@DP&#"PBQCU#C.`Z73&O&O^N$>61'7BC*=H:*.*[+FX1BF*RA571Y<Y
M9P(.7!8RP=D8VU4NR$><?*,H1GIG/X_CP/8N`X%*_;EUASS<@^C-K-2+,2T1
MV&Z6NSQ+]<;(6(R38W-T*U,8<[TK99@<8/Q#9:>$1`%!@5:9&6N7$G)#TR]2
M'@=\ZV^TEBW%=Y]K1?<`5:N]B&NPA,VQ.K$L<D9ZP8VX#<2;;%..Q9XRK`IF
M3C<DZE&O2B.RD+6$A$8H2G(G!>%MG`<!P/_6W\<!P'`<#BWQC99,RN\;DC0U
MR".R!K<&-_8'QO2.S*]LKLD-0.C0[M:\I0A<FMR0J#"5"<XL91Q0Q`&'(<YQ
MD*3,=4=M:>SIRL_J/V*+UV8Y$X*'"<Z17\7*+8T:DXLD.:PLROHTB<"K"UN?
M%S\J!E2MBJPU%XGH4%NR4241D(<VWK1V_;/;D:$6+=6FNF%6VKJ'LA#;%=^P
MK7G9R2+HD\:U+AN22Z-;2*-G-?,UX27];1AX.)*RN6IVPIR"/))B4A:K.R&H
MW@.`X#@.`X#@.`X#@.!Y#?E#U1L]35C4!>,/;9[4]K1E;$YM%'7!F$[DUK,E
MFEFIU!`RU;:[-2\@E8@6IQEJD*Y.4H(&`TH`\!F83:4]VW3=&F5FZU[?:^SK
M45I?$S0T:;;/DQR+V[3<*&2K-Q^VUPG36&I71G:\)24I:(@TA&D$H`-+'AAP
MH-P'JFOW\J/0J12#]IMVX-=_75L"PEJFV?P*^H0\/46CTP0%-RA5'4DDB;:?
M.$J=0D<L')%TCBD92J0E&!`+)F"PF!8?<VHG4WVXQE#/71IU[ON2.#6@5PW8
M^B)I&4=ZQ7ZI*G5L#C&+IK%T(G;>9%QN)"DEO5JCT!)PB\*$@\9]F0A^[L?9
M!T]8.G;98MS]L'7>V&#46%!9\!'*NQ/6N,I$00"F-?3(G#,T;0P=F2(LF.S:
MY8;'LC`BQI?[(5JD(75:R;+4UN#15<[(:_RXN;U+:;'A]B;_`(0.#2J,)+5*
M&]>WNC.[)D;HT/#0Z(SDJI,>4`91Y0L?B'VBR'O'`<!P*VK?[7-1*JO61:M,
M:^WM@MFXG&4,KDM$ZNT5:E\S*-M;TS$/L;Q+GB#QE97D$.DB!8E&FR_/;826
M4L(/4F$)C0GY#./O:Y;^=GE@TM,4O2-N'J19])6XY(=9]_ZTVFIMLV#J=E5K
M&]0B?YA1\FBL%:I97[RB<4JMQ8%,V1MZ8_*].D?<>B_*H+1=)^WRRX)?+)UN
M]O<#2ZS[JX$N8ZAOHS"-IUDWF;VAQ/;6F;57)0DHF"'S*9)`$&8833`$GN1O
MAE!0.9Y+`2&AC@.!_]??QP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`\-NW6+
M6[99I3L.Q6O]*WPS(PB"B;+BJZ$V2C;_`'CP;D;<3,61X`WG!-#@83"?C&`S
M&!!S@6,9X%'MG_Q8>I&;V"59U=P.ZM89:4Y'NX%.MEVR6%(DK@I+/+/.9&Z3
MD3A)$21`4""%.S!;DQ0/R%E@!D0<AWJ,=$#Q7IC*U5MW"=QT3@;$UB96N$F;
M61MX0,S6K=%*IR1L7D5:G:4_N;50TR-0M0."U`/T.+/R,(,!"RO1#12F^O&D
M%="4>]69(HHYV)-;2=GNV9@&;3!TF,_6)ETD7*'4AK9$!"=4I2A,P2G2$%Y-
M$8</`SC33!A,_@.!Q;XTIG]E>&)8-04C>FMP:51J0W!"HM,Y)#D9XTQV0CP2
MH`4=G(!>W/M%Z9],\#%GJ"Z55T#V4\Z'=H,+GCIK=9DH<8QJYO803+%FGEGU
M?+$R9P(K#:FE&9\.K-);$(?U2Q,9)7YB>W<AM/*),5)HXVMZO@;2(\^,$F86
M:111W9Y!&'QK0NT>?8\X(G5A>&5P3%JFQS9G-M-/;W!K6HS0&$'$#&484+`@
M9R'.,\"*V[^B>M7871[O0NSD!2S"+*#C7>*OR4>&V;UG-`-ZQO:K`KB3E`&L
MC4N92UQGQ&AP-.H+$(A42>F,-)&%&%4;X;(]+-P55HOVQ3M5=&IM@*E$:U2[
M5'D0F@!0$#.!2W5!M@V*U3TH:)<P^$:0"2'.2LQ4D-3JE1B@D+@K;PU"?8M_
MU_VWG(_J_#^Q^R\DGZ_Z_P"'R?.\SW^/X?C_`-SY?=[/9^;U]/QX'__0W\<!
MP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`\]M6IJQO*`2:JKD@$
M1L^MIFVG-$IA$Y86Z21I\;SPY"(A>U.B=2E,$6+T&49@.#"3`A&6((PA%@,_
M*CIGVRT(?'"8](6XI-(05V=AR"6Z)[>$/ETZMRIP#CX2BHE/5*:17%49(&XL
MHD8D)BUQ6C3DX-<BR`B*$'<$_=[8FH36^-/<AI1:VF#A&VTL+5?]--<BV:U4
MN-\)5("3T,.E5=,SX_UN[.;<X?9)&N1^[XTB544H7`6%EICPD/,=\>DCLFUK
ML*O[,VMTZM>@I(RL!=@1JV;0B5<J(_B2+$Z6(NJYNL=QALL@DJ2R!02!K7@`
MC<$#O@O!!I:K`,<"H_K,G:=,/L^_C_7=M%'[>U^JK5BP95K3MQ'YDP/*EBTL
MO")CC4J;97.\/*MB*=*)*MEN*3&JE`"4/PJBBQX:DR$)0?_1W\<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P/C<?K_`*]=]MX?U?AJ?LOL
M?A^O^O\`A'YGG>3_`*?P_']WR_)^3V>ON_#UX%$MY?\`6?\`U&^_OO\`\,/Z
MZ\AP_4GZD_PZ_</S?<I\_P"X\3_>'V'D?+_[O[WD>[V_W.!T?1W_`*XG[9;J
M?X0_XD?H']C[&_S0_3GZF^Y_QP^KD/[E??\`ZV_WK^S'UGE>9]+_`/%]/&]/
&S>'P/__9
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g52875g74h80.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52875g74h80.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0X@4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````O````/$````&`&<`-P`T
M`&@`.``P`````0`````````````````````````!``````````````#Q````
MO``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"X,````!````<````%<`
M``%0``!R,```"V<`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!7`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U5))))3D=;ROL^=T03`NSS6X>(.+G1_X)Z:UUQ_UYRS3UKZK5C\_J
M(<?A[,<_^W:[!)2DDDDE*22224I))))2DDDDE*22224__]#U5)9&5]:>CXI(
MM.02.S,3)?Q_*KQW,7-]1_QL]*HW586%D79/#1D`8[/^F;,C_P!EDE-/_&GF
M-HZMT)\P<4OR'>0;;B.G_P`!<O1N=0O!.J]4SNL9UN?U!XMOM]NT"&,8/H44
MUN+ME+-W_HRSWKJOJU_C*_9&!7@=7HLR:<<;:<JMS39L_P`'5=7>ZIK_`$OH
M,M];^;_P?^$>E/J22XVG_&Q]5+"`?M+">QIW?^>'7+2I^O?U<N`++,DSX8>4
M?^HQG-24]`DLFKZS]'N^@^_7][%R&_\`5T-6G3:RZMMM<[':B06G_->&N24S
M22224I))))2DDDDE/__1]50,O"P\ZAV/FT5Y-+OI5VM#VG^R\%'224^+_7CZ
MNT_5SJH9C$G`RF.NQV$ESF;"&W8^YWN>UF]GH[O])Z?^#7>_5;ZG=*Z)TMF7
MU2FFSJ!9ZN5D7`.;4(+S54ZWVTU4,]MEC?YW^=L6'_C;J%F3T5G^E]>L_!S\
M-O\`WY=/]?.GYO4OJIG8F"'/N<UCO29JY[&/9;;4S^6^MCMC/\)_-)*6I^O/
MU3]H;E^C2XEM5]E-M5#RV=PJRK*F8S_H_P"D]_\`@U*[Z^?5.@UMOZ@VI]M=
M=S&.99NV6L;?2[;Z?YU5C'+)^K'UJ^KWU@Z35T#J#&47FD8SL2W2NT,`J_57
MN_/]O]'=LRJ7_P#%^JMGZM?5BGHC'6OL^TYUM5%%N1MV^S&JKQ:65M]SV-<V
MKU;/?_/)*0G_`!@_4X"?VDSS]EGX_HUJ=)ZUTOK.,_*Z9D-R:*WFM]C00`\!
MMA;[PW\RQBXSZAG_`+-?K/\`\;9_[<Y*UNO8K.G47],Z82S+^M6;LVM`_1!]
M5;.IY=;1M^ABX]M^[_N3<DIZ'IO4L/JF#5GX-GJXMX)JL@MD`EA]KPUWTFJT
MN'^H>4_I75>J?4W(=(P+'78#CR:7EMCV=F_1OHR/;^?D7KH?K3U!^%TA[*'!
MN9G/9@X<F/TV2[[/6_\`ZSO?D?U*4E-WIO4\'JF+]KP+1?07OKWMGZ5;G56?
M2_E,_P"_JGU/ZU=!Z3D?9^I97V6R)'J5V!KA`=^CM]/TK=N[W^F_V+D_J6;?
MJU]:\_ZHV%SL6X?:,)[N3M8W:[0,;^EQV[+=K?Y_"L3_`.-W^C=)'_#O_P"H
M"2GI<;Z[_53)N%%?4Z6VNC:VV:IGZ.W[0VK=N6EE]3Z?A/KKR\FNA]QBIKW!
MI=$`D`_FM<]GO_EKE?\`&9U'ZO\`_-^[#R[:;,]SF?8Z9:ZT/W-FP-]SV5^G
MZGJ_Z2O]!_A$3I/U4MSNB=(MZA;9CY=&+0VRIS02/2]0X[7M?#FV5U95M=M5
MWJ5[_P"<I]2E)3__TO54DDDE/`_XS*O4ZM]6F_OY19']:W"_\BNJZYURCHHP
MKLH`8N5DMQ;KR8%7J,L=5<^?;Z7K5UUV[G?H_4]18'U^87=9^JA'_EDP1_:I
M?_WQ=!]8:>B7X#6=;#78GK5N#'R0^QKMU5?ILW.NW?GU;?YOZ?Z-)3A_7?ZG
M]#S.EYW56U,Q<^BI^0<EGM%AK!MVY#6[66>K'\]_/U_X.Q:/U&SL[/\`JK@Y
M6>YUE[VO'JOT<]C;'UT6OT&[?2UGZ3_"_P`ZH/\`J+]6G-:RVFU^)6=[<)^1
M>[&:0=TMQ'7>AM_X/9Z7\A:K']/ZIB64TV%U$-8XT/?4X!S*\BL,MH=5;7NH
MNI?^C?\`0>DIXKZA_P#BU^L__&V?^W.2M.W#S?K!]9,O.Z?U%V!7T8?LZFQE
M=5^ZYX;D]1<&9++&5;-V+C>S])^AN5BKZK?4W`SV8N/4_$S<EC@T59&36Y[/
M<]['6U7MW[O3LL])[_?Z5MG^"L5[`Z+]7_JQCW7X;/L..0#:/5M=7.C6N%%E
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MZRL_R7U@P[^5^^NQ^L&+T#.&/A]9+GMM=-=`LN:UWNK9ZE]>,]C'5UVOH;ZN
M3^BINMK_`,):JKOJ!]4G5-I=@EU+"XLJ=?>6-+X]5U=9NV,=;M_2;?YQ)3S?
MUIZ19]4.JU?6CH&+4W".VO/PVL:*VZ_SC?:[[-7?[*O6J:S[-?Z?TZLB]=WT
MOJ6+U7I]'4,1Q=1DL#V3&X3]*NP`NVV5O_1VL_TB#TNCI1Z<[&P7?:,)KK*'
M-LL?>)8YU%]!=E/N?Z;',=7Z?\TJW1OJ]]7NC9=M?2:CC7>FUUU+;;G,VV%[
M*K'T66OHWN^SV,9;L]3V)*?_T_54DDDE/+?7&DV=6^K)B=O4@?/2NRS_`-%K
M>ZGTVCJF&[#R'/;4\@N]-VTD#\WO_P"8?SM7IW,KL69]8ZA9U7ZN]R,]Q^[%
MRW_]\6\DI:!$<CC755.E]+Q^EX[J,=UCVN<'%UKM[O:QE%;=W_!44TTM_P"+
M_2>I;ZEBN))*:=O2\6WJ='5';OM..QU=9GV[7;M[=I_K?3^G_P"";RYN'3G8
MS\:_<&/VD.8XM<US'"VJRM[?<RRJUC+&(Z22FMT_!IZ?B,Q*"XUU[B"\R27.
M-CSH&M^F_P"@QOIL_P`'[%*G$JIR+\AD[\DM-DF1+&BMNT?F^UJ.DDIIY?3*
M,K(IR2^VFVGV[J7EF]A<VST;MOTJ_4K8[]__``?\U=?7;:L9ZE;F;BS>"W<T
MPX2(W-/[RDDDII],Z5@]*H.-@UBFDD'8.)#65;OZSVU-]3]^S](I?86?M']H
M-LL:]U3:;*@1Z;VL-CZB]KFE^^MU]O\`-O8K222G_]3U5)?*J22GZ4ZRV>I=
M",@`9SSKW_4NH#1:R^54DE/U4DOE5))3]5)+Y5224_522^54DE/U4DOE5))3
M]5)+Y5224__9`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0
M`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`
M:`!O`'``(``V`"X`,`````$`.$))300&```````'``@``0`!`0#_[@`.061O
M8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0$!`0$"
M`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P/_P``1"`"\`/$#`1$``A$!`Q$!_]T`!``?_\0`G``!``(#`0$!
M`0$```````````D*!P@+!@4"`P0!`0$!`0$````````````````!`@,$$```
M!@(!`P,#`0,$#@L!```!`@,$!08`!P@1$@D3%`HA(A46,2,70;<X.5%A,D)B
M,T2U=G<8>!D:DB2$E-35EB=76-A9$0$!``(!!`("`@,``````````1$",2%!
M41)A,G$B0@.!4A/_V@`,`P$``A$#$0`_`+_&`P&`P&!%SY3MH+:KJO"633>M
MV2%C\E/#FI29EEG1%EH1_<I62G$62#1RW6?.PB8A90$>BI133.8R9BE$,E:U
MZY_"4;*R8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`_]"_Q@,!@,!@5MOD
MI;-#7FD.$ZWNR-1B^;E"V:!C^NCZ8:UJ-P.+O\@W#U&9&@V<!-VB"@]P&+]2
M#DK>G?\`"R3E8,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_1O\8#`8#`
M8%/;Y:%F]"M<':<18X_DYS?]F=-R/.B:?X)AJ*+8K.H\!'U#K?J)P5!8W3L`
MBQ2]>XW25T_K[K8^H[.:[:IUC<SJG7-;M>TNSF6453646-/5N-E15461_=*G
M4%WU$Q?M,(]0^F5SK(6`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/_TK_&
M`P&`P&!1Q^5[93.N1'%"G]YQ+!:7N-E`@HIE3*:UW@(LQR.`'U53G"F`!B&#
MM(!0$OU.;,UUTXJV+XZ[+^L.`G"FQF/ZCB1XJZ#]^<$?;E&4::OK#&6])+J(
M$1"3:J@3I]!)T$/VYISO-;DX0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/
M_]._Q@,!@,!@<]SY/5J+8?)'"Q`=.M%XU:OJINB8$'N>6G9-W^XP*J"J/;<0
M^X03Z!T+V_3N-F\NNG"VSX4+-^K/%EPVE/6(O[76TI6>]-Y[XI?T7>[=3O1%
M?J/8=M^!],R/^3F**7]YEG#&WVJ4K*R8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8'__U+_&`P&`P&!S+_/'>T;]Y6.5CUHLDLPK<QKZB-?2$I@16I>J:/`3
M2)U"I)&.J2R,WO=W`(D$>SN,!0',WEVU^L7`/CEW!"R^*S3\*BY*NIKV^[HI
M[I("(E%DN]V5/WXK8QDS"=0QVUX36ZJ=#]%@``[0*(V<.>_V3H963`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`__]6_Q@,!@,#`?*#DAK/B1HC8_(+;<LE%
MTW75>>2ZS<%VZ4E8YCTQ2K]/KR;DZ:;NR6R8.BP8I"(%%=<HG,1,ISE+)FX<
MG7;^S[/NW:^RMQW5<CFW[4OELV%954O4]O\`F[A.OI^13:%5.H=)D@Z?F(B0
M3"":12E#Z`&8=^%H3XOO-ZO:YV%M#A-?YMO$,-SRK;9FFE7S@K9BXV;$PJ<-
M=:N!U5/2-,7"HQ$:NR#HGWF@U$>JBJR!,L<]YW7@LTYF`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&!__UK_&!Y2VWNCT%@$K>KE5*7&"54P2-ML,17&`E1%(
M%C`\F'C-N)4A7(!A[OM$Y>O[0P-%-G^7'QIZ@!R%RYG:/<K,Q7([9T&S'VW(
MMUFI@(X;+1FJ&=UD$W:2@]HHBEZO<!B]O4I@!E?6WLBZWQ\H;@_0H]\AH^@[
M@W[92)./QAU8AIJNBN%DR]$`D+#:3O;>R274,'04ZXX$"@;J!1Z`,RU-*J6>
M07RC<H?(S:V;[<$\TK>M:Z^4>T;2E),^8:_K+DR)VI)EZ@Y<N'ULMIFBAR'E
M)!151(%EB-"-&ZID,F72:R(XLBO]\3+2L#*QLY!R4A"S<+(,Y:'F(EXYCI6)
ME8YRF\CY*-D&:B+MA(,':)%45DCD424(!BB!@`<"W=P1^4`^J58@M<\[]=6.
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M5S,Y18$C*`0W:!NG7H/3]F#%\,D%,4Y2G(8IR'*!BF*(&*8I@ZE,4P=0,4P#
MU`0_;A'ZP&`P&`P&`P&`P&`P&`P&`P&`P&!__]>T3N#P^ZPW-[H)[F-Y(X=-
MVX=+G;1/,>YS$<B1T\1>&9LXC8$7=HAFQ3.@4I$DT"E`H`/U,4IBS#4VL[1%
MEL3XJFGK2X=2-9YF;J82[E+H,GL2E5?9+@ZQ6QTTE'2L?,T%RY236[#=GJE'
MTRB0#`(@<K#7O\--;[\4#?T<5R.L.6NG[@<A5?9EOM%NFN"KF`%_0!R:O/-J
M"T*H)4^\2`MV=YN@&[`[YA?>>$<>\_C\^3S2+%],(:6B=SP4<05',EHRWQMU
M?&*`%$H,:7)$K>QI8YQ$0`K2&7,`E'J``("+%6;ZWNAIF869KDM)0%AB9.!G
M8=ZXCI>%F6#J+EHJ0:*&1=,)*.?)(/&+ULL02*)*D*<A@$!`!R-/F8#`RKJ#
M1>Y^0%J3H^C]5W_;5M4(58T#KZJ35JD&K4Q^P7\BG#LW18N,2-_C'3D4FZ10
M$3G*`"."V3E*?3?CY^5NWH-G:_'*.IS-V9H**]RV[J&.7*BY44357<Q$==Y:
M>8E8`GW+)KM$UQ*8/334'J`7%9]]?+8:N?&$\D4WZ'Y.<XT4_P!7U_4_4>S[
M6Z]KZ7?Z?K_I+6EI[O<]H=GI>IT[@[^SZ]&$]XSA7_BF<MW()_JGDEQSAA%H
M!U0KZ&S+*!'W<D`MDQD:=4Q5:`03CZP@0_4I0]+[A$K![SPS+`_$ON3CT_U/
MSBK,1U9$.M^!T!*V/LD!]'U&J?Y#;M6]5D7N4Z+CV'-VEZHAW#V7"?\`3X9Y
MIOQ4Z365RN7/.C:1%U(\K5\O3=61-,7=..J)U#E64V%8CIQYEDQ,#<_JF#[?
MWHB7J9A/?X;34KXZVN:J6&*KS\Y\(%BCF4`M*VG!4HJ*@**K(J0P&K5A"&.F
MJ<IA']^(F`PAVB;[6#W^(VEI?ALH](,<[+GWY4GYUG:+AV=?FK8X4SYL@*8D
MC'9J95JL*C'J!QZAVN"^J?M5#[>UA/;XB1C1NB8C1$"]@HO8N\-E"_,R%>:W
MEN&[[?GB$CR.4FJ;*0N,H_+&E%)R(+F;II'=B0AW!E5"@?*EN6<,(8#`8#`8
M#`8#`8#`8#`8#`__T+_&`P&`P(._,QXF-=\[=+6S9VNZG'0O+O75;=S5$M,,
MR3:R.T64"U7?*:JMY6Y4RSIIUL0Z$*Z7_?QLD9$`5*T4<I*2QK7;%^'-[434
M144163.DJD<R:J2A3$434(82G34(8`,0Y#`("`@`@(9EV;S^.?@Q>?(3RAI^
M@*D\5K\$HW=6W:%Z!F9\C0];0:[1.=G?;!T(ZE'CI\VCHQ`YB)K2;YN54Z:/
MJ*DJ6XF735XN\3]#\-]4PFG>/U#BZ55(INV_(.T445K-<)A%`J+BT7>P^BF^
MLMDD!`3*.%A[4RB"2!$6Y$T2:<;;>M;&80P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&!__]&_Q@,!@,!@<MSS":>B=%>3#F!KV!;HLX<VTOU]'L6Q4R-(]ON&
MLU_;Q8UFBB1-)LRCAO0H(HE`"HI)E('T+F;R[ZW.L65_BC:?BH_17*3?IV95
M)RV[:K^GVS]04#F:Q6NZ=&W1ZS:%`PN6Y7[S:#<[@1`"+>V0Z"(I#VV,;\R+
M9F5S5!^>WG;Y*[/Y.'X0>+&M,96V*7%QK8NW"0,1<K1=+PQ<N&DTWUE%6`'E
M'AJ1!"T<"YGI9N[36005>$%FT1]PO,^'2:S&=GOXSAS\F.GQ!=D1?.W45DN`
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M$F\BQ4(55(YDU`#N*(@(#DS6O35,F[MWRFV[9=='5_'!^JBD=1-DTD-#$<NC
ME#J5!`[[8C)F550?H`JJIDZ_M,`?7+U9_1J[Q?\`,!Y4R>1S1O#3F/%4K6Y[
M1M*`IFP:C):KBJY8`8V!FNK$GB)IM(NFKAM-JJ-Q9/6:B[9V14ID5#E,`XS5
MNNN+8N5R4BPAXY_+RKUM'1<6R=2,E(/5DVS-@P8H*.7CUVX5,5)NV:MTC'4.
M80*0A1$1Z!E<U27QB^;*\\DO*ENC5VQ[I)K<?>14A8XKC#5Y=!JU94&2H9W#
MJAL4"`R;K1CG85#CGAI$BB@BYGCMB!W',&27JZ;:XUGE;GRN9@,"MG\A_P`E
M&S.&U%T?IWCGL)[0=X[*L;C8=@GX4K%Q*U_5E/\`6CFK)="0;N4$T;[;W8)I
MG]-0%&\(]2,!0.`C+6]-<YMX33\)^35?YB\5=(<D*\#=!/9U(CY*>C&QQ.C`
M7:,47@;]6TS',90Z5?N<4^:)G-T,JDB53H`&#*S9BV-I<(K]^3C8GF%XETC<
M?)W2>Z>-UST#299S8%->R>IC1^RJ1KY_+MF3`PR4@^>0]U/7BOB`^6!PR<*)
M%%5)!0>I"RY;U];TO*"GC/YOO,WR[W14-!:,<Z2LVR+J:5/$1[W6]8@HU%E`
MP[Z?FY*3F)67;,6#&-AXU98XF,)U!*":1%%3D3-,UJZZR9J46][!^4)K6*/:
M"ZRXW;1919%'TC!41CKV7E5&K4/442)!K6VKV"8.N4.TJ$5Z[PX_0A>O3+U9
M_1@OC9\H*RP=_P#X9<_.-I->KQTL>MVNYZI8V>)F*--,W@Q\B2WZ<O3R4L)"
M1JX&%^1M*>_;>D<J3%=02I`RMT\59[V-RMTEKCC'9.7CBWLK5I""UZ.R&%FI
M:S:>+;X9R@D,`QJ8IN$6LE,VF3=MX]@B=5$IWS@B2AD_N$M8Q<X[H,2><#D=
M7=L2\+L/BU0&,'6I.YM+GHRL3F\)#D13FNN*&;:VR6R5\E].Q'&R\7_7>JU`
ML,K5X^=1>$9(&327456("<RUZS'*3K_BZ^.G_P"T5`_Z<G_X#&8GKMX?_]*_
MQ@,!@,!@<Y'Y'T2:.\IFSGAEP5"?UKIJ6(F"8D%L5&C1\$*!C"8WJB8\**G<
M`%^B@%Z?3J.;R[:?59)^,1`C$>-J6D!:I-_U3R2VC/`JF<ICO@;UK758]TL4
MIC"FJ0:YZ``(`/8B4>G00$;.&-^4W_(Z0M<3QZWQ*T3W'ZXC-,[0D*;[0PD=
M?JME2)QS7?;&!5`2N/RZ:/8('((&Z?<'[<K$<W?PI<FM2\3?(;I[:6[7;:$U
M^]C[C09&Y/$4U6M#?7JO.X*)M;TYB&.SB6[]8C60=%,06D<[76,(ID.0V8[;
M3,N'3E9/6<DS:2,<[;/X]^V0>L'[)=)TS>LW21%VKMHZ0.H@Y;.4%"G34(8Q
M#D,`@(@.:<5>GY%7`VO\CN(DGR/J-7*XWOQH2:S3:1AXX5IVW:E?RK9I=*A(
M"T3]Q(M*T#_]0,A5]067LWA$`)[U?OE;TN+CL^=XT^$VQ9SG18?)9M:DQ[.G
M;1X4\06VA9*1D(EU.)VF>XMZ*K&SI=2NA)R%AJ4M#EJ3^)*+X"*K-)-<H&.!
MS#CY+>GJL896')*YH_TQ>6/^\OO;^=*U9AZ)Q'6US;SH7O(/P#O>^N='C9Y9
MZFJL._?<?=NLDMZS#B8A8:0#4\79J];*XZ3))O&KJ;-6),LT*35J59<PRAQ`
MO0`R-2XECQ'R$^7I^-/`JQZYK$D=KM'E4_6TQ5FS-8"RB5+<H).MLS"#4H@N
MY9'JBQ8-04_N2<6!N;^T*FDS5%_D#Q^Y!^-;DO0H*UK+5#<-'AM,;XITY'I*
M)A$S4I$PEVCSL#.2B5TYHMW:NX9RIT%)5_$+]H=G0,G#K+-HZ=7$3D;5N7'&
MC3'(VGBBE%;5HT387<:@MZX5ZRE(>.N-565ZCZCJJ6QB]CE3=1`QVPB`B`@(
MZ<;,6QL=A'X443134664(DDD0RBJJABD333(43'44.80*0A"@(B(B```8'-L
MY[DW)Y0-L^0+R#4(BTSQ_P"+4SKZC5SJ@Z.=752UC=4JJ.JVA]P]AD6[BV3B
M8&4%B$PHJ8"HB`ESR[3&LD[I5/BS<Q_83>X^#ELDC^VGB.-Y:?*Z7ZII2\>W
MC8+9U9:`H!S]\E%)1DJW;IB1),&$@MVB=4PC8SO.ZZ%E<T:/F._JP>:/^IJ3
M_P`[P^2\-:_:*4_QT_ZUG2'^AFZ_YI[7DG+IO]72&S3BHA?*?TW1:9RJT1MZ
MMLX^-MFY]533/8*#%)!!68D=:S,=$P%KE03_`'SB3?5^>1B_6.'W-89$@"/I
MCF:ZZ<5N/X2=?W3F[X:>4O$Y_<_P:D)N67B--V.2(Y?M*--M&>M=TU`B[4IE
M3_IR-VTR&2720("O1XX$H"<2Y9PFW3:5_I/P+YX6'D?>-S0'$UMKGEYN&T[V
MA-I[^M]KT_<>+-7UEO/5E2U(_G=:J-[Z\W&>9I)8N3GH#V]?8S1QL+J*E$W#
M%-<%1F8YZ,U_\K-Q&_\`FG;'_<HW_P`PQ@][X?_3O\8#`8#`8'/2^3DQ:-/)
M2S<-T2I+2G'/5CY^<#'$7#M.<OL818P&,8I3%8QR*?0H`'1,!Z=1$1S>7;3Z
MK*WQQ8MM'^+#5#M`515F]B;FE'@*&`Q`<I;!EX4H(`!2B1+V<0D(@(F'O$P]
M>@@`6<,;_9.OE8<]'S->%G:7$?8U[Y#:`ITA=.)-LF7ME5;UAFO)2^@W4JJ+
MR0KEKBF;<5F^O6T@LH6'F"%.V;-129OCIKE15>9L===L]+RU[\=7FZY7\`RQ
M5#4=DWIQY;+()GT_?99ZFXK#`%$Q<%U==`3?R5(.9(@@1FHA(0I3&.<&(+'%
M7&5NLOY7N>"ODGXL>0BF'L&BKIZ-PB&2#F[:AMH-H;9M).IZ9#*R,&5RY1F(
M,5E2D3E8Q9Y''.8$Q6(N!T2:<K+.6_.$,#DE<T?Z8O+'_>7WM_.E:LP]$XCK
M:YMYS`J'W3N\K?R`8.DD[)[C/XZ6JC^:24]-S!R]IUU.L'-A353^YF[<V;>3
MMC$+MC**$?0-=.IV=H*D"<UT^NGS66OE!\/OXC\=M<\OJM%`M:./\V2F;#<H
M)JF<.M3[`DF[6+>N1(54%$JCL%5L1$O0@$3G72AC"!`#%32]<-=OBS<R>]'<
M?!FW2OW(>XWGIM-VM^U$YHV!VE6&1UA``]-4T7+-6B0B(]\FX[>@*&Q%WG%7
M'\KFAC\\?+\O$WQ];*;04F1CLOD#W:)H)"'4]XW;V]B[_B#/(`@8B[?\-KYO
M($1<@8I6\DZ9B(B)BE-*UK,U];Q3\`JKHKQ@U/CSM.L(N97D51K%=>0D&\2)
MZKR1W77$6#ZKR":J2A47M7U\,="+E#U$RNV*BA!$#]<3@VN=LJ'/_NMXI?(Q
M_E*]]XF;T_PH@MZIK1U_VD[*#VQK"7_PS%82W\HY.'7IM'47UKL*I[;UY1=I
MT.3)-4G9%0KEZJ,LF42%D:W:XAI.0SP4C?>B=>/?)F,F;[DS")1Z"`YIP:#>
M8[^K!YH_ZFI/_.\/DO#6OVBB;X0M[:CXW>1+56W-XWJ'USKBNU';:$S:YP'I
MV#)>6UK9(R,;BE'M7KU9P_D'*:*2::1SG4.!0#J.2.FTMG1<&W1\C+QC:NB'
MZ].V7=-[6)NW.+6M:QUO;F17#P[85VB2]EV+&4:M)-%%#$*LJW<NU$.X?W1S
MD,GES'.:;54/Y(;3YG^=/F(-JUAH^R3BK**BZ-0M?5'W<G3]345&0=ND'-TO
M<DC%5N*<2<K)K.I*9D#1Z*ZRA4B%(DDW1).728UG*][XO>"<7X\>(].T)^6C
MK)>'<I*W_;5KB6ZS>,L.QK,FR0D319714W:D/7X2*81#-94B2KEM'D7.DB=4
MR1-1RVN;E(;A#`__U+_&`P&`P&!0-^5`FF3R$ZA,1,A#+<.=>J+&*4I3*J!N
MGD$B"B@@`"<X))%+U'J/:4`_8`9FNNG'^5FWP&1KN*\2?$9L](5-95CN62(4
MIR*`+28Y#[<EV!^X@F`#*L7R9A+^THCT'H("&6<,;?:I:;#9ZU48\):UV&#K
M$49RW9!)V&680L>+QV?TVC0'DDX;-A<NE/M33[N\YOH`".5E]E1--9-1%9,B
MJ2I#)JI*%*=-1,Y1*=-0A@$IR'*(@("`@(#@5VO(M\>'C3RD9V'8_&5M"<:-
M^+I.Y`C&'9G:Z2ODL?\`?>C::?&MEC4IV^5+V#)P"2::8J'67CWJH]<F&YO9
MSPH]N$^3?CVY.N6GN+7HSD9HBV@BL=D[!N_C9!N5)P0/6;*+1EEJ-GB'!#]!
M%S&3,4Z#J"S9?H:.G2SX=.+Q^<L&'-SA_I+DJVCVT/*7^LK)7"#9>M[.$OU6
ME9"IWB.8%<G4=%B2V:$<J,?5,90[%1$YC&$W4=.-F+8W*PCDE<T?Z8O+'_>7
MWM_.E:LP]$XCK:YMYVC/DDY9L^$W"[>7($%VQ+37JLI`ZT9N12/^2VA<%25N
MC)`T5^K]M&34@21>HE^X8YDX-]`*(@63-D4Z?$GSBY#>/K66R)2N^+_D5R9L
M_(6S0U\D]X,I'8U=9V*HLXDQZE&QPM>/>Q23;,LA-RLD,F654*^-)]0('I@=
M3,=-IGND@W1YK^2V^=1[*TK?_"%R8?4S:E(LE#LB"=UV>#@L59HIS%.'3)0_
M$(P-Y%B#D%VRH!W(N$R'#ZE#+GX2:XZ^RJ'Q:W?LK@?R\U5N8\%9JQ<])["8
M.K?3)>/?5ZQ.J\H)XF^TB6BI4D>\CUK)3Y%ZP437*F8GN`,/00`0C=F9AU;J
M+=JQLJDU#8M*E6\[3KY6(&XU2::"(MI:N66+:S,+)(=>A@2>QSQ-0`'H(`;H
M/US3@H[>8SE+8.2WE>HU!HVC;YRKU-P#DX=.RZ<UTA./_P!;VQM8*_8-O$E'
MD#4KXO7H96=:Q-3DU58I8`/$*)AT%9,P9O+KK,:_E))_S!/,7_\`B=R7_P#6
MNTO_`,B9<_">D_V5Q_+_`+PV9S"W%7^4MUX%[@X;N7-7A=;6^3O![A,UW8$_
M$&EG=7D/S=AT_JULRLZ5:349&0`SL[EC&HB0$P;J">5K68F,K*?QC.8P[:XN
M7/BC:Y0J]RXU3?Y6F)N5B^[?Z@V`^?2+5N@0Q`6=%J%V"0054[S%0:R+!$`*
M4"=;&-YURE&\QW]6#S1_U-2?^=X?%X37[112\'>C]3<B?(QJ756[J)![(UW-
MU;:[V6J5C266B7SJ%UQ8Y:*773;KMU1.QD6B:Q.APZ'('[<D=-K9.C:#SL^)
M8O!S9K??.AZZY)Q3VS+';IQ3,KMVAI38*Z8N%Z4\<KJ.%2U.R@15W`KJ'_==
MB[`_06[=1TL37;/2\IL_CQ>4RM;OUQ$<']M'AJ]NW6,&H?6$R@UCXAON*AQ+
M<17;N$F;=JBZV138]`HO5#=SF7CB`\,*BZ#Y4;*SOKCK.%HC*P8#`__5O\8#
M`8#`8%$'Y6!2AS'X['`I0.;C.W*8W0.X2DVEL(2E$W[1*43B(!_)U'^SF:ZZ
M<59\\+,4C#>+;AHS0455(MJ]U*F,MV=X+3UQM$XY3#L*4/21<2)B$^G7L*'4
M1'J(V<,;?:L9^?2@#?O%9R6,W3,>5HY=;;$B3E[0]N>K[1IZDRX[O155(8E5
M=2`%%,4S`<0ZF[.X!7@U^T?U\,WDKJ//WC/6HJQ65M_M.ZAKD36MV5=^Z2+.
M6`T8DC%1VW8Q$PD/)P=W(FFL^42(4L?,JK-CE*F+51PAM,7X3$Y67/\`?E$O
M]>O/(%0VU64C%+I%<<J6RV?^.`@+(3*MNO<E6F\[Z?0#3@4]^S5ZG`5?QRK0
M!$2`F!<UUTX6;_`=IFV:7\8&@V5T9/8J;V(M<=NHQ+XH%685N_V5](TM8I0^
MI$9VFHL)0A1^XH/^ANA@$H6<,;?:ID\K+DE<T?Z8O+'_`'E][?SI6K,/1.(Z
MVN;>=4$\XNRGW.[G[P]\4&KI\IXIC?8"S;L?1:R;DL/:K2T644*[2[NTTCJS
M3)).9,F'T/\`F@3-^\3$"R^'37I+LMM5&J5ZAU2L4>HQ32"JE,KT+5*Q!L$B
MHL8:O5V-;1$+%,D2@!4FD=&LTD4RA]"D(`97-Z'`H@_*!X@(ZRY):ZY;U2-*
MWK7(F!-5K^9NF0J+;;&NF+)FUDW`E],J1K=05&14R`0PG7A7:QSB94`S-==+
MTPVM\2WE[K>DO$ER"8;,FFC_`&9PG8K1FIX*6=`H\O4%M-T])IF!2(LZ_(R+
M>`V,X>1K[VY!)%U]%H;^Y+T"R]$VUSM/EMQ\:;C=(U_C;M/FIL%5:9VCR[V+
M/.4+#(#ZT@YHU&L,W'/)!50Z:9D)"U[.<3KAYV!V.$FC,_4>T`*B;WKA99RL
M-&_)%Q-9<V.%V\^/_MFBMIL-46G=:.W780(W:-1.6Q45<KLPE,P;R$VP(P>*
ME'K^/>."B!BF,4Q9<65SN_%7RX?<$.>.H=KSZKB&I:L\OJK=C%\59D+?6]U=
MMX2T.91N=,KHJM'DTFLZ5N($,=W#IIGZ%$P9F.VTS,+^_F)436\7O,U9%0BJ
M2NEY!1)5,Q3IJ)GE88Q%$SE$2G(<H@("`B`@.6\.6OVBE5\=/^M9TA_H9NO^
M:>UY)RZ;_5T,]VZ6UMR)U1>=*;=K32VZZV)`NJ]9H1WU(*K5QVJ(/&+HG1>.
MF(IZDDZ9.TA*LT=HIJIF`Y"B&G'CK',LYS</=\^*'F(C6V5@L$8I6;`SV5QR
MW="@I&JV:N1TJ5W7+$Q=(D*@QM]:>(D:S+$.H-GR9NT%6:[99?/#O+-HO?\`
MB,\G5.\C^@DY*2/'U[D1K%M%PN[Z*@)$$E7JZ)DHW8M5;]PF4IMR,V5,5/\`
MQD8_36:*=Q"-W#FRN6VN+\)9\K)@?__6O\8#`8#`8%'#Y7J")>17%)R5%(KA
M72UO057!,@+*(M[R*B"*BH!WG20.Y4$A1$0**AA#IW#US773BK2'BHCB1?C;
MX0MB,_8%5XUZKD10]$6_>>8K#*64>>F)2B;\BH]%QW_L4]7O`1`W7-3ASV^U
M9KYE:BD]_<2>3.DX)JB\L>T]$;5HU50<+IMD!MUAI,U'5-55==VP;)$;6-9J
MH(JK)(_9^\,!.[!.EE52-$?&RYA:LH>MM[ZNYB-N/W,2*([DG]01BGZ%<JCE
M9V];HPJ6VZ%:)]S)(N(E-'WY`A'K%V#A1`Q#)D$59AN[SC'1ME,0'REHJ+_A
M^RM?'.R&.T)'_P`8X?\`@DA*)`98R9I'V\_`P"8NTT$_N/\`IDP]B@&`@K=1
M*ZI^CPW#CXX5MDMS'Y'^3#<47O"U.[(:Z2NL*U*S]L87NS*NS/!>;<V':F$1
M)ST=ZQ2F<1+)F"3L>B:CTS8JC==CRMWZ8UBV8V;-V;=!HT01:M&J*39JU;)$
M0;MFZ!"I(((()%*FBBBF4"E*4`*4H``!TRN:/KFM1_)7>GK"'X/[CXT:>J#V
MH.6-EGMKU.XV#9+2W.G[TGY*I.8^.GZBUC&L,+?T0=QZRQ77JF-W%],"EF.\
M579;XLG-B>E9*<F^37'66F9F0>2LO*R+_:[R0DY.1<J/'\@_>.*$HNZ>/72Q
MU%5#F,<YS"81$1',X;]YX3I4_1/GYJ.KD=:_[7?!>SR#*OA7HW:5KU[LR2V:
MQ210*U8RAWS:L1]2F9QBW3*`.I*&>G<G`5'(+JF,H:]6<Z^$5&G_`(_OD]T?
MR0A.6E(YB\>%=]0MIL-Q->K0;9EK?3DY;V$Q$V]Q9"SFO7A9K]4Q=A?-WIE1
M%10CHXE.4_:<K#7O+,8Z+8O'EIR'8:J@&G*:8U+/[H1<2Y;'+:2C+3#Z^>,O
MRCH8$\;'W%RZG$7Q8842O.XP)&<@<4BE((!E8N.S-N$5GO(IXR?+!Y%HQCK[
M9O(?A=`:?J6QY2^TBIU.J[0AI(KDK>>A*T[LDS(5JS2CJ1B:O/N&QTV[M)HH
MHL8YR*'*D<DQ6YMK.R*7_E4>8X%$@<C.-0$,8IC%]?:7:8Q`,!3"7]`=!,4#
MB`#_`"=1_LY,->\\)_/&-PW\FW"*,UEHG:>].*VS.)E)_6*:D#"UO87\7X%E
M-LK!-P\;3+*K"5>$69([#D$G+C\NF^4+'KNDD3E$&P(UBV7KCJF_RLM.^7\!
MSIL,#4V?""_<>=>S8N)XM\E]]5JX6019*M8\E</34*PFY9H/FKKW1W(OT%TC
MAZ(%*(`<!+,=U2"Q_%OYN6VPSUJL')7C1(3UFF92P3;_`+=D-?>R\R^7D9)W
M[5EKELR;>Y>N3G]-%--(G=T(4I0``F&_>>$@EO\`%=YI[SQ"B>$=DYR\:G^D
M8R.95UR*D7L%2]SU*B7#-U`T.=N[C7:\PZJL"JP1(W23%%P9JF5JLLLT*5`&
M*GMKG.&G^AOCB>1CC/MRD;STKRUXYTO9FO90\K6K`T_B2Z!$[EFZBY)@^8/=
M=.&,G#S4.^<,GK1=,Z#IHX42.42F$,86[RS%BUUQ.B.8\)19ECS3M^AKML$M
MAZUJ:T'`W&O09ZH$3&I@G8V=O.!U+":9(Z4$[1)%MZ!R`!0,`]*Q<=F%_)?X
M^-=>1CCC,ZCLYF,!L*`,[LNEMD+-CJN:)>RM!12%T9N47;FI61(A6DPS+W@L
MW[%B$]RV;'34UN*K@\=/CO\`DNXG[8KN[-!<Q./=`V)6O<(M)9@?9#MG(1CT
MI4Y*!L$-(ZY=1%@K\FF0H+LW:*J)C$(H``JFF<DPW=Y>EBV;QHCN3$5JJ-8<
MM;%J&U[C;R<L61GM(Q%G@Z2^A#.`/"&_'VPYI%.93;F,5T*94FYA`HD('W"-
M8N.S/V$?_]>_Q@,!@,!@4FOEDQ[-/:?#"5(CVOWM`W#'N5_45'U&<98J*Y8H
M^D)Q1)Z"TLX-W%*!C>IT,(@4H!FNNG%6K>`$6Y@^!_">%>BD+R(XC\;HMV*!
MA.B+F/TW3&BXHG,4ACI"JB/:(E`1#^0,TYWFMJI24C82-D9J:D6,1#Q#%W*2
MTM*.V["-C(U@W4=OI&1?.U$FK)BR:I'4664.5--,HF,(``CA&%-!\H>//*2"
MG;+QYW#1=O0E8F`@;"]I4VA*?A94Z`.D&LDW+V.VA7C<1.W4.F"3@I3"D8X$
M-T+99RSSA'AM@[+H>J8-G9-B6>,J4%(6:JTUE)RRBB;9S:+Q8(^JU.%3,DFJ
M87L[895NT0#IT%54H"(!]<!`[+HEHNE]UU7[/&2MWU=^EOX@UMJ=0TC5?UM$
MK3M4_*$,F5-/\Y$-SKH=IC=4RCUZ#],#W.!C/<.X]8:`US8MN;FND-KS6U2_
M$?J2X6!59&(A_P`].QE9A_=J((N%2_D)Z9:M4^A!ZJKE`>@?4!SP^3I/D'H[
MDC4E;UH3:]#V[4F\@>)>SE#L<;86D9+IMF[Q2(ERL5U%XB639NTE3-71$EP2
M5(82=I@$2V6<LQ81\&TVFLT>N3EQN=AA*G4JQ%O9RR6>R2C*$@(&&C4#NI"6
MF)>27;,(V.8MDS**K+*$33(41,(`&!K]H/FIQ-Y22,]#<>^06K]LS=92]S.0
M51L[)[/,&'JI(?E3PBID)5:$%PN1('R:)V@JF`@*=P],+99S&S^$,#PVM-ET
M/<5#K&SM8V>,NE`ND829JUIACJ*Q<W%JJ*(IO62BR:*AD3*(F`!$I1ZEP</<
MX&'-X<A='<:J:.P=^;5I&I:<9\A%MIN[SS*%0D95R!SHQ4.W<*>]FI0Z*9U?
M;-$EEP13.H)033.8I9+>'T--[PT_R&HS'9>CMDT[:E#D7"[)O9Z3.,IR,)(-
M"I&>13T[-4ZD;,,2KIBNS<E2<H=Y>\A>X.I,8Y93P/PHHFBFHLLH1))(AE%5
M5#%(FFF0HF.HH<P@4A"%`1$1$```P,=:DW!J_?-!A-IZ:O5<V1KNQGE$X*X5
M203DX234A99]`RR;5VET`YV$Q&KMU`$`$JB0A_;P<<LD8'AME[+H>G:'9]G;
M.L\92Z!2XP\S:;3,G42BX2+24314>O5$4UE"HE46*`B!3#U-@Y>YP&!__]"_
MQ@,!@,!@4POEIQ!49_@C.@N8QY*'Y'Q!FWI@!4BPKW1[PJX*]PB<S@9\2B7M
M#M](!ZCW?25T_K[K87%6)3@>+_&^#15.X2A=":?B4EU"E*HLG':]KK,BJA2_
M:4ZA40$0#Z`(Y6+S7\^5\!^K.+_(JJ&U[/;:0M6C]IUEYJZJSR57M&PH^P4F
M;AY&FUFQ+M'Z4+8;&P>J-&+@R*H).E2#VC@G,1<^'UEL!K9N1!GE'VP.I&]-
MXTU37FX.1W'R%X_\B9QQ1*/8(1]I.[GB:_3UMQ0&@HQ9G'QUH<1#,QG+YXV3
M5>))D43D7;LG%RLH[?*13K];.)CV2UO1K%LVQ:PW1QPW4XH%-:&DKI:ZUJ#>
MU`OUMC:?$E`!F+$6M0CI=NS*8JCD4A32`ZIDTSRM:\O"<"9:>VOR2Y\<GV^M
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M=H629-XMQ"P[-O[E!0RBI.PMQ)\K&F5@P([?$M6++2_&_P`0:M<:].5.SPFI
M(YE-5RRQ+^"GHAX64E3F:2D1*-VL@P<E(<!%-5,AP`0'I]<1=N:D2PB(CFJQ
ME-3\W^*?,&\:0V%OK0>MM3[AU@\'6%*E]KVKC[MF\V6@3E>W8364&W?V)_&2
M=9K+Z#<R44T=.8\JH'5*7_JX'C4XLSU;(<++;6=ENMY;6I'$.P\8*C?;U$/H
MVU7RI(ZQV/R'>,($C:3V?9M4J0D9.U..34.1K&/)9521FD`.Y41;D`GJU+TQ
M,MY\(CV\FDYN=QQDD-+\>8><=[BY36RN\:ZS:(R%F92(U;!;-.Y9;&VO<)"&
M;JK5BN4G6S667+(B=,R$B=KZ7>L9-,RKKC.;PU)\7&E=\\%=M[?X6[4A:M):
MPN-6A.2FD[EINI7Z-TS6)<Z[76VV=6IO;E)6A]`6!PXA8:Q(Q[F3,#I20D'3
M8H@98B,B[662Q-_E91V^6FL66Z>-_E]5J=7IRV6>;U)(LH6N5J)?SL]+O#2D
M4<K2+B(MNZD'[DQ""()I)G.(`(]/IBKKS&R_'[D;0^2E:FK50(3:4'&P,X-?
M>M]K:CV+I^96?`P9R0K1T'LBNUN5DXST'Q"^[024;^J!T^_O(8`%F&>\(__1
MO\8#`8#`8%.;Y:T>\4CN!,J1'N8,GO)R/<K^HD'IO)-#C^Y8H^D)P6/ZZ,0X
M-W%*)2^GT,("8H#*Z?U]UM_5S!O%ZSUU&-&Y6;6.HM18-FA2F(5JW:5^/;HM
MRE-]Q2H)I@4`'ZATRN=YKW6`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/_
MTK_&`P&`P&!49^5U'O)>F\&(J/1]P_D[_N:/8H>HDEZ[Q[%:P;-D?57.FBGZ
MBRA2]QS%*'7J(@'UR5O3NMS96#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8'__T[_&`P&`P&!6"^2S`(V&%\>4;T;H/9/E2:`;22C<BRS%&<:5Q!P!#=2*
M^W.JBBHHF4Y04%$G7ZE*(2MZ=UGW*P8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`__U+_&`P&`P&!7@\_57:3S[Q@KOU#'8F\@VJZN]8%*<AG32T+-CN%"
MNTUB*-S((P@D`"E$3>MW`8HDZ&E[-Z?R_"P_E8,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@?_U;_&`P&`P&!"1YC(A]+[#\2"+-H9T5+RJ\:G3D!],J)6
ML>XEY9[ZBBQB(B8L9&N%`3$>]4$C`0IC?3)>S6O&WX3;Y63`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8'_UK_&`P&`P&!%QY-OT]^?\:'ZB_,^G_Q1^/'X
MC\+['O\`U#_#7>_X;\C[[[?PWNNGN?2_?^G_`''UR>&I_+\)1\K)@,!@,!@,
7!@,!@,!@,!@,!@,!@,!@,!@,!@,#_]D_
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g52875g91d05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52875g91d05.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0[84&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````"$````;T````&`&<`.0`Q
M`&0`,``U`````0`````````````````````````!``````````````&]```"
M$``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````##L````!````7@```'``
M``$<``!\0```#!\`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!P`%X#`2(``A$!`Q$!_]T`!``&_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U55\S!JS&!MCGL+=6O8[:YI/YS#^99_PC?TB.G24Y+_J[CV#:[+S2
MSW>PY-A'N:6>Z3[MD^HS=_A$1W0L=^-;BV9&395>6FP/N>Z0T;37[_\``VM_
MGZOH7?GJ]>ZUM-CJ&BRT-)K8X[0YT>QKGP[;N<J?VSJV[;^SH]VTN]=FV/\`
M2<;]O]C>DIY_)SL'$R[<G#MK:QSW6N=9;?07/;9ORIK8UM>1N]?T:/\`1_\`
M#H;;L;`R7UN?50&[B,?]HW,81<S>XU8S<=KF[:+?T'^C_P"-71VY?60X"CIS
M'M)>"7Y`9`:_94Z&U6_SM7Z;^1_-IF9?62+/6Z:P;&AU8;D-=O=N/M]U5?I[
M6;;$E//V74`N?5=6[!LL+!:W-?72UKG>GZ'V5E;Z'>M^DK]C?Z3^C]-7.@?L
MNS(?0W-;E/)L+&-RGW^K6\?2S*'CT_4^S.H=[W6_3_P:U1F]6W.!Z;$,)8[U
MV$%X;O\`3=IN8U]OZ+U/?_I$XRNI^EN;TX-L#7;6&Y@$C;L9O:U^UMG]7\Q)
M2)GU<PF%P%M[JG5NJ]!UA-36N9Z'Z*D_HZME1V5^G]!.SZO8K!#<C*#0(#1D
M6`:3Z>T,<W9Z6[]&QGZ-+[=U_<T?LNO:70YWVH:-]OO#?0]WY_M6HDI'CTBB
MAE(>^P5B-]CB]Y\WO=[G.1$DDE/_T/3FXF+7<ZZNFMEMQFVQK0'.T_PCA[GH
MVUO@%`6U/LV,>USV&'M!!(T_."(DI;:WP"6UO@$Z22EMK?`);6^`3I@00"."
MDI6UO@$MK?`)TDE+;6^`2VM\`G224Q``<8\E)-^<?@$Z2G__T?3F8F+3>ZZJ
MFNNZ]TVV-:`YY`B;'M&Y_'YR.ABZE]AK8]KGL,/:""1I^<W\U$24I))))3%[
MB!`U<>`F9#1MX@P/RI_S_@/R_P#G*3JVN.NJ2EVD.:'#@B4ZBP$#:>W$>'92
M24I))))2WYQ^`3IOSC\`G24__]+U$55,>7L8UKGF7N:`"XQ^>?SD15SFX?J/
MK]>O?0?TS=[99IN_2-GV>U2=D,',"9C<0.!.L_124E<X-!+C`"B;!.UNKIXX
M^.J@+ZGD%KVN`\'`ZGCNG#ZHC<UK1P`0/+M_*24S:")+H)/<>`2W@C0:G\WN
MH;JX(-@@3I(X'(*EZM4GWMG@ZCXI*6W.:?=[M)T'@B(1LH?P]I[:$=^W]I0:
MX.:7.<W</HM)$>WVG_I_G)*3R)B=4D(6UD':]KFZS)!)CZ;>?S$XLJ)AKVAP
MAI;([^YND_NI*2?G'X!.JSSEO).+926^R"YKG=W>M]![?S-GI*RDI__3]2+&
M!P(`!<?<8U.B3F.!W5D#Q!&B&<K&^T_9O59Z[`'NJW#<&NWAC]O[KO3L1/5J
M_?;]X24Q#ZFZ=R!`Y^`:G+@^&L/Q(Y$?%(/H$`.:).D$<I_5IY#VR>\A)2TN
M&A;N/8C@_']U,1:[2`T'0ZZ_%JEZU,@;VR9($C4#Z7_5)>K5^^W[PDI9P##N
M`&W\X`:Z?G*>BCZU4[=[9B8D3`.V?\XJ(>T``6-('$_AW24DA,6@D.X(X*&+
MVDD;V,<!,$@F#(W:'^2EZH;_`(1KY[2!'P24M9BLMW-L=9[MI.RQ]?T22W;Z
M+V;?Y?\`I/\`"(Z!-[WO].RH"&;6[2\@R[U"]P>SZ;=GI^WV?\+_`(,Z2G__
MU/1+,?*S656V`-]LM%5]]0]X&[=Z!J]3^1O^@C5LSZF-K:*RUH@%S['N_M/L
M#GN_M*@^CJ+H=1GVT5EE9;6UE#@WV!CM;SO]SO?[OSU:S,VUF.\,8\'T[#ZK
M75%S36T.;^C=8UKW6;OZC/\`"^BDIC?T_(R'NLL)#G-VD5Y.14V/Y-=#ZV,=
M_+;[U9GJ/[M/^<[_`,BL-N1U`4V`Y66UWJ5AMIKQR6SZA]*MK;G5/]K/TVYE
MGLLJ]/\`PGI1&=GN:RW[;EM]@8ZCT,?>7!K7^MZ6]]WJ7M=_@OT?^CJ24ZMO
M3\BVUUKB0]Q:2&9.0QOM^CMJK>RMO\O:S])_A%')ZPS$L]+*R,6FS7V/>X.(
M`:XN8W;N>W](SW*MC6Y=QKR7=5?0VLAKZ+ZJF!^T5L+WR=[6VNMJ=^AMK]]O
MYBT,.FJS'#+[V=1>UP<;2UG8[JO;7[?T?YCTE-#&.-U#(M?B9`OMK+7VBK+R
M=C2Z=GZ-C_1;NV?S.W_JUISU']VG_.=_Y%6``.!"S.N.LKKIL;?E5`O],MQ/
M0DEWNWV?;6GVMV?X+](DID.GY`O]<$[]Q?!RLDLDF?Y@O]'9_P`%L]-69ZC^
M[3_G._\`(JF39^V*V_:<K])6;10/0]!H(-8;9[/M6[=^D_G/3]3_`+;0*'/L
MHS?U_,`H<UIM><0$BO=/V;:S8QF1^<[*:S_@_224VF].R&7"\$[VDN`.5DN9
M)GFES_2<WW?0V([[.H-<P;:?>[:/<[P<_P#<_D++NLM9@XMXS,\SN86,^R&Q
MQ!LL?9D;F>C^CV>E^@=_Z41[J[F]8IK.;ED/?ZHKBCT0"+G>C/I?:/HTN;]+
M^W_HTI__U?0Z>HT,=7C/KR0^*V"P4VNJ.YC7APOK8ZEM?^D>Y_Z/_"*QEUFW
M'>VFT"QS'-87.EOO&T.<WW;OY*$X"S$Q0PM+F[#R('L+0]WN9[6[OS/TBRW8
M.2:V-9C4';46Q:RIS2W=NKHLK;=_.:^I=M?Z'_7$E+#HN8VJP!V(QI`AL5EC
MH/\`A-N)5M?4QSK*+/\`3?X/T]Z-5TK*:UC['XYR:[F/-@],14UK177[<5C]
MK7-]C/\`P9#MZ?:YCF,QZFU@$UM:RD$O+6[7V_I-CO>_]-L]/U/0M_X'UY,P
M+7;C;12'6^D'%C:H:QL,-5/J6/\`YIM=5GO]2E)3(],S-MS3;3PXU.W,F"6N
M]%\XCO3QW5UL_P!+_-_GHN-@9>.]PJ&/CU7'==Z#MADM<TO8T4?Z1V_WN_\`
M2:K,Q,S=#L:ACVR#<&UP[</3:&_IG7?9JF?SE3_\%^CI29T]V1<T78S::@T@
M&P4':(_F:_2=;^BW?\%_->S]])38KJZ]3#QE4W.+?=7<_P!C3N>-S33CU66-
MV>DWW;/TGJ*]E8]>;157?:*WM+;#LV/!<`6EH^TUV^SW?N;UG5]+N('K#!G6
MLFNL`"H_I65L:\/_`)O(_L/I_P"%_2*-G2LAP&W[#[1I[!)+FM]5OT'-])U_
MYNQ_L_G/424ZCL?'^TLRS8`ZIGI\5ZCW<V%GK-_L6L8AU]+QQ7E,;:7-RC[_
M`&TPTRYWMVT[7_3_`.U'K*FWIUS/4JV=/LH<X%@?7[HW2X6?FO\`:^]^[_2J
MYAU.QKWM8,6K$<-P;2W8\V0QI>_W>G]%NW_MM)2K.D568]..;7M%&Z'!E,DN
MF2YKJ'5M^E_@JZU.[%!SZ,DV//N@5$,VB*[A+7>GZWY_^E5GU:OWV_>$.ZRO
MU*?>WZ9[C]RQ)3__V0`X0DE-!"$``````%4````!`0````\`00!D`&\`8@!E
M`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`
M;P!S`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``````!P`(``$``0$`_^X`
M#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!
M`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#_\``$0@"$`&]`P$1``(1`0,1`?_=``0`./_$`(<``0`"
M`@,!`0$````````````&!P@)!`4*`P(!`0$`````````````````````$``!
M!`("``4"`0@'!@4#!0$$`@,%!@$'``@1$A,4"146%R$BUEB8J!DI5K8W=Y?7
M:2,DMQ@X>#$R)2<*04(T0T0U)C8S$0$`````````````````````_]H`#`,!
M``(1`Q$`/P#W\<!P'`<!P'`<#1'V$DV^R_SCZ4Z*[NBX6W]6-5?'%;.\D?J2
MRQC4M2-K]AY#LD#HR".V)7)<,VLWN-T_36'I2%CRDKQ'S,DF1PVMU@=T</S<
M(/4?QC]GIBM]0X.GO;>^2?;G534M5Z]'$2,7JSKTY!USM9;[-N/[?KSN7JQJ
M.?J.O[$0%6H4<!HNVA&+:<99+-?""I8?Y=NX^P^Q^INL>I]`]<9R^6?LCW,Z
M8;+/L>Q=APU;I.Z.FE<B=BVK:H!XE;D9"1U+:M47NN2H,$H/ZZF5>)BUF8:]
M*5X%A=4?E.[<=E2^JA$UURT7JZN=NO\`G&U'0SOQ6N-ZE:[V"Z>A7H"R6F?C
M1*;6QS-)VF]ZXF8P0-LABP-B!MF+<_WI+#(5QK+YF>T<SUJZ5=H+KU7U;)07
M?+6N[1M-:PI&VG(2XQ?8'6&H+YM/7-5M=OOC05&&H.]L:KFAF35.#OU7!(&3
M%&+60AH()L3YX]CU'27;O8U/J/7W:TGU$TSTY[$V2;I-AG9JCVNH]E[78-<;
M!U#$F5:U6ZO/[*TK>X3+;=@A;)8ZU86$N-I0"^A6$!S-X=H>ZU<[(:,V[V]^
M.;3(]AU#&]Y+]TJCJ7V%NE@VO,V.E]&9S:)\6`%5#,T8M[8BV2]?/*LD,DU@
MUM9X46TAUAQ02:A?.XULN*)"U0?USW?8MA]I^HW4#14M4Y#:&NUPNT^RDMN7
M[OQV6TKLJ+#W+J9S3U8TW(FX#2.0-9G&<-`2*7'"41H2U7RP=OICLW7>FM'T
M%H&Q;[%[,[LZH["][?;S%T:)F:7H6O=F-<[^#DA8>7F8K5LYJ"P/.RD$8*Y+
M8L$2[$!'/^Z9-:#:YT2['V?M=UFJFY+O48&CW==ZWQJNZUVJS<A8:JW<>O._
MMG]>[5+U:5EXN%EWJS9I_5Q$G'MEC(*&#,;9>RMQM3B@P([3_*3L_4&POD'9
MU/JG7MSUE\7.JM#[0[*_=UGGHB][&(V_79C:D]1]2_2PB(2MRU%TA%,2S9TP
M@P:6E948%*!FVR"VPQMZ<:I;[>?+MW:[.;@S0[PYU*V)UE+ZS6B`S?J]9Z95
M-N]%ZM:ZS7XP@.Z.PDK1RZYO.</EXN19.$?LLF^:+AEM?I<"QO\`Y-6M=>7+
MXB]\6RV:WJ-YM>O+UU?(U_*3E>@)*QU@BW]O^O52M0]/G9AC)%9>N%8D'XL]
M;#XZ"PGU,OJ4UG..!AYV*ZJZQL_5#O/V\)^,KKEU(O?3"![9T*U]>"(.%U__
M`,P731GJ'3;Y;:3;=M]0IJL8Q-7-,JN5K\A$R,D-`K2N(4XAY9I389B43O?V
M[C+%L?JO3=<]5ZUMW56U^F>MNOVM9>3W`?%["ZQ=BJ5+V.&VGBQD3"Y]^8UA
MKZBVDN:"2*0EI6O99O!1&31'V@['JK\R5@[)[<Z^C1NMJ7(Z@[1[H[!:FID#
M2)"WS>[M*U[4F;TK7^W]^9>BTZ_`K>UF]9FI?C0WF7X%^9C&4E23GN$X#+/9
MFWNM_=V];/\`CIWWTL[87:@65RX5&W6[</3O;,)U6GOLQ@N49L%9[`R\&+2D
M$*.BD$U6=C3F2_JB17XY]LG#+F`\N2X'6O7#4VQ.G':SJ7HO?U-^"7L)!Q^M
MI.SP5(BHWM3L;O-,4R+Z!1FPY2,JDD]6JW&:UV&J;V_@@$D67.J]>R0F6>8(
M86&[<;Y=]IQ%NM^K"J'H4*DZTW-H>AV3NF+9TU+JK`:MW=J78UIK\I!4?9UX
MUO=[_LZ`V=K!^GO5*M3$B^IJ1#/96LEQJ%>"IHCYJ.X^V1_CO3UTZJ:7V!9_
MD!I_?^/K5)G=D6NK_:.S?C_M4W3K?*.W.9BHD`JA[,)BTEP@9L?%G#N.-`&E
ML>LL\8/0IHJP;8MFE]4V?>^OHG4^ZK!KVHS.UM905G#ND/0-@R,&$5;*C'6R
M-4Y&V`6`FG7ADE#./CN^GXM//H\KRPT/_%%J;5/R6]9MW]N>Y.O:GMGL+N[L
MIV5I)EFLT/%D7OK;1M9;#D=;ZUT_HBU895;]'1^NH:JB38+D.6%*)L9STTX^
MX<]@G@1/7W;7>_Q\].NX6C*$_H??\#\4_1CJCN/56TBG[V&WV`UU;([L?"V@
M2Z-`RQS4)=&"^N;J@S8XDR/(R=ZCF/#/@@)1OKY<.[VA'^\EL.ZS=<[MJ'H]
M0.NG8&V6&/VKL2KVJW:;["/2Y<;1*[!G4F<C5[@@*S$E'F&O&,PC3@+0Z&WL
MR278\)]L+Y2>X.H#=I5K:G7[0-<O&HNS7QZ:ZM4%7-CWBZQJM5=_K@Q28X4.
M>76ZLAS:6GYQ;K9Y*6'(29;:RX.@?"DIX$%[7[>L&]-PURD;@UUJ?%VZ0?-_
MT%U-K'8%6C#3I5^E[BHNEM[MR#!MH;+EJM8#*[M`2)FFH]]`AKD=YL>9KR)P
M"<^97>Z;N[I@'6_7^O;WN-3[\$Q^L3=@M;%E.LULZ?Q$]=J&!OZ9U)<K?5KD
MYNG64+B57$A&56;KY)#++HQ(SB#E!BOU4NW:*^Z2^!BV[6HG5_=6Q]CTO8TA
MUCV!:+_V,@+QKG;#G0S=6WZY==J#0$ZFK7(._MZS-@YOW`!Z(QHE1,>T\_XX
M9#(J3^;3=U*ZJ07<&W:UT;.TFD]9KWL3L[K*O2%]KVP]4=E,=A7^ING.O+<I
M)EV*&$!O78?$E"FSQHW@(!2IN0;&=2^&.V&QWHUWCO/8[;V]=';`KNOYB2U#
M2].[`B=V:,S=G])W,/:05C#G:"(_?0!95J^:UM-/*27EA\L8V*D`"5(">6X-
M@,5/FBZ%Z3W!HGO;W.W#3:/LNSZ1^*3M;1-!Q-NJ8D\O5MY3KS;]^LVUH9^7
M>-C6;AE0E?9@SF`V9"$<!+=8)\Q>,-!0'7O5M.Z>]GNIM?Z(Z:TK0MX?(-\?
M-*MNWFI6M%4[3$!#=3(*)E9#:TQ!:Z3&2%AVEM:U]B8B%?\`;('2H<!Z2,>=
M(0ADP*PZC_)EVO[P?(UK'8NM:GJV(TP]\64IN]6CY:RVIRT,3+G;N4T+O2I@
MVM)L719W90^ZNMTA%5:6-#C8S%>?9=+2P002RT'&[`?(FKO7T5^0?0NW]9Z`
MGI%7P^]LNUTI&4>S0FV`.OF[=5P]HJ1^EIZQQTAL'6NP=@:NM)T3+`VR!EHP
MR-D@U)?AXTQ+>&P]/.IO[*]:?W?TW^KD;P/'/V&H/6_4G?3_`.1#<I3H7K/;
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M*1%4N<V9J*8>`)RTL,^.G"_H4FSA*T/^B@IG*4+<<"O2/DY^546%T?L\[H9H
M&#U3VCVEU9UKUM"GM[2#5QV)_P`SVG+ELA,[:B(`:QN:I%U#*UL,:SLR$*41
MZ!Y&8M$GD!+AX?F\?-[<=4:_**W96]%Z3LU)[3]L>IFP-LVC\=K=UJ7L[KD;
MJ_[-!?GZ!09NYZGK^Z8[9B_2G9\0H&!?A",.MEX(9P@-ZW7;9AFZ-`:0V_)-
MU=B4VCJ/7.P98:DV>)NM.#E[A4(B?E0:M<(&0EH2TU\&0/<:$D`RB1C&$)=;
M=6A6%9"Y.`X#@.`X#@.!_]#W\<!P'`<!P'`<#$CL+TUUOV`V!J;=>+)?-/\`
M8;13=K"U-OW4AM8#O]8KU\"8C[O2Y*+O=4ONN+U1[2.(RHB+L,#*CCD,H*#P
M*6G#^`J&]_&IJ3:$2#*["VCO&S[]A-M:_P!X5/M<1-Z[$W?1=CZJ@[%5]>%T
MN*`UD/HJ%J-8K5RFPT5C-+>K1RIN0,/`+DC2370@-`^)#1NL]E:<W%4]P]B!
M-GZ@OG8K;SUS+F-.'RNUMV=K8WZ%O/<.W&RM*.1]BN%KK@D;&"B@LQ<!"1T*
M"/&1P;;*L.!TE'^+;7'6N"Z\V+66S^V^QR^EEX[";FTMK%FV]=!BKM<>QAEM
MF]N5:P24_JRA1$M'WV1O,TAE!\U%CQBI5Q8Y(JF!'!@PGZB_"A5ME?'/UTZQ
M=YA>R=2L&E-$;#TR#K)W;6G)*M:SNNX*$]3-Q;?TO:]8#7"9FF[3&6>;!AF+
MI+RXT0#)G",P@8;C+7`NZY_`+UQV&JRD73M-WEG)&_:EU+I;9IZMDZ4C&=B4
MC1$^5/:@%F:]"]>HRGUQZB>JR,*BN1T&(\V-A\EA\XD\LP,H>X_Q=Z\[SPFM
M(3>'8OL^AO6FO]BT`<ZCRNB*F;;&MNTF4UQLZT6U#.@BXY=HM]'EWH]68T>,
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MVL7'%TKKY*ZX(BWJY.9C;`9!0(RXL8W&?.&0XA[@3[1W5SJEL38?6?OGKR_'
M;YME`ZK/]?M4[L^Y:A8(6^ZPF):.E0+G+JJ%;@X"0OT)EB7`%/`9CFQ!['-#
M."^<G.&0Q_E-"]1?BRI4;L.]=PNP6F>H5/V]==D4KK=-6FM'Z1JVP+FN[;0F
MXRKHH^G'.S=AI-<\+%:%58JWRM7`$&,D#0,B`Y<&#;O#3,38H>*L$#)`S,%.
MQH,S"S$84R=&RL3)BM&QTE'FCK<',!.#?0ZTZVI2'&UX4G.<9QG@:D9WX8-`
MWF=[96#:V]>TNUC.[(NK'NP35FM&FJX-8+?H:,KL;H;9-8QJW1FO"->W[3GV
ME&OPY4$Y'CO/B)S(CG(4XA8=CL?XD(#;M]TWN+8_>GOO9]X:#LB+!JW;!%SZ
MV1Y591FF6VC&1PNJ(?J['==,&2</>Y59%A32TW!;Y#6<3"6PP&Q0B'7_`.#W
MKEUGVEH':&KM^=NVW.L%\WY=M(TJW;"U?>J=2PNS\^+.;VHC*[9IB5N4G3]@
M-!-B/K+F'YH9&7"QI!B4?(D'0W/<#`(/X]Z/2[;N^Q:%W=V!ZS0792[3^S]X
MZ[TO-ZQ8IMQVG;HH6%N6T8-[8>J=A7355^N`$>-B1.ITQ`8?)92=AM$EX&X#
M7%V4ZO?%?MBPVG0<CV:W?H:J;LHFD?C8MFN-(V*7K&F]L36DK->*]I70H.V)
MW4ETC)?<^JIG8$P')5B#MK960_739XPD1DGP#*6W?#MJ'8-"[2Z\O_9;MK<8
M;N+1=.ZTW>7*3V@`I.4H^BX\N'H,#7%5_KM"QU299AC71C7@1FB#L+4\ZXHI
M2WU!--D_%1J';=@WO:[WN_LC+V/L`SU:.LLJF=T\)FKWKIO:86ZZ*VC18X72
MK4-%7:"L\602<@L8^%EL29+)4>Z.D1H4,:M<_&7U@W19-WW'5W<SNV[,,=TZ
M%N[<XK\GJZ.-BNZ/7^G:^Q"6LL+:/5]=BCB!HEJ(D"(8-2:<4T6@=D#$:T,$
M.$)MGQ$]!NGU+U7N3>/:'M2UISJ9L+8%HUM`WG8%(^SX"-[+7HTO8>D<5[5.
MD*Y=]GP.[]CVT!@D<EV8NTVH<.&;DW(QXJ-,"VNIWQ=]6VH+H_V#T'VZ[1[,
MUQH"#I-SZIR)%UTO+48G4GV%?Z?1J:^&'H*&,EJ6QJ3=-F@<.OK9LBPYTATN
M07*M,&CAD[(_%CT[F=;]XM4R](ECZ=\@VRIK:^_1E3F0Y!JWS`D&0@BA2T:(
M#(586%OD01<`$*<*4-:Y>0-PK*2?10%]Z)ZXRVFY:5L-L[)]CNR%B-K,%3(J
M5WO/ZS]&KU>!>)+0##UK2^JM-4N0FI>0)R_(S\O&2=E.]-IIV14,TVRD.?VM
MZX1/;;15^Z\VG9&S-;T+:U;LM%V6]JIW7XEAN6N;I59ZGV^@&R>P-?;$9AX.
MQQ,^OURHIB/F6G&&_0.9;R\AX,83_C,HQ%=ZW(C.QW9VN[:ZEU&Z:WT;V2BY
M+0QF[:SJV_UNLU*SZXEG;)H&?U=<X$R"I\<A!DS5SIU@D9);<@DS.2,A3\U\
M'O3$J%H57J,KN[5=5JG5J0Z;W&"UQ?8:,7N_1$CLY6ZR8#;5IFZ=8;V]-%;?
M-DK"9*UZ6KQ\L7-23$BX8`8Z'D*NC?@!ZV@4N&HY':+O'*1L)U4MG1]I\O9>
MF`L&=4[3$@0+>G3J]`=?8:D.1=>B,RS8LHB*;GRB9\DZ2//D0X0N)#<]JZB_
MAAKJE:ZQ;;9>VJ16XJL#6Z]/0)-PG`H85L$$NQ%5BOU:#,E,!LH0X\R`/E[*
M/.O"G%+6H-?AWQ3:3L.R.\&Q;QMOL!?\?(=J\;3W9ZD6:6U$Q2;-1*_1[1KG
M7@%:%K&FJY8J3(:NJ5Q.8ACHV28,<?<P5(N'EX]?(0;5WPV:1T05K&W:'[#]
MM=2[LUSJJPZ/DNP\3=-0WK:^U]33,G&3,52MLB[DT?LS5MC!H<C"AN5\D2LQ
MQ\8ECTTOJ;=?0Z$SLOQ)=;;?<[79+#==_2U:V=I+4FCMX:PEMD`3E.WU%Z'7
M?"-17G:]@GJK*;<E]C4B1V-(&#F@V>.#?+;%=)$>4*SY0J([X1-(249*QQO:
M/N>3FP=/)/H#8BW[EH5]<ST^D018MK2N8Y_KHY`0D?&Q@OI,S44&!9G7'7R2
M))\PA\AP,J;I\?\`5;W1>H%!E]_]B18[I;>JIL?6TI$GZ5"F;=:Z!%/UR@&;
M.6K2+T5/"T^IR!L6P-'B10YHYSKL@@PQ`Y3`4A6_B&U=2=O%[PI'9[MS4[])
M;%[6;.EWH^?Z_P`E79V>[F*TZO>$98J?9NNL]5['49)S1=?<CHD\0D&,(840
MRW[C#+S(;$-%Z7H_7;3^N]'ZV#("H^LJO'5:OM&*$4:\,"C.7Y`_Z<'&QB9"
M5-==*?2(**(EYY6&&&6L(:0%L<!P'`<!P'`<#__1]_'`<!P'`<!P'`<!P'`<
M!P'`<!P'`<!P'`<#SX]X8F\7'YKOCI_#ZR[3UHU2^N';2IVO<-4TI*7NJ5"P
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M.M9MMD+EKQJ-)HE;CH")?$C8\J1&=DPFG9*E=O\`K7>>SD+I3O%\FNTV-4]<
M>EVX-/7"TL[2V3'%;GV;W@V&SL"-S7FM='UC9D;K7J[,5D>6J[XLB"<$0HJ6
M$=*8Q@0*Y[$]J^[-$B]Y:1J=J[UVR7IO:_Y"J;UN/(@^Q=<(OVO:]UHT*7H4
MJ0W3KK7TSL[9MYB>P5^LJ==5I@`BLVTD$D>;.CHF,:)R%[:H["=A;C='^PL/
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MS852[1@;3@.[T/;=)7_6)H&L(+9`05M%LK[CT/?7;`"*H\5U\T4D("B<[25/
MKUKOLM/]P?D,FR9WNK9NKI77:1+W%2];B:.KW9C9FPM46?=.TI'7TSV?UY"W
M32&N`A9C8=5&LME,9M`D.P,\EYEL0*<K':;LC=(BTXE=\_([2-\UKXF[)LG5
MFLVHCL0S*6OOAJG=>PZ!J%HO6LU66%7">GA8Z$K4I7Y4(>&O4@+*/2C!)XA9
MS89P:+V!V&J'=&.V@Y:NP\23O+Y6HC6NX-(1>KMIB]?8W2LY\<3<!=]BF#&Z
MZ&&/]WW"J<!%"6\J1<'`:A@V1G60RI/)H;"_F4KE=LM"Z:,6(7=!D;$]^^LM
MCL:=,F[^%D8O7D)<FB]@VB:5H,D>:!#K,+A)+,D_E!$6[CUPG67\97P-)=YV
MKW_I'61<?3R>TL5O>'ZQ=_Y#L]KFH_CS$PVB]_ZK[!ZVBOCAJNH*;4<CQ]-K
MMJJC<G#QT13_`#15YI.79B7^J);Q+\#U#=*=46/5NI)$FR=DMT]GG]J7(O;X
M-QWAEMJ<J@UPK-48.H-0BU5:FR%<US'6"(-DHJ*,`9?B_JKHV$H9:9:;#+W@
M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!_]+W\<!P'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<#2SVM^36[:A[!]@NO^KCNM^=R:1T_6-B:JZN[NF[?1MQ=Y9>WUJ3
MFQH?KA=FSAJZ,1&RPB8(&/`K]VD9^R,/@.IA6\(-X&..R/DR^32L[PD=&UCK
M+UI.O<_UM[@=J]3T6;E-SCVNST#K/N)O75/I,OED1CVFQMRULEB4C_;ANQ[#
MY`XZG%-O*(8#-NE_).]:?DZ/Z,&ZR.KNLI;1LA.ZUW%,M$ADW/L=K^"U?M/<
MNE&1%%N#>M2='[]J,JK*&?,T<U*CN/*6-Z38=@S\BI"?E6;Z`2%)C0-93>E;
M4]3=R/'+P?9>U^M8C6^W=EZ$$`28L;*:]UGW16+6AU3*'G/5+0G*TL+\@8(4
M/YE]RG7_`&S0)Z"ZXWG96G_E!8^/A_K5K,JYA]A-F:Z251@+)VLH]==MEWFH
M^JT5FZ$RTC&$0)49B+K<GZD\,M&%(#=-W"WT5U=ZO;T["A5AZX%:AUS8+LU`
MMCSA(S^8D;SY.F45F(L%A:K,(E>3I5X($LD>,&?=;:6I&$Y#`_0'R=5ZR7T2
M)V5MSK1MK1-["TS7]%=LNK7WS.Z\V=O7;\_=XY[KU8Z:!*[?1J?9%+!K0+JV
M9&SE*D1Y8=]QN->6Y'LA9M@^8_XU:C#YL%O[25VGPN0;\>S(V^C[7JPQF-5;
M1B=,[-`CU3]"CLR4]K[8LV,%-1H^')",'6HXAEL!MPI`0;L=\QW3?5NI]DV#
M7F[Z/.[$BZ/M.=U8Y<*/V"_!B[R>LGK1!3-AQLW7NH;F!/:@KUQJ9D?+VF`^
MJ1`CPZVLDX<RGQ#(>Y_)%TMU;9K70MH]@Z'5;OKROW66OH;35LE*U%2FKJ]4
M[+M&HP]R&K/V[9KY1HF\0Y!U9"?=L[#$J$IV.0HEI*@A['>V-M_:?JUJ;5+M
M?MVK-]Q_:Z!MY\U6[W2-HZRVAU::J#L[6)RK7`:!EH<@UZW)8(CI6&!.&2P@
ME"WF"VO*$^[<=JIO1UTZN:)UA6H&W;_[A[:G-:ZNC[;)$1=,JU>U[KRS;<W!
MM*XJ`RB7E86A:^J;^1XL);)4O,'`AX?&;><*9#$6%F*OHWNEN?L5W0J3E)V\
M[!Z]Z_\`77:6HKIVYOL5V@U:57+KL^PQ%3ZDPMHV%5HV<UD_7I(^<BHB!FRH
M%L0J?+DO:G)?0%_2'RU?')%3A4!(=K]<BD!1-'GS)5P>U?:(M?V=`/V;6<^_
M>TUU5):@=D1(^<UXU4A@6;)6V,$M\EUIE8<PKY5.A(9%8#?WRGWMQINP[Y7P
M6-9;D+.)K^GK<91]RM&!BZ\>)AK-I>PQS^+G!FH'FZD&RLZ7$#!3DC@6!(?(
M)T]CKE(4+.ZXF3L4;"OS;^:W6KS;*\0EG1KW9EJ!B[G6*O+TV;O,GUZ&<NH%
M<#/?GY*M-JD!0WATY<P%6Q7RV?'K/TT?8-=[$!V:GE_@XL6:K&M]PV5H@/?T
MR=5=22[(L'KV0/=K]KO4<[6,R.&L@1]N\D`:\-,NM`K#+K46^]6[VSL9.L)R
M6F\ZFV38M0W_`!*4J]4W,'L6IH#<L-<:Q=JU7,S2HQ$@PI14?[H)>'4Y0\KQ
MQP+AX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X'_]/W\<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<#4)VT^/;9?9^0[55G8:.K_8#2>_VX1>HJ'V)UY8I:>ZD6\#3
MU.UM+[-UG;H]Z:.ER)F:A'IA,%&XJ#H1[."69O#IY>&@[2Q]#^PS7>S1'<*F
M;NUG(Q^ANI%BZI1M<V91KI/V^Z!VZ3HUBG]@VZW0U[AQ';(]8:4E>$,A);6T
M4O*\Y<QA60QLG?B/WR58NM.\ZUN?1]7[::3[C[5[877<(]*WE(5K9(NUL7`&
MV:M%UU,;TDHBG5NX5C8DC"RKP:_<8C8V*;%4TEAY+H<6T_$/ON:D>OVYXG=^
ME8/M]J'NS?>XMLW@U3-YF5^^)NDS.^]U,SKF0WJ;&UVG36NKB=3I!0[_`+KZ
M!%P[;#B/:.8>"-@_$#V]KH6SK=0^VNF:#O>R?*!9_DNUYL>$TE;3(^G36V-4
M.:+W#IF<AI791)-IU[+4!U)8S.2!TF2@K*#D.,I1EL-Q/:G3FW]T=<YW5>GM
MVN:8V\=*:GDJ_NY^M_<.:](T+9]%N\S,FTJ,E*T%9AYR*K!0Q$*HL./D6RU"
M/K0*ZYX!J[O?Q*W.V;;;[%:]$ZI]9MKPMLZU[`-JNE]?V=G5>_MF=?=T)V6Q
ML?>X8/V1(MRBJP^=!P+(3)LG#IE37#)B6:='&$#Z=;/BGWQJ_?&GML;MVWUW
MW;$ZJV!\C=U>C\Z9N4-)V([Y$]]T?=%YGFQY+8M@K\-,5@>DKC`A5L&C)'F2
M4N./*9:=6&KWJ3T2[SV[2UUZUWN!AP)?L1TP[:=6A=C;.TYV-IF>@.H^P\U]
MW7C4L3#V>.K&K]N&3MOF61F_MNUV!""X(%P23,K4:*VL-C]K^*;M5(ZO[`:Z
MK^Y.H>)?:NX-\[WINV[;UDD+7MS7<IVUV'5=E]D=,4BV6&WSB-?:_LDS$F!A
M6(4>1G$QGTI"AFRH<8M0=MU"^+/M=H+LGJ;<&PNQNF;GKS5FPNSM\!HL71MS
MS5[,<[3UFJ!VT>2W%M/<]WM5GDJQ(U&-#'D9E)YLH-'N'%.)*D7&`@S[[C]/
M[%O_`&%U,[!:HOL+KKL'TPVM:-B:RDK=73K51+C5ME:_FM7[@U1<HR+F825B
MXW8%,F,-CS0CA!4(>*P4D4M*5C.A1^S>DO9?9'9?3W=TC<U%%W5H::O,?JW0
MD@W>)?K=7]87_5-FUW-PY<N.5"VB0VT79+2N>D+B/#`-RL?'@0+D2R@1F5;#
M![6'P5W_`$[K1&IJMOW6=EJT79/BQEXLB[ZILYDC,QGQPW![8LO$VQ`NP_;D
MA[CN!1"&1V,H8@8HA0Z<%+3AY0061ZB]G=/][-':XKDZ#:'KC$_,_MTC:C?4
MCLA/Z#IW\1CL!H?9M7U5?-M5IR>U[5[U7S:[;I(1TR7"0='UH6.,8`=L$><H
M.PKWPD]N]8W[5$UK#MQJ$R!Z^O4.%U,?L36FQRCS=?4SH&?T(!A+KKRD;(J.
MLI&[1M.LTW*_=Y`\G9I)TF.`=-8B8AB/?",[V^./:77OKK0]9V>!M'9JHV+X
MZ-3?%&B,ZFZ4G\[(U_:M7!WW9FM.Y$I@_8RQH*+A=CUR+=+4TAQP2QF!$Y?2
MSEYQL/07U0U!-:+Z]ZSUU;IANS;%&AR[5N"W-"B`HNV\-BS$EL3=MX2"!C`0
M#=RVM:9B20.SXLC-E):;SE"$\#(?@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@?
M_]3W\<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P/_U??QP'`<!P'`<!P'`<!P
M'`<!P*SN^Z=.:SD!(G8^V=9Z_E#P\2(,;=[Y5JI(&Q^7G1L'"!STJ`02'DAA
M;?JH2I'G0I/CXXSC@6!'2,?+QX,M$G!RD7*!C2,;)1Q+)L?(QYK*"0S@3!EN
MCEAECNI<:=;4I#B%84G.<9QG@=':[O2Z&%'R5YM]7ID=+3D36(N0M<_$UT*2
MLD^5@*"KT>5,%AL&3DT:K#(@C:E$$NY\C:%*_)P)1P'`BM7O5(NZ[,U2[C5;
M>Y2K5)46Y-U>PQ$^NI7>&'!+F*=9D1)A:H&U10LF,Z3'E>D6PV0TI;:<.(SD
M)5P'`C)-UIH0),H9;:R)&!36:V9(DST4P")8DF)CE0!);I2!V)I,@O#&15JP
M_A[.$>7S9\.!])*WU.&DAX>7M%=BI<Q46@2*DIN-!DBES<BN(A4C@E$M%/JE
MY9M0HN$ISD@A.6V_,O&4\#AHV!0W'I09N[5%PB#%D#IIA%DAE/1`43XYE3)1
MI)N5QXL;A.?<..X0AGP_/SC@!-@4,^%D+(#=JB;78E242L\)9(8B%C%K:8>0
MF0E&35@A*6R4TO&''$YREQ.?_!6/$.T+LE=`-+C3I^%#D0(5RR'`%R@(YH5=
M:=='=GRQ7GT/C0K3["T**6E+"5H5C*O'&>!R(>9A[#&!S4!*QLY#2+."(^6A
MSA9.,/'5G*</AGA.OBE,Y4G.,*0M2?''_CP/C`V&`M44/.U><A[)"%N&,BS$
M#)A3$42['FD1I[0\A'OD"/.`R(CH[R4KSEIYI:%>"DYQ@.*=;ZG%V*"J$G:*
M['6RT,R1%9JYTW&B6*Q#PS'NI=^"A2"6Y*79BA?]H2H=IQ+#?YR\IQ^7@?2T
M6FL4BO3%NNEC@:A5*\"])S]GM$O'P%>@XT?'F(D)B:EB!(V-!83^5;KSJ&TX
M_P#'..!\:U<JA<QRRZ?:JW:Q8\@<0\FM3D9.CA%%QH$T*,6]%E%-C$$P\H*6
MVA>4J6,2T[C&4.(5D))P(O=+O2];U>8N^Q+?5Z%2Z\.@N?M]TGXFK5>#%=(9
M$;)F)^<+!B8P=PHAMI*WG4)RXXE.,^*L8R$HX#@.`X$?9ME5(9-)8LU?>'C;
M`S4Y$AF9CG&8^U$2`42Q6374$J;%L#\I)##("<RDE1!#;>$96M.,A\TW*H+F
M_ME%JK:K'B0*B<U],Y&*F\2H,%%6@V,^E8*R?]0#K4Z#(NL^GZC8)C#ZL8:=
M;6H..S?:,3%%SP]TJ;\&!.)K!TRS8X=V*"LJY8:!17BY%!B@QIQ<X:R%@1:T
MD9+>0SY/44E.0Y`ERJ!\;"3(%JK9L19C&XZMRHDY&$QM@D'<%*:!A#F2EBRQ
MCJ07\I:84XM6&5^&/S%>`?DJZTT%FQ$&VVLAL4]3*+:^5/10[-762.R8.FQ.
M/%(1"*($(;=1@G+65MK2K'BG.,Y"0#D#F#L%B/LE"E,M$#$CNH?'('?0EUE]
MAYI2FWF7FU84E2<Y2I.<9QGPX'VX#@.`X#@.`X#@.`X#@.`X'__6]_'`<!P'
M`<!P'`<!P'`<!P'`TW?(GKC8.Q^ZGQBXUM4&2)&IW'LZ_9=F7/JOL_L;IK74
M)<^O]@JL5C8C],F:%7JZFRSRFPP\R5HC6VBUM/N-O-)\BPUPU33OR3]&X#L'
MI;K=V5[*RG63H_+=4:EJ"G7+I]K:ZE[6T[N5FH-]L[UK?80FCXV2M9W6=5JG
M[-4H6!59$Q[L+B$-`E0E!BMA'=J;P[S[H!V-K7>HW9<C4%-WOU:FNI<M"]4&
MIPWN92ZG\H%F3==F;MQ5>NB)#6$IJC1^M:?)Q[,*FA,GB2")Q3)PDD(-@+$E
M^V'R7P\W0Z2FS]OY6"B_O"I=HMER'32L9-U[1X'Y+X+4;6X=7OU?K-"1%HVN
MSU!?+E#6PH^<K;4`\U8QH5U3#JU!4?\`S:?-A6!MG,O7"7V;-:Q<<K\:8#U#
MW#0);;FDYCK'#RSW8W3NA)GIW+XE]D4_>4/-GI7/[0#BC&HQ<`BHJ.EX/$@&
MW;XHH.P0\[\F,A-/[7G8Z[_(W9+S2]A;<UBYK"9VE3S>H73RLL7J'`$USJZK
M3M?*L=2DPAY&(B61#,`Y>\5J<]5P-<&X^T/R^2<))L:R>WQ3=L&;0V/#[@H]
M=ZM5;9U7ZPUN#^4'1FEM`.ZQ><Z_2<GNBM[?Z%W.YW*QF+EK"OT*TS-!%5\?
MSB&!NOZXRG8&W=3]C1-HMNP)O?$#>^X>MJ3L+=&L1=16JP`T_>FXJGUXO$[6
M(;7&L*L;'RNL@:R<F8A(`.(FF%^]&;\'LXX'DFA.NN[X"JU`%SKWNB`@!?B\
MZ\:VV!-%Z)V-<-71/=[772CL?K;M/`;;TS"V>D'[8WGM%>T8.K1%D^W]B(7:
M_;%JCI+,6M0X9`['U+M;?NL]<]H['H+;,KJS87QO=Q.J>JM($0ECW)M+5FY=
M8:!UMJCK)6K5*P5>&,F-G2^Z$[I^V+KZ`6%.689>"!5FL82&3^G>C^O-+[%N
M6CQ]`1M0VM<=<]<>E5MWR)JBJ!;%[!1FY*-(=L?DTW#;-UUJH15BV]9K;KZH
MOU8*22DEF!LS88XK#*Y1;:PQ*Z^Z"KL)V'ZH[%+TGW((ZQT2P:^U;NG4NZ^B
M?92BQ\3UTTUH_N'7.N%Q[/26R-$Z\A>U?8R9["[QBIB=*J\0="5($./$:4;@
M7ZB8&)VHNHW>^J]2],:^[1Z%[*[([DQO;W5=MLEJUW7;2BVP'0![XQ->Z<U_
M4K!L6/N.I03:CIKL"JOL7:KXM<2;)358F"5$+>4Y(.!ZJ_B9K-GK77G?499:
M5;*%(G]T^WM@#LY%4GZ%5MJ1UMVC*66/W7HS3]Q!-.U/I^X)EO/`U]QV;:\P
MSIBI&84:N0+#4#H^Z?)[J?5E+8UZWV+U[6==4_65D&Z_5_XYM>:\INP-B7CY
M2]GT#949,Q-$Z=5E^H0=@ZMJ;M=K1`IAY)I4NU9VB@F%&*+",VZ[?)9LC6NJ
M-UMS'8FY]OJ#I'=^R*Y6P.@]AK4KU;[<E_'_`-Q@[CJ4&Y3^G9;4>PJ#.=BQ
MJM5Z]&$XE%+!9CGWSSBIT8M06YNWLWW*VI5=ZZW+G^XK6@+K$]OVA+X?T7'D
M[5/G/=(>J%GT3U^J];3U>2W+::O6Y[SMUD21,BV[=)9KH`F+"ADV.?D`JK0?
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M`!'86-V%2K+4.F**;9:13M$?)-HY@%HI$QUUOD5(5VM:*^M3+)!D]8B[=%QL
M'+2,1#AR!D9(!F_T*[B]O-I]RYFA[@KO;'&BK?7>QQU$=WOU&5H<JF2%,V;1
MF]605S<A-4`0D%--:XS-I4>]>)55MP7'GX@*WAU@<H'>F]]F]!=J-]W[0\EV
MIL,_M3KETWK=0A:-I2M[4TO0:O4-V]EU]E]EO/JU!/R:+=I#3<TY88:*3*EE
MS]LL,9'%@2@A,8"(&>_2ZY]D]C:&VT_M8N6=LL7O'LA2^ONSKU7(>IVO9FEJ
M_>)V+TIM6\4^"H=*@(4J2$QZ3&1*^(-*Q`0LFAA:3O,L/*-CK[>Z9"]%=B%=
M<-W5Z!ZZ,_`E(=GYK&@=O.N5OLYUQ[`[CNGR$[IN3D=2S7I-ZK:Y^AF7&ZO9
M=#DAVA<J+)4PGTPR5[":*WO)VG?6[I;K[N_8N].UU?\`C"[)==\:[I-ES?*:
M1"]X-P;+[6Z9B=@")C8;4>S]?])RJA2IPDZ5B4S,5&!#^Y<;;PVR%=TC4DC<
M_P#G`ZF;,T7V\1JD[J1UPWAM>>TKKV_0VQ]@TSKAUD,UKJOJMKS7TC*;S)NG
M<^A]A+3$2ECNS4[<X6Z3M5>9,PP+'9&;"L]F=:=UWF>[6;`IVI.Q$_\`CUU;
M[D#ZDA#NHG8[KUKW6?R(7\GH?#Z%&TIK_=.JM86V'G([6&KU,XVN?7Z\U-6Z
M+L4IYXQ+F!V0MBB:`[!US9'6T:Y:9VXC:=.D.S`_<[>+6F[S,:A&[+2GR&3F
MV]);^[$PP5^ZX/\`:32CNDXC8#P047.'X1&7N%SB/6.<*)D/1E\1D!8:I\;?
M4:L6K5&R-(V&NZOQ"2FMMMG2)M^A7XNQSP29*89EH"J24"';F64S,=#/1<:N
M"C)`>.]J/[7TD!L;X#@.`X#@.`X#@.`X#@.`X'__U_?QP'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P*+J_63KY2;T_LNHZ=U_7+R18+
MS;<V&(KH`10]NV@>1*;+MT>PRVD*+MFPY,T@B<DQFFCI9\HA93KJB'LN!>G`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P/_T/:#WRG-KUOI[V!F=&EW
MB/VV)0#DT0_7%3C+O<`9LHL(-!D97969@!WAQ1B'%FDME),C@4O%BH>*899<
M#SX!=@/FP.@LA@4??#3[/4S3A^N9=6IU695G[#4W3?R`L1J[Y;F]=5V&DXO<
M_8J)TY(V9[,'4_9U,^.%D18Q&)QYX-L/3RT?(O8.K6XS;?&PIG8D*]:?:TZS
MVGA;%K:LF1LKUEZG63L,S9?L&G-VSZ+!=EY_;($`\/&O#J2"$.*XN&;%?X&=
M^M+=O"SZYH%EM%$U2'9;#2:K.6(2!VA;GH(6=EH(`^6&A7I#4;9[L2P>0XD9
M3Z4O*9PG*\85XXX$V^I;4_H;K_\`Q+L?^4W`?4MJ?T-U_P#XEV/_`"FX#ZEM
M3^ANO_\`$NQ_Y3<!]2VI_0W7_P#B78_\IN`^I;4_H;K_`/Q+L?\`E-P'U+:G
M]#=?_P")=C_RFX#ZEM3^ANO_`/$NQ_Y3<!]2VI_0W7_^)=C_`,IN`^I;4_H;
MK_\`Q+L?^4W`?4MJ?T-U_P#XEV/_`"FX#ZEM3^ANO_\`$NQ_Y3<!]2VI_0W7
M_P#B78_\IN`^I;4_H;K_`/Q+L?\`E-P'U+:G]#=?_P")=C_RFX#ZEM3^ANO_
M`/$NQ_Y3<!]2VI_0W7_^)=C_`,IN`^I;4_H;K_\`Q+L?^4W`?4MJ?T-U_P#X
MEV/_`"FX#ZEM3^ANO_\`$NQ_Y3<!]2VI_0W7_P#B78_\IN`^I;4_H;K_`/Q+
ML?\`E-P'U+:G]#=?_P")=C_RFX#ZEM3^ANO_`/$NQ_Y3<!]2VI_0W7_^)=C_
M`,IN`^I;4_H;K_\`Q+L?^4W`?4MJ?T-U_P#XEV/_`"FX#ZEM3^ANO_\`$NQ_
MY3<!]2VI_0W7_P#B78_\IN`^I;4_H;K_`/Q+L?\`E-P'U+:G]#=?_P")=C_R
MFX#ZEM3^ANO_`/$NQ_Y3<!]2VI_0W7_^)=C_`,IN`^I;4_H;K_\`Q+L?^4W`
M?4MJ?T-U_P#XEV/_`"FX#ZEM3^ANO_\`$NQ_Y3<!]2VI_0W7_P#B78_\IN`^
MI;4_H;K_`/Q+L?\`E-P'U+:G]#=?_P")=C_RFX#ZEM3^ANO_`/$NQ_Y3<!]2
MVI_0W7_^)=C_`,IN`^I;4_H;K_\`Q+L?^4W`?4MJ?T-U_P#XEV/_`"FX#ZEM
M3^ANO_\`$NQ_Y3<!]2VI_0W7_P#B78_\IN`^I;4_H;K_`/Q+L?\`E-P/I6K+
M99"RV"MV2OP<,_#0=7G!B8.T'V-HYJQGVT!;#Z#ZE5U@N`KJ_FQE/KX=P_\`
M_9Y/SPGG`<!P'`<!P/_1]_'`<#KY5N5>`?;A#8^/DU>E[8R5C"9@!GP>;4]Z
M\<)+09!'J#X6E/E*:\BU85GS83E"@A.GDD)U)JU);K+Y2=<TA)+P["Q1WB,5
MF,P\ZP,Z08X.RXYXY2VIUU2$YQC*U9QYLA8W`<!P'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P*_C?[5+E_=
M_K3^L>V>!8'`<!P'`<!P/__2]_'`<#KY4(F0`?#$EI"#(>]+TY6*;BGCQ?3>
M;=7Z#<W&3$8KUT(RVKU1G/!"\Y3Y5^520A.GFEL:DU:RZ0\8XSKFD-.%D)'2
M04MNLQB%D/I$8%%2\^K'F5AIIMO"LY\J4X\,8"QN`X#@.`X#@.`X#@.`X#@.
M`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5_&_VJ
M7+^[_6G]8]L\"P.`X#@.`X#@?__3]_'`<#KY4(F0`?#$EI"#(>]+TY6*;BGC
MQ?3>;=7Z#<W&3$8KUT(RVKU1G/!"\Y3Y5^520A.GFEL:DU:RZ0\8XSKFD-.%
MD)'204MNLQB%D/I$8%%2\^K'F5AIIMO"LY\J4X\,8"QN`X#@.`X#@.`X#@.`
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5_
M&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?__4]_'`<#KY6,&F`'XXMR09'(]+U'(J
M6E8,]/HO-OH]"5A#8^3%\5M8PKTGD>=&<H5XH4I.0A.GF$"ZDU:,TIY38^N:
M0PVH@@@PA2&:S&-H4^66Z^44]E*?SG'5K<6KQ4I6<YSG@6-P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<"OXW^U2Y?W?ZT_K'MG@6!P'`<!P'`<#_]7W\<!P.OE8P:8`?CBW)!D<CTO4
M<BI:5@ST^B\V^CT)6$-CY,7Q6UC"O2>1YT9RA7BA2DY"$Z>80+J35HS2GE-C
MZYI##:B""#"%(9K,8VA3Y9;KY13V4I_.<=6MQ:O%2E9SG.>!8W`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P*_C?[5+E_=_K3^L>V>!8'`<!P'`<!P/_UO?QP'`Z^5B8J<`?BIN,CYB,
M*]+W,=*A#2`!'H/-D,^N&6V\.]Z)#*'$^9.?*M.%8_+C&>!"=/#CAZDU:((P
MR**+KFD#C##M(8'''8K,8TRPPRTE+;+++:<)2E.,)2G&,8QX<"QN`X#@.`X#
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#
M@.`X#@5_&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?__7]_'`<"/VG[5^@G?>WV_]
ML?[K]3^Z?IWT'_\`,']E[[ZM_P"G_P#\AZ7I>I_^MY/+^=X<")Z6^G_@YJ;Z
M3[/Z7^&=#^F_3O1^G_3_`+6BO9^Q]M_N_L_;^7TO3_,\GAY?R>'`LS@.`X#@
M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@
M.`X#@.`X%?QO]JER_N_UI_6/;/`L#@.`X#@.`X'_T/?QP'`Z^5DQH<!^1+;D
M'AQ_2]1N*B96</5ZSS;"/0BH0*0DRO!;N,J])E?D1C*U>"$J5@(3IY]!6I-6
MDM)>2V1KFD/MI('(#(2AZLQCB$OB%M,%"O82K\YMU"'$*\4J3C.,XX%C<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<"&[%N#>O-?WB^NQ,E/MTJHV.UY@(9+3DS
M.YK\09*IA(=MY;;3LM+K%P.,A2L86^XG'C^7@22,DP)J-CYB*+9/BY8$23C3
MAU><<T`\=LH,MA?Y/.R0.ZE:<_\`U3G'`YW`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P*_C?[5+E_=_K3^L>V>!8'`<!P'`<!P/__1]NO:[>;O6?KE
MN'?(]5<NY.KZ9(6<6J-2"HM4X4.MD<8+)C(,L?AO+Y*5+;""/D7T)RT&(44M
MD=T-&];_`/D0UXR)9/LG61F/=QHZT]B755OL%4[B&;JW5&A=L[ZW/*PI4%32
MP9.>KL;IR4@XV)'(??39%-Q]C<K#W_B&RS1/R.5+;W7C;/8:2T]MP..U%:-0
MP,Q0]14J\]D-C3@>\^OW67LG0SZK0]5T@R]V,P#7_:F`18!@8DAN'+`E',/D
M1PF)!T,P>OMA%MNA-(VL(">B@K/J'6MA$C+3`2]3L\:+-4R%DAP+'5K`''S]
M:G@VB<-F1YP[!@9"5LO-H<0I.`M[@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@0
MVY.P[J*S"RX\D4J>N5>:B68Q6&UXF*T0Y?A"#"%/C-L1H3=0<??PI7^W;;RR
ME+BW4-J!KT..BJ56X"*DWID2IQK5*S)D,.C$&&4E2ZG).OLO)2K#V)*&=PK.
M/,VI6,J0I2,I5D)EP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"OXW^
MU2Y?W?ZT_K'MG@6!P'`<!P'`<#__TO>!LG6U&V_1[%K?9-:B[?2;4&V%.0$P
M.D@,M`Y0\@"0C&?!8TA%R8;!89+64/B%L-/-+0ZVA6`QLK_QX='JN&@*'ZMZ
M890DA!BR"*1$&G/G*'LXLF>0>8P^6\99FKM-?6G,K\9O,N;D_P!QDI_SA?M.
MUS0M)5,N#U-K6-@H?W09N:I1@8.'4<0Q&PM7#6WB4D86+\L+6(,$$=#I+:!8
MJ-'$'QAIAAC`<C3SJW]2:M>='>#<>US2'7!"%#J(%6Y68Q:QWU"/E"J>85GR
MJRTZXWE6,^52L>&<A8W`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`K.R8^H[,UC
M#O);P-%Q]^V`P\E?E*^KP8,%0Q1?)ESP7'O16TCW'?!&58?98\%)QXI6"AI^
MGV+:D%Z;@8XUX8G8>/<SY6\1%JJ=;E3Y:/9RA&4Q\S?<3RUKQE:7)!!?YWCA
M24A9G`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P*_C?[5+E_=_K3^L>
MV>!8'`<!P'`<!P/_T_?QP'`Z^5-)CP'S!(F0G"&?2].*BG(ID\KU'FVE^@Y-
MR</&)]!"\N*]4EOQ0C.$^9?E2H(3IYU;^I-6O.CO!N/:YI#K@A"AU$"K<K,8
MM8[ZA'RA5/,*SY59:=<;RK&?*I6/#.0L;@.`X#@.`X#@.`X#@.`X#@.`X#@.
M`X#@0F+?AY&]6M\09YZ3@(FN5R0E%KPL04@CZC8W8(-M:<+%.1'2H!ABD9\A
M#10>,YRIG&$A^FQ8>/V(::N0\)^VTN,%&BLLN_G0^O)R6>-D$$8\S'YANSQV
MU(5Y%_G)RGSX\WD":<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`K^-
M_M4N7]W^M/ZQ[9X%@<!P'`<!P'`__]3W\<!P.OE7)5D!]R$"CY"33Z7M@Y63
M)AP'O%YM+WKR(D3.$#^F/E:D^45WSK3A.?+A65I"$Z>40K4FK5%M,L%*US2%
M$LCOK*'9(S68S+S3!+HX;A#+;GCA+BFFE+3C&<H3G/EP%C<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`^)!`X8[Y9;[(HHK+I!))#J&!QQV$*=>??>=4EMEEEM.5
M*4K.$I3C.<Y\.!6>JBF9P"VW80A3X%ZO4Y+Q64_GAKAJ\-&:[AI2),PM34G"
MVJ*I#,R(4UC##[$DE367&_*ZX'VNV/I]NU3/-);85FT3%1EI-U?D:'KEHJ4X
M:F.=6XXD9OZS>ZU7FFE9QZJRDM,MY\7LI6%F<!P'`C9EOKD?;("C&2;8]IM$
M'9['`Q2V2O-)0]-,JX%D*9+2QD!#D:3<H[&65NI?=0^I;2%H9?4V$DX#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@5_&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?_5
M]_'`<#KY5R59`?<A`H^0DT^E[8.5DR8<![Q>;2]Z\B)$SA`_ICY6I/E%=\ZT
MX3GRX5E:0A.GE$*U)JU1;3+!2M<TA1+([ZRAV2,UF,R\TP2Z.&X0RVYXX2XI
MII2TXQG*$YSY<!8W`<!P'`<!P'`<!P'`<!P'`<!P'`<"#W*TRT&Y"P]9KS=H
MM5C(,1&QI<O]`A0`(L7)<K/V6;;CIPZ,@Q%+'#PL6.D"%R!XC7HI:<=?8#BP
M=2L#V))_8EG%N2Y4%<:]7`JZ)!T$$)U:<D($@#"9^8DBCFVFTD/2<F>CQ0KV
MK0C;KK2PL+@0V_QP,A5C')%4E@6!.@;GE,0$Y)2+[]"L$7=@Q!8YEMPB0489
M`-M*8:QAYY"\H;RE>4JP$J$+%/%&.!)'-!-'9+#,$>;)%+%);2\.2,0RI;+X
M[[*\+0M&<I4G.,XSG&>!R.`X%"RH8&-GE7^SQ<LT'5)J@T"F%N(])MB:LH4T
M!*3X*B7ATE5FRE;3C(@G`OJJ<DX9"GD9P&VMH+ZX#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@5_&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?_UO?QP'`Z^5;E7@'V
MX0V/CY-7I>V,E8PF8`9\'FU/>O'"2T&01Z@^%I3Y2FO(M6%9\V$Y0H(3IY)"
M=2:M26ZR^4G7-(22\.PL4=XC%9C,/.L#.D&.#LN.>.4MJ==4A.<8RM6<>;(6
M-P'`<!P'`<!P'`<!P'`<!P'`<!P'`AKV84K8,<GT3GK%!TV:SE]IMKZ;'0MI
MFX#"63G5^#WOIDZG94(EKS)],`C+OESZ7F"9<!P'`J_3O^YT0"LJ_-709"<U
MVVT[^:?B*I$P;7:N;*LY\N69">J`,?)*SA#;;R#4O,H2RXWP.RNBC+".91:S
M:A:]9#A8PR9,%>4Y88"FGR3H<A*Q([.%>PFID<`P*(+(RAE@M+A24%>Q=%<"
M-ZR.<JZ)[5LZ84Z_K46.?@IJ8D'329O5\KB0339B2E323"B)*"3#&P<@^:2Y
M(&$0^9(CRI/9\P1<PJ7.Z\_>LR^<7+,QHN\4QY@Z'R1'(JR,[EB*'Y5H86L6
M%:#8@FG_`"-O^@PEWRI=_-P&17`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"O
MXW^U2Y?W?ZT_K'MG@6!P'`<!P'`<#__7]_'`<#KY5N5>`?;A#8^/DU>E[8R5
MC"9@!GP>;4]Z\<)+09!'J#X6E/E*:\BU85GS83E"@A.GDD)U)JU);K+Y2=<T
MA)+P["Q1WB,5F,P\ZP,Z08X.RXYXY2VIUU2$YQC*U9QYLA8W`<!P'`<!P'`<
M!P'`<!P'`<!P'`<"MX/'NMI;"DAT^<02KZYJI)'D\GDGHLF]V<V/_/8;==]O
M"7>,?]1*W&<^Z\B?*XAW'`LC@.`X%+S$G*UBTV*NT*GV";MU^(`NA-@FQ"0]
M7P66H6*I))<I:6&<>)$5'U$->(,7#\L>0:TIO#063#8X)A2:9FJM2I\G*N62
MWV<QB3MEG?"&C<R1@XC0(4?%Q@N7&X2KP0;.&(X'U2'&F_,Z206<^6:2'5[4
MI4A=JP?$0>*V),3(:J?(S<Y&O%FA:[MLK##;,!KYH;C14?.'UD)3P'J>L"N5
M$#44RXTWGRA/I.,`FHV0AY41D^+E@2XR2!(3YQS0#QW!3!'T?D\[)`[JD*Q_
M]4YSP.EI,J+.4^LRP69#VYL'&NX;ER6S)D9W`C39(4X0TZ^AR<!)0MDW\]64
ME-N8SGQQG@2C@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5_&_VJ7+^[_6G]8]L
M\"P.`X#@.`X#@?_0]_'`<#KY4(F0`?#$EI"#(>]+TY6*;BGCQ?3>;=7Z#<W&
M3$8KUT(RVKU1G/!"\Y3Y5^520A.GFEL:DU:RZ0\8XSKFD-.%D)'204MNLQB%
MD/I$8%%2\^K'F5AIIMO"LY\J4X\,8"QN`X#@.`X#@.`X#@.`X#@.`X#@.`X$
M+IRX4QZY3,(R8EN7NDFB2*)R)Z)\U5X^)H4H]'-CNK(:#"(J60U8)2VZH@5U
M:4Y84RM833@.`X#@.`X#@5KK'&0P;?`O85@Z!V5?\G9PPAD=6+?8B]DQ.1EH
MSY2$XKMW"PZOPQGW.'4J_.3G.0LK@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5
M_&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?_1]_'`<#KY6,&F`'XXMR09'(]+U'(J
M6E8,]/HO-OH]"5A#8^3%\5M8PKTGD>=&<H5XH4I.0A.GF$"ZDU:,TIY38^N:
M0PVH@@@PA2&:S&-H4^66Z^44]E*?SG'5K<6KQ4I6<YSG@6-P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`K?4V?7HX<JA7G#LTY=+G$N>?SJ=@;O=;#;Z\\O_;D^FX]
M!S8ZU(\W^S5G*?*CP\N`LC@.`X#@.`X#@0LRL2(9$K(TV5CX&4L$XB<L"YJ'
M*LL;*$-UV'K3:\`L3M?+!(8CJ\$EM3)2&?!MS*VG%N>=`*!-RU@KJS9WZ>J4
M$LEWKY+L4&9'`$IJEUL%7',8!/,D2A?>BPZ'E(R0\E*UY\BU(\JLA-.`X#@.
M`X#@.`X#@.`X#@.`X#@.`X#@5_&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?_TO=]
MLS95(T[0;5L[9$^+6*12XEZ9L,V6@AY(HC2D--,C!ALD'R4D>6\V.((,TZ48
M4ZVPRVMUQ"%!AE5?E6^/FZB1IU8[.4>6%F(-JS1)`X%LR-*5U$*=8;!/1A>:
M[@23@]>Q$2<[;C1W'1:=]/,3-N1ZA"<-!E#K7;VG>RE.EIO5-^%O%5$E@X23
MEZA,ST&2(>1!5J]POI2`#D+-C@V2E6J&G8PME:1)JO3`1XKA$<<P\\$@T\P@
M74FK1FE/*;'US2&&U$$$&$*0S68QM"GRRW7RBGLI3^<XZM;BU>*E*SG.<\"Q
MN`X#@.`X#@.`X#@.`X#@.`X#@.!T]AG`:Q`3EEE,N)C:]#R<Y(J92A3N`8D)
M\\O+27'&FU.8''5Y<*4G&<_^.<8_+P/G6(D:`K5>@@QR!`X6#B8D40LK!Q0H
MT:`.&P.2;A;F#"&6F<)6[YE>HK&5>.?'QX'><!P'`<!P'`<!P(73@08IZY1D
M=*#FBCW23.S&LMH2Y7#K+'Q-NEXLMW'^T)(D9BP$2V%+SG*&I)#:?!"$8P$T
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@.!7\;_:I<O[O]:?UCVSP+`X#@.`X#@.!
M_]/VZ]KM#L=G^N>WM`$V+[5&VK3S*J3-+KM;MHC(Y+P[[X4I6[;%S$%,P<PT
M/D,]AQG#R@B'?;NCD8:(:#4=&?`AJHBM%Q5Y[%;=N4O*:UV%IXZ9E(ZIR$F%
MJK;&F-@:!M^MXNTS$;(WPFLU_6FT9EFM.2$L8<%*O)E)%Z5,66LH,[=1?&WH
M#7O7O9W6F\B&;GUIMZP:IFKS%7'+T:S,-:,TEUWZ^ZM8>17C`'F3(N@]6ZD3
M(O,.L,GSK19;;`HY"`6`RIZ^UB!I.A=(TRK1K,-6*CJ'6M8KD0.IY8\5`P-,
MA8J(C6%D./$+9!CQ&VDY6M:\I3CS9SGQSP+>X#@.`X#@.`X#@.`X#@.`X#@.
M`X%9[C?;3K.W1JG/2(M<>U0(MS.5):;GMC'"4*NK)6AX=UH-,[8Q\OK;5ZJ&
M?,I&%+PE.0LS@.`X#@.`X#@.`X%;PF?;;3V#'L*\@I53UO9B!\+\R5S<D;L"
MNF2.4J?6M#A,-3HT?.,-MMY2(G.,J5E?@%D<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`K^-_M4N7]W^M/ZQ[9X%@<!P'`<!P'`__]3W\<!P(_:?M7Z"=][?;_VQ
M_NOU/[I^G?0?_P`P?V7OOJW_`*?_`/R'I>EZG_ZWD\OYWAP(GI;Z?^#FIOI/
ML_I?X9T/Z;].]'Z?]/\`M:*]G['VW^[^S]OY?2]/\SR>'E_)X<"S.`X#@.`X
M#@.`X#@.`X#@.`X#@<,>1CS"#Q!#@RBHHAH24&')9?(C2GPQI%@8]EI:G`R'
MH\QE]"',)4IEU"\8\JDYR$)).AK1>?M9V*>D,Z_9AK@5*9.(9C`;',MS<=7X
ME08CGM9F2$B4%2!`YG@F/R]&%MM+=>8>'"PN`X#@.`X#@.!PS)&/C_:^_.#!
M]\8Q'!>\)9&]Y($^;VP(OK+1[@PCR*\C2/%:_#/AC/AP.9P(:^"&UL&+DFY1
M(L@=39\$J%2.^I<Z'%3=;?`E'2\$)&:35'YDEIMM32G',S*U)6G"%X6$RX#@
M.`X#@.`X#@.`X#@.`X#@.`X#@.!7\;_:I<O[O]:?UCVSP+`X#@.`X#@.!__5
M]_'`<#KY66BH,!^5FY./AXP7TO<R,J:-'@#^N\V.SZYA;C([/K$/(;3YE8\R
MU83C\N<8X$)T\0.9J35I8C[)0I6N:00,2.ZA\<@=^LQCK+[#S2E-O,O-JPI*
MDYRE2<XSC/AP+&X#@.`X#@.`X#@.`X#@.`X%<[%OAE(&@4Q%5DKK-STU[(>O
MPY+`\AB'CH\V=LTRWE]#C;BHR#C'4"-+])HV6(""4^/[M+Z`_4SLJ!$UTO8T
M"XW:8TV/`=JPT>_Z"K3,SQ8T15:\(^^UG`,A8;'(#1Z/<(1@8A_P>PC"%^4.
MABM;V"`HP<97K6+#;!4=]S6.W8@!)*,MUL/-.F+&F?AR7&CG:K+RTJ3AH04T
M,F/%RTT*0REE..!)M>5J3KL,:18W(]^WVF<D[9;B(M;I`.):34TP%$!G/AQA
M$K'U&M@@0@ACHHCQ@<8T\ZPRXM;:0GG`<!P'`<!P'`JN-J]6O;]IM4J1%W^K
MW:/AX**B)*':,JS=5KKQ;WD9"E,G`3_URREEG*DVVVQCPL1^&TN-BM$O!V@F
M)^L6*MUD&+<DM>OUOZ6)*K-EI6Q5NPP>'GFL666FY:3.L$/9H7.&V2UX00$>
M!E)#I>9%KV8<>Z8]*VZ@):3Y"';Q-Q3Q#:/!Y<45K#8$F3'.O)8=7]/)DX0(
MAQK*VVUOB,+SG*VVTY"R.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5_&_VJ7+^[
M_6G]8]L\"P.`X#@.`X#@?__6]_'`<#KY63&AP'Y$MN0>'']+U&XJ)E9P]7K/
M-L(]"*A`I"3*\%NXRKTF5^1&,K5X(2I6`A.GGT%:DU:2TEY+9&N:0^VD@<@,
MA*'JS&.(2^(6TP4*]A*OSFW4(<0KQ2I.,XSC@6-P'`<!P'`<!P'`<!P'`C]D
MME7IL>B5MMC@ZQ&N$)#:/GY4&)%>,6R^2@-A\]]AM\QP<5Q:6D94XI+:LXQG
M&,\#\UJTQ5L$*,B6YIEL(Y4<4S/5FRU,]HM(@AWES%VJ)AI)3*A3FE)=2UEI
M?FSA*LY2K&`Z&!/B;9;)^::AF_7H9DO0(BS^\]?$FB4&J<Y=!XUH?&0_IX4Y
M%AQY"U.+?1*113"D,^CGU0,ZRJ8TVQ-C#&#Y&MAU\8B6I`G$$Q<I."E*[)V`
M6*4M3`1$F!-%NDL,>F$1(D.R#C*I!UPI06!P'`<!P(C=).5CHR/;A(]4G(2]
MFJL&L9.3VO2A92P1X]LD\&1ZFG0'H6H>_-9=4XVGW`[:,9RM:4*#\T?Z^)7X
M^%M\F'*VN''6))'L.C>YF0!I&2C(*U'A#,C-1IEKCHO!CX[;>!QRUO,-*6EG
MS9"8<"/VFT0E+@)&S6(SV43&-M9>6AE\LLHDLED&-BHN.$;?/EYR:DRF0P`1
M6W2SC7VAV&W'G$(4'6RKMID9#Z,+7Q6:R:"H:8L#]Q+@K`)[X9Y#F:W'PD++
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MII([N5A<G`<!P'`<!P'`<!P'`<!P'`<!P'`K^-_M4N7]W^M/ZQ[9X%@<!P'`
M<!P'`__7]_'`<#KY4TF/`?,$B9"<(9]+TXJ*<BF3RO4>;:7Z#DW)P\8GT$+R
MXKU26_%",X3YE^5*@A.GG5OZDU:\Z.\&X]KFD.N"$*'40*MRLQBUCOJ$?*%4
M\PK/E5EIUQO*L9\JE8\,Y"QN`X#@.`X#@.`X#@4+C"-YR6'%82[I.".SZ./'
M"VMQV&.(?8=<<2A]3;NI:Z8UG"$.MYS9Y%OU$^6'&;7.!-*G=7C";E`6[,;$
M66C'.E2OI+]I%%TN6?DS*9<@O>&D$LQ,E$1[XI3C^4(:F8N18;RMD=#S@?&H
M4Q]BQV:_6P6+)N<W('1<04PTA]RLZ]CBW&*S68\UQ'K->_9;S+2F$9SA<J>\
MWA;@XXOD#N+I6YJ>%`)K-G,JMD@S/J$09X%R%>-<4VI@B+ME9:D(X>QP9XZU
M(6C+K)0RLX>%?8?2E?`^U#K#E.J,'7B34RDF&*LB>F4LNC8G;/*$/2UIL&17
MB2U"*G[$<49EG#BT,Y?RA.?*G&.!+N`X#@.`X$1?8G"KS%DC2#+58B*S/CS$
M9A_&2#[',R5;<KY666E94VS"Q,3))7A[P2XJ1;RWA66U90'#G80:,G7-D@A3
MQ\W&560@CH&O+C\.VZ+P8S+1@I0D@5&B2$M7C4$YB5NDMX%3)GMH_P#RU\#L
MHFZU6;KL9:P9L-,#+D!`AFR.7(9:94^7;KP\"<%,-@'Q5DQ8W<1CL:4TR>Q)
M^(CK*"4J:P'5PP<_.RLG)W2!KXD=$6##VNXUT<:5GXK``4E#E6X^5204`!*6
M%B3(0*.%C#@D6YC#SZGBGQA@GG`<!P*GM4'2)";EZ//PY&0]WT^R0=D>8E#H
M8"<1"Q8T01#I(C38\MFX3-2L!66R@W&Y)<;"9SAS#8#660LX$$*,"#C8T,6/
MCH\4<$``$=H0($(1I`XH88HZ&V!A1F&TH;;0E*$(3C&,8QC@16Z)@PVZ[:9\
M@P86F60>99?&;9<'8?F(N7HJRYA3@SRA8..!M[Q)1*5L)%:9R\ZYAAMU*@FG
M`<!P'`<!P.&=(Q\6R@F2.#CAW3(Z.;(.)9$9<D)>0&B8D%#I"VVUF2DH:R,.
MUC/G?(>0VC"EJ3C(0>$8VH'6$.3LA1YRXK('-="""FH.O#,D8;=D:^S-9?ES
MRFXY]QUL.25&M+=';:]</U<N.9#F2\ML`"*C38VF5^<D,.878(8:[D!D,")-
M&2ZFKF250%`GY1<8IYQID]R$'62AME9+3;BB&@F`Q8IK:G@R1RV4$%B+=&>;
M?;04`4\"<,I;2EI20$<,XR\C.?,VZVI"L84G.,!T=HM]<ID>S)623;CV"S&X
MV-80R4?*34L\R02/"U^%C6#)BPSA0XCJV0@6""WDM+RAM7ESX!W$<<S*1X,D
M,@QH>1#&.';D8Z0B)!MDME!#2#HF6&"E(LQ#;F,.CDLLD,+\4.(2M.4X#F<!
MP'`<"OXW^U2Y?W?ZT_K'MG@6!P'`<!P'`<#_T/?QP'`Z^5-)CP'S!(F0G"&?
M2].*BG(ID\KU'FVE^@Y-R</&)]!"\N*]4EOQ0C.$^9?E2H(3IYU;^I-6O.CO
M!N/:YI#K@A"AU$"K<K,8M8[ZA'RA5/,*SY59:=<;RK&?*I6/#.0L;@.`X#@.
M`X#@.!69LFB\6&TZ]^C$$5"*AW(F\3_U8Z%>S89H&(DHZGP.(H@68?<35Y7!
MTF=AT9@=!8;`ZBW73<1X6(((*`*,"",.$"$.R(&&(RV,*(*,VED<88=E*&6!
MV&480A",82E.,8QC&,<"N[UJR!OTM69:4.F`<P!"FY(&*(&8!N5>6;'3*Z=:
MVB!"G#*V[9(*..=;84.^]@18;CJH\V1$+"S.`X$3GY&RLS%6B:[%CO,2<@05
M9)V10\Y'05<BFFW2F1V!WQW#;)/&$CB`M*<:98:62:O+WL\!E`%E;9F7DHT^
MI#LA);,(@Y\"R#'11;3*TMAASS!0$5.0LP;YO/EL4.4#:;3GQ*RORMJ#CUR2
ML+);D-=SZ?B?D?J$Q7XVMN2+3SE<CFH%F5P^-+.N$GN5^9G&Q7CF<-,D(?'=
M4.*M[T$A-.`X$?M%I@*7"&6*S2+<9$A>BA;V6B2R2BRWVQ(Z+BHT%DJ3FIR7
M/?;%!`#9?-.+=;8':<><0A0<&J0&8EVT3#S[SAMVL2;4:.Z*@+$;E-<KU8CH
MQ(Z2CLX>#A*T*DE>7EX>,]9Q&&FUH9;"7<".R%3K\M/0=EDXY,A+UI)N:^Z8
M060'#E2#.12I4")=(5$CSV07'142*6/?-!DD#H=2R0^VX$BX#@.`X$5N3DV)
M"*E*W!"V2=ASHV2#B'O9),,#;-98L0L"1)2,/&B68VJD'#QSA1@H?O'FTDNH
M'4[G@?DF6M2)F+'#J#;]?>;&S,RI5B"$EHYTQ+V$(CH-H4T26;C74(]\IR0#
MRAI?F%28M/IY#@R::WM:BVJ#BIX4Z'LD3:*7(24,2,8[&%D#'5Z:#=1XK2+-
M0A2W6B!7TI='):4VZA*TJ3@.90+&1;Z-3[28.R&=8:S"2\B"QE>6H^2/C1R)
M*.QAW.7D*CCG'&%)7_M$*;RE7@K&>!+N!`QB9ZQV>+EX.QP>=;`Q;[V5P;H<
MR?<;*\5+1)4<:<MA\.%K=4;%0]_N3BSI&2>2A;H8X#S$H'YC=74"#`FP*_60
M:VJRL^E89>L++K5IFW/]IE4A*7*"(C[8=-+<>6XH]PU1JWG%N9=RM2E9#YF@
M7>L0#*:H:F]G`G.$.QUYD!XT^2AE,.--PT;9X6%;:#.CU^1Q@B1"/<-]/+))
M#:GLFL!)@K'#FKDAFSPTRD&."_8H1)\>9,5M4B#B1%&FPXTL[V9#P><K;QYE
M(>1CS-*6CP5D(C$>QV,1"6J2K-JA!:C/2!].'L[+D`1*E$0C\*FW/5E3B)H!
ME$;,G"B"S#0A2%.NO.A(6D1Y(65P'`AJ:'7FI2URH:)*,?O`HC-H:AIF4AF)
M,T$7,<-84?2BPWXRU8BL-AN28:QS2!!A6GG'$A!X8#M*]6XRL"/AQ:I9QLHK
MWI#TU8;!9SWB/:"`X6Y*663EI)24BA-)PCU?)CR^.,>.59R$3L@P-)D)[:SL
MU-`PD?632;W`#H<E8>3CX(;)C%I%B5.>XCK-7X]AU#CP'^TDX_\`W<A@MT:,
M4&%D(6AQ"7&U)6A:4K0M"L*0M"L84E25)SG"DJQGQQG'Y,XX'ZX#@.!7\;_:
MI<O[O]:?UCVSP+`X#@.`X#@.!__1]_'`<#KY5R59`?<A`H^0DT^E[8.5DR8<
M![Q>;2]Z\B)$SA`_ICY6I/E%=\ZTX3GRX5E:0A.GE$*U)JU1;3+!2M<TA1+(
M[ZRAV2,UF,R\TP2Z.&X0RVYXX2XIII2TXQG*$YSY<!8W`<!P'`<!P'`^)!`X
M8[Y9;[(HHK+I!))#J&!QQV$*=>??>=4EMEEEM.5*4K.$I3C.<Y\.!6^H1B%4
MD.Q2`Q0DM?CI/84F/(X7]7"^[RW):%@9AQU2W'CJ?5W0(3'Y?(VS&MMMX2TA
M"$A9W`<!P(>JV/O&PB82K3EG@)P<$QBYP,E2'JPP#(82XP>M9UO`FC0_:N)>
MPX$$5AQI6,M^?.?#@?2I5HFNM3KLC,D3\O8[))V.4D76<A,842D:.B(R.C$$
M$#1L?`UJ,!`0EO/F)4,HI_*RGWW5A+.!";I&A(:!NRHN:EYC7C-AL4/%USTO
MK,\IVL2\<75VFG5,XD69C!3:V@UNM,N2(P;J\^+",X#@N;,@RXBL350!G-C!
M7,,>3K)-%!9E(B3B7T,$9E7+:>7%4F*#0"]ZZ/?28SI249;&0^_E+2@YPM2/
M789R?F[7/2;<@"3"PT`"637J]6X8O(JRE#A1139,K9C'0FU*EC'WB1,)4B.P
M"V^4@@.5"4\&&2RTX?,3X\=(9DJ\FU&HL9M9(<CRXPC,3/RC#]F?<)%D2D*>
M.-,)2T4XPAU(^<,I"6<!P'`<!P'`<!P'`ALU72!D6.=HH=5B+[.,PB2YN6AE
MOLSK5>(6H&-L+\60!)OL_3B2A!R,N/*C_<^JEEY*/0<#H=92L9EBP59$<1`V
M2OS#TW;*\7*`RZP9?9"WMA'$1T@&I"CZ^N:L!P@I+C`RG'`7DX;QAOQ4%>[P
M+B[==-1Z!.9EBQ]GJV%;;>+%2*8E3>LM:5H<*8D'9%DEB7'4QLO8-/8:4#Y"
M&W2L.X=:]/Q4%M8UGKQ%?A:J-2:O'5VLA^PJT3$0@$,)4QL-H:;34TQ3`:JL
MX,EM&67(_(SC"D)4VI*DIS@(Z;KV?A'ER^N;I/`22E-.&UZ^3UEV!3["VQZ:
M$BO8L<O(V.HE>VPXADN&,'8;?=P08%)8:0QD+$AI-$F)XN/1*I0%30,^%#2N
M)D2'G4B#$GQ/OE"1Y#BA?<IRG+PPKRVEH6IEOSX3@/B16:X9/1UJ+@8<FS0X
M9D?$V!^-$=F8T&0\OO1`9)QE1@HY7E\%H0M.%8SG&?R*SXAWG`@MJV##58E,
M2D*>LUF?!Q(!U.I1!$U-OBN/K%%(,6G+$-7`3BV7&F#)<N/!<<:<3A_Q:<\H
M=Y6+/!W*#`LE;/3(Q$BE_P!!_P!`H,AD@,I\"1C9*./8%DH>:AY(5X0X$ME@
MP`QAT<AIIYIQM(=]P'`<""U`EP$V>I&*VS7HJF)@!:?F-$=8@I"DEPS#41D#
MTVLQP!4-)QQ\8Z`AU3S+(3!2FV631DY"=<"-HN50<GU51NU5M=I1_P">M(G(
MQ4^GP&<,SYH=)69%/^Z,K=_*W_\`\T95_P"7&<\#XB7JD'KE&P;C535P@I1T
MT@2PQ!"X@(+.4FF2B63%Y`%$SCP=<=\B&\_^;..!3]+W'JRW=D=MZNJ]]K,_
ML"E:9T'<;35HF38.DH:L7^P[M<ITP5AC*V,BSK$,\\UY%K6EA3+J\);)'4Z$
MNV9OW2&F,I3MK;6N]<.*@Y"SX8N=NA*^5]L0YL>!-V;(LD:P0FMP1$HQ[\_*
M<"`MK]1]QMM*EI".57M9UIO&=7_:&]M661.[')MG3[D/=(,UG9K]:&)+L`]&
M?9,4S9B(9D$GW+8BG5M+$(0K&%COI;"_^`X#@.!__]+W\<!P.OE7)5D!]R$"
MCY"33Z7M@Y63)AP'O%YM+WKR(D3.$#^F/E:D^45WSK3A.?+A65I"$Z>40K4F
MK5%M,L%*US2%$LCOK*'9(S68S+S3!+HX;A#+;GCA+BFFE+3C&<H3G/EP%C<#
MH;+9X&GPQ4_9))F+BQ%#M*><0\^^28:0T%'1<:`*V_(2\U+R#[8P0(K3QAI;
MK;##;CKB$*"(@VV]3J6"(;69$0`KT7''MB6:/K!Q(I+:G&2(N(JX6P#L.(3C
M'K#RF(@EG*TIRWE6'$H"90UBA;!F71#R#)CT!-&UV<&3AQDR(F@$,//1\B$0
MADL-YT(L<MC+B$I*!*'*9RX,0RZL(F5>)$T=N6H=>9O\&#+3T'8<QTXU"SK4
MI!R34,0/51+`!'U>SI"E&RVCG'IJ-:&R&M#2B7_,RD.\J=OCK>-)N!BRT8?`
MRRX"PPLY'.QTI"3C4?'2CL<1^5Z//3B/EAWFRP2"X\EIY+@[[K><*R$JX$!O
M\_(Q#%4C(-]EB?MUZK-=C?72UEMP!@ERT77"5/M/,H*9US6YEX?S)SYB&VT8
M\%*QG`3[@1<BZU0<V>B4ST>=.UF+<F9RLPSN9ZV@QS8K)B7LU.%2?9'W"1R6
MLL--"K>)4\VEI*U.(PH.R@IZ%L\0#/5Z4!FH639]<"3C26BPRFL+4VO+3S2E
M(RIIUM2%I_(I#B5)5C"L9Q@(+)%`;*,MNO78:8>IX8:(JUV9)3T/'RLJ\0$^
M;1X-:6\&3P?T?+K,Z8PMD0;)&`&GGS$R#<:%E#CCACL"",,BBBLM#C##M(8'
M''80EIEAAEI*6V666TX2E*<82E.,8QCPX'VX#@.`X#@.`X#@.`X#@.`X#@.`
MX&/YL#'4CL/%WIN2<`8WA4Q=72L.E(N`IB]ZW'MM_I,JAI+/NTS#E"=M+)97
MGPEX6,!9=\WH#8;"14HM%FV/M:Q.1"1<522@]50DH\.0MR8!B:_%W>?EHLYT
MC(R8UVQWA<00RPPA7O:\O+SSWE::%"WN`X%/R'_]&V@%,)_V58VQ[:`G/#\T
M:.V/"QZ_M6;>\/389^\*P$Y#%$O*4MPJ+A1&4^9[/B%P<"O=EV:4KU?9$K*1
M7;M;9)FHT5@Y"G`ON22%-+^IR#:<IR]$U:$CC9DYM*DN/!1SS;7B\IM*@E5>
MA6*Y`PU?%*D#AX6+`BVCI<M<A+'I!&;&]]+2#F,.R$H;EOU2'U_GO/+4M7Y5
M9X$73240]R.N];,(C?KH[F;Q5QQV'HJYGB1[8D)8&FGRP68:\1[(;`2I)*_)
M(1:4BG-O>UC'XX.VI]S@;Q%NRD$0\KV9Q$1,1AXST?-UZ<#2TLV"L$24ELR)
MEA6R&W,M.IQZC#K;S>5L.M.+"5<!P.CL%>`LP*8Z1(G!ATD-DX<K]GLM3.RX
MVAQ"4JE*K+0TDL?*7<^9G+V6EYQC*DYRE.<!T9^N:G+_`$%$R)*38U<'2.!&
MSEGM$U#E>GZ:F"[#"RDR7$VV4#>90Z.9*LFECOIPZTXAS'GX$XX#@:AM$_%-
MH31?R:=@N_U(V3V!SNG<M1%*V-7Y6\58C5MCB;_*V<'%4)J(5!CS$5VE-Z\A
M%06$GX,$7'(]4@A+CZ70RV[9=+Z/W`C`8:^;`V14H<:KV&G'1%*#U%)1-AKM
MKLU"M%BBK+%;6U/L^-F8N;>UR`$<$ZU[$^*=+"*8>'+?0L*5U!\7.F-)W+0]
MIJ6SMS%P_7-4T5K?7<Z/H@RD!3%BJ[=0G+"M06C(ZYQD[)PS>4N/Q4Q&^5PN
M14C"?K,WB1#9;P'`<!P/_]/W\<!P.OE6Y5X!]N$-CX^35Z7MC)6,)F`&?!YM
M3WKQPDM!D$>H/A:4^4IKR+5A6?-A.4*"$Z>20G4FK4ENLOE)US2$DO#L+%'>
M(Q68S#SK`SI!C@[+CGCE+:G75(3G&,K5G'FR$=VMO.FZL;;CBR&YNZ'ML_1:
M5'%-?5C%F*(;`?/PE)#T9'EO".H8\&7SI)YI0D6)(R*V`7@Y`D';9&>I]HL5
M3H<U+1$>C#5@Q9;=$N5U<YZS<ZY6Z3+5:8$'E!H@CVF#G#`SCVLN-.8#9=4P
MD)L,3=W9,]DN$JH,,VHW$7(C6B7E),U"<>6/4?"NU"'%C%/J5YGL-GEX:PGR
MIRYYO.@*E,HLCLAS$Y+)LFF+IG_^B7W[3FQ"V+_3QTIEG8:)LZ!`##X=?OG_
M`*//(#B[)"(*D$B8C2"">!>T9&1L)&Q\-#1X,1#Q`(D9$Q,8(.!&QD:`.V(#
M'QX(C;0H0(0K2&VFFT);;;3A*<8QC&.!"9&(8@;XU?\`,J'%QLS7XZCV80K"
M_-,2ZK0"SK0@5Y7J-BD1\A9I8)3:$MJ-5+,^HI6!64I"Q.!5<%%3MCO4C=[&
M*1$15:^NU"@5PGR*?>94>./8]@RZ4*<';,L)$2D>$:;RM8L'A3ZW<.2I`08<
MBOIC]@JB=A!V&Z9KSWG?K4%B19@ZZ6T!('B!VUE%?:#E;)#VP!""Q&Y,XV/?
M`=8>2*TXK/`GT?&1L2PL6*CP8P9PHPYP>/$'"8<-D"733S%M#-MMJ*.,?6\\
MYG'G==6I2LY5G.>!$[#1!YML86.L%BI8"YI^:L0='<AJ^Y<7"6O(0+.S2(4B
MR@I?=2AU940=%R2U-I2HG+>5(4$ZX#@.`X#@.`X#@.`X#@.`X#@.`X#@.!5N
MYHV+*UY/3I]15=Y#7S*=H5*`'^IIDBKOKGS6VIHB7(3"IC!Q,Q%MCY:'2YDQ
MAYP5QIYA]UAP.OZ_5"=HNF-=5VV24E+W%%=8F+O)RZEJ.-O5I>?M-V?<2Z7(
M/,LJM4R9Z+3A)3C+/D0M]]2<NK"XN`X$;M]7C[I6Y:LR3Q@@\H.E+,E&.,L2
M\))"O-&P]A@BB!RV0;!7989@Z/)RTO(Q@[3N$YRC'`X\%;8J5%L67"'`WZ7,
M'U^T?5D#`*CS8T(.5P<2ILAX)F/EJ])"2HZ\.?D"-:RYAIS#C38='"Q3-EMH
M>T<2P<K!.TL.-UVP&R^A(L39U@S]EL)!+F6?=$6KV$2RRRME7L1XSSMN84<2
MTD+(X#@0N:U[4)Z5S/F1;@=B6&)&OV:O2DQ4[.5$@DOF!PIUDJQ\/.'08YA+
MCR0GB%B8=6I?I^;.<\#HT/1.K'8X,^8N$A!W*V1L)&&V.6)LH%1EY*,8C8F+
M,LDV8_/#Q=JF@&APLFOF*<G9)`J'4^Z%82%H<!P'`<!P*_C?[5+E_=_K3^L>
MV>!8'`<!P'`<!P/_U/<SV$B+M8-!;P@=:,SA&QIO4&RXB@,5F[M:SLC]VDJ7
M-!U5FO;(?C9EC7TXY.O,)$FUAE(B2,H*RR[AKR*#R]ZCZB?,RWJ-JO(.WU1I
M&2ZS5BL5XZ7[2NG*A=ZL5;Y-%4'8!$19M]V"?H]=UM<^PVDS)FN,,+#(%HV&
MFHY_$(!&OAN(ZC=?^\,#U=V_K79F][QJ+<-ANFG"=7;1G2Z;V(ME+B*IUGZH
M57=4AD&ZRMXK$P/MKL90MES;2)`E\E`ULP<IL4Q>!APN[56M^RL)T6CJ`[V-
MEKYOJ6URL:J;YC]4ZNJUCJHEF::762XC7)+K>K9NS:TK!R&@OJ?HQ\R:"VX:
MAMMYU*0Z>I:LOVKNM]1U-#7C:U0W;&)UZ?:^U5GU!7]Y6O:5\CY>CD[MO,S2
MJY:]E,5^2W=$0\A'N-NO#!5T>23B,QZ,:,TD+SNUY;F+!J^5A-Z,Z4@*O;C)
MW8=3V%KMJOE;@I[E6LL6S4`3MI#U:8JK,=8R!)=R4B6B'_".]LYA+)"U<"7Q
ML3>)_;L7M&!W='RNA2=4'UAO3D53ZM)Q\MLA^X`2H>WQ=N"FNV'+<?6`R87Z
M$TVJ.=R1DI2\/-)3P/X#K*>DKCLR3VA;8/:>O[!9*I.ZDUO/:UJ@P^EV8>B!
M5BR!C6/'O9&[&6NPJD97!IS;)$>U)+!9\1T8RH(-'Z&NGX:SE?L.W4R>V1RM
MB8U=N>O:^A]?'ZR@IN8FS]65/[2ITO&Q=RJNJ8\R.$>C9%_,=9OI:'9`?S.J
MPD(O:-0]B[SH>:T-/;W3&WU59U`.CM5#ZKI&).Q'P\C7']L.*U.5-E5ZM6ZT
M+K$DL$X)#`E?:L8;@.'3HA3SX=_<](;BOLIJA^;[(20%7J]J^J[BUO6M:5B)
MI.\JJU5YF+&IAY)<C+;`IP+MH,"EC\CSY8<FT$N.($6"4\UD)+<8G<H&ZJG;
M(#8*I34T[5AM;R6C']<1),.'<'[8/<)O=\YM<9]5KB&8[5]?DZ\!"*'5$ES4
MB$IY:5KQG`2^BTNZU2V;),E]A"V#7,Z=3L:AUD#0Z]5`M*URO4B%KLY60Y^'
M=R?=1;)9X\F8;=-:95&H+P$PG+#*,Y"-4Z@;NA=/6REV[L%][;:E_P`2/M?=
M7X45&M_:'W,=-D:\_P#;B,-=K5@_#$(X,?\`WAU/UKV/G)\BGEXP',M%&W'*
MZ7A*16MZ_:FX`0]:,S.\?PQJT[]=+J\]5I#8QOX:'EMU>+_%*#B9./\`3:=R
MF$^K>N+YW!6L9#M[U4]FS]SU/-TG;?V!4*A9)F3VE2/L*OVK\8*\;738V(K'
MW++$LR>O_HD^^S)>]CD.OD^A[=>,-K5G@<W[9V%^+OWE^)W_`+4_AQ]L_@U]
MEPG]H7W/]5_$[\1/<?<G_P#F_P#TKZ+Z7L?_`-SY_5_)P/Y4ZSL*(O.U9ZT[
M.^\*5;9BK&ZPH/V7"5_\(XF)IT1"V:%^ZHXAV6OWW;;@RYOW,@AMT#WGLVL9
M990K(1"G4#=T+IZV4NW=@OO;;4O^)'VONK\**C6_M#[F.FR->?\`MQ&&NUJP
M?AB$<&/_`+PZGZU['SD^13R\8#F6BC;CE=+PE(K6]?M3<`(>M&9G>/X8U:=^
MNEU>>JTAL8W\-#RVZO%_BE!Q,G'^FT[E,)]6]<7SN"M8R';WJI[-G[GJ>;I.
MV_L"H5"R3,GM*D?85?M7XP5XVNFQL16/N66)9D]?_1)]]F2]['(=?)]#VZ\8
M;6K/`YOVSL+\7?O+\3O_`&I_#C[9_!K[+A/[0ON?ZK^)WXB>X^Y/_P#-_P#I
M7T7TO8__`+GS^K^3@<*BU/9L!<]L3=VVW]_U"WV2&D]6TC["K]5_!^O!5T*-
MEZQ]RQ)+TGL#ZW/L/27O9%#3XWK^W1C+:$YX'45>C;CBM+S=(LN]?NO<!P>R
MV8;>/X8U:"^A%VB>M,AKDW\-`"W*O*?A;!RT9'^FZ[A,W])]<KR.%.XP'#N-
M`W=-:>J=+J/8+[)VU$?AO]T;J_"BHV3[O^V3H0C8?_MQ)FM5JO\`XG!`F#_[
MNZKZ+[[SC>=3*,9"7VRL["E[SJJ>JVSOL^E5*8M)NSZ#]EPE@_%R)EJ=+PM9
MA?NJ1(:EJ#]I6XP2;]S'H<=/]G[-W&&7EJP']^V=A?B[]Y?B=_[4_AQ]L_@U
M]EPG]H7W/]5_$[\1/<?<G_\`F_\`TKZ+Z7L?_P!SY_5_)P.%1:GLV`N>V)N[
M;;^_ZA;[)#2>K:1]A5^J_@_7@JZ%&R]8^Y8DEZ3V!];GV'I+WLBAI\;U_;HQ
MEM"<\"GP!.P(%*E]&A[AB[ONY57V!-R?9":U]7ZW':W9O]PN6-+D,:?A5.P-
M[F*9"IR$@+)X+$DU6LE21`[LBTV\$5VA#]G*CK&KQS_9.)A"AWM;L[`[!`:3
MJ3Y%9<K4U$*N4W-:WF;"961=>[6A1'@Y>19)P_2#"UR:$KB<NY@PR6ME9V%+
MWG54]5MG?9]*J4Q:3=GT'[+A+!^+D3+4Z7A:S"_=4B0U+4'[2MQ@DW[F/0XZ
M?[/V;N,,O+5@.(BI[-3NTF]+VWZFFG=6`U,;1'V%7T^UV:Q;9&8-VW^)^"?N
MI_W]5)'AOH*F?I[7MO=I7ZSBDX#ETBL["@K'L^3N>SOOROVJX"3.MJS]EPE7
M_"FILU>!BBJ7]9BB'C;S[RRQYTM]1/2V2W]0]KA/I,-YR$/B*!NX/0]IH$KV
M"^L[NEH?:H59[!?A148[[2EK;,6PS6,U^%`QJJC/?A'$R\6%[8AY+4_]']8O
M*%EO82'-L-&W'(ZMHM4@=Z_;FS(`S5KUUVS^&-6F/O\`$JDK`E[+"^Q#"T0%
M5_%F,CSA/4$<6J!^H>J+YUL-XR$CME9V%+WG54]5MG?9]*J4Q:3=GT'[+A+!
M^+D3+4Z7A:S"_=4B0U+4'[2MQ@DW[F/0XZ?[/V;N,,O+5@.(BI[-3NTF]+VW
MZFFG=6`U,;1'V%7T^UV:Q;9&8-VW^)^"?NI_W]5)'AOH*F?I[7MO=I7ZSBDX
M#ETBL["@K'L^3N>SOOROVJX"3.MJS]EPE7_"FILU>!BBJ7]9BB'C;S[RRQYT
MM]1/2V2W]0]KA/I,-YR&.<WUBVS9M83U=G^RQAFV;)5]CUJ<VT-J&D@QM@;.
MLMWL>@\676#9;E<F(?0V;4.*_&X(9%NX@CP\WAX4Y\?`738:-N.1U;1:I`[U
M^W-F0!FK7KKMG\,:M,??XE4E8$O987V(86B`JOXLQD><)Z@CBU0/U#U1?.MA
MO&0[BWU/9LSLG4-GJ>V_LS7E-,N[VU]8?85?L7XS"3M4?B*8%]ZR1+4YKO[#
MM"T2_J1K;JI3T_:O^5I65<#EL5G82-O2=R>V=Z^J"M;P=9CM,_9<(U]+V$!9
M[#*S6SOQ$01FR'?7JW(@17T5QK`(OTWW+:\ND.8P"D5G84%8]GR=SV=]^5^U
M7`29UM6?LN$J_P"%-39J\#%%4OZS%$/&WGWEECSI;ZB>ELEOZA[7"?28;SD*
MP#T_N0_J_<-+["[`#W_<=JI>UZNWV!+T[388:/D;N5;/L2=?TW'GKILJWK.(
MFHX3(3A"69OZ5ZI*D+*=\H=!9]1=FH^B4>LZK[.)$G(6S:K)N-EV3K>`N$O8
M:C6[/67=D5ZO2:'1_H2KM3PY-A!$L-8Y-HDIO*#V%I]RD+5G8:]W*]Z9O6O-
MU@P.JJP5>2=FT"-IM7N(.\`9JKDP=/$'OY!OU2@IH-L\)7+L6EY4FIK(C_E:
MSG/`[EBL["1MZ3N3VSO7U05K>#K,=IG[+A&OI>P@+/896:V=^(B",V0[Z]6Y
M$"*^BN-8!%^F^Y;7ETAS&`4BL["@K'L^3N>SOOROVJX"3.MJS]EPE7_"FILU
M>!BBJ7]9BB'C;S[RRQYTM]1/2V2W]0]KA/I,-YR$$J^N=\Q77B;UO9.Q_P!U
M[].K>S(R&[)_A!38+Z#8;1(VDG7-G_!T`YRERGX6Q\M&#>R=?PQ-_2?4*RA1
M3N,!*Z8%+1MTEHZ?FON2=`U/J$*:L7TX:'^ORPLMM)B1FOI`2W`XOZH8VM_V
MS2LM,>IY$YRE..!;'`<!P'`<!P/_U??QP'`Z^5")D`'PQ):0@R'O2].5BFXI
MX\7TWFW5^@W-QDQ&*]=",MJ]49SP0O.4^5?E4D(3IYI;&I-6LND/&.,ZYI#3
MA9"1TD%+;K,8A9#Z1&!14O/JQYE8::;;PK.?*E./#&`L;@.!2=FBY+6LQ*[&
MJ(!DG7)4A$CM&CQ(63#RLH:8$)V-4`!L>[+M$5'#HS)QK"7GIL$;'M&ER3;3
M)P7!'2,?+QX,M$G!RD7*!C2,;)1Q+)L?(QYK*"0S@3!ENCEAECNI<:=;4I#B
M%84G.<9QG@<S@0^\5)NY02H]LYR&F0#!)NK6,=I3Q=:LT6O+T5,,-(?$64.E
M>5,&B9=;9DHU\@)_S#DO(4'.23;,SF1UPE=36O,O&)9-HDESGDP*I;:LU[-0
M0!A2C?!O./JG@EK.7,9RK'IY#AU&J+K(YSIT]-6B>F2L'3<]-E94LA]*/2'#
MB8ECTX>M0,</C#8P(++36,^=]_+YKY13X2[@.`X#@.`X$5-O5(CK*!3)"XU4
M"X2K*"(NJ&V&(%LLD.Y[GTWP()\Q$H8ROV;W@IMI2<^DOPS^:KP"5<!P'`<!
MP'`<!P.AM%DBJ?7IBSS;KS47"`O'%8%&?..(]/'@R#&1XJ'3)26D2%(8$$80
ML@HEQ#325.+2G(1G6==E(2`(D[*TVU=;K*/7.[MLO-D,B3TD$`"/`COCY]H4
M'3JY%@0@Y+:&_>,1J"'$Y>==4H+"6A#B%-N)2M"TJ0M"TX4A:%8RE25)5C.%
M)5C/AG&?R9QP*AU>VW4Y"UZG_P!FV'32`YVDC-I4EL;6EQ>DWZ]$LH0AL$(.
MHST5+08(3&,)#AHT#S)QZB<J"X.`X#@.`X#@.`X#@.`X#@.`X%%S#RM-3TO:
M_;^&H[08],W=8V7,HUE:B/)B0OS@/YS3&O[+A/K6)X?#:8B2PN8(:6.;,R`0
M7DA:'$)<;4E:%I2M"T*PI"T*QA25)4G.<*2K&?'&<?DSC@?K@0.S7CZ--QE4
MA8*0M=LEX\^6;BH\N)`$A8<-38B;!:9.4.%Q%P;\N2R(C`K)\D^I3JQ@B&Q2
MU,!K\T=9?D(DOD>[*0^Z->:CJ_3\'2>HF-2V:HS*['8)JQQ,Q>)8A;JRIJ(G
MPR)\C8IL>44;#M#95158'#&2:V86&17>-_M@QUGOF>D0<2;V57)4)-"3.NTY
MN):!1L&KOWC)WWX\Q6O1*H3,F/YW<K>8R_AX=MY]MME88/ZB'^5X"W]68*_'
M7V;@F;5M)SL];[ZCI8U6GZ;%WBIT_76!'=1AP]T-GK72-6SEM&#A*[&LQSNT
M`PY"0=<@W@Q0W*\!P'`<#__6]_'`<#KY6,&F`'XXMR09'(]+U'(J6E8,]/HO
M-OH]"5A#8^3%\5M8PKTGD>=&<H5XH4I.0A.GF$"ZDU:,TIY38^N:0PVH@@@P
MA2&:S&-H4^66Z^44]E*?SG'5K<6KQ4I6<YSG@6-P'`<"AXJ8B=-3<]5;+*!P
M6NC`YV^4:=EW_80U>&&43,7^B$RACRP1!ZXIQ<S$M./,?^C$DBB#)#@G'.!U
M[^R-@QGDV=/P(\'I=7F%+@9"&E1MEUZO+\'!]O6C#A6&X>'PYC_?:T['IDHF
M'<Q)&EL%LEPHX9#(6AQ"7&U)6A:4K0M"L*0M"L84E25)SG"DJQGQQG'Y,XX'
MZX#@.`X#@.`X%1W25F+)9P-85*9,@B,QZ++L.S16`<RM9J).9`&!BX5\]HY@
M.T7>=!<0.\H,A#$3&R2\."F9CW%A)H[6]#C*\?51ZI"D0,P5F0G@)4-$Y]S2
MJL!X>FK65-?4#;5/%9CV%/GR+A)CZV4*<<4I.,\"!LLN:?LT4$V4<[JBX%1U
M?":DY4Z1QKB\FFHCZ]'AF3)9A+=)O;I;,6$$AUMF'EVA!A&5LR><`A>7`<!P
M'`<#H[+8X>HP,K99\KV<1#!NFFO):=(>RA'@EL<,09#I1\@8\I+(PS*%ODON
M(::0IQ:4Y"L=?7&^+L#]6VI'1,-.6.)?O5+"B&UK;`KS10@,Y19F19D):/EK
M=K\B1C\FR#+@HDFF51D)A2!"7,!S+'A%SV17:;A2G8.BL@['MS.$XR.5.K+(
M%UC"EY<7Z13+$G''SJFT)R\(=#QKJE(0ZC#P6]P'`J79J':^;4=GBI3G%).*
MB[5G*6_%6M+B[&"6]_+[^%-`"UF3BXFQ%/I3ZR@X)YA&<8(7XA8$#9*[:@,2
MM7GX6R1>7G!\24#*`S`&2&?+ZS&#(]\@?+S7GQYD^;S)\<>./R\#NN`X#@.`
MX#@.`X#@.`X#@.`X$!70_9!QD34+3/:^K\."/'1M<J,9140@0HS[KK3`0M@I
ME@=`%;86D=L<=QH4<9M"&6F_+X\"-@O7_7\D'&S;\MLRCR1PX`-H9C1'+_4"
MI`A#0C5PBX(,`*UU7W;WH)EHX-@Z,:RPJ0&*82=,,!)J33WZ^Y/3TX4/+7.W
MR"#[%+L-O(89#"2Z/7*K#X)<=>&K=5C7,ML-)])M\QXL]3391Y65!\XW^U2Y
M?W?ZT_K'MG@6!P'`<!P'`<#_U_?QP'`Z^5C!I@!^.+<D&1R/2]1R*EI6#/3Z
M+S;Z/0E80V/DQ?%;6,*])Y'G1G*%>*%*3D(3IYA`NI-6C-*>4V/KFD,-J(((
M,(4AFLQC:%/EENOE%/92G\YQU:W%J\5*5G.<YX%C<!P'`Z6:K==LF(I-B@(6
M>Q!S4?9(3$U%@RF(>Q1*UN14_%8.8?Q'S48MQ2ARF?(^SE6<H5CQSP.ZX%0Z
MR$'J$I;]5BN*3%5!4#.TJ-RM#J(/75M%-&A()E:4MY8!A+35YT,`7R^4.)'$
M90K*4XPD+>X#@.`X#@.!&[A9P:96)RTR+1!(\+'OEI`"2AV2ES,8PW'0<.,M
M:/?3D[(.-!@C)SZA);[;2,96M.,ATNN:F?5H)]R?*%D+I:))VUWR3`43F--M
M<@&"&2S#(,PDIFNP,;'"Q<6AW'KHC`!\/J<?]1U83[@=7-PL39(:5K\Z`/*0
MLW'EQ4M&EH\XQT>>PL8L5].,XSEM]AQ2<^&<9QX_DSC/`J5F3O&JV4"VA,EL
M;7P3+30]XCQW3MBUT5H=6,YOE:"8SFY`CY&_/FH5'U!2B6D/Q&6V"I186]$R
MT5/1D?-P<G'S4-+!CR,5+Q)HTC&2<>6TE\0Z//#<>%-#*97A;;K:U(6G.,XS
MG&>!%[M>0Z>P`,R`98K5/N$BU.G1*A\3%B,$92\4I#A3K(<7#QK:T+-D"EM"
M"(6C"UY==9:=")LZN)MC#!6XY?[V>>;]4FAC8R)J6.>=6M:@L5K##!-[''0D
M?_;69R31[P;!@8T<IST$!QP(Z[ZM>1%0,/,;,UV[_LH6)'F8A%\H2FF,*:C?
MJ5VGX:/N-+>]-267")!N7BG?39PF0&>\\:'.;K-RN<Y6Y78@-9AH*J%*G0*;
M`3LK:V)BVM88^@3\_*'U^H#Y9J'B0\''Y",9^J+&D$O-D`"YP$@V/4S[5`-*
M@"A8^Y5F2'M=$E#E$ICPK7%L%,B,R_LL9-779\`TF*ED,>#[L2>2AI2'5(6D
M/GK6MRD!`$&V7`OWI<)8JX7903ZBPV9^48$&9A0C%,B^_C:A7X\&$#)RPPLH
M.-:><;2ZXYP+"X#@.!5>P=>M3*<W"HQ\'&[7@?0D*M9R!DBO'/Q[;Z/M2RR8
MC*CC:?8P27P"V7,/I&03[L=M)@XSK83"H6B/NE;B;-&LF"#R@ZE/1LFVRQ+P
MDD*\Z%,5Z=%'(+9!L%=EAGP9`;#J\C&#NM95G*,\"2<!P'`<!P'`<!P'`<!P
M'`<!P'`<"OXW^U2Y?W?ZT_K'MG@6!P'`<!P'`<#_T/?QP'`Z^5B8J<`?BIN,
MCYB,*]+W,=*A#2`!'H/-D,^N&6V\.]Z)#*'$^9.?*M.%8_+C&>!"=/#CAZDU
M:((PR**+KFD#C##M(8'''8K,8TRPPRTE+;+++:<)2E.,)2G&,8QX<"QN`X#@
M.`X%6VK*X78VM[(E*?9S2;)K>7_.R,VRN:!9MM<F#R<(6T2D&3I3L4(P[Y,Y
M(L&<M.87G+3X6EP,=Y#;5H=)+OE;B(N3T757'0[+,I&.-MEJ&3G.)N_:\P%(
MX!)H^O%->!+;@I)]D:]\]&)3@`!%@"\C9^"C(0FS24U$Q];#C7)DRP&R(8D(
M+#M#Y+=E295]YL!B-;$QZJGU.8:PW^=E7A^7@4[D"P;I\SDM]R4G4N?/D*'$
M,L=)V%L)2?79:-GS0'X6S42E^;*2&(UEP:7D\I:]\L83W,::'.]Y?-89<Q*H
MFMH:];4I0\O'`KE-I5$3"'7U-34)&#I=V9"A(1EIDF,8S9,(P.TZ%+/J)D,!
M:4!8(.TQ(D]6Y:/G(8[U\"2464R8&\L0EX(QG#S*EI20$<,XP^WGP<9?;6VO
M"5I4G`5[;,9M>P*=2$X4Y$5Q+.T+@G+"'AGG(LY86M(,O#N6E-*/MPY$Z,^P
MIQ3+]4PVZC""$YR%M<!P'`<"IR=69$F925I%SLFNF+(8])VB*K8E8.C)*:??
M;*(L4='VN`L4;`6"3>;RF0>&8PU(I?>=?:4:IHQD))6:!6:H89*Q[$@=/2(Z
M`S[+8YJ8M%C)!;(>,;C$S5@.D3@8-DXEU]J.&6Q'#O/.*98;RM7B$TX#@.`X
M#@.`X#@.!2,ZU(ZJL$U>(L)Z3UY9BFI78D''".$R]7FVA!X\C8\"*.APJ4C2
MHT$9$Y&-)RYC`V)`1"B5&MFA<@)P4F$')1I@LA'2`HYP!X)#181P1;2"!3`R
MAUN,$BDL.)6VXA2D+0K&<9SC/`Y7`<!P'`<!P'`<!P'`<!P'`<!P*_C?[5+E
M_=_K3^L>V>!8'`<!P'`<!P/_T??QP'`C]I^U?H)WWM]O_;'^Z_4_NGZ=]!__
M`#!_9>^^K?\`I_\`_(>EZ7J?_K>3R_G>'`B>EOI_X.:F^D^S^E_AG0_IOT[T
M?I_T_P"UHKV?L?;?[O[/V_E]+T_S/)X>7\GAP+,X#@.`X#@5_M.%D)V@V,>%
M&<,L4<.):*H&V\EC!5QIDB';Z>,^IQUAI8;]G@Q$OMK6AMUG*D*4E*LYP%?M
M2LIO@4;[?5.5C3)XXQ!MA,C)*N6K:,<4VI;T17(^78C[!4*64WG#1,J0,/(2
M;"U_3<,,*8DW@O@004`48$$8<($(=D0,,1EL84049M+(XPP[*4,L#L,HPA"$
M8PE*<8QC&,8X%-PNDXJ,EA_>SLI+T:NS'UW7^LR&QF:E39+)C,N.]Z+6,OSX
M]9FVU$5P0K.0*XGT4@L-J#!<&"[.`X%<S&KZY(2YEEB'YJE6L]3#AUDI<FY#
M$RA`R&&!RK'"N-F5&YE#`CX&87-1LBH9A2DL^G^3.`Y5(I3U478Y"5L!ELL5
MGF$GR5@D`8\`E4=&@BPM<B&AHYID08>.B`4.OI92T*_+%'&,L"I+R.T$\X#@
M.`X#@.`X#@.`X#@.`X#@.`X%2ZZ''K-CV)KT9I(D=%2T=>*S'#CH0#&U?8C9
M[Y`S+[;+>,O/;'K]E(]NK*\BC/,(1E+.66FPMK@.`X#@.`X#@.`X#@.`X#@.
M`X%?QO\`:I<O[O\`6G]8]L\"P.`X#@.`X#@?_]+W\<!P.OE9,:'`?D2VY!X<
M?TO4;BHF5G#U>L\VPCT(J$"D),KP6[C*O297Y$8RM7@A*E8"$Z>?05J35I+2
M7DMD:YI#[:2!R`R$H>K,8XA+XA;3!0KV$J_.;=0AQ"O%*DXSC..!8W`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"J[ECZ%>];W'RN>S*(F
M=:SKOG]$($*Z(`E*_+'YPXG!!";G5(^&"0I"_*[/K\N4^97F"U.`X#@.`X#@
M.`X#@0FZ7J+IC(#+@IT[8YUYP2K4Z#P(]9+,8SZ/N41HYI8(C`,<@A#AIQ3S
M`(#*L.$/-ISC.0X-0V$-8)`BK3L814-@Q8:C9:GR+N"/7"9>8%=L%1FDLCA7
M.GNOE,^0\5*'1_<LL2`X!V7`F@L3@.`X#@5_&_VJ7+^[_6G]8]L\"P.`X#@.
M`X#@?__3]_'`<#KY63&AP'Y$MN0>'']+U&XJ)E9P]7K/-L(]"*A`I"3*\%NX
MRKTF5^1&,K5X(2I6`A.GGT%:DU:2TEY+9&N:0^VD@<@,A*'JS&.(2^(6TP4*
M]A*OSFW4(<0KQ2I.,XSC@6-P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`A]^K3]NJ$W!!$M@R[P[)U<DGLO8:B+9"%CS=2FW4,?G/MPMFC
MA"U-*2MI[#/D<0XVI2%!"W=>W2TMJ.NNRK!#22?`F$B-6D_:T#5)!"L/@'N%
M'L2<GL.4BUN+9=3-85691I*%O5]M6,IR'!58-UAXQ3/M&)D[00I"(S:R<CM:
MP1$>=*"Y^RU?%A'N@=FBV_'.*^(IP:4?<'PS+#,.'/1(?8?4\]7V_JU0V?<,
M7)_T79Z2O)I-TJMS+2K"7R)RD8,A8FMN*9<<PQFJJKJ65)80XA\09L/(<YW:
M)E6;6K:M1.HX@Z6U%7&*,5=-:,I4THD@@NT`Q\9/5B)B14Y4=)6&%@XL?*%>
M!*T82M06XA:'$)<;4E:%I2M"T*PI"T*QA25)4G.<*2K&?'&<?DSC@0VVW^MT
MQ0(DF209.S'JIK]3A!'IFV6)QEQAI_Z/`A)<,>##<+:]V:YAJ/CFE^L8^.QA
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M&8^RU2;0.^*S.UJ7;0M^,DFQBG6'/#"F"Q'GA26WQ7WV'`BM1NDL%,-:\V.L
M,6ZI;>77YL=KV,%LV*$:<>=EZZRXXXD.P!"LY7+0WG<>!5C+S>70UM/J"V.`
MX$9MMPK](B,S5C-4(*LH:/"''%+DI27E3EY;`A8*&C6"I6<FI!W'E8$%9=?=
MSC/E3G&,YP'ERZB=./F2KWSJ[6[.[LW7M+'0>>L6Y;=#:,LG;"S7&$KVOMBQ
MFT`-%UDO2H5KG:`*JGV#"EM`A*)"A7_,X*XK'@XH/01W7U1N7>'6Z]ZOT%L*
M4U7LZT&4QN(O<+LFR:DE(2,C+Q79FS^SOM.IMXM<0X?6H\L;+<>*.08E[(V#
M0DNJ);#!#2'6OY7*X=H-G<_9G5ELBJAVON&XMYGP>P=CDR^RM-SFN9FJ534L
M&`_I^M1T-7Z%8G1Y%$+EQL.6>6V028D@%U4N&YK@.`X#@?_4]_'`<#KY4TF/
M`?,$B9"<(9]+TXJ*<BF3RO4>;:7Z#DW)P\8GT$+RXKU26_%",X3YE^5*@A.G
MG5OZDU:\Z.\&X]KFD.N"$*'40*MRLQBUCOJ$?*%4\PK/E5EIUQO*L9\JE8\,
MY"QN`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!
M1;.O[]3G<5K5D_6X/7,BXM;0$_'FR<GJMOS-N$QNM`&%,QDG6ST)6B.BY%UD
M6L/NY6/[R,:&@F`L"G4*!I39KT?@R2GIKVSEFM\Z3]3MEJ*%44M@B<EU-M94
M.(Z<_D,$=`\9&-/*8!&%&PAE(33@.`X#@.!'[/5:]<X=^!LT6/+1C[C!"6GL
MNLD!G!NI)CI:*/%<8D(:<B3&T$!'B.L&!$MH>8=;=0E>`K=.KK-)MX@[CM"P
M6*D"-NCBP8`:*K89\5Y6%I&V%=X4]$K86X[+:$,8B6Z\DICSMRF))+J_$.\;
MTMIQEI##6IM9M,-MX9;9;H=60TVUA+R,-(;3%80EO""7,>7&/#P<5C_[L^(=
MY":\H%:.^J5RCT^`DLMN,YD82LPL4=EIY;CCK7NP0F"/3=<=4I2?-X*RK.<_
MESG@=?&_VJ7+^[_6G]8]L\"P.`X#@.`X#@?_U??QP-2?S!][]H=`=&ZGVAJM
MC7IDC:-ZU2HVJ/O%9M5OD3Z`Q%S=GN+%)@:S/U7!%A;AH%QUQ;AKY6`FWFP(
M\XYQA+0<KI]WH[&=BNK6X-R#:!K>V=K:]NFEZ_4=::LLP&KXK8(NT.K_`%*[
M`7`02T;:M$I7XN4TY8.PM@K<DZ_(I2<72WT88$.>6`.%S]/>VK.ZNGO7;>,3
MI7:D5"7JCZ^BFXLJ0U.09'3A$I'ZZ+$R]C9@Z2X\6U-.)03Y&ENB)P]EE"E>
ME@,I9'9<O%F0`).I=C9>L<L]#1^6C]5*0DQB"FK"O)"L[.3EMGV$"_C"L85G
MU,IQX>&<YP!G9<N_.R->1J78WOXN)A9DG*C]58'R'/&3X(.&G/Q.RI3V'JX1
MZB<IQA*<HSC.?'.,!U+NY3&JM8+>K4FS/I5:^\/J*<%ZHR6K[(D9>,F?;,_B
MCA#OF)A'O0\5I\Z<ISGR^.<8#MI'9<O%F0`).I=C9>L<L]#1^6C]5*0DQB"F
MK"O)"L[.3EMGV$"_C"L85GU,IQX>&<YP![9<NQ.QU>7J78WOY2)FID;*3]59
M'P'`F0`)V'7/Q.PI+V7K&/Z:<)SA2<+SG./#&,@CMER\H9/@C:EV-AZN2S,-
M(9=/U4E"C'X*%L*,CJQLY67&?83S&,JSA.?4PK'AX8QG(=2UN4QVK5^WIU)L
MSZ59?L_Z<G)>J,%I^]Y&(C(;W+/XHY0UY29MGU_!:O(G"LX\WAC&0[9[9<NQ
M.QU>7J78WOY2)FID;*3]59'P'`F0`)V'7/Q.PI+V7K&/Z:<)SA2<+SG./#&,
MA5&O^V$1LG;N_=*U[4.WD7'K?+:YAMA.2*M1C0SQ>T*#'['K6:Z:UMHE^291
M7Y-M)*G61\M$84A.%IQY\A8+NY3&JM8+>K4FS/I5:^\/J*<%ZHR6K[(D9>,F
M?;,_BCA#OF)A'O0\5I\Z<ISGR^.<8#MI'9<O%F0`).I=C9>L<L]#1^6C]5*0
MDQB"FK"O)"L[.3EMGV$"_C"L85GU,IQX>&<YP!G9<N_.R->1J78WOXN)A9DG
M*C]58'R'/&3X(.&G/Q.RI3V'JX1ZB<IQA*<HSC.?'.,`A=ER\\&\<#J78V&6
M):?AEX?/U4VOWE<G9&O2&4I3LY>,LJ/BW<MJ\?%3?ESG&,Y\,!U+6Y3':M7[
M>G4FS/I5E^S_`*<G)>J,%I^]Y&(C(;W+/XHY0UY29MGU_!:O(G"LX\WAC&0[
M9[9<NQ.QU>7J78WOY2)FID;*3]59'P'`F0`)V'7/Q.PI+V7K&/Z:<)SA2<+S
MG./#&,@CMER\H9/@C:EV-AZN2S,-(9=/U4E"C'X*%L*,CJQLY67&?83S&,JS
MA.?4PK'AX8QG(=2UN4QVK5^WIU)LSZ59?L_Z<G)>J,%I^]Y&(C(;W+/XHY0U
MY29MGU_!:O(G"LX\WAC&0K[8';"(UMMW06E;#J';R[CV0EMC0VO7(Y6HR89D
MO5]!D-CV7-B-=VT,_&LKK\8XD933)&72,I0K"$Y\^`M=G9<N_.R->1J78WOX
MN)A9DG*C]58'R'/&3X(.&G/Q.RI3V'JX1ZB<IQA*<HSC.?'.,!U+NY3&JM8+
M>K4FS/I5:^\/J*<%ZHR6K[(D9>,F?;,_BCA#OF)A'O0\5I\Z<ISGR^.<8#MI
M'9<O%F0`).I=C9>L<L]#1^6C]5*0DQB"FK"O)"L[.3EMGV$"_C"L85GU,IQX
M>&<YP!G9<N_.R->1J78WOXN)A9DG*C]58'R'/&3X(.&G/Q.RI3V'JX1ZB<IQ
MA*<HSC.?'.,`CMER\H9/@C:EV-AZN2S,-(9=/U4E"C'X*%L*,CJQLY67&?83
MS&,JSA.?4PK'AX8QG(=2UN4QVK5^WIU)LSZ59?L_Z<G)>J,%I^]Y&(C(;W+/
MXHY0UY29MGU_!:O(G"LX\WAC&0[9[9<NQ.QU>7J78WOY2)FID;*3]59'P'`F
M0`)V'7/Q.PI+V7K&/Z:<)SA2<+SG./#&,@CMER\H9/@C:EV-AZN2S,-(9=/U
M4E"C'X*%L*,CJQLY67&?83S&,JSA.?4PK'AX8QG(4EO7N37>O.AMC]B[[J#<
MCVO]6_5?N5FOXU#(V%SZ/<\T4OZ9'$[=CQBO&;QXH\Y#7BQ^=GPS^;P+MD=E
MR\69``DZEV-EZQRST-'Y:/U4I"3&(*:L*\D*SLY.6V?80+^,*QA6?4RG'AX9
MSG`&=ER[\[(UY&I=C>_BXF%F2<J/U5@?(<\9/@@X:<_$[*E/8>KA'J)RG&$I
MRC.,Y\<XP'4N[E,:JU@MZM2;,^E5K[P^HIP7JC):OLB1EXR9]LS^*.$.^8F$
M>]#Q6GSIRG.?+XYQ@.VFMER\"&R<=J78V67Y:`AD88/U4XOWECG8ZO1^5)5L
MY&,,I/E&LN*\?%+?FSC&<X\,@>V7+L3L=7EZEV-[^4B9J9&RD_561\!P)D`"
M=AUS\3L*2]EZQC^FG"<X4G"\YSCPQC(([9<O*&3X(VI=C8>KDLS#2&73]5)0
MHQ^"A;"C(ZL;.5EQGV$\QC*LX3GU,*QX>&,9R'4M;E,=JU?MZ=2;,^E67[/^
MG)R7JC!:?O>1B(R&]RS^*.4->4F;9]?P6KR)PK./-X8QD.V>V7+L3L=7EZEV
M-[^4B9J9&RD_561\!P)D`"=AUS\3L*2]EZQC^FG"<X4G"\YSCPQC(&=ER[\[
M(UY&I=C>_BXF%F2<J/U5@?(<\9/@@X:<_$[*E/8>KA'J)RG&$IRC.,Y\<XP%
M(Z8[DUW>VEIC?%)U!N1JD0=LWU336IS&H0)W,OUTVWL72^P%,`#[=.'6&]<-
M822HY>7TJ)#4RXM+2EJ;0%W2.RY>+,@`2=2[&R]8Y9Z&C\M'ZJ4A)C$%-6%>
M2%9V<G+;/L(%_&%8PK/J93CP\,YS@#.RY=^=D:\C4NQO?Q<3"S).5'ZJP/D.
M>,GP0<-.?B=E2GL/5PCU$Y3C"4Y1G&<^.<8!';+EY0R?!&U+L;#U<EF8:0RZ
M?JI*%&/P4+849'5C9RLN,^PGF,95G"<^IA6/#PQC.0ZEK<ICM6K]O3J39GTJ
MR_9_TY.2]48+3][R,1&0WN6?Q1RAKRDS;/K^"U>1.%9QYO#&,AVSVRY=B=CJ
M\O4NQO?RD3-3(V4GZJR/@.!,@`3L.N?B=A27LO6,?TTX3G"DX7G.<>&,9!';
M+EY0R?!&U+L;#U<EF8:0RZ?JI*%&/P4+849'5C9RLN,^PGF,95G"<^IA6/#P
MQC.0ZG\93/L;\0OPDV9]!^T_O+R>[U1]0^D?1_K?E]O^*/I^\]G^3R>IY?/^
M3S>'Y>!VTCLN7BS(`$G4NQLO6.6>AH_+1^JE(28Q!35A7DA6=G)RVS["!?QA
M6,*SZF4X\/#.<X"H:+OJ`LG<';F@":I=*Q?ZEUKZ_;A.Q/M51Z%+I]\VAV6I
M4+F/DJU;;$I<HU-:YD/<,/-,X0TIE25+\ZL(#+3@.`X#@.`X'__6]_'`ZN7@
MX6?&'#GHB+FQ!)2'G!19>/$DAAIJNRH<[7Y<=@QIYIF4@IN/',#(3C#HI3#;
MK:DN(2K`:VKY\I.G]9;BGM,V73?84<VK=G0NL=INT;2:O(ZXK]CF-7=?-TBW
M>3M85V<"Q57===D(VQ$BMX=L8-;@;',&1C`4(8ZD*ATU\J77*3HKL/7^J^[]
M1577L7>#).CR%!U/7!:'.Z\U.;V#9USFAUS8!4U$[4FX4/#H$$B):)9/>'63
MD;!L<X:$"*^>OJD"3%QUST_O*I6]=JME1C*W:,Z'`,%OE$MS%$O<?B:/W6/7
MP8FMQ\TLEZS8+Q6'FVRHYJ27*>C'DAGWT^[I4_N01LF7I6D]TZU@Z:S1E1%[
MVO':E!BML5FZ,V><ILY2FM>;9V-;8J-,JHXEC'C[='5B8S7K7#2;8*A95IW(
M9FYCH]0A("@0\@F>]]V%D9G(A7U)UYZ1]R-E'HO^_>)<6_YDY]53BLJ\<JSX
MA]G1QWUCNO,,O.!O*($<=:0XL4A0[XBGQUK3E3#RA2G6LJ3X*RVXI/CX*SC(
M%#CJ(:+4PRHIAE\=DE32,D,CE+'=)8:>RGU&V2'`VE.)QG"5J:1G.,Y2GP`T
M..PLAUEAEEPQY)!;C32&UE$)'8$2^0M"<*?>2**TUA2O%6&VTI\?!.,8"G=V
M[.KFBM;M7*8I<Y:*Y&6C7%7^BU$6JY>AEVR\5RF5V;4'99^M1[<'69R8#((]
MHX^<P.UE8@I#J$M9#5W;/FWZ_P!2K2;M-=<>UK1479MEU*5AB]:5.*MM=!H6
MMM9[.G,'C3UZBVHFQ2TGLB!I2*H60)9E;.PY6G(_!PV%9#NK%\L/6S5S5@V/
M_P`MVZ!)*?E.SL7N"5J]1U"];HFX].[3VHU5&0&Q"XK9&%660V0GI%L1NI'#
M&2<9'QL`G,J7%,/-9X%+V+_Y"W0RKILD%8*ILB+'CKIL+74@@YO3OVO/W/7T
M-K&R[=C(N8&VB7"R4/@K=$?$0D^2H>MW>TJ?CXJ0)RILAX-^CHX[ZQW7F&7G
M`WE$"..M(<6*0H=\13XZUIRIAY0I3K65)\%9;<4GQ\%9QD"1QTD.EI8924^R
MP.\2EI&"'AQ5D.C,.O83ZCC([ACJFTYSE*%.KSC&,J5X@8''%0IH9AD=M3Q!
M"FV&D,H4080Z66^I#:4IR\44^MUQ7_F6XM2E9SG.<\#XXCH](@P"00\`A^R]
MH%@9G`@OTUUEZ.]L-A'HL>P>&;6QY4X])3:<I\,IQX!]E#CJ(:+4PRHIAE\=
MDE32,D,CE+'=)8:>RGU&V2'`VE.)QG"5J:1G.,Y2GP#YY:9$2:2,$E3Y"LED
M(%;':(D"FA61FU...K':=*4,(TRE;KB<80A"<JPE./`-+R/FDT#]O%+QU@[7
MM,1^MY'8%.KGX4U1W-M+J-YUC2(FE4YT&[%UF1G).X[,B(N%D@C'ZP[8(R7C
M,2K1L0XA8?@WY?>L=AIEMW4[UQVY:K-H6EQ.S:.!]'T7+7*V5JY6ON;KF^6;
M0-H)VHN!*AXJD]$]DV$@YR4AD3].`')#]RT<RVH*OF__`)%71.JR=B3/T?>$
M3)URKR=OMN%PVH\S4/KR`[!`=9HN6E8W\7$334Q.[BGC/I54=:3;/H`1LP]%
MC#81AX-KW57LGJWM[J(_8FNH@B/@6+I?=>6RL33U+EGHRX5B9)C[?&'F46QW
M&G2[9Q1.2,N#GD9=05X$):)]9AL,FG1QWUCNO,,O.!O*($<=:0XL4A0[XBGQ
MUK3E3#RA2G6LJ3X*RVXI/CX*SC($CCI(=+2PRDI]E@=XE+2,$/#BK(=&8=>P
MGU'&1W#'5-ISG*4*=7G&,94KQ`T..PLAUEAEEPQY)!;C32&UE$)'8$2^0M"<
M*?>2**TUA2O%6&VTI\?!.,8#XXCH](@P"00\`A^R]H%@9G`@OTUUEZ.]L-A'
MHL>P>&;6QY4X])3:<I\,IQX!]E#CJ(:+4PRHIAE\=DE32,D,CE+'=)8:>RGU
M&V2'`VE.)QG"5J:1G.,Y2GP#69L+Y.]1Z>W#/:LO.D=_5S$/NV5U)<]E,5"F
MR>OH@J(U#0MO(V#)3T!>)(J5KJ]4W`*:?%$8+LD17`2CY*-"&!(]$,0#/G'Z
M6SXHVMNP_6G?NGH"R/5]G9$!V.U9K2NU&J$W"PZ6#Q"7&N6F]XD[-=HNY[\@
M%3==C8B3G8EE3TL8(V`H(LT.^/\`GMZQ5F#VI8]S=<^V^FO^7&EP>S-W"[&U
ME1P9?3T/:6:Q6H%N;B?Q(78%W"9NFP0ZXB*CQ"9)I1S1I+;$24P:\&7_`%_^
M271^_P#>\MHJ#HNQZAL6(L&S]6VDVT@T)R,A]PZ&/><V%IF1D:I>;))%3D#`
MRB9T`]@=^O&1I:O3.09G(JPV'YCH]0A("@0\@F>]]V%D9G(A7U)UYZ1]R-E'
MHO\`OWB7%O\`F3GU5.*RKQRK/B'V?''*0EHEADAM+PY"6WVD/(20&0T6(^E#
MB5)P\*4PAUM7_F0XA*DYQG&,\`H<=1#1:F&5%,,OCLDJ:1DAD<I8[I+#3V4^
MHVR0X&TIQ.,X2M32,YQG*4^`&AQV%D.LL,LN&/)(+<::0VLHA([`B7R%H3A3
M[R116FL*5XJPVVE/CX)QC`?'$='I$&`2"'@$/V7M`L#,X$%^FNLO1WMAL(]%
MCV#PS:V/*G'I*;3E/AE./`,0NTG;ZK]6Y6LIL>HMI7]Z?IMPL4=/Z_C*;)`0
MP-=MNL:U8!;$3,6V(FZS`Q^+\%/3<V^(FN05:AI"3DSAV@<)6&`-F^=CK/3B
MHJ5G>O\`VKKT1/:SU[=Y*XVC5,158NI#V[4J=U.PVP9:5M+0T7#Z8AK`"!L"
M:$?DX&A3EEB!I(IGZR&Z\'+1\PO4:AET;7=0ZY;ISKW:;-7*K\_0-<:S:U++
M[*[$4V:W@-4&I4&\@5.;DK3)V:*8LLZ&Z7"1]GV)752QK3-A8/4%OZ5^6O0/
M839-/U[4=1;U&-G]M674,79K5`:P!@Z]LF@,S4#MF+E?;;1E+`(]K6V!DU@X
MH`(T>0/>P[&NFQ#BI+`;5TCCI(=+2PRDI]E@=XE+2,$/#BK(=&8=>PGU'&1W
M#'5-ISG*4*=7G&,94KQ`T..PLAUEAEEPQY)!;C32&UE$)'8$2^0M"<*?>2**
MTUA2O%6&VTI\?!.,8#XXCH](@P"00\`A^R]H%@9G`@OTUUEZ.]L-A'HL>P>&
M;6QY4X])3:<I\,IQX!]E#CJ(:+4PRHIAE\=DE32,D,CE+'=)8:>RGU&V2'`V
ME.)QG"5J:1G.,Y2GP`T..PLAUEAEEPQY)!;C32&UE$)'8$2^0M"<*?>2**TU
MA2O%6&VTI\?!.,8#'?LGONA=9-8QMDM55FK6#8;55M65/7M.#K7U6T3=K<=#
M%@8UFU3=7J(H($"$8:1[TX5C`(3J&_4>RTPX&M][YR>IA5#UMM1C76YY2IV^
M'[,7WW:(37;DQKJ@]78"Y6.];(ML>YL/.(^'LVMM?W&4@&8Y\Z8E&($H3`B"
M7,L)#JY3YD^K\#%QN\@^KO8>7M%DCY^DWB9J^KZ!-7.GUS64;!W>KT_8%UB+
MH5"AN6:R[3DZW3ZZ1,8)DMI-2=3$'Q8',C/!]A/GGZFRB4XB-=[V.7F!T?:G
MUKA]<"!Q52[3T&)V=U>N,V4]LKS`57<5-D7B%/(;?*K+D>4F;&!;0VZX&VC1
MVW:YO[3FL=W5"/L$35=KT>N7ZNQUJ"$CK$'#6B,'EHYF7$CI"7C6S,"DIRI0
MI90KF,X6R\ZTI#B@M3@.`X#@?__7]_'`<#7)MKXH>D>[-EV7;]]HNT"[_=+P
MO8-Q/BNS?9R!K5LG"X33M5F0K-K6)V^+JZ?J=BIV@:?#GPA<*]$$1L$*UD;'
MIX5P)`)\8O3",V!![/A]9V.*N-?V!6]E`E,;AW.;!KLE1G9&S5QHNF3-_DZ4
M17X6>F3BPXS,=@$$@\IP9IE9+ZG`X\-\772J`$D@HK7>PV&Y,RR2+A#O9?M"
M;)`2%PO$-LBTG5^7.W,3*U8RP72!8-+=C7A%O94^TK.6"BFG@RKU9HW5&DEW
MQ6JJ9'TIK9=HK=QN(,23)YBCI^GZ?U;H.LO1D.6<5%UF/AM1Z6K,,R!%LA`8
M;B\/Y9R4^2^\%L<!P'`<"L=O:?H>]:05KO904](U,V6KLX2%7;Q>=>R+DE5)
MV/LT`]]Q:[LE5LB&09R*'(RPDO##RFDX=0M/BG@8!17PQ?'E&5>=I!&IMB6>
MHSX:8YR'OW9SM'L,J)BG=?;GU5+P-=M5WW+/W:`J=FU]V#MT9)P@LFW"FMS+
MSBQ/7SZO`LB,^+[IM$Q!T`%2=D#Q!FV-J[K0,)V+[%Q98>P=VPUQA]G2C<Y#
M[5CK"<'8\[,M9;0AQ98T6;;)AV/0)[]Y.0XL[\5/0^S2(\M.:6ECY$,6[!QY
M2]T[[9<C&MFZZ'U5M%<3@;:#*(DK:M,$91:GQL-/6618:E)-94HV@Q(;`P0@
MXP(.-CQF0P(\4<($,=M+0XH8C2&!AF&DXPEMEAEM*4IQ^3"<8QP.5P'`<!P/
MF\TE]IUE>7$H>;6TO++SH[N$N)RA66GV%MOL.8QG\U:%)6G/Y<9QG'CP-7@'
MPT?'U'%R;K.L=IG1<[6[?4+#3[-VP[:WG7L[6[SK&^ZAL()>O+UO"R4D.0<I
M6S9MH65"`%F8\D]XD4ME]YY;@38;XJ>CH<KLV7#U=;AGMS:YO^K=H,M[WW\I
MJVU?9NP]I;2N1#KSNSG#X*U2MRWM>GE3<4\!+9&NDR(HA0IJV<!V4?\`%[TF
MCA&PT:OMYZ$MDLOD3_8#L;9I*2'7<([8<8)-RUBVU*2D^'3]@1C<]6V37B&J
MO-./G1"0BB2770RUU-J'7NCJ8/0-8P3T!5QY:PSN1C)VQ6B3,FK5-GV*>E):
MR6V6G;+-''RLDZKU##'U-->1EO*&&FFT!97`<!P'`<#7=L[XK^F&W]I2FYKS
M4-M25_G[LQ>[*0SVC[0BT^UG_4-6ERE?M6J6]Q?A+9*#8@=+5>-/KQD$]"NQ
MD*(.D9"1F/3#K1?B7Z.#*#]:B;7L`P5P;NZ(C8/:GM7MFL/S/XFU[<)@YM,V
MQNF[T\Z#D=CUEB6=CW0%AMGND$LMM$$O.K#YH^(GX_EMW@:5TO:+9';)^ZF[
MS!W_`+"=EMBUNR`72ZKV5/P1]9O>X+%7_M=W8[SUA%B6QD1L=.DOR`C#!;[S
MS@7IJWHUU<TOLG\7=<:T(A-B+<V$:383K]LRT9D9_:\\Q8]BW:7BK9<IR$F=
MD6R0'2V59BQGK!D#*@4F)"6L=099\!P'`<!P,4NS/2?KMV_8AA]]5Z_6!FOQ
MI\3$)IF]]]Z9R(%)S]6LYN,KTKLW7KA!3TW2HM[W#N5D)P(EM*\-*<0L,<XW
MX?.AT=*:^G%43<4C,ZS5!O5PX_MOVXRP>=6=J6S=M=FKQ"![P#K>S+-#;3N\
ME-MRUB"E)1P]_#SI#CB$*2'*@_B$Z"UTZJR,5JB\!OTR#MU=@A0NQ79**@LQ
MMQV9LK<)A4_5(7;<;4[E;(39&V):7AK',@R%DAY%`!0A[147&O"A.J7\9'2C
M7-EK=OHFIIVI6"I6J+O$$9!;JWS'L#6^.&*8+L9<8QLY,5+2UN?-=,LSQC#Z
MK9*+]_->_-Q@C`9Z\!P'`<!P*GW/I#678*E9U]M>`,GZSB<@;,*F*L]LI,]%
M6"LR3,I"S$#<*).UFX5Z0&(9RVMP$\=1`CKPSWJ#/O-.!AY%?$ST'B*'8=7C
M:1,=H-EL%@G3*X5M7<3[8@MMI6R:!:J7&2N;^F?#UA9*UN:X-&U;!:J^1FS'
M^8/RN(2V'1N?#YT%7"2->9U?L2(C9&T:ZMRR*GV6[-T*S-RFI]/2>@]>#+OM
M#W!6;_*0=6U'.GP8D>?*%A-1YCC"6\,I:;;#MG_B-^/5_,%G/7Y0_P!MRVNI
MF(P!MG>$:EDS3D/!0&F62D1^RQ42D3I>(K(+--`*P\#4\,85$LAK4M2@SCU;
MK"BZ6UY4=5:S@DUJAT6%&@*S"XD):8=#CA?,K&3)J?/E9Z;DBGW%O%''E$FF
M$N+>?=<=6M:@GW`<!P'`_]#T6:3VE\[F\=-:DW77X_XDXB`W!K&A;2A(J9QW
M%Q+QD1L"JQ5LC8^5P$04%B2""ED-O^BZXUZJ5>1:D^&<A9W\_/\`T@?WS^`_
MGY_Z0/[Y_`?S\_\`2!_?/X#^?G_I`_OG\!_/S_T@?WS^`_GY_P"D#^^?P'\_
M/_2!_?/X#^?G_I`_OG\!_/S_`-(']\_@/Y^?^D#^^?P'\_/_`$@?WS^`_GY_
MZ0/[Y_`?S\_](']\_@/Y^?\`I`_OG\!_/S_T@?WS^`_GY_Z0/[Y_`?S\_P#2
M!_?/X#^?G_I`_OG\!_/S_P!(']\_@/Y^?^D#^^?P'\_/_2!_?/X#^?G_`*0/
M[Y_`?S\_](']\_@/Y^?^D#^^?P'\_/\`T@?WS^`_GY_Z0/[Y_`?S\_\`2!_?
M/X#^?G_I`_OG\!_/S_T@?WS^`_GY_P"D#^^?P'\_/_2!_?/X#^?G_I`_OG\!
M_/S_`-(']\_@/Y^?^D#^^?P'\_/_`$@?WS^`_GY_Z0/[Y_`?S\_](']\_@/Y
M^?\`I`_OG\!_/S_T@?WS^`_GY_Z0/[Y_`?S\_P#2!_?/X#^?G_I`_OG\!_/S
M_P!(']\_@/Y^?^D#^^?P'\_/_2!_?/X#^?G_`*0/[Y_`?S\_](']\_@/Y^?^
MD#^^?P'\_/\`T@?WS^`_GY_Z0/[Y_`?S\_\`2!_?/X#^?G_I`_OG\!_/S_T@
M?WS^`_GY_P"D#^^?P*QE=I?.Y$;EH6E'H_XDW9_8&L=M[2C95K'<7Z0%$:?M
M6DZG-QYV5D)-Q)29N\8]P3TVEM>D(1ZBT*]/"P__T?9S\>W_`$"]'O\`M`ZT
M_P#!BE<#+_@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!ULRF85#RJ:\[
M&L3ZHTY,&],L%%0[,QD5W$:[*C`D!FD1K9ODR^VRZTZMK"L(6E6<*P&LSXO^
MW_87NI2-V;%W'6=,TV$UGV-WIUO@X?6:;N5*RTQHB]D4B7N,M(6F2>$$C;&0
M&ZZ-'LL+=&1A&5DN95E"`SAL/8KK[4=HUO1]KWKINL;IN;8KM/U!8=G4F%VC
M:VCD2;@3M;H$E-C6R=;,;A3%-*%$=PXD1[*?'#2_*%<73O=T?UM8[73MB=R>
MJE!MU$<=9O%5NG8?456L=-=87"-OM6N#G+>#)UUQE=ECDK28TSE.9`;&?_\`
MNUY@D!W<'J3%V;8%+DNTG7..N.IX.S6;:=3.W=K,2S:TK=*1&N7*P[`@2+,W
M*4V#J2)D-4F7(M##@8+9R^MOU4>8.9K3MCU8W/8Q:=I[LMH#;%N.I\?L(*JZ
MTW)KJ]V,R@RR\MQ=X%@ZO8Y63(I\DO&4CR:&LA/9QX(<SP,,:G\@T;L_O]IW
M06CMO=4M_P#6[;.CNR=L*M>E[P/L38VO-M];+'H"+L%5M]CJ%ZGJ&Q&ST?OH
M=QD%0#$F,X`YEQ>4K3C@;3>`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@8@77_KZZT_]H'>'_C/\>W`_]+V<_'M_P!`O1[_`+0.M/\`P8I7`R_X#@.`
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@=;,R:(6'E9ET.2D&XF-.DW`(8`B
M5F#D`"NE+#BHL1*RI*2)2UY&&&DY<>=4E"<9SG'`\U'17;?9CI;TN[DQ+'1'
MM];NP=J[<]W]VZ)URQJ`D>)N(>X+].W33LG/VPJ4;@*U`GNR`R95!#N9,%"'
MO*&[G#>'`PWA^F/<.7"[F:S[=R??:Q[![-=B^N_9VJ%]?=`Z$L,%O.2J]5Z]
MRVN!Y[LA,ZVD@>L%HT!L;6;\=*Q\C.5"&B(>-41`B/Y.RR4%*]'IG7N]K#UI
M$[9ZKO5?Z0:&[Z]Y;1IB^[%Z=;`W-K7L/8NYNX-S:TH=8V/V^@2[+U\M^I;A
M8-W)4JQMPV8*=EVHZ(<+2R%B0D`R8Z/]3NP&G(#I54>SH?R$VK>G1WM#O':L
MS3=<]>M7,Z(F#[7,;ASL'?3?9P'7@5EW14=V4R_/FNUUBS2ETE)Z70$[%MM#
M.$C!0G_(KVI#Z<?&WI[KIU*W%I#=,%UN^5J@;0E54,2I(UKN+M)IN<I.K';[
M<F2\L@`V2RF"QP<R.Z4-7X]D9["Q1`FE,ALVZQ:_N0_?7XLMBQ?3?>6IZ;JS
MXLMB]4MJ7.?U"958K7>S(<WK^;`Z;M):TM$8A:5]JS.(R;8035I=<DOZ,>=A
ML[(X>DC@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X&(%U_Z^NM/_:!W
MA_XS_'MP/__3]G/Q[?\`0+T>_P"T#K3_`,&*5P.EU[WOU7L.Z1E:%J.R:U5;
M)/;QKM.W':AJ")J2V2'7F]*UOL=H:?BMA3,Y6"F[@VX-&AV&,AI&5;8>?&'<
M89=<0&3>=K:NQ(HA\[)H.)=PI`+<7FXUW$BX:XU(OH#0#]1]RHI;$.6O#>$^
M?*!7L^'@VORA4U%[8ZBV!O?8/7F(E/:W:CT_5E_ACSINC/5_;%-VU#V^7A+#
MJ5R&M\O/6:/@TT629E%$1X"AU-(=;P\*\T0L.7GL_K9_=NL=(0GU"UR&V:?M
MVVUB^U*1I=@UR.[H^8I,+L&IS,F!;G+&#;(TO8$=E+*8MT7.%.(60AUI3?`R
M,X#@.!2>_P#?E$ZWZ^QL.^HL$B.?;*5KZIU2G0Z[%=[]L39%HC*91*+3(%#P
MN).P62QS##2,NO#AB,8=+,?'#'((:##:T?)[3*C;J+KB6ZP=K4;/O_8J8ZLQ
M.OE1&@`98?<,1UZI7:!$818)GL-&:_D:[+:DN+I(DU&3,A%*.A9`-Q]HA(B#
M`^D1\JO7FWU=NZZTIF[MI5@+2M>WW=3:=3ZT/*:WH%IV7M73T(5;ZA<;Q4[N
M^\[L?2-ICRGH>-EH^+:AW3CRA8U39BPYFI_D]TYL_:M;U)*:KWSJ67NF_MT]
M6Z98MF0>LEU*S;^Z_P`%:+/L[7`A^N-K[%DXPZ,KU-D2P3Y(,&(F&A\X`+)7
MG">!(.Q7R&U+KMM%&J"NN_9W;4R\]4HL:;U#5M625=D+9=*=M/8,)1(9V\[@
MH$W/W)5+TW.2#H@`)*6D(%9ROW)P;#X6A2N\?62]5GK798G:%='SVNDHNOZE
MKYLM#+LKULD=*3G8!ZG6>-BY.3;K-FA=;U]]\X<AWP'+<'&\^72AL.A))SM1
MJZ+VCI#5T.05>R-Z7;:&MX>XT&6I%DI=+OVJ-<RNTIVI;")9M[%BB)J1JL"<
MH5L.-D,-$"Y;-R'ZPRG@A?8?N3`]>=J:BTZ5IC=NU;ANNL[2M=,1JH;4Q`&(
MS3,7$3FPFY5W8>V]=EC'1$-.B$,M-,/Y.];#0V72,*9P'W;[X]45=:8SMJ3N
M&LQ6F)?KJCM6!(S9&86U/Z.<KC5F3<$T.4P+<,IR(\@?`_L_75(+2(E.2%);
MR%W&[OTM&M/D2.WM7@,#.',DO&W^J"M#NQ</&V&3:?<?EFT-.1T!,AG/I5G&
M60RV7E^#;J%*#F1^WM32T\[58K:&NY*T#RF8-^MQ]UK1D\S-)^L8S#NPXTFY
M(-RF/MX_Q'RWAW_<2/S?]BYY0D%8N50NX1DC3+56[='Q\H;!GGUB<C)\(&:C
MLMXD(<PJ**+8&E`,NIP\.M276O-CS)QXXX&,VE>Z&LMO)V9B;@[+H@O5NRKG
MJN8CMY6#3\`;-637F(K%V+JZ:;M2]L2==KCLZ$A\YQQAG*RF_3RO&<YP$EM_
M:S6=+[!:_P"N<FW*%VN_P=WFE62+DZ(34J*JAU9J[2<5L=MVZC7:IR$G57T'
M1[CD*X$6/G*L$)PA?E"X(W9VMID8$R'V%1Y4.3;C7HTJ-MD"<-(-36/&'=!?
M%/=:+;EL?_C*;RK#_P#]GFX%%=E.W^O.LDWIJIV*K;&V+=]YWT&CTRBZGAH"
MQ6UH-9`;-CO\M%3MHJWDH5$'/:*F2!%EG,"Y4XR(1AMWR!<(^Z=.&(CW1-LZ
MS*;EFX]Z*<'OE6?1)M2TN77XIV/6U*J2:W)SP#X(ZF_-AXQEQE'BXA2<!8PY
M`Y@[!8C[)0I3+1`Q([J'QR!WT)=9?8>:4IMYEYM6%)4G.4J3G&<9\.!]N!AU
M0^@G5#6;U0:I.LY*&JNO):/GM>:I5L_;DIH37L[#SS=I@9J@]>)F^2&C*3+5
MJSLHDHLF+KPCT7((20(IE[&%\#,7@.`X#@.`X#@8W=F.V6D^HM7KUSWG.3U=
MK=FEK'"QLG#4JWW!A!M3UQ=]LSB9%55A9=,6D>C:[EBF<$9;68Z-@<9+Q"T-
M*#$-SYCND;2JL*JR[&S+6Y5HCHZ':U9;B"!K;4MT6GKN=0I&2'#=KH]ND=TT
MXZ#C6DG."2:F_>C$.1OF-2'QA?F5Z/V@6(,IT]MR\LV&4C8N!31=$[4N1,I[
MVS2M!.D$!5NM21H$76MFPA-6E'3&QO96'#0B\>8H13X;4^!K2>^6SI6-;Y2C
ME7*[`S\,5N*,DA9;6%W@70YS2,=OR9MU?*"GHB,E0Y8V(ZO7PB.2\.VT2F!P
MA2VGI"*;."O1_FXZ#$8C$_>&R!R9IR5$AX\S4=W#DSYBLZ_QMZ[UQ4<1&MEQ
M=DHNGWF;1)@G(%(Q&/H;'20<ET-L,U^N';G1W;`6ZR.C[4W;XBC3F821F0U!
M$Q1RLR,[#M&1YD<=((9\\K6)!E8)WLY<7VZ7"0V62!7'P['L)VDU#U>CJI+;
M?D;)#Q=R(OPT3)PU*M=HC&'=:ZCO^[K.F:E(")/C8%S%"UI+/!-ENLO2)#/H
MC(=7A?D#%>+^6?I_-/5`**EMD'2=WB\NP<>SK.R8PJVJ[&/=31-7&3#K+=;$
MV9)[_9^@AQJC?(8E;9[+RXUQ!B@B,-\U'Q_V$JI,PVS+,<%>XERT5&81KVUL
MQDW18I(K-UOPRB0&36JKK68,1%V%;K#9<=*>(V1UN8SC`;3Y.0'B(V0EBVSG
M18P$N0):C(R2FY)T<(=PEYN/AH80^8ESEMM9PT*(P\20YG#;3:UJ2G(:OC?F
M3Z+QM:FK=(W2^`04)J.C[J>?+U9=62S*7>6>O)(V`(I<9B6<F*^+VJHCDF,M
MAOVZ9EWTU.JC)7`(<4#YH>A4BP5@?8%NS,!W+:6LW*QC7EG>L3^U="Y@#-_:
MMC@1!2&9>]:7JMH`L,N((Z^V977\R$2Y)#LOJ:#,WKIVLTEVK@I6S:2LYEG@
M8UN`D1I4JOSD$'8JK<(U<Q2;[4WYH`)%EH=UC&778R4$RX,1Z#S?BEUEQ"0Z
MCL[W$TCU#%UT9NN1MD6QM6P7&JTM^O4.W6T(VQ4C5-\W+*P\C+0,29#0$@;2
MM<2C@#1Y(SA[K"\,X4VP4ZP&&]J^;;X_J0[#9M6PKI$QLG2XZYG3F-9VZ3BJ
MW]5L&TJJ'5)W,*#)'_>BY[3LTS[$-@S_`&>!",+R*>&^^%P5OY0>I%KLXE-A
M[%?";*]MLC0A\>QJV]'B5S<\%M/56E[]KRV6"*AI"L5B4UALG>%3BIPLTUF*
M;-G!QQ2RR<K92&<]RM]9U[4+5?KI,AUVG4>MSEOME@D%+1'P59K485-3TR<M
MM#CB0XR+"=?=RE*LX0C/AC/_`(<#7A+?+CTLA*OL*S25LO@J]41>O9'8-;=U
M==6K57R-E[1F=1P,(U%.Q;:+%.`V6N2!<BQ$NGX`@PURCJL`Y;?6'0UKYF.B
M%M81F%O5Z)D7WMR1X%>3J>_.V.8GNMT5!63L?6J_#"PA!=CFM%T^T1LS.8`P
M2P_'&H5&.R#J76FPH:Y?*%U&7VFZW[B39;YFF#Z$[KZW>S^%.P,3J),QOH#V
M3&F_M[,%B656W.OP+ML];#67\!I]GEG$MG$=D/_4]G/Q[?\`0+T>_P"T#K3_
M`,&*5P/-!L?JZ[)6[:=JD/CS[6+LNVYS>U7W;;NN.H[5KY78:J[OG96,J.P=
MDZ=MET$TJG<'6]V=$O`MV%?+L%DLU5%6VB/R>[D<.\LG5W\6ZA0I'<'1W?MF
MVP=2^KT]N:SSO2;WI%EW72>[59[L=HO:8C;P@837>\3@#:9'!#.-N5ROO)9:
M<)!Q[#`0?_DOMIXMOK)?7_MI4(N^3FGS1MFZQZA3-7W9HR`TIVL["=G8>IZ7
ML"[L0"-!VX'=PU/,'QF)9!BXEXA*"\&M`QX;+_CAZAWF.["T[L.92K+H\'5&
MKT:<G]7V_3$QJV(M@I&E-(ZIB;Y0$.RBV7K`:]UZ%,G/7'RD4.0#C$.DYCD'
MF!Z"^`X#@:UOE$UW)WG36F+#5*GL:W[(TAVQT1V#U9':\UQ*;2:3=M12TM9?
M;7RL0MFJDHQ0;/5VY.")DF"778LV6$)0.2IO#*PU;]EF]M]RKAH"U;YZJ]IA
MZWJ'LK:=Q&ZEKW5R9L$)C7\QUUMN@8^G1UXF9F'D)J_)/ODA:'+(3#!L#/BQ
M\>-&H]NN2=#"*0ZI[ZNNJM:T7<76_?%\V7IGJ91^NG7CLWKOJILOKCO?J]?=
M?2^S@(C>%)M>MK\?);1#GZM9(`^>I,N7$P,M.Q+Z5.-B&/\`JALWZ@8IW7N_
M;SW%?.A':R[[GVEV;[";XJFS(KJ.^W9J'6-ZV,F530`9*>NAY;$A7X-_Z69+
M`K"^LLJ<RH45IS(V`NOL=V(M^W[CUAL=3Z?=U(0;0W8B)WK8DSO6J3=.MPL5
MJ_:6L45..<C;9AN*(='V@X:F0?R4EK("6/:JP_EY@--M1Z>;3U?MWK=O+6.E
M>U`%]ZHT.AZAUZU=.ETM;J_L6.I6N^^&OT]A-OA@7ZK$RV[)`WN>'/D1K+BA
M2C:>H=<PGZLDN*">=&]&]@.K^\=4['N^B^RE@I^N)^K6LFMT3IM.ULT^8@>J
M&P^KSD77AAKE#52I5`-BXL2,4$@`H@*+$'B7R2WQ5S!P9D]_0U=X[MJ"2ENI
M?=**IVOM1=M]73,?.]42IJP9/[/:WKU!B+Y2ST7=H2N6;5!M>1*B.*0ZZ8ZK
MTD.A*3@C(:IME=">PG8"G[4C-]T[MQ/WK:6OP@@;;3.F,W3J?JFU0G3>Z]/H
M6ITK647?A3)+7:(.PCS"\OV,2.04_*X^WW2C1#XX,EME:8[![.E=X?6>N>Z@
MZMOC:6]MP2]>BNC<\"JG3N\/CI9^/^(JD"5B^.CR=9T_$5F(G\O*8!>ND@\2
MX^U"N#C96$KOO66G+V%%[+T5T+[!Z6LL'6>EJJ_(`=,,GR\%L+JYW/@^V=\M
M#$R#8X7)KV]P(`>M2161V"6&4K?=26RZL/@96?&;.V[HGJ>UZUL76+OE:0[%
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M3I#9;1>NIN-@H$*I2I=A>Q%/B3N0`@RQ^0A1O>/[-CVNK/>.C1]?UEV*U](3
M+_5IV5L+R]XZ\;I(#HJ4VYIAR!@B6?6D@%O(S,`OOAI=#RY[G`8[U+1=>(W[
M==^[<^//<U_59U;4MM1U%-=,2+1J_5&S+;.:%LVOY6)`E)R*3:A:!8=!-G9,
M0+`EDEVJ8<9;%]5Q)0>F'1:2DZ2TZDZI1=!.3JO7J3*+"5!S7T+2RL5*(P14
MHBA/'2;U(BZX]XACQ"R2%1K3*1\NN9;\^0M3@.`X#@.`X#@.`X&I;MYU)[X]
MHB&(0;?_`%FU[2Z7LJU7K4DE6M2[VAMKU5$M3]A:S@39"^0?8@!K-RA]?;'/
M:S)18<7AN47@T5L=QH?T@PAKWPW]O8&M0-:=[)=9)EJJV2P3E<DI71VWGI")
MBIJM4BHA445I&^&X<:@56OT(0>)AV!&0`\/E92UE1+N5!W.I?AT[$:1P'C7%
M]Z25_,9,:-EHM8F@M\"O`LZ!VV+O&HPBB`>R89$G!S6S`FI.89.64LQ]O"T+
M9<SE>0WC;M![#GP$2WUQM.EZI:43&%SAF[:%>-@0!,![(I.1HF-HFR-:2(4Q
M]1RPOUWBR&?12M'I>925I#1RGXD.[C6W0MS#]J^O"+"/L"S;"-@GM.;G>ILH
M===R2&_;E!DP"=^,I'J]NVL0%*2H`[K0TLJ"AVCD%,Q0*&`K^4^#'?5@'$&L
MNW.IEE0!7[?5@US6DMVDK&@+^-&AW*.9]/L$PVVW.,1+/Y^$^H&YYW1%#NNN
MK6&RWXV^A-JZ/-;A8L<KH8X?8R=>M1(NBM2R^I!!FJ8Y?7"";D*9;[(/>;,9
M]X-HS8C4N6<]IC#<K(R#8X"0PBO:CJC\@G990L,GL3U@U_5:K;-A3NOCJ?IW
M>D%L>%$O&L=G:3P^==HWL2RZS:`-8[8EAT2$4S&*8DGTF#I9=9'](,/*O\1O
M=&L4Z$I;79?JY(`U^P3<W&ER'7[9K[[09\AK!R`JJ0'-VK@A*70Z]IJMPD)#
MBB#QD?$1_MFATM+RG`0.)^"/90IU*;E+-TLE*O2XC7U/$JCVBMZ+C2->4!?B
M-1R5O]BW3"X>6_(LG+SKC^'&T^BXRWEQMP-_F]8SL7+5@`7K9<=.TFVKDG,3
M,ON6@W#841B#<CS&\8@HNG[!U\^)/,R:V'4/%O&"^DA:%#JRK"DAH?A?AN[I
MU^="FXOM[I@;,;J..TU%C,:[WV`N%K%8TH]H#7I4#)1/86.DXB4UAK^6FG*Z
MIMWTHB>L4M+BH:D921(+")B?!1O\)F-]'=75C$A7C+K+T^6;TCN(5^CV+8FM
M-:Z,N$_3HP'>XM;@R)#0&H:[1!0VP<Q,/68[#48(&2\^4Z&U_P".SI?>NF-2
MN=1N-GU98HHP/7M7UO':OJVPZO&Z_P!9ZWAI:%J6M&6[_LG8IAU;J(<CE$6Z
MM[,DK#Q"CRC7%MK;"C^XO2OO=VZ>KT1*]A.LE(J&N[YL.XZR74-0[U@+W$YO
M>IMK:"6_.V^+[$,N%S@^F]S6&,6Z`S'C*)D5E(80ZR)D<,*G/A5[=2E48I=K
M[1=?K/6VV;Z"1#/ZJWO$1!,5=P(VICQX47`]AXT2GLU+5%9@J5&(KB85ABHP
MK,5Z7L'S!R`L*A?$?VSH5J,M,9O[K`@R>W9.]@[8\UI3<67Y[;5YWAHSL3M"
M[K:?WP]'"RFQ=M=;:7+&#-,(B@UPOH1X@0ATFP:&XOM5KC;VW=33VL=52.CQ
M0K_%V*E;-C=\42^7ZK636ULK4M7[%7@H[7VR]7RP,A)LR.&UD+->;P-EQ.&\
M+4EQ`:4(?X=NX\!9YRY0_:#KQ&VFRT^R5J=M$7J7>D):")FPYV2$WL`";K_8
M6)?@[I#5;<=GAA70TLAH`DTJR/DH48EL(Z)\(78X,JN2C6[^K7UVEB[;$H\^
MG2^ZQI*CM[\U72-$[H144`[_`!8V!%OFDM;P552*P.D*`B8UOZ$S%$J=(<#'
M*V_"9M5O8O7_`*WN;ETPJ4-H?<#<8=C31=Q^P8AXRF]'>LDE'O.N;I<NGX@%
M5"6%<:MK,NS8?>,N2#QCTKZ![`?_U?9S\>W_`$"]'O\`M`ZT_P#!BE<#ZD=Z
M.M8I#XK]GOR7AGG6'DHT)V`>1AUE:FW,)=9U>XTZG"TY\%)4I*L?EQG..!\?
M^>_K-_2C8'^`'87_`"LX#_GOZS?THV!_@!V%_P`K.`_Y[^LW]*-@?X`=A?\`
M*S@/^>_K-_2C8'^`'87_`"LX%G:M[':DW-,2$%KZ8LTC)Q<;F6-:F]9[/I(Z
M`<%#AY<:D+S3JY'EO>X*1CT677'O+G*O)Y4JS@-7,_\`.?UZK_RXL?#V3J+<
MSV[R)JMPB=G,-TC\*DD6;047V#$=4MRUHMWHCUJ50$Y_Z;YO?)5Y<9:\',AM
M>V_NJD:1AZ[*7+[B,*N=J9H]*K5/JT[<[;<;<]`6&U_0*[7:Z"<><<U5JE*2
M+GBE#;8H#RE*QG&,9#!JL?+YTSNNP:-KBI';PG978M@K];J\P-UOW<-5G3YZ
MP]>*BX]+3LE20F*['U>T]K*#'3S\@D9$$;86F3O06T0EH+^>[Z]46.N$EVV=
MVS$XZ^Q&QC-5'[$P!+*CF+F%O7/7!P)0:0<R207=K>41LO+.!EA.(.\_LU8?
MX'!LG?GKI2]\3'7>Z26P*E>(:R:7II$W-:GV,C6KML[$SA]7T?7V]FAULRF#
MF;-M$27%Q;A);`STH/[/+J271VG@GF^>V6F>MY`@NS9&V(?=I]FV+)M4[7UW
MV$]6-<4R2KD-:M@VL>DP,Z1`4^!E+;'M$F/H2AI#SC^<>V%+>8"^7;)71_#+
M\_"LXREQ>,NR@+?BAIF6)=5CSOI_-:'@3G%9_P#!*`GU9_(RYE(0>P[GUS5[
M?K^C2DV4Y8=F35M@*RF'K]CL4./)4>L6*VV9-OL\!$R59U\*!$U0Y"")XN-8
M)/9P$PMPQ:&%!U.Q^P.J-6-4]ZU69M2;QLC5^JH1$`*59G6[;N6<%KFN<3#,
M$T>Y!0=BF#666Y(O#0.,O(SEW&%I\0C&Z^UNG-!V""J5X.N$G;IZIVW8;=2U
MQK>_;6M,5K2@N13%UV3/U[7-<LTO#4NO%SH0RBGF4K--);%";)*5Z/`NN)M]
M:FXT25`FH]8A<?'R:</%,CD,"2D1B>!4:*\M!`3CT/XD^1U*5892I><>5.<X
M#G+GX)LT:-<FHE$B:I]`8"Y$-)I:QG7AR4C"J>P^^H=\=Q"\(3G*%H5C/AE.
M?`/F)9*[(*90!/PIRR5%('2)*`DJ?6"4D$U+*67UY=4&:O#+N$^.6W<X0KP5
MGPX'=<!P'`<!P'`<!P'`<!P'`<!P'`XY93`(I)I3GI"ACO%$N^5:_38';4\\
MYY&TK<7Y&T9SX)QE6?\`Z8SG@8(2GR?]$X080V6W]%@!G5M5G&+(I6S$"J&7
MC:*HJ!=(^RLM#[`M;.E+6[`5=S*+)8F(,EV,!+;2E2@GTWWNZH5NLZKMT[ML
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M3*98@IX,9H99$@`T2%3W'Y-.G%$J>F+M/7C9C]<W_(7J*UD35NL?:2]G&2&M
M;[7]7786WP=&TQ8I[5KD)L*T@1.?ND:%P08_Y&,N^FYE`9[\#H;59X.DUBQW
M.T'IBJU4H&8L]AE%L%$HC8.!CR)66/4,$P2:0D,`1QS*&6W'5X3X(2I6<8R&
M!6J?E;Z*[FO$=K6F[6ND;>Y6T5VF"UG9_73LSI"2;LMQ%273(V01NK3NOVHG
M[TPO#,,\6ID>6+S@81;Q'^RX&7^KMUZRW.O8S>M+-]R+U+LR<T]L''T:P0_V
M_L:MQ%?G9JN^,_%16)7V45:0'?=A>Y!<]?RMO*6AQ*`M3@8<;8^0#J+H_8SF
MI]H[=;J][:,$B/I.:/LF9!=LTC!1%IB:,+9*_3I:L&;'FZQ.C28%::-7/GQR
MEDCAN,M/+;#YQ/R"]0)VOZ2M,3N$<Z#[#F&`ZN+:I>QL.F$1NSJWI.3S<P'*
M>B1U./%;EN$54BWK8S",BV:0'C'5(-=2QD,R^!`]F;-I&GJ7*["V+-_;U2A2
M(0,Z23&R\R1D^R3T75J]&@P\`!*3<M*3ECFA`A!1!GB""2$-H0I2L8X%0Z?[
MC]9]^&:VC-2[8A;=,[<UKL;;U$@&XVQPUDD->ZCV%6-3;*G9>N6&&B)RH/4[
M9EO"@C`9D<"11*>X'PPIP(S`X8C77N%UF_Y[.M,I^,53^D?9G>'J1]:\\A]$
M_P"8_P#'KX]H+\)OK/L?IGW)]R?^D^;U?:_6?_3_`%O>_P"PX'__UO9S\>W_
M`$"]'O\`M`ZT_P#!BE<#+_@.`X#@.`X&(AG33I(?VE;[/'=?M#E=PDCAV9K<
M1%2K#F[,!Q-9$UB%/(GU,YLOLP*HPS"()QGTT#)2/YL8\$\"-][^H3O=#7FL
M]:&2^NVZ95MR1>QMCTO9^O9B^UK:=0B]>;*K#%(&-K%\UQ<-9V@*X6^)L,1;
M(>3^H0DE`LN)'*;6ZPX&+]7^-O=]"#T@30.U%'A[5I'J9V>ZYUZRW?K[:-JS
MV+9V.V#H#8L1M,VRRG8NMS5I,T@=UKJX$$F:5(3<F((I^4F"3EX)0%$)^#Q:
M-6[0ZPH[)Q^.GNT+Q+[+D-)KU1L0BT15NG>L9/726C`MME=G'Y(K6\D5@6S/
M09,8ZOZBPI#1C67<OI"<B_%9V'+V7KO=]V[FZ]NVY]=B]01!KP]U6G`461[K
M+7MQTVQV"VP$WV<N<),6+9D)N^2E&GDLL?0K3'1T@/EQMEP9P,@N_'Q[']U+
M90K0W=:'5W];:[V16Z+)3-+V'C9.N-DWPRL.0^X]6;CU/N?4%YI)E/8KN%'U
M[U"XJV^`S9BA?9LO<##`SX,(VQWJ@&;1V'U\V]I37>Q*?<,Z1L747$.S?ZA3
M:UWCJP6M[9/0V^!Z\AQZ.[H*<^IMP*H_!%2B6_H^`&?99#`#KW\#G9R^T.`*
MW?):GZY[FI=PTAL8W8"-1T/8LSM%BA:M$UT?UDE\ZWW,%&JZZ!"U09,_(R>'
MYO8S5GE4R8(KS*2S`S1UY\$5ZUEV)UYMJD=GM14?6&O[U2;$'I"H]6[HU'*J
M6N[KTSN=/I[%RF^U<Q8SY:$;Z?AQ0D]/JL)0<=,%M,LX8R,,&&V/:/6"\2O:
MNI]NM0;%JM3OT9UZN76FQ0&PJ/-7FJR%/L^P:ILB%ML.S7[W13HZS4^Q5Y[+
MHSCCP\V&7[=3H*VFRL!JVM?P*1]WL2I&X;ZH%[BPK7V1M0KFS>L[-WN-TD-_
M8[''04EN"SC[EK`%VE-%RN_F!ZI@2-B@PX:O^R]!*)#Q!"E(KX.MJ5'LI3PZ
MQ;=8!ZX8U?+S!G86#Z[U"M26LM@#;-Z3V>#K^H:ROL3,7*M;,+DNL%ALB;1F
M/)B0#+J;C+9)3Q*G@EM,^`6V58"!-LG8C1NP;)KP&G':WD5].D5J1K]@JAG0
M)YX2+5$]A`ZM"0I,%T)&B(U(42&[%(O$X^EQ;;[@CP;,?C+Z?O\`5G6.Q)FS
M:]@]97S<VS+5;<:^C5U&4,T[J)NTV>5TYUY=N%(;9@+I!Z=`M<FW&&MIRI+$
MDIE2W,MY<4&RO@.`X#@.`X#@.`X#@.`X#@.!QRTE+%)0"\.,<L=Y(9!8SAHK
M!2FU8'>)#9+`>+':>SA2VD/L*<3C*<.(SGS8#SM[&^!>:VT%9H^]]JZZZW:M
MK:FWR:16>ODU`I8VSH*0[)S.HW\!2/82R+(I(TWV#8?FHY)3!<BU6T,LF"?4
M7710N*Y_$-?M@MUJ.LW8VCMP0(_=F)L@D+H^QB2LK`_(_P!AXKLWVW8CI4W>
M$@)'2B;[7@@:(^H)QJO1*B/J+,V^MI;`;RN!4^]-5HW?J*_ZE=MU@HK%]KY%
M?)L]9#K4E*`B%.-*+&7$W*"LU6FX>8&;6%)`'@D#G1Q#XZL)]3SI#3SUF^(_
ML3UCG*3:H;O!4[]<]<2EFE*S<;/U.J=6DI*&L]$O%(SJ*Y(UEL:G2]KTQ!RU
MW<N(\4?*%.KN`(!*'1A@_;/AFST'Z36?IG!7F.LNY`=I$W:-U*$2+6M80FGZ
M>U.ZPU^-1+!LO-(K4O)5T?8VZ20VY>RD`L`C*?:'8PTZH99A0;!>!IS[M?%;
M:>Y>U)J[%]C8G7=9.*KTI'0\=HJORENRU7=1;%UZWK*WW^)M]-G]@:*GKQ<X
M^Y2U<E5OJ>EH`)`),8MILM`6GISHIM;6]<UK1)_>%!L-!U?VFM&]JM"U_3LW
M6)&'U5:;?MO:@76AF3E=L7`9S7.L=E6ZJ?:/M18QB*AZ2`RL1]U#+C`;.>!P
MY&.CY>/.B98$.4BY0,F.DHV1&9-CY&/-96,8"<&2AT<L,L=U3;K3B5(<0K*5
M8SC.<<#3E,?&GV+?GJ9?(?N#45;!UWNK:N_Z8?=.N8=M@(^_7O>_:C:D?'SC
M`&RZK<K53<ZZWY7*`8`1.MXCH*BM$U_,-(R&"@`SLZQ=?[YHV:['SMZV;4=C
ME]@=ZO;Q0W4]73.LQZ@:;K+6VM9"O*1,;7VD[817&-:#%LD86"MI9#K:D.8\
MBL!E;P-/W:OXX]_;^[!VC==%[&=8M<QQ\"%"4V'OG1&3W->*@IREBUJQR9%]
M3VTUQ7YJ>FI@`(\:<9K$=:H<>'C8T*6:!:-:D`KY/Q'[!GX#5%*OV_=+YHNN
M(-O6Y57U'U@M6J(V1U`YVCT!VR-K=?25V9ODC7;1]VZ.S7V)LTR:/=B93ZA)
M.24TT2:>&\+@4+V=U9>-UZ,O>L=;WFFZUNUH9@6X&]7[5SNYJQ6WXJTP<Z4<
M3KP>^:P,EI)0$8ZW'%#3\87$22V)%AW+PB$+#5KJ_P")?=VF]OZQW=KONC5:
MU9*;HW:O7^:H\)U-@8?5(=#V_L/1]@G(W3@@VX'=N:W!K=3TB&[$HG;G=C<W
MPA^S'&F?4)Z*F@PSN7PT6].\.N/6Y7=BU+JSL]W5[5L6+/7S3B;&-KQB]=!*
MF5I%(*6OLMV:-P0R=FVJB<^F:/C*8C#2UM9#_]?V<_'M_P!`O1[_`+0.M/\`
MP8I7`^Q'27391#Y+MS[<I<(>=?<2/\@/?(,=*WEJ<6E@03LBP**SA2OS6VD(
M;0GP2E.,8QC@3#7O5[6NLK2%<*W9NQ,E+`,FL,";"[?=L]MU9Q!XKH;ZC:-M
M;=ETI4D\VR]G++A,>ZX,[A+K*D.I2O`0\CI+ILHA\EVY]N4N$/.ON)'^0'OD
M&.E;RU.+2P()V18%%9PI7YK;2$-H3X)2G&,8QP)AKWJ]K765I"N%;LW8F2E@
M&36&!-A=ONV>VZLX@\5T-]1M&VMNRZ4J2>;9>SEEPF/=<&=PEUE2'4I7@(>1
MTETV40^2[<^W*7"'G7W$C_(#WR#'2MY:G%I8$$[(L"BLX4K\UMI"&T)\$I3C
M&,8X%D:MZ]4+3\O(3=3G]XRYLG&YBB6=I=G>RF\8AH7)0Y?JQ]?W7MG8$!$2
M7JC)Q[P09DSTLK;]7TUK0H,=R/C[UV5\@@_R).[&VU^)`VIDZ:1JY-PDD:35
M7$)P0FSN4S!'J*V%B00A.2O<8A\A-IQF+S(8^I<#]?)+J1W>765W643(;7J]
MRLFW-&M479FD*_89S9VF9T?:M6)E]PUDBO`FJ@7-?T5N8-()+RV$4*ER/7ZZ
MS6Q"`TL3.W?EBZTUZ/L=3ZJW!_;MBWI?I/LG%:<TK^*&N=RR%5O'2_5\GM^L
MR+$45:PZGLS7S6V-AP579(J:W#I=M"YIHJ+?A)@(=N[:/R_W*B5)5TU/NF9L
MNG-A:$W)K)S5W7Y>RG-F6>#WANF3V&[+R\AKSJ;-Q"=;ZC@J$&'%RD#KY%I7
M;)T!])@C2I2/#('4G=[Y-XB;UXWV4HULUG3!>Q'732T;<KCHT>&![`#[Z[.Q
MM)MQED?-A:&1JQO7^G9V$<KA(\<`]*3$J6(:"X_&$J9"Z/E/UOV+V/N0$;3%
M:O$B'%Z/J*1T":KV99AKI9#MJ6F476=&[[UHXXQU0WQ!9JT:HV7MT;.:^L\+
M,CB6-AB.CW$FABM6NPWS*ZUTSKV"ING>P6Q+M0*-K^LW#.W-+ULTK8DA,4CL
M'*=F-M)G(N-@3I&Q:'V37J-$T2%2Y#JNV#)'(X%ABCXVP1X9"](+-WNB>]>P
M8C;L+N`SKYM64-NCFXT:!L>O8[85QK^D=&4^FLWJEWC7D=^#-7-#K4Z^^9%$
M1LE,6KU,'PT$.H=IX,5_F-TAWNN'9/L](]+*IO3%2WS\?#?7#84A0(6\0\0K
M=U?&WMO^B["J!\3#>RG;Q-C:WJ>HCIEAY(X@6P1D$FC)A7<BA94=O;Y7&-D_
M@KJNE;:U=IW,EKBIZQV3;.FILI3M24FM3FHJ/-`RU/$A7++;XU_6MLL5E$*<
MG@WC)"`C@GDP"FY>->"M]07OY<-*46?TK`5/94/&Q_:+?CD%M;/6ZT&U(G1F
MR=_=]]F06UXVFA:=VI==?RSUM7J2&#H045:8^OZWLN'&'QRF)-RH!MQZDRW;
M+_E,W_'W(?;AO9^+L_:>;IKVXZS5Z[66;=;=G;AM6FJEKTK$%!JLM$B*M(5E
M_!A").(%:DD1K!ZW`#H^-#7IUYTP9,SM^'E]6[CV'KSL?0/B3E:78+?3KY:C
MYLO7.QEH[F-[GN9XI3&N]GPQL(03?XZT2$9,21"%,99,(\!^!<7Q'T[L97-@
M34YN37%Z@HVU]:M;9+GKUK#9.E+Y5;9$620);UQOF(M$K.:MW_OY(MA-5);0
MHZX],V#&,)G`62G`4H"J>K5][\&_+=O*S;.T3L^EZ:VK(6Z+C)2S:5V=.4JC
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M$:4=VA+P^N(T\IB?ELUYF+6Z&*`&:M3W#WY.3!0VS-A;$V6S8=ETDKK3L>,Z
M^HTM.V>;@NY9%7BFGDBPT13K5#[?Z3GRMML8[PF`8ZE(>>;0(?$2A[H>B[@.
M`X#@.`X#@.`X'7RWMOI4G[SZA[3Z>;[KZ3]5^J^V]LYZ_P!,^A?^M_4/2\?1
M]G_O7J>'I?[3R\#QT[@TY\G,S'2HFD8KN&Q(P]XU4)1)&7F]\PYHW4Z,F.[$
MAVYJ4I-70\23E=F;)AK#0EAK.=)M-BE2JZ^*2X3`%O0893;.JG>^>K6AJ50:
M1VA`%U?)?("=K,QT78\4%7[?M+MC`2WQ8EVV2?.18"*]I_J>',Q%I^X,.!5H
M)]<=-86^8PT^'J`X&F+Y6ZGM>SV72J-95GM+:HXC7O8>IWD#K\]L9^%$^^:I
M!P-%E[3!Q,B%0994=,K+45AS&9UR#4<&*XC!N$N!KPZ>5#OYJ;M-4=N[9U[O
MJP:DJNT=Y5N8IJ*'LM5Y_"[-6[!3&O+MI!QYJ1K,!TJMMBNM;CH#1=IDU[(I
MDQ%1<F26Z)&/X*#9O\257WC4M?[%!W%JJW41N3%T]90[#L;.T`-A3>PK#KUN
M1W;2IR`V=L78;8T3J[8CCXL;(5M4=5))DU?T]AWT'3"@SO[:#3IO63?`=7<V
MTW9RM6W$>MYT0F-SN%<^]#DMPS.N\S41/0K=F(DE--L+-#)#;\V5/HRUA?`\
MJ8VA>]]>)N.-4Z7[625KO&P+C1A+GM&/W)7J/HO2VV?Q_OY=_P!-5M.U+"W(
MZ?Z[;(M\'21*;.U:1V9:]=DR28UN)20+B/#)IRI=N+9JCKOK&WU;O#2]K:8V
M5ME^P6#2.O[P-HXZOC]M*KN#6%MT>+=XB#M5..M&L87-&J,/9IA$7K;7,Y-1
ML[B8?""%F`]3'`TJ?*76]PS6RM7+U=3>REVK\OUX["ZUV1'Z;9VS)5F-_$C8
M'78.LV(F%K%BKE17>*[38:ZG"&"OLV5D8=8H[N'#@1R0PFZR.]L]8[WJ^QKG
MTY[#(BZT=?M)A@P59WB^DGKZ#%;MSJ+M#3!KQV0V35(G;.T+I(5QJSUR\!R]
MUA6K7(%/%,A1+[I89]_#CKWM)K+4>R*SV<%.*/Q+:O.J=N.A]B4R0L^5ZBJ@
M-V1<*/LN(B9=S:T1;X]]-JMT>AJ$O4L\J5%&$<60PD-N-A]E]`G/J7UCZ=]'
MD_?_`&]]?^O^R]D_[KZ']J?_`-I^L>AYO;?3?_4/6\OM_P#;>3@>1&NZB[>.
M0/7Y5AU]\C=CE*MJNBZOW)"S4;L611/B775M=U[MUDVU2%LHMM,U!KL2NNV@
MAD67GKY9=H229"'2`&(:]/!E'.P'938]1Z<T.7U%W4TW:]0WS+EI=T]4[PNB
MNURG]JM6;'U9L&&GK]:[/8`=J;RU#7UQML>M-MD8ZKUZSW"/F0I.4;C1G`],
M?`PX[_5_:UKZF[.K.DG)0?94](:RBH,^-CY6>'B`3=MT1BU3MHJ$$(;.[#UW
M`U%9YMHJP"$G6JN,'1`[C+QJ'4!IJZS]8]HZIEH;?FX-8=F6MVIU#OGZS==3
MF[JO$9"W#8>Y8[K%HV)T=I>YVJ*'JFJJ;I]L[8$75K1&OV*J5^:$:E3?7@EY
M6&N&WZM[^X1UZ%?H^_50#FFNX[D9KI%6W!^/K%(9Z"=%=53EG(UO^)";YG8Q
M7R#OQUD91]=7$XV$R[8?JR(S/WNL/__0]G/Q[?\`0+T>_P"T#K3_`,&*5P+!
MJH?:5L>\8N]AT"64[`R*-:JJM.V)'C@6=2"?I!%X1+WJ3<EH%IS+/N60%!$+
M3A?D=1G*<X#AB!=M,4*59.LG75>T%3PJX.0$I.RVZ$S6,,,X.'E8=[8#MA(G
MEDX<RT\R<T.EO*<*:5G&<Y#[3X?:Q=.IS57L?7L?8#7U/\0#9^E[',IQOF?Q
MF&^SHR.OH,U&>D+XX*]Z67ZCGY6_)C\G`[*:%[*JN51=KL]HUC7K;-9Q?`IJ
MI7XJY&$(,QFXJJ,H#=0X2-9*`\4QF#`RU,/?G/Y>3^;P.9&#=A4[/,?F9O3+
MNF,O'Y`BHRKW=C9Z!\A*Q%I,GRK>35'7FY'RJ?RB-0E;'BE&$J_.X#6@W85B
M8G%;BF],RD`ME.*TSK2KW>!F&"/=*RI4X3:;?8PBV?9>7&,#M,*]7QSX^7\W
M@:QC^U/R%#_,K':.8ZF[0>^-16D\T60WPU6X=VOI[!F!M[%&VDF928JP_888
MB$T=P3#&$)DWG#UY]NWA6`S6[Y;2[':5Z[R>S>K%9US?]LUZ_:G`!U9LJ/FE
MQ^VHJZ;'K5`.UO6K1#W6GMZXO5C?M3&(FPGM3L:`2WA),42AWSLAJVO'S*V*
MI=2K-V\K3VK]DU*7[.05:U_3"-8;(UA>*;H&ET"K;P[+U/:$&1LG8LQ+]C]7
MTM,_1&UB!P\4ULA@!!$=E@C(>0ZGLY\K79_7PG:B;U+'Z=`KFF]7=O\`9NI+
M;LKKON"Z:;W6-UDU7?\`:4=`:T[':T[#`:IV'=I-C6$M&VFKEKJ%LJS[)9+$
M9+B1![G`L#MW\D^WNJU$[-5C85+T=N_=/76]=>9JERD-2K;2-<;#JMYU_=]X
M7FNLTF4V%M6Q4_>-=U=HRZL5U.9\H,^;EJQE>&D'/,<#OIOY9Y)[<<VBER&B
M)344)WOZ?])X/74C(2[._=L07:ND]=;"UV5H\K]W"QD;0ZP;VH@7QHE=5DE2
M,579)U<H(Z8P@$+/[V=_=N=7][0M!J5;@W-;`4/3=YOU])TW>=TQ-.;V/N*Z
M4DT;;\QK/;55F^LU3F:G0)'-6N4_6IJHR,T,>U(G10\4^M\(D[\WO7>EZPU9
M<]M:ZV]"S=VH/5XZS!T^-H-E@*QN;MOJ6S;7TGHQ,@5LB+DW;5L6.J;S4:<Z
M(U`!9D8[,O(QF"',LA!:C\VU,A=C=F:?NW5.W(`S5Q%(O%.U6+J$:@;ZI.FK
M=!=:X#WN[J9L#<SS)M@:W+V#'CTGP/DC689M)YK0@B/>/AG_`'#M\N9Z_P#4
MS<.EH`=\SN?;.ND/JYO8&02(RIUO>,$QLF5L=TQ2K0?$RDA4]2QTJ2,#&3:P
MYB>9$`8D<-%)+P&H"D?+AW)N(^F&9."TOK>V[(VOT6J,O0[[U<W>,7)4_LQ:
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MSW2Z.I,*83D`M;]BS-NM$1SD4U(ALKAODUZVD2>HJE98GL76]@[=I^G;5&UP
M'I[V^O=9@7MU5FMV6M0L_N"AZ'L&GXTB,:L[#$J^1-L#Q#R'<'J%RR]AL-56
M\/FK[(:?N.S*NSIW5-V#JS-^L4-,ZMC;EMQ8E4J-J[F5V+GCX6MWF)EK;IY*
M>O589N^T(YL2"UM89\N%-BY$@5QX8)INKYR92JN[=O&I=?4G8VE-2E72S"3-
M5=L.UKYL77],UEKNZUT9%9UU(YQJ\K>9\]8G:_8I7WT3#0\$,Y*"?4))4>$&
MR/N+MG9=2[#?'GI6I`:5DJ-V@WSMG7&S$;8U=/[&EXL+7_5[<F_X.:UZ1&;.
MHL/79IUS4A<00N0`F4*9F$O-I:R*MDP,):%\BO:X7<>K]7;6'TV7#3VU-4:O
MMVUZ)UTW`QIMRP;$M/H/4:5V3%]B-JC]=MR'5^VUABMP-ZCT1MF*D&'@)=\B
M4#A6`SJ^17O]0?CLT0G<UUIMVOYDC:JC5JY5*C2]J3PL@_/7.K5V9*GK9KC5
M^T`**S"0E@>/$S,#BM31@R(P1Q1A+2>!D'G;X^PNNDWNG3)907UG6-JMVNSM
MIZNV-57!)0*$E7H(J[ZDNS>J-FA@CRH:%EQ1:H&0('QE"'ALN(>2&D'I9\R&
MZ+O5-:7GM90`9"$VYUUTGN"(C-)=>[+J.1I,A=@.L"KS:)23W3VDNL?L/2J+
M)W%I\37Y.%;9EBU1\J8Z%D5"<M!:DE\[FF[/JZ\SVOM"=I:C=&=!(WG0$;1U
M=J5YDND77K_M/>VH]L$:^'[/4ZT6_6-BB]4R(Y&!)**<'/2P#(%P^3PRU!:5
MS^9_3=0V:?J.!Z[]H]VV&!V18-.6&RZ<CNM9E3CMEUNY=BJ$[!2HUN[15JT5
M1R>G.JEV)#;DPV5#Q4<V:8H<5]I]89A=2.V(?9U_9/LXUMB+@`].[#HDRQ'F
MQ*Y_4'8C4U=V_K-RQ1!ITMB&OD%'3),7,,#F%"/.!-&M9'P9D$0,S.`X#@<<
MOW7M2?8^W]][=[V?N_4]K[KTU>W]SZ/^V]OZWAY_)^=Y?'P_+P/,[MSYRMY:
M?A9&1F=):SF#:KLSK_UWM($,[;UCE[>[)6#MC!5R\5PXJ9'>5JO7+W7^'S*!
M$C)DY=J6D'6B8_,>PR:&3FT_E:V=KNGZN.8UC3Y.Q+_B3R^UWU#V!N*FH7XR
M.U]3ZL[!AM:0R)_)T%8-X'6=4S6WY(Z4:B6QTBDL&J>R^R&\[@8J]U=WW?KC
MURN^YM?PM5L,]3I*C)<B+B]+L1!,18[[6JG,.H7"J0:J2"`G5OC(RI#3KS6$
M+6A*LJP&*6A.\>Z-B;^H6J;_`$_4\)6K);/D4I\Y-UH^UKDH^0Z4;SI.L:\8
M'F:=;`Q%VNN7#!D@X]C"VRV<I:0VU^7(6%\>7;_9?;"O;2SM>I4&J6O6\MK$
M9Q&OY23,@)8?8VGZ;LM1]7<F##R[MK5D^QOC5N]BJ&B+P"PHP(,5MI:5AL)D
M?J'T\[Z3[/ZI[,GZ;]1];Z?]0]%?L_?>V_WCV?N/+ZOI_G^3Q\OY?#@:$HOY
M?MD539&BX[<E$TZ#K_:VM1YB5=IEEF&YN.V(O4>P]@HI\=9[3*!T\6W6"T52
M-C8:IRJ`9$FM2!ML*/#B8DE#@?BV_,7=X+0/0[>HFN:C(0G9W5LQ?MP2U,"E
M]K4G24Y'7;2]2&BK[8*_<J[*ZIU+@K8<J%*;#D8Z9`@I4$)@J,SDWRMAO\X&
M%'<WL=L/KEGKZ52836\M&;6V_8-8VHG8UA/JX<"R+H;<NV8.7'G6E-P\/'_6
M-5H&DS9!66`@"%O82K*/R!J2TM\SG8BU;5IE3V5I"FC5`_?N@^N$H=0:7M0^
MPSUYWI;*#4Y20D&3)J0$Z_1.I4;.BIU#=K0:Y>J@Z--12Q&)!MH4-S?6/=]W
MW%.=IX.\0M5AB-#=H;-I"O+JCTN^S,U.-U9J'8L--33DNK"\6(G&R7&RD,-M
MC->BE#>%^7+S@9-R>9+$;(9AD@JF,`EYB4R:B$1JI+V[GL4R"Q$.%(!R5Y/5
MRVE3F&_'RXSGPQP/.K$_,)ON:K6I;&Y#:!K)>U-6Z917Z](UJU3@%B[&;`I;
M^V;/J2)M<;NH&PPLTWIT<F8JL5(51/W6>"B*&E,&'IP&%I3WRT[>KVF.G&]C
MM,P9=,WE3_K&Q!JE`7R]R:[8YV]ZZ=8VJ'!+@BVQ=/VP2!W#*3T@#:?J.8^<
MC$UA;JC6WBU!OFX&`7;/LWM[1>PXBLTJOZQD*O,===J;>>G;C)'B2<!+ZHWI
MU8H%F)*#>GJK"2]=`UQO^1EF(]N1&E)65B601UH60C"PPRZH?)#V8W+L*/HN
MV*+I^AW"0C[Q2(#4\-%2Y-@MG8*B:C*VV]K>QW;.WYH_04Y*T]UJ6.A[-32,
MUQ0)\([)G3`Y*`PPNN'R&]YG-\]=]J9T7J+!HE)[ET9NTH;*<JKFDI#6/0_:
M[VT2*IC=&"`Z2SV?C$4!F]*LBJL33UN["2TFKL*(4'__T?9S\>W_`$"]'O\`
MM`ZT_P#!BE<#+_@.`X#@.`X#@:X/DSO[U!U9I1X34T7NHZ;[*4EF-HV:$]MR
M\YE:71]E[;BK3J/3HFV])R.T-D461UPU,M1X<ZD\"+!.EA1C"8YH=P-7P7R!
M=(A])Q^YMK=0BMG;<-*WG0]H$Z(U1"4.+M5YN>L>NVP^RS4-KS9^SX3:T$G9
M(NX8@.9A+&+BQN3]7/#E6D&A@*,"G;+V?Z!0-*O6C=<_%M,:C<@+Q4:[V!H^
MS=7Z(EZ/INK['VWU_P!0;LD-T:QI7:&OR8,IL.M[9C(.%+CURA]BCW%R*0):
M`BS!'PM*Q]^.C2(>++H_1>W:JO&RM4W6_:)V9NC7=%!@-A1F]>O#5HI>PC0J
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MHME=UC*Z&WK6!('9\3L"UP]FOAE49E#(U0$Y`EQZ$23L<>-X,!O->*U@?T!H
M.R-C4842CZTZ\ZO[##537;V:TJF'Z=HT!MNLIUJ5+V$%$$]4Y&LLIBT'RB1<
MLM)'.><%<(PL-.5>[D?%56XJOD%?'K;*?K34;=0M4;>*I3]+V;4^I#:5L#LA
MG7JJ=]H;<>(C@P;AI&Q2E::@8O\`*LK):!Q\MO+0&PWXU[I![<:[BS-5Z]Z]
MZW2FH.QLKIO5L&SK2+KL]5:;L?K1U;[3R8UX@*CM6[U(J2D]I;Q-*E5U27A8
MJRL!`FN##&Y<<P&MRH=O:!5I3J7NKM1U<T-L[:?;CK5/[VU+:NK^J2]6;)UK
MM^R;4U%KW8]-^N[$W9;E5V)W2)N@26,G0)J".EAZI,LE"S93@K"0[:Q=\NB.
MU9&@0L1\:MXS,['N&HM$5EK?6K]04*%5IS5FT^L6H;=$!UB9VBS,T5S4=0[S
MQ8$9"R4?$"L.V&5CBLM(:GPT!L-ZP_)O4^V?8&M:NTY`BPU#C!=MQMP:G1H2
M:F"2*A'4,^@S5+MM"V#-TP.)=1*S$?,1+X91@L@#A"7VDM^)`8T;ZFM+Z%[C
M;WK%SZ?:FVY1V=5=$*S1(?2&EX.N]A9BP?(9V5[BZ.,U[;-DW?>U:I!.C1[)
MKF3D)*%%C(N/.,NQA1S7D9+)?#'MWY&_CQW=MO65RU;T.EKWLN^;.TE/'7W;
M58TM5#8H"0?I[<C9(=-MVV*U(RVO&P`(S!S;S=:#F(T;.#WTQR<(#,TWY-=&
M;CUY1=C[9Z2=H(&M8LG7^W:0G;M"Z/!F)J3W['PE/K6QM12D?O5JP0X\`;LQ
M^NR<LE<8IU@]UL910KQV!PQDH7R!?'!%MQNW@OCHVYJJ7<A^K955.*UWUSC7
M+/9;)%]8(GJ#3Q(BG[UF"V9R)KW9^ENP1,W'`!U1I3_G?"*&6WD+-WW\NNHK
M[J39=.LW1W?,Z2.57P8>G;XJ>JXW7UHV)`1^AMN"0,FRO:A4I]5HH>SXJP8P
ML5@9U$:RMHQMPP+*PV&=;NZ>F>\ME[.Z3@J/<HQK2Z86H;$CK]BJAHM4)L<S
M9U3;?C(FO6R;G6:[*JUM*)'-+9#&E!'&R`'2659<2&JB:[]?&\]7*;3E=";E
M<]?]80;U7:212J]HBT5O1VG=;N4>\R,K$G,;<"56ZC'26OH]Y$&`MYP.P5..
M8:8R2U%+R%B=39/J)WF[`[!U0%TZU2QU;J'3;2<AHA^[ZAC(JUW'4Y.[.UVG
MH\!R2CMI7:#GM),D4*6+I\')P==FJVB5,]8-O!C?`UI=3!M&Z5[/E57;NG=F
M;%U?=ICMC?=*Z[F-8!1-:,LT1O._["J^\]+[N+V?&:?[`5LO5=O)@"CI8UB^
MTZ7L8X10,='3$Z\*&?\`H3Y9NI6EJL+':HZ:]FZE"[3O%$@:(*M[1I'WG(NT
M_IA7ZI4*L*UNXC[;K>M=*=F:&-"`*9"CVHJ((%PI,DT^AT./'?.XC\3YB9FJ
M20/H$#?<UH(*!CM8L$;@7L]FFZ&HX6FYZSD=BQZ="WR)[9;3D*^3."PTK4S8
M<)+N"PFV\298;&>K'R;ZG[7;YFNO%:U?NG7-\KNK9+9LNUMRN0--\&J_(ZQB
M+/!P\4Y92[#9DP$KM:/&=F8T,JNN$-O--GK<PA"PV2\#CEBL'"DA%-^J*8.\
M*2UYEH]1@AM3+S?G;4AQ'G;7G'BG.%8_^F<9X&*@/0[I@`,H-OK!I,H94?,Q
M2FI:@0$XG(%@Q;L2['C-"'JQ[I.PK%C"L9\[2;%+8;RG$F?@@.T9Z3]0V)6,
MG&NM.E$S$*17"XJ3SKJLK.!)J1))M>?8)<CU.I<CI$MPO&?'/JF9P0YYWDI<
MP&3_``*[VGJ76V[J9(:[VU3(._T:6(CRI.K607WT+(/Q1C,C&N&!96ELGV4@
M.V^WA?BE+K:5XQYDXS@,>G_CTZ2&.O/']9M52BBBK<:8B7KZ9<<XN_R,5,7P
MD\62>*&.>NTO!`E2ZGD+S)$A,.D>HMEM20OO6>E]3:9$E@-4:[J.O@YUZ'>E
MQZK"A1#9V*Y7XRI5H5[`K:,_3:Q5(4.+BQ$^`T;&BM##-M,-H1@+"D0!)6/.
MBSVO7!D@R0#6/4=:]80QE8Y+7JLK;>;]1EQ6/,A258\?'&<9_+P,;J'TMZH:
MOD(N6U[H#6-/E(-Z5+AI&#K0@1L3(S=8,I$I,1I2,>L%/%TF0(A<GMY2:F(?
M<"2ZD9:FLA':MT`Z54A_W50ZR:@KA*XN-@2GXBH@!.2E<AI."F8JK3:V4IS/
M5./E:O&D,Q1OKQZ'@!U89\66_*&7_`J';6@M+[Y'K0>Y]:5'9H-/EC)VM1UR
MB69N-BI>1ACZY(',QIGJ`NO'UV6+CWO4;7AT$P@=6,LOO(6%0D=`^E)I5A..
MZNZ3D)"W0<]6[9(R%#@SY&TPEFK,I29F/LD@8,^9.MDTR:+AT**6ZX/%$N",
MJ;'5EO(7%JK1&G='8MJ-1:[K.O6[W/-6BX-5@'$<Q8;$S&!PK4U),-KRR])-
MPT<,'AWRX7[45AGQ]-EI*`LZ1`$E8\Z+/:]<&2#)`-8]1UKUA#&5CDM>JRMM
MYOU&7%8\R%)5CQ\<9QG\O`Q0K_03I5508J,KO5_2\3'P!`1]?#%H\/@>OS<6
MB#:AK3`-K86F#ND"-5XMB.FQ?1EH\:,#9&(::%80V'.K/17IK3+77[U4^L6D
MJ[<:NH5R#LD1KRN!2X3P+U-+!(48R"ETPH*4UY!2#+K^77&I2($.0K!C#;Z0
MRMX&.>[.HW6?LA)1\MOC2M#VP?%0;E:C7;M$)FD!0+U@B+6_%#C$N9%;#)LU
M=CCW4X1_M"XT1U7BL4?+85LU\<'0EB`35F>H/7YNN(*:D4PJ-9UE,?B89F*S
M.IL&1\`^3-F<D:5#9<D\_P#J#K,0$PMY3`C#;88<7+XU^@C?:_KCIQ'4/0R=
M6%]>NZNS2:$G7T)BLO[!C[MT$UX#<'8SV_HKGA:+)D1#;^<>=,<\MC'^S5E/
M`__2]G/Q[?\`0+T>_P"T#K3_`,&*5P*%U)\M?5#=NPI'4]`3LXW9%6[,WCJ;
MLRGR5.#AIC46UJ!5+M=YHG8S<C8&&8N@F576-H+CK`(LZ,D/MN198<60/Z2@
MS%&[.=>3KO7-<Q^Z-;R=RMNL[;N2O1$5:XF43(:MH\[&5FSWG$G'DDQ`M?`G
M93`Z'GB&_=+$.R/AU,<>H8)0[NG3C.8C#VV=9M9GX,"SP.';Y5F\S=:E3<QL
M788C"I7'U*#DI#&6!RV?..\]CR(7E7Y.!9G`<!P'`J_:FD]0;QC:W$;BUG1]
MG1U-M@=^IHUWK458TT^^1L1-P,5>:HY)C$/5NZ0T39#V0I8)3$@$DMS+#K:E
M9SP*6DN@/1::)BC9OIOU>G386-1$1QL[HC6,T8U'-@Q,8V,Z5*5DL@Q+<?!!
MLI4\IQ:6QF\8S^;C@5#`_%OU2B]R[#W'/0$IL;.S;I9]B6;6.RP:#;M4D72Q
MGU*1$G':\71&IF9^RB::*NN"2DE(`0;N?6%800P&Z,$\,^-/X[I+$8F3Z+]2
M)5$*W`L0S<KUZU5)MQ(M4DI&5J04:V=5B$`Q]1)ERT1`[6$L18I3HPJ61W%M
M9"V=9=5^OVHM87'2U'U118O4E^L5[L=KUGBIUQ.O91S8IKY-DAET4:*&J#-9
M(#=2']/;!2.Z,UC+Z7GG'WG0BA/1'I,6E6'NHO6KU<PI5<9-:TCK<:3CX`R4
MA9U^'B)4>N-24+&XGJW''H9$=90T='BD(PEX=E:`ZU_X^>B)9CIQ_37K!)D/
MD$FOYEM%ZUEF7Y,X&#C)&;>%DJV4*[8)2-K$:.7(*1DTIB/&;==6AAK"0ZF2
M^-SX^)K*OK?2+JE-H6\\^IF:T'K&7'RIZ<;LF6O;2-:)'P*S.(40RSA/HL+>
M>PVE"7WL.!95`ZE=<=9Z]VUJ6HZ=UW&ZLWE,6:6VGK)FEU8;7%O9MM(@-935
M?DM?1\.%2\U<W6]6CH-\!(&&#0A?,7@@AXE]X(;#?'UT.KR9]$+TLZI1V+7-
M1]DM"A^OFI\.6.Q16"OIT]/.JJ:G)>:#</)=;*(RX^E\I]WS>H^ZM86WK?KU
MHG3U;M5/U9I[6NOZM>SE2=XK]3ID!"Q-SDG*Q#4IV0M@00+3%C.?J%>!C''3
M,/..`B-,JSE"$IP$!9Z2=.`Z^558KJKUW@*^8W46GHNLZ<U_6&,)H$T]9*'E
MA5>@(QX5RD6$EP^(6TI"XPQQ;PV6W%*5D.D/^/WHA)1R(@OI=U45'->MZ`K/
M7W5`B!O<2E/FR?:J$JC#@ONIC7L`4[Z:D^J_"`+5XJ$8RV'=:TZ1=-M,7MO:
M&H^J?7;6>R6`51@E^HNFM?5>Y`QJAI(#,?'62&KX<O'`_2Y9\+TF'FV\1^4"
M^'MVFFD!*;+U9ZQW2VS5^N/7+0]LO5C^U/N&ZV74.OIVVSWV',*L5&^M6.4K
MQ4Q*?9E@7DZ)]=YSZ<9G+P_IN?G<"MA_CWZ)"58RBA].>LP=(..<DR*:'I/7
M8M4]^_)Q,P66Q7!Z^W#B/2,A7X]1>6F4>[1'"-O>=L9A#82:Q]*>G5NKM`J-
MGZJ==)RJZI;:8UA6I'2VNB(+7@C,N//8CZ3$KKOL:O%NS0K93HH2&1WGD84X
MA6>!PU=&.E*H_$4CJ'UD&`0.,*R.#HG5\?@1D*,JT*!@!P&KCO1[D=$T:$&&
M6PIM8S,,`AK*<!CX;#\D]%NE)@$E&E=1NM3XLP]/%2V5Z0UMDN2/M,"S5K-*
MFR/VW]0)FK#6QVP335NY+*%;2VXXI*<8P%AZ>ZZZ%Z]@R,9HO3FM=0QTLR`-
M(@ZZIT%412@XLR;DXV/6Q"A!MIC09BT2IS0R<881(2QY6$>X.*=>"GHSX[>@
M4/)3$S&](^I@LO88,VL3DFGKQJ99TM69%@L,ZMGE.U-QXFOE1QJPUA*SD;(.
M$#>3V[3;:`M75O63KKH^=GK/IS1VJ=76.S@XBI^<H=$K=7E92(Q89VVHAB3H
M>/$(S"MVBSR,@@/"L#(,->=2C"W%9R$!<Z(=*2(TB$,ZG==Y"")'EQG*_*:A
MHLI7D8L4ZS:;,0/`R$(3$"2%IM`K4G*E-,H)E)%ELHIQY]M#B0QX8^)+IZ!7
M-I5B(J7T4#:^RZ7L"45&T[2R?MJOT&3TE)U[250CR]3%P<=HS/\`RZT\<V")
M$,5)B0S+19#R<8\`OIWX^^B+[66W^F75IYW*6O&1=T+J]R:R^Q'`1#)^9Y=8
MS-9EF8V*%929[CW:4C->#GBVC.`LO6O67KOIJR3-QU/I'5NN+78DRV)VQTRD
M5^O34LNPDPAEE)/D8P$<HDZTE5>*<E2%*R_**B`,E+>]B)Z(7EP'`<!P'`<!
MP'`<!P'`<!P'`<!P'`<!P'`<#$"Z_P#7UUI_[0.\/_&?X]N!_]/V<_'M_P!`
MO1[_`+0.M/\`P8I7`UA;_P#@+U'V81(V78VY):M[AG`>[M7M.S=/T7-#3=-?
M]QYW=5VCZO<JQ+WNZLSQVB[MO*8S`R*S$.%0!9D62UGW>2V0Z>\?`PQ<J/M*
MD#]LYJI`;W9[6YVXBJZ:BHB,65V1W%J;=T*-JN($V$RC5M9UY;=(0#9$<EV3
MQ.BNRB?5`<.;<$#I:C\"]#KFS&;57>Q53=DJM!O@2>N9_3DKNRB9=NEZL>Q9
MUVW:][(;^WI%S8\S*3;Y,2?+LE6J.(%'PS..QP8T<P&]:>WUHRK6AVCV?<^I
MZY=&"(\1^H3VQ:?#VADJ6'%+BAG8"0F!Y9LB3%.8='1EG"GFWD*1C.%ISD+8
MX$;K5RJ%S'(+I]JK=K$$<99**K4Y&3HXSI(K)H[1#\644VRX^&0V\A*LXRII
M:5X\4YQG(23@.`X#@?-#S3BGD-NMN+'<PR^A"TJ4PZIII_#3R4YSEMS+#Z%X
M2KPSY%IS_P"&<<#Z<#HYFSUJNNQ#%@L,'!/V"4&@X%F9E@(QV;FC%80)#Q#9
MI#"Y*4*7G&&QV<+=7G/@E.>!](.PP%F#=D*W.0]@`8D)*)?.@Y,*6#9E88Y^
M,EXQTD!\AEN0BI(9P<EG*L.,/MJ;7A*DYQ@/M'3,/,9D$Q$K&RF8F2(AI7$<
M<*=F,F`T-.%Q4A@9UW(4D*@AM3C#GE=1A:<J3CQQXA\8"PP%KB1)^KSD/9((
M_P!?V,U`284Q$F^U)>")]I(QSY`9'MS!W&G/(O/D=;4G/@I.<8#Z+G(5J:&K
M;DQ%MV(V+.G`X!<@(B:+A8LN.`DI@:*4]@Y^+CCI<1E\A#>6F72F4+5A3B,*
M!-SD+6HB2L%CF(NOP,,&_(R\W-R`D5$14>*C+I)TE)'O,!@ACMIRIQUU:4(3
MCQSG&.!V#+S1#33[#K;[#[:'F7F5I<:>:<3A;;K3B,J0XVXA6,I5C.<9QGQQ
MP.K@+#`6N)$GZO.0]D@C_7]C-0$F%,1)OM27@B?:2,<^0&1[<P=QISR+SY'6
MU)SX*3G&`Y4=)QLP(D^(D`90%;Q8Z#8XL<X11`!;X!S"2!G'65/!'#.,NIQG
MS-NMJ0K&%)SC`=?'6JL2YU@BXFQP,I)U,I@&U1T=,1YIU9-)#;D1@[`(,0Z1
M#%$1[R'T-DI;6ME6%XQE.<9X'ZK5GK=S@HVT4^PP=KK,R/[N'L5:E@)V"E1?
M.MKW,;+Q9!4></ZC:D^=IQ:?,G./'QQG@=YP'`<!P.G9L,`3.'U@><AR++%1
MX$M*5YF3"=G(V*E7C!XN3/B4/J/#CY)^.(0.\XVEMY;#F$9SE"L8!$V&`GG)
MAF"G(>:>KLP_7K`U$R84BY!3XPH1Q,',(#?>5&3`X,B.\L9_"'D-/MKRG"5I
MSD(Z7M#68%/QL,[8E%"H"E90F\EVZ`&IZEI.<C%)Q9GI!$+E29)E8^<>OXX?
M3EO_`,V,XX$V9>:(::?8=;?8?;0\R\RM+C3S3B<+;=:<1E2'&W$*QE*L9SC.
M,^..`=>:83A;SK;*%.,LX6ZM+:<ND.H88:PI><8RX^^XE"$_^*EJQC'CG..!
M].`X'1P]GK5A>EAH"PP<X1`F,1TX/#RP$F]"R!,>)+#`RS01#[D<81%R#!*&
MGL(6L=]MS&,H6G.0^TG/P4+%ES<Q-1,3"@*4@Z7DY$,"+"6@KV*TEGE/-"#J
M0;GT<X6O&<._F?\`F_)P/U,SD+7(YZ8L,Q%P,2.X*R1*3,@)%QS#IQ;$>"T\
M:<\P,TX8>4TPTE2L9<><2A/BI6,9#YS%A@*]]+^OSD/!_7)@*O0OUB3"C?J\
M_)>K].@XOWK[/U"8D/17Z`S7G>=\BO*G/AG@=QP(O6[O2[DN7;J%OJ]J<@)!
MZ)GFZW/Q,XN$E1GR!2(R73&%E*C9!@H-YM;+WD<2XTM.<8RE6,!\8'8%#M,K
M-0-8NU1L<Y6RC`;%#0-DAI>5@38\]^*/#FHZ/-(,BR@909P9YM]#:VGVU-JQ
MA:<XP'TA+U2+*2&%7+C59\R1K,9=8\2$L,1*DG4V;?(%AK:&P"8^Z369<D1U
ML4]&%"D+:6E"U93G&`[*8L,!7OI?U^<AX/ZY,!5Z%^L284;]7GY+U?IT'%^]
M?9^H3$AZ*_0&:\[SOD5Y4Y\,\#N.`X#@.`X#@.`X#@.`X&(%U_Z^NM/_`&@=
MX?\`C/\`'MP/_]3V<_'M_P!`O1[_`+0.M/\`P8I7`R_X#@:D]*]5>Y^JN^^Z
M>UAU@TC.Z\[1QL16MU49>R]A^\JD;J.YV:.Z_6C64(G3`L(?9H?2$OB*L;!9
ML>W*2S_KI)PV$W@H.!W0^.N2[![#VS;J)K;1#+VT=-R4%(7*S7JZTR_+W:3(
M:IKT+LG)=4U7:2HLBJ:FUDS#AG"2:3/*EMG#+2%..Y#MNB/5GOQI/;=DMW:C
MLRG<%",HI]5JU/"VW?[U'P*!@=-1E0&/A[UK.OOS5B@GZ1:91ZX+ED3,JY<B
M`I0>12%&FA!CP?\`'EWD`EMVV74^UZKHVV;#V[N_<-.E*-VI[`.U*#LVU[CU
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M[NB,2-=H!C]SM%U@G6H>-G<D5U0T>E(&`Q@&G&2PR[ZZ=+NZ6J^LW=+6EZWC
M7[#O+L+2Z\9KO=,;N+>$A:(7=:NI.N-(6:\6&W2\&#+54.*V5K]F5AW(`')6
M0,)RZEKP'"##'T#X]_E""=GT,]U#FH8FQ/3U<@C.T?9VPOQ<DFW[_/KTN7;9
M6L)LY<34J7?:E&O51;KM>LKT!ZYZ4/,,.NA4+OQ.?(;*L5(6Z]BJWLE<96^N
M-0D++?>W?;6<OU?%T]=^M&Z=BW*C77-%9F`;_MS=^FYV10?YA2*]&3;(0+Z6
M1`VP0R:Z.=4.ZVI>P57C=[6R]9J]0K-LVGN.\U';LM+Z,[";MN4C8`*EFJ4Q
M4S49:*DGDWVVSNPQY.G!"%S,54'A"B<-$J6'1[>^/3OO+[=W_?M$]B!=2P6S
M+G=Y^K5^&[0]A*]#J8O%?L\#,3MGI\-K8VOQMZ=:E`U`'AN%NP7MV<B.J<C(
MIP4,?*K\6GRETBE7RFT'MO"ZW:DI[:$QJS[;[9]GC:[K6/O>U0=IHAY6J.ZI
MB<[$L4AE$]$&V@^0:DTHO!TFMHR0AX5;8;'.]'4SM1OJ<T79NO.QZ_J>4H.K
M]A:YOQ.-R[1H=SEX78VSNK5XF:]4]NT[7UCO$4.J/T&4T_,82-(&N/,-O,Y8
M?*Q@,0+S\:_R.2->S"!=VIS9(+KF[*\?7-A[_P!S5J`L5%V4=K.RTL:]-A4#
M847=9#7CDELNG."/18X,O4)F")<RU+PXSXP90:+ZB=ZM?]6.VVLKCV@#-W7N
M0.ZOZ(M@E[V7;XK11\Q`R\/7:_7K/8H:$-JE/B$_3T`I@J^(1">5TAOWQ*6W
M%!AO6?BY^0D=^>K4AVUM%"U=.[HE;C&5_37='L94Y:E:JN?:V'WEL"ELRHVG
M(N:O.R)ZDD6B/<NA\D)+&%VMYLC&4@@%LASH+XM_D.HM0E:WKOO)<JU&KVE(
M7JN5D?LAO)UV`A+G7-O1EWKGW]/TFU8E4QVQQ=:[%B<FULEM^>:MT-(I(@IQ
MQEX,E>N71+M/0M=?(%![NV93]B;&[8Z["JM:OXVV-M3!TK:!=67BA'66SD3U
M-CY+3L/)RL^*6%"U=R5`K8RG!X_&$#,8=#&*"^*GO3KZC,PFF>U4]J5II.QQ
MH[4T%VT[%F:@I>9;:VJ;U0YJCDL:[A)P)YNB/[3JLW&EADAOD7"+GV',2%>B
M&0@SEZ*]5NYN@)+:3.^NPYFRH2UT\")I1$ENK<&\Y.J6:/E[`^Q/,B;I@!T`
M^<&92M_#)CF"U--#O-K:%8<P&'6?CP^3U=9U_&/]T;$9.1)VH#+_`#1?<#LF
M-FP1E?L\I.;PIT&W6-8U;V,3MF4?'E8R5*P1/U8-O-7'+>AL>NL*?)Z*_+6[
ML%>K*]VCV=0C1^J4!FM=HGNUG83;.MJQNT>&I%,MY,CJJZ"14=L:Y6JU"V.P
M#@S0"XZ&B)$;(QF21F1V`O(/H!\E(QTU7CNSLA-:RE-SW"\1@Z>]O<2!V%5]
M1S>_^I%\J^CQKV/KZ4L\X/3]']?[;2ON$B19F#\[(D3UJ;*P2Z>%,TOXQ/EC
MA;G`;-LO<>JRVTS:S5*UM?8\1V&WE&SU\$I5N[5V2AAQ,7(:3EZK3:KKUG<M
M/PJO#`K@+>95229L1QR2)RZ&;W7/I1W)U3U`[F:DLV\X='9+L-[.Q4W?4;MS
M;-_FF=EXZ;=?>OECN\]<+E4(2[T<BS[/TW)6$)N'5(HJ4?-L"1.$-Q8C/`UU
M6GXB?DOLB[W3W=\Z>(T59K5>;'7M/6#LWVELT#6RK+VQJ_9:%GI8>6U4_"7B
M[1@`5@A#I60`]U++L[AI*UO@#Y<#;%TDTGV`K5<[%R6Z2=K`?<$L9K;36L+S
MO6ZGLP=)KD(2_-V:)MM:N]O^T!;EM>T3H=:EHJ/BIF-H,-75>R8,0\VH,",_
M%K\AZ976.9?NS<MI5>@2VG+_`"%;VIVGW^8-:;Q5P*:;L&%F#:OK^`L"8G&T
MP9NVUZ<CY"+-$'/9KJ0!(\4`J.#M8SXUOD<L:\26RNY6QHF:K]1UW&UM&J^^
MW;:%@;%::_!=<JK<)R[0Q>NQ@D)G\4_8]A9PRV4TN8M@@I3#P@C*PPSBZ9]8
MNY&IMD[0L?97L&K:%#N&N:!2*M3`ML;<NI%3/I5%HE5+L47)6F,J341+6J3B
MYN0DY!II^:.,-9)?.6[Y\)#5?3OB<^4O7&KZU2];=I=::^L,?J32^GKK.5;L
M=VMC1]E1^EH3JM5HZ[2;@5.#G*O?+#!Z4M#3A\:6@P"+LS<(R2J,94G(9Y:@
MZ-=LJY\=.Y.JFW[WK38^Z;[M/:FQHB\#[9W6Q7Y,C;G823W_`"+MFM$I5#K+
M"#U4VSD1;4-&Q+L5-#Q2'#,(Q,',C!CI$?'5\FHCLQ"6?LZ/L?6QFN[E`@4&
M[=QNP=@"=ONP*(+3K#9+U(W#K[=I78E'CLE$DQ%:)?%;B9`$(\,L=]Z308'S
MV?\`'-\GM[KX%7#[25-IFHV>`M&N[!9.R'8RVO0MQIMPZC6.H;2M53LNMIN&
MV)-P"^O]D-!KLL2_#1TO;%%LO9+P686&75[ZF=Z9;XZ2NNM&[(/07:=ZW8F`
M]MV+>VXY9V)K*MI/6]=41O>M4VG[EEF6*JO$>P23'9)PSX!OK(&1YUA-^G_5
MWLWIVD[U$V9:=30.T-E0%R^W-@ZPF;+>!Q[]>-^=M-[$72:@;KKRD(936Y'L
M5'B#B*>E,')B'%.N-(6AK@:TM`?#SW7UWNB<W'8>R_VE)V[:&MK%LAJB]JNT
MMPE-LZVCZ9]B[7IENL\Q7-?6$*QV?+(]AB)QD@@N.F`Q6',.C,*4^'0T3XD?
MD?HH=&:A.Q]1K,M5M#4;1,G:J;VN[)0]A+K-,KAL)"1=-?)TP<)K>)J\SB+G
MO3CVG&;3+1&5S@Y&9*06X%E;:^,_Y(KU7P(:"[+CH$`<AKC$P]V[I=J;>-5M
MPPNX]#[)AKN%-S&IY,^T1=-K6IS8:OQDD/Z$2>=B<:\)5\YY\-OO2S7/8_46
MG<ZW[+7&L[(M%;MUQ=K&QH>^;$OMAMM,LEFEK;#8O9VR88"8`L55;G?H;;3!
M<B&\#&,$,J#0]B.##+G@.`X#@.`X#@.`X#@8@77_`*^NM/\`V@=X?^,_Q[<#
M_]7V<_'M_P!`O1[_`+0.M/\`P8I7`R_X#@:0^I'Q_P#8KK+W.N/85-5ZW9HF
MRIKMI'VB+J>Q;(!9X.J[Y[/5_>=`EH.+C.MM&!GY:L5T`N/F@K%+SF,$>S1`
M&0HV)9,P'S[U_%:'V/W#M7;5%TUUJ7;MA:M1D#;-^N4[6]GP_8R/*U+3J-L(
M-P+0NRPP@:3JC768\!S)A?B4]Z?T_"7WG\!=?1G1_P`DNM=IV.;[E[TH.S-?
M?9)5;J,#2[O9+0L9UD'4@=6)FU6#4>N\2]BASZG;SBY9+01I>;:EHUZ7;&CT
M0@8@6GH+\E8M5V!1*)MK6H&I-A7K:N)[3#.^YYFO+U)=[E0[*)`1!I'3M'TR
MW6M#=G1;"L>`Y^))Y>4DO2A[B0Z<#IE\VE:I==K-&[2Z6K9U6L6M@!F6=P7(
M>D9U'4H^WPAM"AX$OJ;:"`99J#F:XE,NUB/R8Y3,(>$P]/2,DV&6/2_K;\F.
MM]VUJY]I>SE/V'I^.TX;69G6\7:KG:ILS:YIX$BNTCR,O2JK%N5<$AR20/[S
M)<NZV^SGUQ`VF(@,,9)CIO\`-;9=D[^EFNYM/H=`E".T5CZ\,US=MF+L(-JM
M]\BISKU7]IUFP]3;/4P];UJN0N8LO$"6@F+C7V_0$+-S)OR89]VKK]W!N76S
MK]JYO?\`.4C9D)ML:0WCLVG[%?@[HO2!?XD@EU^FV.4U5L%BTW2!K]B@V0VI
MT1>7RXSW)<V48U]0,#`JJ]-/FH85IHFV=](7U7K%&X[%1L1+XEXUV#9B]44"
MS2^G3S]5P!\3-64N<OFQQQ9%IZ*!G(6#AA0P("1(AHD,8]T=<?F:U+#4F;&N
MIVT-E;!.U'0]F[CT9>9N<V7#U/5VJ>R)=BC8^.=TI6)$2)O.^=J"66MM3,^]
M31Y1E(\L-`02F8D4+$K_`,;ORN:BEZ/^#>Z]0PM-I4+MVGP=2;[!;*8C:Q0]
MJ;QZD[3L%>@XB)ZT4P9"I*A:0N=684"7"&QQEN8E(^2C"67'4!L-Z0]7>XFJ
M^QNXMT=K+[1]HR5[U74=?C7F%N;LC.R#E1O5RL->CV:2#I+65>K=?A*E:F`G
MWQRDX/F!B3$1HWO'77`U%F_%U\T2B]SBQ>YNLTC%=DJ+9(;LB)=-WWK%:W-L
M>[=.Z)UXV'L*4IP'4*RU\:%EMH0AMBA8&0"F(\:OO?3,-Q2VVU.AL5Z8ZO[K
MZ0[.P.J9NI3D9U7H]8NL;9H6O66O":1J]^O,U>-E4^Q:/..HU2M>Q]7P=./A
MZS*Q#T=`&P]W.,('0?$BI=9#N^UG5_Y.]JVBX0ND-Z:TH&K9JV2\BP?8=X;5
M199BBFP6SB54-REPFA28FF$2-ANP,>S)M3\TQ%AQ0AST=+M"9@BPUI[1ZO?-
MOUHU=H2B:QVHU.4K,E4]:VFL=>=F6289U=4J9UV(JU28U75$=5=>BTV!;VL&
M0?&"$R0U:26Y#1,MZ5?:<P&&U[OETV[&=AC](.:<L,,7%5S5-@H.PA]O[CGJ
M.</.)W1U3V]1]C!QE.TUM^H678L$[HV8_P!\4($T%,%`$LY>996TD.Z^/G1W
MR2ZK<O#W>S?=#W(;)5.%@:WB@6V>E(=!L#$0$=%S"\3NIZ(_$SCV!Y+ZF6&(
M/[]]]LLELUY:,`!AU:NH7S:L:<DJS3.UNMC=GR59I<*BR6OL1LA^$!F(:C]=
MAI68:37^I]5M33)VU:_LB4??'E&"W(6;C!GVST#.@*"/F=`OF#`M%>W!4NUV
MJFMR2U![&U;8)=OV[9+.)74W&Y7>;ZTTW5ULQT[`,)UKIULVNRL^/-PKY5FE
M8M\9M0(A3[CX;%>H^B^X&L+'NZ<W5?X>T+VE7X<ZHR1&SK=>G=<S4%&9KM4I
M@%0L5.:&:@X*&;P^?(/6"8D)`S*5%D2ICILN4&J"^];OG)UW=-+6,OL-(;*U
M*7:.OM/WE5*EOVZS.PDB2>]*Q+[GL5)-HG3>IX`UWFG-S?N"20,6>,AC1V`Y
M!26&HX8.55OCN^9_7=<DY2E=CM!1^]=A1-+7M'9`&Y]D1=.L%LJ,SV<M$I9Y
MFBQG5V)Q+SUQL^XZL0L\9<>EO[6<;D19B)<5`F!WP'Q[?+/K2G7"*Z^[&ZZ:
M2)N=TW/L&R0FO>PEM&C9B2OM2U?3-?PKLB1T1BK(4'JN,A)\L!;4K$/O'IB6
M4$@@X+;X$;I'QS_,2'8ZY>+_`+MT)+;+C[9.2=KV=$]A-ER5H*J]TU'USUY:
M:]J4FS]27YC5\@4?HGU"I9F101(`&*'?:=<\Q2PVD]'=&_(-J/&VE=M>P-1W
M/)7>H@%5*3C+7+V"(IFT6MJ]A9:5)K]0/TYKQ5<H,MK&VT-C`.9:4R)(P9@[
M"$"X9??"G>M_6GY1*;V0K&R=W=CZW9=,`RE!$L.K1=TV*X-R5?&T/O"#VX<Y
M&2?62I#2$Q8^RUEJ5FKR1Y.&3&UL)^.=5A`@PCX4UOSHC\DD]V,W+N;KKM#2
M5+G'=O'[$T-M>^;6NQEK@JM>:IU5JU[U38-;KZYWV!`UZQ&Z%DDX!&G'FI=\
MX5QQL3+*G,ADG*Z_[O:]Z#@5&_7ZU7GLBWNK0K\E/ZBM]UF9C&NS-_:D?VY&
M#7>.UB=?V:ZWK[[H<(,^B2QX\4YX#CYRD>+8#&37_23YB8Z/H_XA]\4GRA%R
MR/L'%7VB1)B05#C@M9/UJ:HY4[UB@,RUV:-%O`DTQ,AEQ$PU-QQ"!A'(\1J/
M#[5GI+\L$;88ZUR_9O5Y]SN6D-,4C;>S8^V256NI>R]>[OV-:9"4%#CM"S#I
MVEZ_I7:-AB86HJG?(NSS2Y1M^*)3]00%Z]5NNWRFTSL16;UV/[!:JL>C(V-*
M`L.M*YM+:&Q9V9D3:M>V7+$!(6#3>JH./99N!D.\J+*&/4H;.,B'QZ8QP6P!
M2FSNDWRD*E;UG2G9(*I5R-V=N78>OX(KLUL4"(V27MWN1C;@4-M:*&ZZ2-HI
MFO:5UTM\[7U1=4M04H1-L,>SDP&/:&`AA],_%/\`+A?-K4KL/?\`=_7R1[+4
M[4%TIK>X!MV6X'$)L<[2V_:)JR\:RAT],9$>`;UO9-K13ICV1XU^99%F$J'0
MS+F,F!F1TDIWR:USO[LJO=K++M*>Z]Z^>VZ-JJ8B+V;;M>W.H6>*U&=I56P9
MN?UAJF&L!VK8+[@BO<PK!5GG;7*GDSC2(Z(B2'`KZY=+OE:J_<7<?:/6VQ]6
M$5F[734!5PB<[HNX-RV;HW0G9?N?L>J:J@X.!T"#$U>0(ZP]@J]31&BC)((>
MSQ19)*))1`TZ&&S_`./>/[2C:9F9#M;(6"2M$U=#"=>DW.3CL;`?U+&0D'7:
M3*;)ID-58*&UOLNU@PN9RR0HATP,+/2AB6'11L,1X@9W\!P'`<!P'`<!P'`<
M!P'`<!P'`Q`NO_7UUI_[0.\/_&?X]N!__];V<_'M_P!`O1[_`+0.M/\`P8I7
M`R_X#@:INNW6':>D-W,WN2T%J&VW\G8W;"-O_;!=^?B=CWS2O8_?L;NRE,8B
MQ()T^Q26OX*LPT%(Q5@;]*#Q``!UHW,449[8*I[-_'A9.P7?<O<EBU)K>TZ(
MLD?T-C+BJ6G8-N5LZ>KMU[I7>Y8ME4,JQV;%#R$AONC>R'<+RLERH94YZ/M8
M]2@X/:/J=WFLW;VU[LT5*Q+,3DK7UKUK=I#9->`G*"NG:0V?KJ7U+#U.U:SN
M+4?2=B7J[,SUB<$+%]W[$9/^WRMY#`6]1-6_)LQT&W?1-B[HK\QW?G`VF-2;
M)KRJK7(*MSS.NM81$A,L$+K%BA_H<CMN)M$^.V=%/_\`I<HR)[`%A#48&&(C
MNCOG9P#:XR+W[5!0W`YAVFF3ERUY*6`:8DM]19:&9N0"TF&VY!@=1`#ZZ#E&
M%$"[!.&F'4E-H>*9"![+Z1_+%;Y<NR*V%%VC8D!#T63U=MFP;@I8DQ2]C:V7
MW(9J]E#HPVC'M?L&2D7V!A`)<P<%A_$2*<&T@CU6GV0ROZ'::[?Z\[#V.M;(
ME;I1](T</<E^F]?1@,(SI^9VYO;L5N[:=5!UI8VJ]'9M=/`U3M414^$"T,W`
M6Z`8:;?<'?6RL*YN'3WY!\S>X(S7=WDJAJFV[*LEW%H5?VIKNNBVG-F["]D]
MX7:==-A],@6B(N5YK\CK.O-NOS+C+>1YE1N2$DND/AUU8ZL?,G?<3K&T>Y5@
MT[)XU7O60@)+4MCU-8*M^/DHW00=#1TK'VK1$I8IC3=<>C[+(S"A55Z4.5*A
MCMLB-!X2H%<TU\KVO]]U#;FVH^B=I]5ZF]/;%0IAFQ8*(V+`;9G^GQ6N;M5M
M;EHU64EFMYW%L&V1L2\84T<W`&^I(GGM9&'CPO'Y$.L7>38&ZJSO?HE:*CK[
M:L%UBV+I8"ZV"SP<$D:6LVZ=*;)2!.Q\WK;9`DO`R5$UW9(B/*<"-Q`62=CY
M',>:.R6E`8K1^B/_`)`3CA;Y?9#4$((Y<+^AL`'Z9890>G$4J6"U$8`9-@HC
M2"('8LP"=+1Y"&R!8ZO+63)V],RY#1@9*],.L'?'3FF>^DCL>=H(G;;L-&UJ
MWT;9PL[6I2KS78F(ZAZ]U)-[!DHR"UG#@UNDF;VI#\K%!%Q<J8Q6R!6BD./-
M."H"RNK&JOD8J6^L6;L#MLRVZ8?(W'%-4PZSZ_EL`5.2MADMH>2/8@]:0<T3
ML2M:^%BH.R/,RRHXJ88-/&0MLU?`P\GNFOR<4S9?8J[Z"M]7K%PMUD[.YUSM
M&=V;6)UVR5O;TSO&WZ5BKO"6?3MDG8JK]>[#=*^_#Q3!SP;4@[-.*%(84-AT
M,D^U'4#L3VJ^/RI==]OC0^T=C2>VPK%LZ&E;-7(*NSNNX39%PL]9KLXX;7;=
M`V)N$JOT(5(AC$EEV0#:?**-=:=)?#"RO]5/G?JD*57ZWV&UA6J=7J'8ZYJN
MCTFPT.J1E0.CI.2KU)A9D>8T!>Q9^GQNJE"*C,PKM/R%,,-QJPVL,?=KX9G]
M<=1=M=)]1>XA_85)E<[$[<G(Z_8O/6$<7;5Y.O`O5?K[H-_9$/5Q:56DV.Z*
MNNH7IQX)<<]@P5Y*7,N*RXG@8F7[0?SZ3%6,/UQV.I=<M5NI;%D1`3UBI;4/
MKB]7G75+FI#7[,HO5MKE9JOZ4W8B=CHPI&$/R57*9+/*F'16X)X,QXG17R:Q
M_7N[2(W9HC&^+=M.U6EK6EVQKR]5BFZQ=WNT=3]::VVW6]?:MFH]P#K<,F+/
M.EP9`Z2LCCI3)L5A:760PTWATU^7;;W6^]Z4M6Z1]AL[3I=]I6S8BSW/3@\9
M88^1ZZ[MH=89KCK6@E-5R/G>PUKJEPG6WVS,L0<8_%"86EAE!09Z]MZ/V\[0
M]8=16#4VLJKI[LA4]Q3M\B:W?[75K"-KY<32MXZXI5_C;#)T"5P[+.N6:&GQ
MQV`X6:$'+6*X0(0T^A0=;NO3_P`D=@ZDZ%I>L-X-UWM+4A[ZYM7:-?EJA6(J
MY&!:5W!&ZPS(0=UHFWXAL.>W852#YL)M)KD;&#R3+$B<I+;I80GK_H7Y+(OO
M76=X=B=F5F[Z(!USO77SE/BKH+$IJ,Y=;53K9$V^NU6$HP`UDJ,U'TV'AP(J
M5-7*PCP)QKIK^"FAUADEU;J'>F'W/VQSV=M%7G-(V^X3Y?6MRNVL4VVTVK*V
MEMYZ%!.#!HE<'8<)U/.51K"LNX5&$0_MUXDRE&3D@&JJ#ZF_.92],4@#779&
M.@-AZ\FM<5&%UE;=M4.Z:8G-:4[K5!527L-GMQO6AW<Q%IG^P=;?ETALS"(\
M&(DT#N,R>$/>F%6ZR^.GY7J'L>Y;HB+73ZCNG8TI=+)LK:4)?=,D6>V6>T=5
M.BNMI]J-+7UP;"A:??=_=7)Z9D1V`0\O0Q<$0X,B6#=6V&=WQPR7R27RI=O)
M/M3*[:IFX\"S%<TM%;!J5-B=(0E@)E=I)B+#2R<TN'N-G.A94:.^I.JCW*JJ
M$<B_IKDDXX:I@,,2M#?+WULK.Q+73BK`NHV2R66_66K:UM=*V7N.S;:V&+(U
M\"X-0]1TI58>P>XV7*5^9MC>1@L2$!%%.8DX-:9,F9#9+L;4_<C<_0[5U4DX
MEYGLQK_L%K:SW^K6C:@<1![B@-$]HDF3+Q-WA*>Z(%KW<-)JC5CBHTB*??!B
MC1`"\%%,.*>"J^K'7GY.M1[(T/5[5LJNC]6]71-0KS]":G:)+R;=;A]':VJ$
MW4WR8+6U02JLQVR1)PRN889=+%CPPF''!\/D+P$&V+KGY0MX=PMYP>J=Y[LT
M=UDK/9N&K>+`L>CU&3=T=/:,Z3RDI.Z!1LS0]RB[DY6-F,;I$6<8^>)@TT!#
M8[[#`SS(1$#K]\[R&8?$KVDK)AD58M8R)[@Q^L!H:PUV*^B0W8FNS<&QJ`6?
MDWMHQS:YJDDQ=@J3D!,),&<5%1[XK+05F_T3^5F:V?$;CO%MIUGW=$4Y,9G<
MP-STZ$^);*_1^ZM;U;/4FID=>FQ8!FC&[ZII!C)RSTEO1TZAG*!CE(.#*OIB
M3\BO_/GNBB=EI#?2NO.LRM@HT_83HO7QVNMD5(^JZ.&UTF_7EBBTWZO9JT05
M92D+K+;A<E,'E)E%#BQ`S#P00WJA\K5?%V2#K+?<]4T06]=^;(UI'-;<I$U4
M-NU3;W>>X[+@H'9K-QT?8[S2@:;U9V<>'B,KDM$D&V.$!;:F8YGP?0&+HO0;
MY?IS9-6[`WNU:\)[-16NX:KR.W(W8&LI%F#L=6BN]=5IEBUK"R>A`P(4B(J'
M8ZJLF**#4\0M%D$4X0";C!H9G](GODB5WEV=2NU<CO3.EM71]T#U_8FP*&;J
M#:D6;3-!@T<RV6W["ICQDY7BL60IC[<2^;)S4D=F56,-&##.!0%ZZR?,%4>Q
M>Q]^4"WUQR$LUPI1FWLP%THT99-OZ<T]V5W1<:Y2Z/"0>BI">A91?4J^#5:,
M6<[(RK=FPMI[);.0):*#..CZ5[2;3^.\.J[?EI3:&\;WL#5&P_HV\(FJU\@:
MC4+=&L9R"#LU7DJC+`5&T6?6FNT6>7@C1""82W39L<P^,D898P2K6.MOD4KW
M2FOUC9.R*S?^W,'M;5=FE+!%6!NC0ULUJ'M+7<[M^B.S#T%?F(HHW6OW5"1)
M66G\F.8`-7])=?6-'!K^K^A/_D(-1,?F3[-ZD$GW*I7QTK6Y6IL>)V3$6=PP
MN9L,@32VHRR4.>J@JPBU!5\!X9J3:'1"%R$:JSGAL-^-'178+KG4=RT;=5/A
M8\*[[JV#O*%N+.PJY9[/-RNSIU]V8A[57JE0JE7(R6"8AQY`@X5\A!9$FMI6
M%N#N%$ALUX#@.`X#@.`X#@.!B!=?^OKK3_V@=X?^,_Q[<#__U_9S\>W_`$"]
M'O\`M`ZT_P#!BE<#+_@.!I6T/UM[+ZI[/Q6R1-0R4%6%;Z[L3^S["%LVC#)V
M?JKL/O6MR6AHEZJQML-1/BZ5IJR)UQ4NT&=7VHUR+@VRLRQ2>!\?D#Z!S&^]
M@;/LFOM:WBPS^P.L'8406^![&J5=&@NQ\Q$]=*[UQ'AVYNZ1$W"U>I16E9_,
MFXR`ML1RWDO!K<(.,6$%H=,X3Y1Q=\70OM[?AY'1<:9N2'UM744;0"3K'2'-
MCI?T5==A7?6EFC[#&;S%UX/@>P145744QW)+CK#Z"&VT*#&+\*?EUKMHN<?5
M+1<G-.3F\K,231C0>C)93VF-B=HMG;,V5::P3+U$UT[;4IHV3CHN-"GBDUUJ
MQR1F"1G!%-&QX0W2NLOF[UEHS3=`S:"$SNO(OK72)FKY`ZJO5L75^MM=M5?<
M+-8VK.SMZN]MV7>FH]MV+)G($4&.M&&2'GBX=PD1(9I]RM:=ZCNP4)?>G\Q(
M4>-F:'KFF7Z\`0FF;V1F&K1?8R:5!":_V_>J;&D^G>;A4B9$QIX4M-?S(I`?
M<-2V,X&)&T]'?,O>85VI7C:$7?Z23'RHDA4JA2^N`_W;.TJ[7:NU&SS5UDYK
M3]FUI]SQ5;IVR(I<$S,$Q4T<?#EH;8#8R^&1?R#:#[I[`[%Z+W#U1/G(U_4V
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MT2Y(,GN1@RP6Q@X9FC_G"I-AWK"Z?[`2#M5DKA&3&J;/L?6?3.8G;GB2LQBM
MDVW9$A6E5,&FV>0!&C\0(L55CXI$)[A)@S4MAIQ89R]T*Q\H<I3>O$UTRO\`
M3:[>!XU,;V)I-A>U?B$,/1%5ZU.3]>M%QU+:WEO$'5B7J2$B,",LO6H*94*X
MQ%$!DA0VFZM\U+&\J0#M39,.5H>N;SV+(W&7EP^M+EFV%I'-CH,/KZ">70]>
MQ1$$0/6X:=E\J"C@Y(MV9P,04)D5C'`G6^JW\O)7;&QFZ2V7687J(;==?O04
M>)2]&62^05<CM/98M,8S%WDJK&2]9LVZ'L/S$@5/,SD9&M93$`DXSX+#BCZD
M^147XZM%:]9G[@1VZU)N#1LQ>9:2VOKAV>W94];[FK]CO*K#=QZTW6P:I<HL
M1]U(2$HE#:^,RQ(><DHZ*6$?WIJ?Y"=L?%-V-UCM#ZY;>TUBCZ@[60J/==>:
M_N,M#Q>=/6/9T(F8U_29.@RT.1;8RZ#0M>^GH?M=(5&PDN<))2!\BP&N.<^.
MWY:IS7.T:O6+M>->VF;CZ@SJJ8>[0W29'H%FB=/_`!JT+8=L9M=FW;M+9B1]
MBQ?6'<,%'H+D)J4KC6Q!R&S'E24N_'AGS4.LG?5%[T%F0>LT'0M7[IW?+18I
M&X8U+=*UE=OD&UWV(UV.>+!6J1?M(M7Z)CS>E,1:DG)CB%/CC*<ACER&0F7;
M:I_,'8=\V-/6?9_V'HMR<LB:TY5(GJ^>8/4V=&:>S1?>_C;2;;8_O`[L,O8:
M;"[E+D<Q6DUE4>PLA,NAX)]W_P!.=G]U4#2*M4T6_3E]CJK:\;!A8#=L#JZF
MMRUEI(D>W#7&,>NR(*V@M6M7^^M"@EK+A$'QP\F"B04_D-4ER^._Y&;+KZ!D
M8>)W,/LQG7-RU"%,R_<EX:]P5'J>L=VZ,HL7-V.F7#6<'"%6JWR4/M1PN`;E
M$%-3GVV;Y1H%@B4"VNRG1WY#MZ7N][)UP_LS6\WNZKIOBP9S>0453=:[.,UY
MW"USKJ%L%+JFUW<Q<YIBF;2U*^1)5G!`JKYKU,^VF53'!B286QU>Z0]V-+6S
M6VP=NG7C="J#<(V315X[>)5:D#8J@=6JM1?JLM$/[(S0[/<-_=BY"8M]K)+?
M;$-DHP<[`D6B3D(]8>@[@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#
M@.`X#@8@77_KZZT_]H'>'_C/\>W`_]#U&=#^^'1VN]'>F=?L'<SJE!3\%U2Z
M[PTW"3/8C4,9+PTO&:AIX4E%2L:;<&#8Z2CC6%LOL/(0ZRZA2%IPK&<<#*W^
M(3T%_7AZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(
M3T%_7AZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3
MT%_7AZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T
M%_7AZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%
M_7AZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_
M7AZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7
MAZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7A
MZ@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ
M@?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@
M?M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?
MM+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M
M+:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M+
M:8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M+:
M8_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M+:8
M_37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M+:8_
M37@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M+:8_3
M7@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX#^(3T%_7AZ@?M+:8_37
M@/XA/07]>'J!^TMIC]->`_B$]!?UX>H'[2VF/TUX&*5P[X='7^\77>P,]S.J
M3T!&=4NYD-)3;78C4+D1'2\[M[H>;"11TDBX9"$DID*NR#PC#BTND-`$+;2I
&++F4A__9
`
end

</TEXT>
</DOCUMENT>
</SUBMISSION>
